0001641172-25-001193.txt : 20250328 0001641172-25-001193.hdr.sgml : 20250328 20250328161207 ACCESSION NUMBER: 0001641172-25-001193 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 100 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250328 DATE AS OF CHANGE: 20250328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Investview, Inc. CENTRAL INDEX KEY: 0000862651 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services EIN: 870369205 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27019 FILM NUMBER: 25786363 BUSINESS ADDRESS: STREET 1: 521 W. LANCASTER AVE STREET 2: FLOOR 2 CITY: HAVERFORD STATE: PA ZIP: 19041 BUSINESS PHONE: 732-889-4300 MAIL ADDRESS: STREET 1: 521 W. LANCASTER AVE STREET 2: FLOOR 2 CITY: HAVERFORD STATE: PA ZIP: 19041 FORMER COMPANY: FORMER CONFORMED NAME: Global Investor Services, Inc. DATE OF NAME CHANGE: 20081001 FORMER COMPANY: FORMER CONFORMED NAME: TheRetirementSolution.com, Inc. DATE OF NAME CHANGE: 20060918 FORMER COMPANY: FORMER CONFORMED NAME: Voxpath Holdings, Inc. DATE OF NAME CHANGE: 20060619 10-K 1 form10-k.htm
false FY 0000862651 P5Y 0000862651 2024-01-01 2024-12-31 0000862651 2024-06-28 0000862651 2025-03-20 0000862651 2024-10-01 2024-12-31 0000862651 2024-12-31 0000862651 2023-12-31 0000862651 us-gaap:RelatedPartyMember 2024-12-31 0000862651 us-gaap:RelatedPartyMember 2023-12-31 0000862651 us-gaap:NonrelatedPartyMember 2024-12-31 0000862651 us-gaap:NonrelatedPartyMember 2023-12-31 0000862651 2023-01-01 2023-12-31 0000862651 INVU:MembershipRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MembershipRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:MiningMember 2024-01-01 2024-12-31 0000862651 INVU:MiningMember 2023-01-01 2023-12-31 0000862651 INVU:HealthAndWellnessRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:HealthAndWellnessRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:CryptocurrencyRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:CryptocurrencyRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:MiningEquipmentRepairRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MiningEquipmentRepairRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:OtherMember 2024-01-01 2024-12-31 0000862651 INVU:OtherMember 2023-01-01 2023-12-31 0000862651 us-gaap:NonrelatedPartyMember 2024-01-01 2024-12-31 0000862651 us-gaap:NonrelatedPartyMember 2023-01-01 2023-12-31 0000862651 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0000862651 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0000862651 us-gaap:PreferredStockMember 2022-12-31 0000862651 us-gaap:CommonStockMember 2022-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000862651 us-gaap:RetainedEarningsMember 2022-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2022-12-31 0000862651 2022-12-31 0000862651 us-gaap:PreferredStockMember 2023-12-31 0000862651 us-gaap:CommonStockMember 2023-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000862651 us-gaap:RetainedEarningsMember 2023-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2023-12-31 0000862651 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000862651 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000862651 us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-12-31 0000862651 us-gaap:PreferredStockMember 2024-12-31 0000862651 us-gaap:CommonStockMember 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-12-31 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 2017-04-01 0000862651 INVU:AcquisitionAgreementMember INVU:MarketTrendStrategiesLLCMember 2017-06-06 2017-06-06 0000862651 INVU:BitcoinMember 2023-01-01 2023-12-31 0000862651 INVU:MiningRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MiningRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:ForeignRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:DomesticRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:ForeignRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:DomesticRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2024-12-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2023-12-31 0000862651 us-gaap:ComputerEquipmentMember 2024-12-31 0000862651 us-gaap:ComputerEquipmentMember 2023-12-31 0000862651 INVU:DataProcessingEquipmentMember 2024-12-31 0000862651 INVU:DataProcessingEquipmentMember 2023-12-31 0000862651 INVU:ManufacturingEquipmentMember srt:MinimumMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember srt:MaximumMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 INVU:MinerRepairRevenueMember 2023-01-01 2023-12-31 0000862651 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0000862651 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0000862651 us-gaap:WarrantMember 2024-01-01 2024-12-31 0000862651 us-gaap:WarrantMember 2023-01-01 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember INVU:ChairmanMember INVU:DBRCapitalLLCMember 2020-04-27 2020-04-27 0000862651 INVU:ConvertiblePromissoryNoteMember INVU:ChairmanMember INVU:DBRCapitalLLCMember 2020-04-27 0000862651 INVU:ConvertiblePromissoryNoteMember INVU:ChairmanMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteMember INVU:ChairmanMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-05-27 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-11-09 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-01-01 2024-12-31 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember srt:MaximumMember 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2023-01-01 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-09-30 0000862651 INVU:DBRCapitalLLCMember INVU:SecuritiesPurchaseAgreementsMember 2020-04-27 2020-04-27 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-09-29 2023-09-29 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-09-29 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember 2024-12-31 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 2024-02-07 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2023-12-31 0000862651 INVU:APEXTexLLCMember 2024-12-31 0000862651 INVU:APEXTexLLCMember 2023-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-01 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2024-01-01 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2023-01-01 2023-12-31 0000862651 INVU:APEXTexLLCMember 2020-11-30 0000862651 INVU:APEXTexLLCMember 2021-03-31 0000862651 INVU:APEXTexLLCMember 2020-04-01 2021-03-31 0000862651 INVU:APEXTexLLCMember 2024-01-01 2024-12-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0000862651 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0000862651 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember us-gaap:WarrantMember 2024-12-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0000862651 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0000862651 INVU:WyckoffLeaseMember 2024-12-31 0000862651 INVU:WyckoffLeaseMember 2024-01-01 2024-12-31 0000862651 INVU:HaverfordLeaseMember 2024-12-31 0000862651 INVU:HaverfordLeaseMember 2024-01-01 2024-12-31 0000862651 INVU:WarminsterLeaseMember 2024-12-31 0000862651 INVU:IvylandLeaseMember 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember INVU:BoardOfDirectorsMember 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2024-12-31 0000862651 INVU:UnitOfferingMember 2020-04-01 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-08-17 2021-08-17 0000862651 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-12-31 0000862651 INVU:CryptocurrencyMember 2024-01-01 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-12-31 0000862651 INVU:CryptocurrencyMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-01-01 2023-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-01-01 2023-12-31 0000862651 us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0000862651 srt:OfficerMember 2024-01-01 2024-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:DavidBRothrockAndJamesRBellMember INVU:ClassBUnitsMember 2024-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:DavidBRothrockAndJamesRBellMember INVU:ClassBUnitsMember 2023-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:DavidBRothrockAndJamesRBellMember INVU:ClassBUnitsMember 2024-01-01 2024-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-02 2021-09-03 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-03 0000862651 us-gaap:SubsequentEventMember 2025-01-17 2025-01-17 0000862651 INVU:PromissoryNoteMember 2024-12-01 2024-12-31 0000862651 2023-08-01 2023-08-31 0000862651 INVU:IGeniusLLCMember 2024-12-31 0000862651 INVU:JosephCammarataMember 2021-03-30 0000862651 INVU:JosephCammarataMember 2021-09-21 0000862651 INVU:JosephCammarataMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:FinancialEducationAndTechnologyMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:FinancialEducationAndTechnologyMember 2023-01-01 2023-12-31 0000862651 us-gaap:ReportableSubsegmentsMember INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember 2023-01-01 2023-12-31 0000862651 us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-12-31 0000862651 INVU:GoldmansPharmaceuticalsLLCMember 2024-10-11 0000862651 INVU:ElrtTechnologiesLLCMember 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-01-01 2024-12-31 0000862651 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember srt:MinimumMember 2025-02-28 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember srt:MaximumMember 2025-02-28 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember INVU:DBRCapitalMember 2025-02-28 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember INVU:DBRCapitalMember 2025-02-28 2025-02-28 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember 2025-02-28 2025-02-28 0000862651 INVU:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember 2025-02-28 0000862651 us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementMember 2025-02-28 0000862651 us-gaap:SubsequentEventMember srt:MaximumMember INVU:ShareRepurchaseProgramMember 2025-03-06 2025-03-06 0000862651 us-gaap:SubsequentEventMember INVU:ShareRepurchaseProgramMember 2025-03-06 0000862651 us-gaap:SubsequentEventMember us-gaap:CommonStockMember INVU:ShareRepurchaseProgramMember 2025-03-06 2025-03-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft INVU:Segments

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-K

 

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             .

 

Commission File Number 000-27019

 

INVESTVIEW, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   87-0369205

(State or other jurisdiction

of incorporation or organization)

  (I.R.S. Employer Identification No.)

 

521 West Lancaster Avenue

Second Floor

Haverford, Pennsylvania 19041

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: 732-889-4300

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $0.001 Par Value Per Share
(Title of Class)

 

Indicate by check mark whether the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer   Smaller Reporting Company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act) Yes ☐ No

 

As of June 30, 2024, the aggregate market value of the issued and outstanding common stock held by non-affiliates of the registrant, based upon the closing price per share of $0.0144 of the common stock on the last business day of the registrant’s most recently completed second fiscal quarter as reported on the OTCQB, was approximately $26,798,138.

 

As of March 20, 2025, there were 1,859,231,786 shares of common stock par value $0.001 per share, outstanding.

 

Documents incorporated by reference: NONE

 

 

 

 

 

 

INVESTVIEW, INC.

 

2024 FORM 10-K ANNUAL REPORT

 

Table of Contents

 

PART I 4
Item 1. Business 4
Item 1A. Risk Factors 8
Item 1B. Unresolved Staff Comments 24
Item 1C. Cybersecurity 24
Item 2. Properties 25
Item 3. Legal Proceedings 25
Item 4. Mine Safety Disclosure 26
PART II 26
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 26
Item 6. [Reserved] 26
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 26
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 33
Item 8. Financial Statements and Supplementary Data 33
Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure 34
Item 9A. Controls and Procedures 34
Item 9B. Other Information 34
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 34
PART III 35
Item 10. Directors, Executive Officers and Corporate Governance 35
Item 11. Executive Compensation 37
Item 12. Security Ownership of Certain Beneficial Owners, Management and Related Stockholder Matters 40
Item 13. Certain Relationships and Related Transactions, and Director Independence 41
Item 14. Principal Accountant Fees and Services 42
Item 15. Exhibits and Financial Statement Schedules 43
Item 16. Form 10-K Summary 50
SIGNATURES 51

 

2

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

We and our representatives may from time to time make written or oral statements that are “forward-looking”, including statements contained in Item 1. “Business” and Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within this Form 10-K, in our other filings with the SEC, or in reports to our stockholders. In some cases, we have identified forward-looking statements by such words or phrases as “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These forward-looking statements may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. The below section entitled “Summary Risk Factors” highlights some of the risks we are exposed to in the normal course of our business activities. This summary is not complete, and the risks summarized below are not the only risks we face. You should review and consider carefully the risks and uncertainties described in more detail in Part I, Item 1A, “Risk Factors,” of this Form 10-K, which includes a more complete discussion of the risks summarized below as well as a discussion of other risks related to our business and an investment in our common stock. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this Form 10-K to conform our prior statements to actual results or revised expectations.

 

Summary Risk Factors:

 

  difficulty expanding into a new Brokerage and Financial Markets business due to delays and the start-up nature of our platform;
  the potential unfavorable publicity that may continue to impact our commercial relationships arising from the SEC inquiry we have reported on since November 2021, even though we have now settled that matter;
  the impact of macroeconomic conditions due to global pandemics, epidemics or outbreaks of disease;
  the impact on our Bitcoin business unit of our need for significant electrical power, particularly as we currently rely on a sole electrical source provider and in light of recent significant power supply curtailment that has caused the revenue of that unit to decrease materially;
  the impact of possible disruptions in our operations and potential liabilities resulting from potential cyber events;
  the contraction in the revenues and net income of our iGenius business unit attributable to, among others, macroeconomic influences following the winding down of Covid-19 as a global pandemic;
  the dilutive impact that may arise upon the conversion into common stock of existing convertible notes purchased by an affiliate of our Chairman, DBR Capital;
  the substantial interest expense we incur in servicing the existing loans from DBR Capital;
  the dilutive impact that may arise should DBR Capital provide additional convertible loans to the Company during 2025 and 2026, and seek to convert those loans into additional shares of our common stock;
  the impact of Special Governance Rights granting significant control to an affiliate of our Chairman, DBR Capital;
  potential adverse affects due to our acceptance, disbursement and holding of cryptocurrency, including additional tax and regulatory requirements;
  inability to protect our proprietary rights and prevent infringement on proprietary rights of others;
  the impact of adverse economic developments in the securities markets or the domestic or international economy in general;
  the impact of defending allegations that our direct selling activities are fraudulent or deceptive schemes, or against public interest;
  potential adverse effects if we are required to defend allegations that our direct selling activities involve the sale of unregistered securities; particularly as those allegations have been made by securities regulators in Ontario, Canada and Quebec, Canada;
  expensive and time-consuming legal proceedings, including regulatory proceedings and investigations;
  our ability to collect approximately $1.87 million of credit card receivables owed to us by our credit card processor and its clearing bank for which during 2024 we were caused to institute collection proceedings;
  the adverse impact of any customer claims that may arise if Total Protection Plus, a third-party vendor, fails to honor its obligation to underwrite, manage and administer a “guaranteed assets buy-back product” on behalf of our Apex program customers and customers of ours that purchased ndau;
  external factors affecting the Bitcoin industry;
  inability to compete and grow in highly competitive markets in a cost-effective manner;
  the impact of climate change, including compliance with regulatory and legislative developments related thereto;
  failure to comply with government regulations to the extent they impact our health, beauty and wellness products;
  disruption in our supply chain and changes to tax or trade policy;
  the impacts of raising, or failing to raise, additional capital needed to execute on our growth plan;
  volatility of the market price of our common stock;
  the impact on the trading price of our common stock if sales of substantial amounts of our common stock in the public markets occur due to current lock-up agreements expiring in April 2025; and
  the impact of interested party transactions with certain of our officers and directors on our business, operating results and ability to obtain additional funding.

 

3

 

 

PART I

 

Item 1. Business

 

General

 

Investview, Inc., a Nevada corporation (which we refer to as “we,” “us,” “our,” “Investview,” or the “Company”), operates a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion; an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

Services and Products

 

Financial Education and Technology

 

Through our wholly-owned subsidiary, iGenius, LLC (“iGenius”), we deliver multiple tools, products and content, both domestically and internationally, through a direct selling network of independent distributors. Our tools, products and content are offered through a membership-based revenue model to a large base of customers that we refer to as “members”. These tools, products and content are designed to assist the self-directed investor in successfully navigating the financial markets, and include access to our library of financial education content, as well as access to live and recorded education sessions, and trade alerts provided by third-party independent market professionals. who are experienced professionals. We also offer access to education and software applications that are designed to assist our members in debt reduction, increased savings, budgeting, and proper tax management. In addition to the financial education technology and tools, iGenius members also gain access to a variety of member benefits provided through third party partnerships and affinity arrangements.

 

We have multiple tiers of membership at varying upfront and monthly costs, which provide members with the ability to meet their product needs and price point. We offer first-time members a guarantee of satisfaction, whereby, during the designated trial period (10 days from initial purchase for domestic customers and 14 days from initial purchase for international customers) if the member for any reason is not satisfied with our tools, products or content, the member may request a full refund.

 

We believe that the use of a direct selling distribution network is an effective way to market our tools, products and content for purchase because demand for financial education and other services is strengthened by the ongoing personal contact between members and distributors. In addition, most of our distributors are members and use our tools, products and content themselves, and therefore can provide first-hand testimonials, which can serve as a powerful sales tool.

 

Although the principal focus of our direct selling network is currently on the distribution of our financial education and technology products, we believe the network has the capability to market and sell products and services across the globe. One of our business objectives is to locate and develop new business opportunities that can generate additional content that can be offered through our network, including, particularly, products and services that may be offered by other of our business units. Toward that end, we intend to use our direct selling network to expand the scope and geographic reach of products of our health, beauty and wellness business unit.

 

Blockchain Technology and Crypto Mining Products and Services

 

Through our wholly owned subsidiary, SAFETek, LLC, we operate a vertically integrated, sustainability-focused blockchain infrastructure business specializing in Bitcoin mining and transaction validation. SAFETek owns 4,847 and actively operates 1,916 advanced ASIC miners at a hosted data center in Northern Europe, powered entirely by renewable energy sources—primarily hydropower and geothermal.

 

As of December 31, 2024, SAFETek maintained a deployed hash rate of 0.186 exahash per second (EH/s) and produced 85.92 Bitcoin—a 78% decrease from the 394.26 Bitcoin mined in 2023. This reduction was primarily driven by the April 2024 Bitcoin halving, which cut block rewards by 50%, a more than 29% increase in network difficulty, and government-mandated energy curtailments resulting from low hydroelectric reservoir levels in our host country.

 

Despite the decline in production, these power curtailments reduced overall energy costs and helped mitigate operating losses under our existing power purchase agreements, transforming a potential setback into a cost-management exercise to minimize costs while we on-board additional hashing capacity with the expectation to return to profitability.

 

In preparation for the halving, SAFETek implemented several key operational improvements:

 

  Retired older, less efficient mining units
  Deployed next-generation, high-efficiency ASIC miners
  Consolidated energy usage into more productive and energy-efficient capacity

 

These initiatives significantly reduced our hash cost and enhanced our competitive positioning in a post-halving market. We intend to maintain this disciplined strategy until market conditions support further expansion. Notably, the company has incurred no debt related to equipment purchases, providing enhanced financial flexibility and operational resilience.

 

SAFETek operates a 24/7 Network Operations Center (NOC) to monitor system performance, optimize firmware, and ensure uptime and efficiency across the mining fleet. Our internal engineering and R&D teams remain focused on improving energy efficiency, increasing hash output per kilowatt-hour, and developing proprietary solutions to maximize return on investment (ROI).

 

Bitcoin mined is strategically allocated to support infrastructure reinvestment, cover operational expenses, and build a long-term digital asset reserve. In select cases, it is also utilized to support performance-based compensation programs within our iGenius distribution business and to pay dividends on our 13% Series B Preferred Stock.

 

Looking ahead, we are evaluating strategic hosting infrastructure acquisition opportunities that align with our cost-optimization goals and present strong return potential.

 

4

 

 

Brokerage and Financial Technologies Services

 

In March 2024, the Company advanced its fintech strategy with the acquisition of Opencash Securities LLC (“Opencash”), an early-stage registered broker-dealer. This strategic acquisition is intended to position the Company to capitalize on the rapidly expanding online retail brokerage market.

 

Opencash is being developed as a modern intuitive electronic trading platform experience accessible via both mobile app and web-based desktop interface. Designed to offer low-cost, commission-free trading of stocks, ETFs, and options, the platform is expected to support our broader mission to democratize access to financial markets. It is currently in the advanced stages of application development, clearing integration, infrastructure build-out, and system testing, in preparation for future commercialization.

 

This initiative builds on our strategy to bring to market the proprietary “Prodigio” trading system, acquired from MPower Trading Systems, LLC in 2021. Our long-term roadmap includes the full integration of Opencash’s user-friendly interface with the advanced algorithmic capabilities of the MPower engine. This is expected to result in two distinct yet complementary platforms: Opencash for everyday retail investors, and OpencashPro for more advanced users, together delivering a seamless, all-in-one brokerage solution tailored to the needs of today’s self-directed investors.

 

While Opencash still remains in the pre-commercialization phase, given the trajectory of our development efforts, we believe this business may have the long-term potential to disrupt traditional brokerage models by combining cutting-edge technology with a customer-centric, low-cost, commission free approach. As we also make continued investment in product development, regulatory readiness, and user experience, we further believe that this business can yield a competitive, scalable fintech offering that delivers transparency, value, and accessibility to clients worldwide.

 

Manufacture and Development of Health, Beauty and Wellness Products

 

In October 2024, we entered the over-the-counter health, beauty, and wellness market when our subsidiary, myLife Wellness Company (“myLife Wellness”), acquired the business of Renu Laboratories, Inc. (“Renu Labs”), a contract developer and manufacturer, producing both proprietary and non-proprietary health, beauty, and wellness products for third-party clients. It is our expectation that myLife Wellness will serve as our marketing and e-commerce platform for the products developed and manufactured by Renu Labs, with a focus on aesthetics, health, nutrition, and cognitive wellness. These products are expected to be distributed through both retail and wholesale channels. In addition to operating as a standalone platform, myLife Wellness will also collaborate with our affiliated business platform, iGenius, to promote and offer myLife products to its global membership base and its customers. Over the next 12 months, we plan to expand the myLife Wellness product line, enhancing our position in the health and wellness industry and supporting our broader strategy for global growth.

 

Sales and Marketing

 

Our iGenius unit markets its tools, content and products through a network of independent “distributors” located both within the United States and internationally, to customers through a direct sales model. Approximately 90% of our independent distributors are members who elect to participate in our distribution program. Approximately 9% of our members are currently also distributors. We have adopted various policies and procedures to which our members and independent distributors are expected to adhere, and for which we provide regular compliance training programs and conduct active compliance monitoring. We seek to motivate our independent distributors by offering high quality tools, products and content and providing product support and financial incentives. iGenius members are eligible to receive bonuses on sales of new memberships and on upgrades in membership sold to their personally enrolled members. Bonuses for enrollments and upgraded enrollments vary depending on the level of membership that a member is enrolled in. In addition, our distributors are eligible for additional bonuses each time their personally enrolled members renew their memberships. We believe that the opportunity for our independent distributors to earn bonuses and commissions contributes significantly to our ability to retain our most active and productive distributors.

 

In the United States, we generally sell our products through ACH, wires or credit card transaction. We also periodically accept Bitcoin as a form of payment and use it to satisfy liabilities and certain operating expenses.

 

We currently market our over-the-counter health, beauty and wellness products through our subsidiary Renu Laboratories, LLC. We also intend to pursue product sales through the iGenius direct selling network of independent distributors.

 

Materials and Suppliers

 

Digital asset mining is dependent on specialized digital asset mining hardware utilizing ASIC chips to discover blocks on blockchains using the 256-bit secure hashing algorithm. Almost all of these miners are produced outside of the United States, mostly in China and Southeast Asia, by a few manufacturers. As the market value of digital assets has increased, the demand for the newest, most efficient miners has also increased, thereby resulting in an increase in the price of miners. Our mining business is highly dependent upon digital asset mining equipment suppliers providing an adequate supply of new generation digital asset mining machines at economical prices to enable profitable mining by us. We are also dependent on the host of our power supply in Northern Europe who provides our power generation through hydroelectric sources. We believe that our relationship with our power supplier is good and that we generally have sufficient supply to conduct our business operations as presently contemplated. However, since the beginning of 2024, our power supply has been curtailed up to approximately 60% as a direct result of low water levels that have cutback local hydroelectric power capacity. We are currently in discussions with several power suppliers for additional power, as we see no short-term relief in the current curtailment.

 

For our health, beauty and wellness operations, we source raw materials for products as well as other items purchased by us principally from the United States, China and Canada. Raw materials and other items used by us are available from a variety of suppliers and no one supplier accounted for more than 12.4% of our total raw material purchases in 2024. We seek to mitigate the risk of a shortage of raw materials and other items through our relationships with our principal suppliers, including identification of alternative suppliers for the same, or similar, raw materials and other items where available.

 

5

 

 

Competition

 

Our financial education and technology services are sold in competition with other companies. We rely on our independent distributors to compete effectively in the direct selling markets, and our ability to attract and retain new members depends on various factors, including the training, support, product offerings, and financial incentives for the independent distributors.

 

With respect to our crypto mining business, we operate in a highly competitive environment. The primary drivers of competition include the demand for Bitcoin, the Bitcoin Network Difficulty level, sufficient capital resources to acquire large quantities of high-quality miners, the ability to secure these miners from a limited number of suppliers on rapid delivery schedules, and the ability to generate the highest productivity. Recently, there has been a significant increase in the number of Bitcoin miners attempting to expand their mining operations at scale. As more Bitcoin miners enter the space, we expect additional pressure on the industry, with greater competition for access to miners and mining infrastructure, which is in limited supply.

 

Although it is currently in the pre-commercialization stage, we anticipate that our brokerage and financial technologies business will encounter significant competition from full-commission, online and discount brokerage firms, as well as from financial institutions, mutual fund sponsors and other organizations, many of which are significantly larger and better capitalized than us. We believe that additional competitors such as banks, insurance companies, providers of online financial and information services and others will continue to be attracted to the online brokerage industry as they expand their product lines. Many of these competitors are larger, more diversified, have greater capital resources, and offer a wider range of services and financial products than us. Some such firms are offering their services over the Internet and have devoted more resources to and have more elaborate websites than us. We anticipate that we will compete with a wide variety of vendors of financial services for the same customers.

 

The over-the-counter health, beauty and wellness industry is highly competitive. Our competitors include a number of large, nationally known brands, and many smaller brands, manufacturers and distributors. The sales of products through online marketplace platforms such as Amazon and firms’ websites continue to expand. Private label products also provide competition to our products. Private label products are often sold at a discount to branded products. Pharmaceutical companies also offer prescription and over-the-counter products that are or may be competitive with our products, particularly with regard to certain categories of wellness products. Finally, as the health, beauty and wellness market generally has low barriers to entry, additional competitors enter the market regularly.

 

Government Regulation

 

General

 

We are subject to government regulations in connection with securities laws and regulations applicable to all publicly owned companies as well as laws and regulations applicable to businesses generally. We are also increasingly subject to government regulation and legislation specifically targeting Internet companies, such as privacy regulations and taxes adopted at the local, state, national and international levels. Due to the increasing use of the internet, enforcement of existing laws, (such as consumer protection regulations in connection with web-based activities), has become more aggressive, and it is expected that new laws and regulations will continue to be enacted at the local, state, national, and international levels. Such existing and new legislation, alone or combined with increasingly aggressive enforcement of existing laws, could have a material adverse effect on our future operating performance and business.

 

Distribution Network Model

 

Our direct selling activities are regulated by the Federal Trade Commission (“FTC”), as well as various federal, state and local governmental agencies in the United States and foreign countries. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, which compensate participants primarily for recruiting additional participants without sufficient emphasis on providing tangible products and/or services. The laws and regulations governing direct selling are modified from time to time, and, like other direct selling companies, we may be subject from time to time to government investigations related to our direct selling activities. This may require us to make changes to our business model and our sales compensation plan.

 

Cryptocurrency Mining

 

Cryptocurrency mining is largely an unregulated activity at both the state and federal level, but government regulation is being actively considered by the United States federal government via a number of agencies and regulatory bodies. Regulations may substantially change in the future, and it is presently not possible to know how regulations will apply to or impact our businesses, or when they will be effective. United States and foreign country regulation of cryptocurrency mining is also important and determinative with respect to where we conduct our mining operations.

 

As the regulatory and legal environment evolves, we may become subject to new laws, such as further regulation by the SEC and other agencies, which may affect our mining and other activities. For additional discussion regarding our belief about the potential risks existing and future regulation pose to our business, see Part I, Item 1A. “Risk Factors” beginning on page 9 of this Annual Report.

 

6

 

 

Brokerage and Financial Technologies Services

 

Although it is currently in the pre-commercialization stage, our brokerage and financial technologies services will be subject to extensive regulation under both federal and state laws. The Securities and Exchange Commission (“SEC”) is the Federal agency charged with administration of the federal securities laws. As a broker-dealer with the SEC, Opencash must be registered with both the SEC and maintain its membership of the Financial Industry Regulatory Authority (FINRA), a self-regulatory organization (SRO) overseen by the SEC. The principal purpose of regulation and discipline of broker-dealers is the protection of customers and the securities markets, rather than protection of creditors and stockholders of broker-dealers. The regulations to which broker-dealers are subject cover all aspects of the securities business, including training of personnel, sales methods, trading practices among broker-dealers, uses and safekeeping of customers’ funds and securities, capital structure of securities firms, record keeping, fee arrangements, disclosure to clients, and the conduct of directors, officers and employees. Additional legislation, changes in rules promulgated by the SEC and by self-regulatory organizations or changes in the interpretation or enforcement of existing laws and rules may directly affect the method of operation and profitability of broker-dealers and investment advisers. The SEC, self-regulatory organizations and state securities authorities may conduct administrative proceedings which can result in censure, fine, cease and desist orders or suspension or expulsion of a broker-dealer or an investment adviser, its officers or employees.

 

Manufacture and Development of Over-the-counter Health, Beauty and Wellness Products

 

The formulation, manufacturing, packaging, labeling, advertising, distribution and sale (hereafter, “sale” or “sold” may be used to signify all of these activities) of our products are subject to regulation by one or more federal agencies, principally the Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”), and to a lesser extent the Consumer Product Safety Commission (“CPSC”), the United States Department of Agriculture and the Environmental Protection Agency. Our activities are also regulated by various governmental agencies for the states and localities in which our products are sold, as well as by governmental agencies in certain countries outside the United States in which our products are sold. Under current U.S. regulations, our products must comply with certain labeling requirements enforced by the FDA and FTC, but otherwise generally are not required to receive regulatory approval prior to introduction into the U.S. market. Among other matters, regulation by the FDA and FTC is concerned with product safety and claims made with respect to a product’s ability to provide health-related benefits. Specifically, the FDA, under the Federal Food, Drug, and Cosmetic Act (“FDCA”), regulates the formulation, manufacturing, packaging, labeling, distribution and sale of food, including dietary supplements, and over-the-counter (“OTC”) drugs. The FTC regulates the advertising of these products. The National Advertising Division (“NAD”) of the Council of Better Business Bureaus oversees an industry-sponsored self-regulatory system that permits competitors to resolve disputes over advertising claims. The NAD has no enforcement authority of its own, but may refer matters that the NAD views as violating the FTC Act, FDA regulations or FTC guides or rules to the FDA or FTC for further action, as appropriate. As a result of our efforts to comply with applicable statutes and regulations, we may from time to time reformulate, eliminate or relabel certain of our products and/or revise certain provisions of our marketing and sales program. We believe we are in compliance with all material government regulations applicable to us.

 

Human Capital Resources

 

As of March 20, 2025, we had 42 employees, of which 33 were full-time and 9 were part-time. Of our 42 employees, 9 are employed full-time in Investview corporate, 11 are employed through iGenius (10 full-time and 1 part-time), 1 is employed full-time through SAFETek, 3 are employed through IFGH (2 full-time and 1 part-time), 2 are employed full-time through Opencash and 16 are employed through Renu Laboratories LLC (9 full-time and 7 part-time). None of these employees are covered by a collective bargaining agreement. We have experienced no work stoppages and consider our relations with our employees to be good. We contract with a professional employer organization, or PEO, that administers our human resources, payroll and employee benefits functions for our employees in the United States. Although we recruit and select our workers, each of these workers is also an employee of record of the PEO. As a result, these workers are compensated through the PEO, are governed by the work policies created jointly by us and the PEO and receive their annual wage statements and other payroll or labor related reports from the PEO.

 

In addition to our employees, our human capital resources also include our independent distributors for our iGenius products and services, who are located worldwide. For information about our independent distributors, see Item 1. Business “Sales and Marketing.”

 

Intellectual Property

 

We rely on a combination of trade-secret protection and confidentiality and/or license agreements with our employees, customers, partners, and others to protect our proprietary rights. Relative to our distributors, we rely on a more customary form of confidentiality protection. It is our general practice to enter into confidentiality and invention assignment agreements with all of our employees and independent contractors. Such agreements include a confidentiality undertaking by the employee or independent contractor; ensure that all new intellectual property developed in the course of our relationship with employees or independent contractors is assigned to us; and require the employee or independent contractor to cooperate with us to protect our intellectual property during and after their relationship with us. With respect to our financial education and technology business, the intellectual property that makes our business competitive consists of, among others, valuable trade secrets, know-how, concepts, methods, techniques and materials used in our business, consisting principally of educational materials, domain names, relationships with strategic vendors and customer lists.

 

7

 

 

With respect to our cryptocurrency mining business, we actively use specific hardware and software. In certain cases, source code and other software assets may be subject to an open-source license, as much technological development underway in this sector is open source. For these works, we adhere to the terms of any license agreements that may be in place. We do not currently own, and do not have any current plans to seek, any patents in connection with our existing and planned blockchain and cryptocurrency related operations.

 

With respect to our planned Brokerage and Financial Markets business, in September 2021 we acquired the source code and object code of the proprietary algorithmic trading platform of MPower. This also included all know-how and other intellectual property necessary, useful and/or used in the software. We also acquired a proprietary trading platform in connection with our acquisition of Opencash in March 2024. The proprietary elements of each of our trading platforms are protected as trade secrets.

 

With respect to our health, beauty and wellness business, we own two trademarks that have been registered with the United States Patent and Trademark Office and have filed applications to register additional trademarks. In addition, we claim domestic trademark and service mark rights in numerous additional marks that we use. We regard our trademarks and other proprietary rights as valuable assets and believe they make a significant positive contribution to the marketing of our products. We protect our legal rights concerning our trademarks by appropriate legal action. We rely on common law trademark rights to protect our unregistered trademarks. Common law trademark rights do not provide us with the same level of protection as afforded by a United States federal registration of a trademark. In addition, common law trademark rights are limited to the geographic area in which the trademark is actually used. We may not register all or even some of our trademarks in every country in which we conduct business or intend to conduct business.

 

Corporate History

 

Investview was incorporated in the State of Utah on January 30, 1946, under its prior name Uintah Mountain Copper Mining Company. After the commencement and abandonment of several business plans, and after several name changes and change of domicile to Nevada, on March 27, 2012, we adopted our new business model and changed our name to Investview, Inc.

 

Internet Address

 

Additional information concerning our business can be found on our website at www.investview.com for the most up-to-date corporate financial information, presentation announcements, transcripts, and archives. Information regarding our products and services offered by our wholly owned subsidiary, iGenius LLC, may be found at www.igeniusglobal.com. Information regarding SAFETek LLC is available at www.safeteksolutions.com. Information regarding Opencash Securities, LLC is available at www.opencash.com. Information regarding Renu Laboratories LLC is available at www.renulabs.com. Website links provided may change in the future. We make available free of charge on our website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, as soon as reasonably practicable after we electronically file such material with or furnish it to the Securities and Exchange Commission.

 

Item 1A. Risk Factors

 

Our business, financial condition, and results of operations, may be adversely affected by a number of factors, including the risk, factors, and uncertainties described under this Item 1A, and elsewhere in this Form 10-K. This is not an exhaustive list, and there are other factors that may be applicable to our business that are not currently known to us or that we currently do not believe are material. Any of these risks could have an adverse effect on our business, financial condition, operating results, or prospects, which could cause the trading price of our common stock to decline, and you could lose part or all of your investment. You should carefully consider the risks, factors, and uncertainties described below, together with the other information contained in this Form 10-K, as well as the risk, factors, uncertainties, and other information we disclose in other filings we make with the SEC before making an investment decision regarding our securities.

 

Risks Related to our Business Generally

 

Our growth plan contemplates our ability to create a Brokerage and Financial Markets business; however, this has been delayed for several years, and may be difficult to achieve as our platform for expansion is a start-up business in the early stages of its development.

 

Since 2021, we pursued the development of a brokerage and financial markets business. Our growth plan, however, contemplated the acquisition of a registered broker-dealer, which was originally to have been acquired from an affiliate of Joseph Cammarata, a former executive officer who was terminated in late 2021. However, due to delays and complications in that process, relating primarily to Mr. Cammarata’s then ongoing legal proceedings, even though unrelated to the business of the Company, we were caused in 2022 to abandon those efforts and continue our search for alternative acquisitions within the brokerage industry. With our 2024 acquisition of Opencash, a broker-dealer in the pre-revenue and early stages of its operations, we believe we will now be able to launch our expansion into the retail brokerage and financial markets industry. However, to do so, we will need to, among others, develop the infrastructure necessary to achieve retail operations, on-board customer support personnel and software developers, develop and implement a marketing strategy, secure the necessary securities clearing arrangements, continue the development of the online Opencash trading platform and complete our integration with the proprietary algorithmic trading platform we acquired in September 2021. Despite our best efforts, there can be no assurance that we will be able to achieve these objectives on a timely basis, if at all, as the development of an early-stage securities brokerage business involves inherent regulatory and operational risks and uncertainties.

 

8

 

 

Our business remains heavily impacted by interested party transactions with certain of our officers and directors.

 

Prior to 2022, the Company had engaged in a series of interested party transactions with its former directors and officers, Mario Romano and Annette Raynor. Those transactions were terminated in conjunction with a January 6, 2022, Separation and Release Agreement by which Mr. Romano and Ms. Raynor resigned their positions as officers and directors of the Company and surrendered 150,000,000 shares of our common stock. Subsequently, on September 9, 2023, we closed on the purchase in a private transaction of an aggregate of 302,919,223 shares of the Company’s common stock from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities. These shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share, with one-eighth of the purchase price paid on or about the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

 

During September 2021, we acquired, among other assets, a proprietary algorithmic trading platform from MPower, a business controlled by two members of our Board of Directors. The assets of MPower were acquired in consideration of the issuance of Class B Redeemable Units consisting of non-voting membership interests in our wholly owned subsidiary IFGH that are in the future redeemable for 565,000,000 Company common shares, presently representing over 23% of the Company’s current fully-diluted shares. To date, we have been unable to monetize on the assets we purchased from MPower.

 

Further, by virtue of an April 27, 2020 convertible note financing arrangement we have with DBR Capital, LLC (“DBR Capital”) (see “ITEM 13. Certain Relationships and Related Transactions, and Director Independence”), an affiliate of our Chairman, David B. Rothrock, we borrowed the principal amount of $3,300,000 under an aggregate of three convertible promissory notes that bear rates of interest between 20.00% and 38.50% per annum and are subject to conversion by DBR Capital at a price of $0.007 per share. Under the first three loans, DBR Capital had the right to lend to the Company up to an additional $7.7 million for which the Company had no call rights, on substantially the same terms as the prior loans, through December 31, 2024. In February 2025, the terms of the note financing arrangement were amended so that DBR Capital has been given until August 31, 2025 to lend to the Company a minimum of $2,000,000, and until December 31, 2026 to lend to the Company the balance of up to $5,700,000. The amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million. The terms and conditions of the credit arrangements with DBR Capital could make it difficult for the Company to attract third-party capital in the future.

  

We might fail to realize the expected benefits and strategic objectives of our 2021 acquisition of a proprietary trading platform from a business affiliated with two members of the Company’s Board of Directors.

 

During September 2021, we acquired, among other assets, a proprietary algorithmic trading platform from MPower, a business controlled by two members of our Board of Directors. The assets of MPower were acquired in consideration of the issuance of Class B Redeemable Units consisting of non-voting membership interests in our wholly owned subsidiary IFGH that are in the future redeemable for 565,000,000 Company common shares on a one-for-one basis. While we believe that the trading platform that we acquired in the acquisition will become a fundamental part of our overall strategy to create a Brokerage and Financial Markets business, our expected deployment of those assets was unexpectedly delayed due to complications and delays in the process of finding a broker-dealer relating to a former officer’s then ongoing legal proceedings. Although we have since acquired a broker-dealer through our acquisition of Opencash in 2024, we might not achieve our expected, or any, return on this investment. To date, we have been unable to monetize on the assets we purchased from MPower. If we are unsuccessful at creating or growing this line of business, we may not be able to achieve our planned rates of growth or improve our market share, profitability or competitive position.

 

Substantially all of our employees are employed by professional employer organizations.

 

We contract with a professional employer organization, or PEO, that administers our human resources, payroll and employee benefits functions for our employees in the United States. Although we recruit and select our workers, each of these workers is also an employee of record of the PEO. As a result, these workers are compensated through the PEO, are governed by the work policies created jointly by us and the PEO and receive their annual wage statements and other payroll or labor related reports from the PEO. This relationship permits management to focus on operations and profitability rather than payroll administration, but this relationship also exposes us to some risks. Among other risks, if the PEO fails to adequately withhold or pay employer taxes or to comply with other laws, such as the Fair Labor Standards Act, the Family and Medical Leave Act, the Employee Retirement Income Security Act or state and federal anti-discrimination laws, each of which is outside of our control, we would be liable for such violations, and indemnification provisions with the PEO, if applicable, and Company insurance may not be sufficient to insulate us from those liabilities.

 

9

 

 

Court and administrative proceedings related to matters of employment tax, labor law and other laws applicable to PEO arrangements could distract management from our business and cause us to incur significant expense. If we were held liable for violations by the PEO, such amounts may adversely affect our profitability and could negatively affect our business and results of operations.

 

Unfavorable publicity associated with our now concluded SEC inquiry.

 

We have experienced unfavorable publicity for several years that, to some extent, we attribute to the SEC inquiry that had been ongoing since November 2021. The unfavorable publicity had a negative impact on our commercial banking and credit card processing relationships, employees, business, products, and reputation, and negatively impacted our ability to attract, motivate, and retain banking relationships, members and distributors, and our ability to generate revenue. In recognition that we settled the outstanding matter with the SEC, it would be our expectation that the unfavorable publicity we experienced in the past will dissipate over time; however, there can be no assurances to that effect.

 

We may be impacted by macroeconomic conditions due to global pandemics, epidemics or outbreaks of disease and the resulting global supply chain crisis.

 

Global trade conditions and consumer trends that originated during the COVID-19 pandemic may continue to persist and may also have long-lasting adverse impact on us and our industry. There are continued risks arising from new pandemics, epidemics or outbreaks of disease, which have had and could further have an adverse effect on suppliers and customers and create significant volatility and uncertainty and economic disruption. We believe the extent to which global pandemics ultimately impact our business, financial condition, results of operations or cash flows will depend on numerous evolving factors that we may not be able to accurately predict, including, without limitation: the duration and scope of the pandemic; the success in delivering and efficacy of vaccines; governmental, business and individuals’ actions that have been and will be taken in response to the pandemic (including restrictions on travel and transport and workforce pressures); the effect on our suppliers and customers and customer demand for our core products and services; the effect on our sources of supply; the impact of the pandemic on economic activity and actions taken in response; closures of our and our suppliers’ and customers’ offices and facilities; the ability of our customers to pay for our products and services; financial market volatility; commodity prices; and the pace of recovery. We cannot predict the duration or direction of current or new global trends or their sustained impact. Ultimately, we continue to monitor macroeconomic conditions to remain flexible and to optimize and evolve our business as appropriate, and we will have to accurately project demand and infrastructure requirements globally and deploy our workforce and capital resources accordingly. If we experience unfavorable global market conditions, or if we cannot or do not maintain operations at a scope that is commensurate with such conditions or are later required to or choose to suspend such operations again, our business, prospects, financial condition, and operating results may be harmed.

 

During 2024, we instituted collection efforts through litigation against one of our credit card processors and its clearing bank as efforts to account for and collect approximately $1.87 million of our credit card receivables that were supposed to have been held by them in reserve, have not proven successful.

 

The Company’s financial statements as of December 31, 2024, reflect a receivables balance of $2.53 million. Of that balance, $2.19 million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $1.87 million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $1.87 million. Furthermore, the Company may be caused under generally accepted accounting principles to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $1.87 million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.

 

10

 

 

Cyber-attacks may disrupt our operations and expose us to significant liability.

 

We are at risk for cyber-attacks, such as phishing, and other attempts to gain unauthorized access to our systems, and we anticipate continuing to be subject to such attempts. There is an ongoing risk that some or all of our cryptocurrencies could be lost or stolen as a result of one or more of these incursions. As we increase in size, we may become a more appealing target of hackers, malware, cyber-attacks or other security threats, and, despite our implementation of strict security measures and frequent security audits, it is impossible to eliminate all such vulnerability. For instance, we may not be able to ensure the adequacy of the security measures employed by third parties, such as our service providers. Additionally, though we provide cybersecurity training for employees, we cannot guarantee that we will not be affected by attempted security breaches. Efforts to limit the ability of malicious actors to disrupt the operations of the internet or undermine our own security efforts may be costly to implement and may not be successful. Such breaches, whether attributable to a vulnerability in our systems or otherwise, could subject us to liability to our customers, suppliers, business partners and others, or give rise to legal and/or regulatory action, which could damage our reputation or otherwise materially harm our business, operating results, and financial condition, and result in claims of liability against us, damage our reputation and materially harm our business.

 

We rely primarily on a well-known U.S. based third-party digital asset-focused custodian to safeguard our Bitcoin. If our third-party service provider experiences a security breach or cyber-attack and unauthorized parties obtain access to our Bitcoin, we may lose some or all of our Bitcoin and our financial condition and results of operations could be materially adversely affected.

 

We may accept, disburse, and hold cryptocurrency, which may subject us to exchange risk and additional tax and regulatory requirements.

 

We periodically accept Bitcoin as a form of payment and use it to satisfy liabilities. Cryptocurrency is not considered legal tender or backed by any government and has experienced significant price volatility, technological glitches, and various law enforcement and regulatory interventions. If we fail to comply with regulations or prohibitions applicable to us, we could face regulatory or other enforcement actions and potential fines and other consequences. We also hold cryptocurrencies directly, subjecting us to exchange rate risk as well as the risk that regulatory or other developments and the recent price volatility may adversely affect the value of the cryptocurrencies we hold. The uncertainties regarding legal and regulatory requirements relating to cryptocurrencies or transactions using cryptocurrencies, as well as potential accounting and tax issues or other requirements relating to cryptocurrencies, could have a material adverse effect on our business.

 

We may not be able to fully protect our proprietary rights, and we may infringe upon the proprietary rights of others, which could result in costly litigation.

 

Our future success depends on our ability to protect and preserve the proprietary rights related to our products. We cannot assure that we will be able to prevent third parties from using our intellectual property and technology without our authorization. We also rely on trade secrets, common law trademark rights, and trademark registrations, as well as confidentiality and work for hire, development, assignment, and license agreements with employees, consultants, third-party developers, licensees, and customers. Our protective measures for these intangible assets afford only limited protection from illegal actors and may be flawed or become inadequate with the passage of time.

 

Policing unauthorized use of our technology is difficult, and some foreign laws do not provide the same level of protection as U.S. laws. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trademarks or trade secrets that we may obtain, or to determine the validity and scope of the proprietary rights of others. Such litigation could result in substantial costs and diversion of resources and have a material adverse effect on our future operating results.

 

In recent years, there has been significant litigation in the United States involving intellectual property rights. In particular, there has been an increase in the filing of lawsuits alleging infringement of intellectual property rights, which pressure defendants into entering settlement arrangements quickly to dispose of such lawsuits, regardless of their merits. Other companies or individuals may allege that we infringe on their intellectual property rights. Litigation, particularly in the area of intellectual property rights, is costly and the outcome is inherently uncertain. In the event that we become involved in such a lawsuit in the future and receive an adverse result, we could be liable for substantial damages, and we may be forced to discontinue our use of the intellectual property in question or obtain a license to use those rights or develop non-infringing alternatives.

 

Risks Related to our Financial Education and Technology Business

 

Our business could be negatively affected by any adverse economic developments in the securities markets or the domestic or international economy in general.

 

We depend on the interest of individuals in obtaining financial information and securities trading strategies to assist them in making their own investment decisions. Significant downturns in the securities markets or in general economic and political conditions domestically or internationally may cause individuals to be reluctant to make their own investment decisions and thus decrease the demand for our products and services. Significant upturns in the securities markets or in general economic and political conditions domestically or internationally may cause individuals to be less proactive in seeking ways to improve the returns on their trading or investment decisions and, thus, decrease the demand for our products and services.

 

11

 

 

We may encounter risks relating to security or other system disruptions and failures that could reduce the attractiveness of our websites and that could harm our business and results of operations.

 

Although we have implemented various security mechanisms, our business is vulnerable to computer viruses, physical or electronic break-ins, and similar disruptions, which could lead to interruptions, delays, or loss of data. For instance, because a portion of our revenue is based on individuals using credit cards to purchase memberships over the Internet, our business could be adversely affected by credit card fraud and other electronic break-ins or disruptions. Additionally, our operations depend on our ability to protect systems against damage from fire, earthquakes, power loss, telecommunications failure, and other events beyond our control. Moreover, our website may experience slower response times or other problems for a variety of reasons, including hardware and communication line capacity restraints, software failures, or significant increases in traffic when there have been important business or financial news stories. These strains on our systems could cause customer dissatisfaction and could discourage visitors from becoming paying subscribers. Our websites could experience disruptions or interruptions in service due to the failure or delay in the transmission or receipt of information from us. These types of occurrences could cause users to perceive our website and technology solutions as not functioning properly and cause them to use other methods or services of our competitors. Any disruption resulting from these actions may harm our business and may be expensive to remedy, may not be fully covered by our insurance, could damage our reputation, and discourage new and existing users from using our products and services. Any disruptions could increase costs and make profitability even more difficult to achieve.

 

We will need to introduce new products and services and enhance existing products and services to remain competitive.

 

Our future success depends in part on our ability to develop and enhance our products. In addition, the adoption of new internet, networking or telecommunications technologies or other technological changes could require us to incur substantial expenditures to enhance or adapt our services or infrastructure. There are significant technical and financial costs and risks in the development of new or enhanced products, including the risk that we might be unable to effectively use new technologies, adapt our services to emerging industry standards, or develop, introduce and market enhanced or new products. An inability to develop new products, or enhance existing offerings, could have a material adverse effect on our profitability.

 

We rely on external service providers to perform certain key functions.

 

We rely on a number of external service providers for certain key technology, processing, service, and support functions. External content providers provide us with crypto mining services, financial information, market news, charts, option and stock quotes, research reports, and other fundamental data that we offer to clients. These service providers face technological and operational risks of their own. Any significant failures by them, including improper use or disclosure of our confidential client, employee, or company information, could cause us to incur losses and could harm our reputation.

 

We cannot assure that any external service providers will be able to continue to provide these services in an efficient, cost-effective manner or that they will be able to adequately expand their services to meet our needs. An interruption in or the cessation of service by any external service provider as a result of systems failures, capacity constraints, financial constraints or problems, unanticipated trading market closures, or for any other reason, and our inability to make alternative arrangements in a smooth and timely manner, if at all, could have a material adverse effect on our business, results of operations, and financial condition.

 

We could face liability and other costs relating to storage and use of personal information about our users.

 

Users provide us with personal information, including tax identification numbers, which we do not share without the user’s consent. Despite this policy of obtaining consent, however, if third persons were able to penetrate our network security or otherwise misappropriate our users’ personal information, we could be subject to liability, including claims for unauthorized purchases with credit card information, impersonation or other similar fraud claims, and misuses of personal information, such as for unauthorized marketing purposes. New privacy legislation may further increase this type of liability. Furthermore, we could incur additional expenses if additional regulations regarding the use of personal information were introduced or if federal or state agencies were to investigate our privacy practices. We do not store user credit card information and rely upon our merchant processing partners to collect and store this information with the necessary Payment Card Industry Security Standards compliance in place. However, a breach of the merchant’s security standards could create liability for us.

 

Our business could be negatively affected if we are required to defend allegations of unfair competition and unfair false or deceptive acts or practices in or affecting commerce.

 

Advertising and marketing of our products in the United States are also subject to regulation by the Federal Trade Commission (“FTC”) under the Federal Trade Commission Act, or FTC Act. Among other things, the FTC Act prohibits unfair methods of competition and unfair false or deceptive acts or practices in or affecting commerce. The FTC Act also makes it illegal to disseminate or cause to be disseminated any false advertisement. The FTC routinely reviews websites to identify questionable advertising claims and practices. Competitors sometimes inform the FTC when they believe other competitors are violating the FTC Act and consumers also notify the FTC of what they believe may be wrongful advertising. The FTC may initiate a nonpublic investigation that focuses on our advertising claims, which usually involves nonpublic, pre-lawsuit, extensive formal discovery. Such an investigation may be lengthy and expensive to defend and result in a publicly disclosed consent decree or settlement agreement. If no settlement can be reached, the FTC may start an administrative proceeding or a federal court lawsuit against us or our principal officers. The FTC often seeks to recover from the defendants, whether in a consent decree or a proceeding, any or all of the following: (i) consumer redress in the form of monetary relief or disgorgement of profits; (ii) significant reporting requirements for several years; and (iii) injunctive relief. In addition, most, if not all, states have statutes prohibiting deceptive and unfair acts and practices. The requirements under these state statutes are similar to those of the FTC Act.

 

12

 

 

Our business could be negatively affected if we are required to defend allegations that our direct selling activities are fraudulent or deceptive schemes, or against public interest.

 

Our iGenius products and services are marketed by a global network of independent distributors using a direct selling business model. Although we believe that our direct selling business model is in material compliance with applicable legal standards, direct selling programs, in general, have often been the target of regulatory scrutiny by federal, state, and local governmental agencies in the United States and foreign countries, including the FTC. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants primarily for recruiting additional participants without significant emphasis on product sales, whereas the more successful direct selling business models have and emphasize sales of products and services. The regulatory requirements concerning direct selling programs do not include “bright line” rules and are inherently fact-based and, thus, we are subject to the risk that these regulations or the enforcement or interpretation of these regulations by regulators or courts can change. The adoption of new regulations, or changes in the interpretations or enforcement of existing regulations, may result in significant compliance costs or require us to change or cease aspects of our network marketing program. In addition, the ambiguity surrounding these regulations can also affect the public perception of our business. In the normal course of operations, we may periodically receive an inquiry from a foreign regulator relative to matters of this nature, however, to our knowledge we are not under formal investigation relative to the practices of our direct selling network activities in any foreign country.

 

We have recently had to respond to allegations from Canadian Securities regulators that our iGenius business unit engaged in unlicensed regulated securities activities; Our business could be negatively affected if we are required to defend similar allegations from securities regulators in the United States or in other foreign countries in which we do business.

 

From time to time, we receive notices or formal actions from foreign or domestic regulatory authorities or administrative agencies, which assert that certain activities of our iGenius business constitute unlicensed activities as an unregistered securities dealer or advisor under local laws. However, we do not believe that our iGenius business unit violates any such laws as we believe we are merely a provider of financial education and related tools that access information that is available publicly or without a licensing requirement, or that through affinity programs provide access to lawful services or products offered by third parties neither owned or operated by iGenius. When we are confronted with such allegations, we may either elect to challenge the legal basis thereof when we believe it is appropriate or economically compelling, or in the instances in which the financial impact of the relief sought is de minimis, we may elect to settle with any such regulator, often without admitting any violation of law. Towards that end, we have recently been the target of regulatory scrutiny by securities regulators in Canada. During 2024, we received a letter of inquiry from the Ontario Securities Commission (“OSC”) in which they questioned whether iGenius was engaged in securities activities without being registered under their securities act. Specifically, the OSC identified concerns that iGenius was selling ndau – which they considered an investment contract – and also noted that they had concerns about certain third-party product offerings and access to market experts that were made available to iGenius customers. Even though we believe that our iGenius business fully complies with all applicable securities laws, due to the immaterial scope and scale of our operations in Ontario, Canada, we elected to settle the matter with the OSC without the need to engage in a protracted and costly legal dispute. Rather, we agreed with the OSC to conclude the inquiry by implementing a geoblock throughout Ontario such that no Ontario-based customers would be able to access any of the disputed product offerings.

 

Later in 2024, we and one of our independent distributors received an enforcement action from the financial regulators in Quebec, Canada, known as the Autorité des marchés financiers (the “AMF”), in which they challenged certain inappropriate marketing communications they characterized as “inappropriate” made by this particular distributor, and as well alleged that iGenius was inappropriately engaging in regulated securities activity without being appropriately registered to do so in Quebec. In discussions with the AMF, it became clear that the focus of their inquiry was on certain “touting” of financial results by this particular distributor which we concluded was unauthorized and in violation of our own internal policies and we terminated the distributor. As well, the AMF raised concerns about certain “robotic” trading platforms that were made available to iGenius customers through third-party products that iGenius makes available to its subscribers. Even though we believe that our iGenius business fully complies with all applicable securities laws, due to the immaterial scope and scale of our operations in Quebec, Canada, we elected to engage in settlement discussions with the AMF without the need to engage in a protracted and costly legal dispute. In addition to the termination of our distributor, we have reached a tentative understanding in principle with the AMF by which we offered to institute in Quebec the same type of geoblock that we implemented in Ontario, as well as agreed to pay a CAD $15,000 fine. The parties are negotiating the terms of a written settlement agreement, and the agreement is still subject to AMF approval.

 

We have carefully evaluated the basis for the claims asserted by the OSC and the AMF and we have concluded that our iGenius business unit operates generally in compliance with applicable securities rules and regulations. Our completed and pending settlements, however, with the OSC and AMF could expose us to similar claims from other securities regulators in the United States and in other foreign countries in which we operate. Were such claims to be made, we could be exposed to having to defend our business model in protracted and costly legal disputes, or else engage in similar settlements in which we agree to limit the geographic scope of our operations, either of which alternatives could have an adverse effect on our liquidity and operations.

 

13

 

 

Our independent distributors could fail to comply with applicable legal requirements or our distributor policies and procedures, which could result in claims against us that could harm our business.

 

Our independent distributors are independent contractors and, accordingly, we are not able to directly provide the same oversight and direction as we could if they were our employees. As a result, we have implemented compliance measures that are designed to train our distributors and attempt to monitor our distributors’ use of marketing materials that are in compliance with FTC and other legal standards. Despite our compliance initiatives we cannot always ensure that our independent distributors will comply with applicable laws or regulations, our distributor policies and procedures, or that such marketing materials or other distributor practices comply with applicable laws, rules, and regulations. It is possible that a court or governmental agency could hold us liable for the actions of our distributors, which could materially harm our business, financial condition, and operating results.

 

Extensive federal, state, local, and international laws regulate our business, products and direct selling activities. In addition, because we have expanded into foreign countries, our policies and procedures for our independent distributors differ slightly in some countries due to the different legal requirements of each country in which we do business.

 

Our proprietary systems may be compromised by hackers.

 

Our current products and other products and services that we may develop in the future will be based on proprietary software and customer-specific data that we protect by routine measures such as password protection, confidentiality and nondisclosure agreements with employees, and similar measures. Any unauthorized access to our software or data could materially disrupt our business and result in financial loss and damage to our business and reputation.

 

Our business could be negatively affected if any of the third-party providers of products or services offered through our membership packages default on their obligation to our members.

 

Through our iGenius membership program and our now discontinued Apex sale and leaseback program, our members gained access to a variety of benefits provided through third party partnerships and affinity arrangements, including products and services provided by third party investment professionals and access to a proprietary digital currency called “ndau” (which was discontinued during August 2023). We cannot ensure that such third-party providers will comply with their contractual requirements to our members or with applicable laws, rules, and regulations. Any significant failures by them could cause us to incur losses and could harm our reputation.

 

Our business could be negatively affected by claims related to a financial product underwritten, administered and managed by a third-party provider, Total Protection Plus.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau during August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

14

 

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program.

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP; despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

Risks Related to our Blockchain Technology and Crypto Mining Products and Services

 

Our success depends on external factors affecting the Bitcoin industry.

 

The Bitcoin industry has historically been subject to various risks relating to Bitcoin, as an asset, which have adversely affected the market price of Bitcoin. Ownership of Bitcoin has, historically, been concentrated in a relatively small number of persons or entities that, collectively, hold a significant number of Bitcoin (referred to as “whales” in the Bitcoin industry). While ownership of Bitcoin has diversified significantly in recent years, whales continue to exist whose market activity (e.g., sales of large numbers of Bitcoin) could have an adverse effect on the demand for, and market price of Bitcoin, which could have an adverse effect on our business and results of operation. Further, while larger, increasingly regulated exchanges with greater transparency and oversight have begun to proliferate, the Bitcoin economy remains nascent and largely opaque. The venues for Bitcoin transactions may experience greater operational problems and be exposed to a greater risk of facilitating unethical, fraudulent or illicit transactions (such as “wash trading”), than traditional financial markets and securities exchanges. Digital asset trading platforms may also be susceptible to “front-running” activity, which is the process by which someone uses technology or market advantage to obtain prior knowledge of upcoming transactions allowing bad actors to take advantage of forthcoming price movement and make economic gains at the cost of those who introduced the transactions. Front-running is a frequent activity on centralized and decentralized digital asset trading platforms. Further, venues for Bitcoin transactions do not typically make complete information regarding their ownership structure, management teams, corporate practices, and regulatory compliance available to the public, who are, therefore, unable to verify the impartiality of such venues in respect of the Bitcoin transactions they facilitate. As a result of such lack of regulation and transparency, as well as the risk posed by Bitcoin whales, wash trading and front-running, the public may lose confidence in Bitcoin transactions and the price integrity of the digital asset, which could adversely affect the market price of Bitcoin, perhaps materially, which would have an adverse impact on our business and results of operations.

 

The further development and acceptance of digital asset networks and other digital assets, which represent a new and rapidly changing industry, are subject to a variety of factors that are difficult to evaluate. The slowing or stopping of the development or acceptance of digital asset systems may adversely affect an investment in us.

 

Digital assets such as Bitcoin, that may be used, among other things, to buy and sell goods and services are a new and rapidly evolving industry of which the digital asset networks are prominent, but not unique, parts. The growth of the digital asset industry in general, and the digital asset networks of Bitcoin in particular, are subject to a high degree of uncertainty. The factors affecting the further development of the digital asset industry, as well as the digital asset networks, include:

 

continued worldwide growth in the adoption and use of Bitcoin and other digital assets;
government and quasi-government regulation of Bitcoin and other digital assets and their use, or restrictions on or regulation of access to and operation of the digital asset network or similar digital assets systems;
the maintenance and development of the open-source software protocol of the Bitcoin network;
changes in consumer demographics and public tastes and preferences;
the availability and popularity of other forms or methods of buying and selling goods and services, including new means of using fiat currencies;
general economic conditions and the regulatory environment relating to digital assets;
the impact of regulators focusing on digital assets and digital securities and the costs associated with such regulatory oversight;
a decline in the popularity or acceptance of the digital asset networks of Bitcoin, or similar digital asset systems, could adversely affect an investment in us; and
changes or improvements in mining technologies and cryptology that could pose a threat to the efficiency or security of current mining technologies, for example, if quantum computing overcomes 256-bit encryption.

 

15

 

 

Our ability to achieve profitability is largely dependent on the price of Bitcoin, which has historically been volatile.

 

Our focus on our Bitcoin mining operations is largely based on our assumptions regarding the future value of Bitcoin, which has been subject to significant historical volatility and may be subject to influence from malicious actors, real or perceived scarcity, political, economic, and regulatory conditions, and speculation making its price more volatile or creating “bubble” type risks for the trading price of Bitcoin. Further, unlike traditional stock exchanges, which have listing requirements and vet issuers, requiring them to comply with rigorous listing standards and rules, and which monitor transactions for fraud and other improprieties, markets for Bitcoin and other cryptocurrencies tend to be underregulated, if they are regulated at all. Less stringent cryptocurrency markets have a higher risk of fraud or manipulation, and any lack of oversight or perceived lack of transparency could reduce confidence in the price of Bitcoin and other cryptocurrencies, which could adversely affect their price.

 

These factors make it difficult to accurately predict the future market price of Bitcoin and may also inhibit consumer trust in and market acceptance of cryptocurrencies as a means of exchange, which could limit the future adoption of Bitcoin and, as a result, our assumptions could prove incorrect. If our assumptions prove incorrect and the future price of Bitcoin is not sufficiently high, our revenue from Bitcoin mining operations may not exceed our costs, and our operations may never achieve profitability.

 

Transaction fees may decrease demand for Bitcoin and prevent expansion.

 

As the number of Bitcoin block subsidy rewards for solving a block in a blockchain continue to reduce in half approximately every 4 years, transaction fees have increasingly been used to incentivize miners to continue to contribute to the Bitcoin network. However, high Bitcoin transaction fees may slow the adoption of Bitcoin as a means of payment, which may decrease demand for Bitcoin and future prices of Bitcoin may suffer as a result. If Bitcoin prices are not sufficiently high, our mining revenue may not exceed our associated costs, and our results of operations and financial condition may suffer. Further, because the price of shares of our common stock may be linked to the price of Bitcoin, if demand for Bitcoin decreases, causing future Bitcoin prices to decrease, the market price of our securities may be materially and adversely affected, limiting our ability to raise additional capital to fund our strategic growth plans.

 

We operate in a highly competitive market and if we fail to grow our hash rate, in a cost-effective manner, we may be unable to compete.

 

Generally, a Bitcoin miner’s chance of solving a block on the Bitcoin blockchain and earning a Bitcoin reward is a function of the miner’s hash rate, relative to the global network hash rate. As greater adoption of Bitcoin occurs, we expect that the demand for Bitcoin will continue to increase, drawing more mining companies into the industry and thereby increasing the global network hash rate. As new and more powerful miners are deployed, the global network hash rate will continue to increase, meaning a Bitcoin miner’s chance of earning Bitcoin rewards will decline unless it deploys additional hash rate at pace with the industry. Accordingly, to compete in this highly competitive industry, we believe we will need to continue to acquire new more effective and energy-efficient miners, both to replace those lost to ordinary wear-and-tear and other damage, and to increase our hash rate to keep up with a growing global network hash rate.

 

These new miners are highly specialized servers that are difficult to produce at scale. As a result, there are limited producers capable of supplying large numbers of sufficiently effective miners, and, as demand for new miners has increased, and will likely continue to increase, in response to increased Bitcoin prices, we have observed that the price of these new miners has also increased. If we are unable to acquire enough new miners or otherwise access sufficient capital to fund acquisitions to grow our hash rate, our results of operations and financial condition could be adversely affected, as could investments in our securities.

 

Bitcoin is programmatically subject to “Halving,” meaning that the Bitcoin rewarded for solving a block will be reduced in the future and its value may not commensurately adjust to compensate us for such reductions.

 

Bitcoin is subject to Halving, which is the process by which the Bitcoin reward for solving a block is reduced by 50% for every 210,000 blocks that are solved. This Halving occurs approximately every 4 years and means that the amount of Bitcoin we (or any other miner) are rewarded for solving a block in the Blockchain is permanently cut in half. For example, the last Halving occurred in April 2024, with a revised payout of 3.125 Bitcoin per block solved, down from the previous reward rate of 6.25 Bitcoin per block solved. There can be no assurance that the price of Bitcoin will sufficiently increase to justify the increasingly high costs of mining for Bitcoin given the Halving feature. If a corresponding and proportionate increase in the trading price of Bitcoin does not follow these anticipated Halving events, the revenue we earn from our mining operations would see a corresponding decrease, which would have a material adverse effect on our business and operations. To illustrate, even if the price of Bitcoin remains at its price as of today, all other factors being equal (including the same number of miners and a stable hash rate) our revenue would decrease substantially upon the next Halving.

 

16

 

 

Further, due to the Halving process, unless the underlying code of the Bitcoin Blockchain is altered (which may be unlikely or difficult given its decentralized nature), the supply of Bitcoin is finite, as detailed in the risk factor above. For the foregoing reasons, the Halving feature exposes us to inherent uncertainty and reliance upon the historically volatile price of Bitcoin, rendering an investment in us particularly speculative, especially in the long-term.

 

We are subject to risks associated with our need for significant electrical power, with that risk heightened as we are currently supplied electrical power by a sole source provider.

 

Our Bitcoin mining operations have required significant amounts of electrical power, and, to the extent we purchase additional miners or acquire new miners which require higher energy inputs, our electricity requirements would grow. If we are unable to continue to obtain sufficient electrical power to operate our miners on a cost-effective basis, we may not realize the anticipated benefits of our capital investments in our miners. Even at our current energy usage, there can be no guarantee that our operational costs will not increase in the future. Additionally, our mining operations could be materially adversely affected by prolonged power outages, and we may have to reduce or cease our operations in the event of an extended power outage, or as a result of the unavailability or increased cost of electrical power.

 

The foregoing risk is heightened as a result of our reliance on a sole source provider of electrical power. We are dependent on the sole host of our power supply in Northern Europe who provides our power generation through hydroelectric sources. While our relationship with our sole power supplier is good, and while we generally have sufficient supply to conduct our business operations as presently contemplated, since the beginning of 2024, our power supply has been curtailed by up to approximately 60% as a direct result of low water levels that have cutback local hydroelectric power capacity. We believe the potential adverse effect of the power supply curtailment and our reliance on a sole power supplier was mitigated in large part due to our decision to curtail our Bitcoin mining operations (and, in turn, our electrical usage) until we could mine on a cost-effective basis. Thus, while the power supply curtailment has not yet had an adverse effect on our business, if Bitcoin market conditions become more favorable and cost-effective and we determine to ramp our mining operations back to their full capacity and the power supply curtailment continues or our sole provider raises its prices or cannot meet our needs, our business and results of operations could be materially and adversely affected, and investors in our securities could be harmed.

 

Climate change, and the regulatory and legislative developments related to climate change, may materially adversely affect our business and financial condition.

 

The impacts of climate change may materially and adversely impact the cost, production and financial performance of our operations. Further, any impacts to our business and financial condition as a result of climate change are likely to occur over a sustained period of time and are therefore difficult to quantify with any degree of specificity. For example, extreme weather events may result in adverse physical effects on portions of our infrastructure, which could disrupt our supply chain and ultimately our business operations. In addition, disruption of transportation and distribution systems could result in reduced operational efficiency and customer service interruption. Climate related events have the potential to disrupt our business, including the business of our customers, and may cause us to experience higher attrition, losses and additional costs to resume operations. As noted in the prior risk factor, since the beginning of 2024, our power supply has been curtailed by up to approximately 60% as a direct result of low water levels that have cutback local hydroelectric power capacity. We are unable to predict when our mining levels will return to pre-2024 levels. A prolonged disruption in our power supply levels could have a material adverse effect on our bitcoin mining operations, and possibly our overall results of operations.

 

In addition, a number of governments or governmental bodies have introduced or are contemplating legislative and regulatory changes in response to various climate change interest groups and the potential impact of climate change. Given the significant amount of electrical power required to operate cryptocurrency miners, as well as the environmental impact of mining for metals used in the production of mining servers, the cryptocurrency mining industry may become a target for future environmental and energy regulation. Legislation and increased regulation regarding climate change could impose significant costs on us and our suppliers, including costs related to capital equipment, environmental monitoring and reporting, and other costs to comply with such regulations. Any future climate change regulations could also negatively impact our ability to compete with companies situated in areas not subject to such limitations. Given the political significance and uncertainty around the impact of climate change and how it should be addressed, we cannot predict how legislation and regulation will affect our financial condition, operating performance and ability to compete. Furthermore, even without such regulation, increased awareness and any adverse publicity in the global marketplace about potential impacts on climate change by us or other companies in our industry could harm our reputation. Any of the foregoing could result in a material adverse effect on our business and financial condition.

 

17

 

 

Changing environmental regulation and public energy policy may expose our business to new risks.

 

If new environmental and energy regulations, policies, and initiatives enacted by federal regulators are imposed, or if existing regulations are modified, the assumptions we made underlying our plans and strategic initiatives may be inaccurate, and we may incur additional costs to adapt our planned business, if we are able to adapt at all, to such regulations.

 

In addition, there continues to be a lack of consistent climate legislation, which creates economic and regulatory uncertainty for our business because the cryptocurrency mining industry, with its high energy demand, may become a target for future environmental and energy regulation. New legislation and increased regulation regarding climate change could impose significant costs on us and our suppliers, including costs related to capital equipment, environmental monitoring and reporting, and other costs to comply with such regulations. Further, any future climate change regulations could also negatively impact our ability to compete with companies situated in areas not subject to such limitations.

 

Given the political significance and uncertainty around the impact of climate change and how it should be addressed, we cannot predict how legislation and regulation will affect our financial condition and results of operations. Further, even without such regulation, increased awareness and any adverse publicity in the global marketplace about potential impacts on climate change by us or other companies in our industry could harm our reputation. Any of the foregoing could result in a material adverse effect on our business and financial condition.

 

The compliance costs of responding to new and changing regulation could adversely affect our operations.

 

We (along with those from whom we purchase electricity) are subject to various federal, state, local, and international environmental laws and regulations, including those relating to the generation, storage, handling, and disposal of hazardous substances and wastes. Certain of these laws and regulations also impose joint and several liability, without regard to fault, for investigation and cleanup costs on current and former owners and operators of real property and persons who have disposed of or released hazardous substances into the environment. Our operations may involve the use of hazardous substances and materials, such as petroleum fuel for emergency generators, as well as batteries, cleaning solutions, and other materials.

 

Electricity costs could also be affected due to existing or new regulations on greenhouse gas emissions, whether such regulations apply to all consumers of electricity or just to specified uses, such as Bitcoin mining. There has been interest in the U.S. Congress in addressing climate change, including through regulation of Bitcoin mining. Past legislative proposals to address climate change include measures ranging from taxes on carbon use or generation to federally imposed limits on greenhouse gas emissions. The course of future legislation and regulation in the United States remains difficult to predict, and potential increased costs associated with new legislation or regulation cannot be estimated at this time.

 

Regulatory changes or actions may alter the nature of an investment in us or restrict the use of cryptocurrencies in a manner that adversely affects our business, prospects, or operations.

 

As cryptocurrencies have grown in both popularity and market size, governments around the world have reacted differently to cryptocurrencies; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as in the U.S., subject the mining, ownership and exchange of cryptocurrencies to extensive, and in some cases overlapping, unclear and evolving regulatory requirements. Ongoing and future regulatory actions could have a material adverse effect on our business, prospects or operations.

 

Our interactions with a blockchain may expose us to SDN or blocked persons and new legislation or regulation could adversely impact our business or the market for cryptocurrencies.

 

The Office of Financial Assets Control (“OFAC”) of the U.S. Department of Treasury requires us to comply with its sanction program and not conduct business with persons named on its specially designated nationals (“SDN”) list. However, because of the pseudonymous nature of blockchain transactions we may inadvertently and without our knowledge engage in transactions with persons named on OFAC’s SDN list. Our Company’s policy prohibits any transactions with such SDN individuals, but we may not be adequately capable of determining the ultimate identity of the individual with whom we transact with respect to cryptocurrency assets; for example, the use of cryptocurrencies, including Bitcoin, as a potential means of avoiding federally imposed sanctions, such as those imposed in connection with the Russian invasion of Ukraine. On March 2, 2022, a group of United States Senators sent the Secretary of the United States Treasury Department a letter asking Secretary Yellen to investigate its ability to enforce such sanctions vis-à-vis Bitcoin, and on March 8, 2022, President Biden announced an executive order on cryptocurrencies which seeks to establish a unified federal regulatory regime for cryptocurrencies. We are unable to predict the nature or extent of new and proposed legislation and regulation affecting the cryptocurrency industry, or the potential impact of the use of cryptocurrencies by SDN or other blocked or sanctioned persons, which could have material adverse effects on our business and our industry more broadly. Further, we may be subject to investigation, administrative or court proceedings, and civil or criminal monetary fines and penalties as a result of any regulatory enforcement actions, all of which could harm our reputation and affect the value of our common stock.

 

18

 

 

Bitcoin and Bitcoin mining, as well as cryptocurrencies generally, may be made illegal in certain jurisdictions, including the ones we operate in, which could adversely affect our business prospects and operations.

 

Although we do not anticipate any material adverse regulations on Bitcoin mining in our jurisdictions of operation, it is possible that state or federal regulators may seek to impose harsh restrictions or total bans on cryptocurrency mining which may make it impossible for us to do business without relocating our mining operations, which could be very costly and time consuming. Further, although Bitcoin and Bitcoin mining, as well as cryptocurrencies generally, are largely unregulated in most countries (including the United States), regulators in certain jurisdictions may undertake new or intensify existing regulatory actions in the future that could severely restrict the right to mine, acquire, own, hold, sell, or use cryptocurrency or to exchange it for traditional fiat currency such as the United States Dollar. Such restrictions may adversely affect us as the large-scale use of cryptocurrencies as a means of exchange is presently confined to certain regions globally. Such circumstances could have a material adverse effect on us, which could have a material adverse effect on our business, prospects or operations and potentially the value of any Bitcoin we mine or otherwise acquire or hold for our own account, and thus negatively affect the value of our common stock.

 

The costs associated with our Bitcoin mining operations could be subject to significant increase in the future should there occur an increase in the VAT tax imposed on our hosting services.

 

The Company’s Bitcoin mining operations are hosted in a Northern European country that imposes a broadly-based consumption tax assessed on the value added to goods and services within its country (a “VAT tax”). However, upon the advice of our local tax advisors, an international accounting firm, the Company has concluded that the imposition of a VAT tax upon in-country hosting services is subject to uncertainty. Rather than paying no VAT tax pending clarification of this uncertainty, and upon the advice of our local tax advisors, the Company has implemented a structured leasing arrangement with its hosting counterparty in which lease payments to be received will be subject to a VAT tax upon which the Company will remit payment. While the Company believes that by adopting this type of structured arrangement, it can avoid any penalties or fines in the future should the local tax laws be modified or interpreted to apply to the local hosting services, there can be no assurances to this effect as the tax laws and interpretations thereof are subject to change, particularly in response to the tremendous growth in the high-powered computing industry. Further, there can be no assurances that if and to the extent that local tax laws are interpreted in the future to apply to hosting services, that the amount of VAT tax imposed upon the Company may not substantially exceed the amount payable under the currently contemplated structured leasing arrangement. A substantial increase in the amount of VAT tax due upon these local hosting operations, if it occurs, would increase the costs associated with the Company’s Bitcoin operations, which could have a materially adverse effect on the Company’s business and operating results.

 

Risks Related to Our Health, Beauty and Wellness Business

 

We have a limited history in the health, beauty and wellness industry upon which you can evaluate our business and prospects.

 

Our prospects must be considered in light of the risks encountered by companies in the early stages of development in highly competitive markets, particularly the markets for health, wellness and beauty products. You should consider the frequency with which early-stage businesses encounter unforeseen expenses, difficulties, complications, delays and other adverse factors.

 

Our products are subject to government regulation, both in the US and abroad, which could increase our costs significantly and limit or prevent the sale of our products.

 

The manufacturing, packaging, labeling, advertising, promotion, distribution, and sale of our products are subject to regulation by numerous national and local governmental agencies in the United States and other countries. The primary regulatory bodies in the United States are the FDA and FTC. Failure to comply with these regulatory requirements may result in various types of penalties or fines. These include injunctions, product withdrawals, recalls, product seizures, fines, and criminal prosecutions. Approvals or licensing may be conditioned on reformulation of products or may be unavailable with respect to certain products or product ingredients. Any of these government agencies, as well as legislative bodies, can change existing regulations, or impose new ones, or could take aggressive measures, causing or contributing to a variety of negative consequences, including:

 

  requirements for the reformulation of certain or all products to meet new standards;

 

19

 

 

  the recall or discontinuance of certain or all products;
     
  additional record keeping;
     
  expanded documentation of the properties of certain or all products;
     
  expanded or different labeling;
     
  adverse event tracking and reporting; and
     
  additional scientific substantiation.

 

Any or all of these requirements could have a material adverse effect on us. There can be no assurance that the regulatory environment in which we operate will not change or that such regulatory environment, or any specific action taken against us, will not result in a material adverse effect on us.

 

If we experience product recalls, we may incur significant and unexpected costs, and our business reputation could be adversely affected.

 

We may be exposed to product recalls and adverse public relations if our products are alleged to cause injury or illness, or if we are alleged to have violated governmental regulations. A product recall could result in substantial and unexpected expenditures, which would reduce operating profit and cash flow. In addition, a product recall may require significant management attention. Product recalls may hurt the value of our brands and lead to decreased demand for our products. Product recalls also may lead to increased scrutiny by federal, state or international regulatory agencies of our operations and increased litigation and could have a material adverse effect on our business, results of operations, financial condition and cash flows.

 

We may experience product liability claims and litigation to prosecute such claims, and although we maintain product liability insurance, which we believe to be adequate for our needs, there can be no assurance that our insurance coverage will be adequate or that we will be able to maintain adequate insurance coverage.

 

As a manufacturer and a distributor of products for human use and consumption, we may experience product liability claims and litigation to defend such claims. Additionally, the manufacture and sale of these products involves the risk of injury to consumers as a result of tampering by unauthorized third parties or product contamination. We carry insurance coverage in the types and amounts that we consider reasonably adequate to cover the risks we face. If insurance coverage is inadequate or unavailable or premium costs continue to rise, we may face additional claims not covered by insurance, and claims that exceed coverage limits or that are not covered could have a material adverse effect on us.

 

Disruption in our supply chain and changes to tax or trade policy could negatively impact our business.

 

Some of the ingredients, packaging materials, and other products we purchase may only be available from a single supplier or a limited group of suppliers, including suppliers located outside the U.S. in China and Canada. While alternate sources of supply are generally available, the supply and price are subject to market conditions and are influenced by other factors beyond our control. We do not have long-term contracts with many of our suppliers, and therefore they could increase prices or cease doing business with us. As a result, we may be subject to price fluctuations or demand disruptions.

 

The prices of raw materials, packaging materials and freight are subject to fluctuations in price attributable to, among other things, global competition for resources, weather conditions, changes in supply and demand of raw materials, or other commodities, fuel prices and government-sponsored agricultural programs. Volatility in the prices of raw materials and other supplies we purchase could increase our cost of sales and reduce our profitability, and we have no guarantees that prices will not rise. Our ability to pass along higher costs through price increases to our customers is dependent upon competitive conditions and pricing methodologies employed in the various sales channels in which we compete, and we may not be successful in implementing price increases. In addition, any price increases we do implement may result in lower sales volumes. Customers and consumers may choose to shift purchases to lower-priced private label or other value offerings which may adversely affect our results of operations.

 

Additionally, any major changes in tax or trade policy, such as the imposition of additional tariffs or duties on imported products, or trade sanctions, between the U.S. and countries from which we source merchandise, directly or indirectly, could require us to take certain actions, such as raising prices on our products or seeking alternative sources of supply from vendors with whom we have less familiarity, which could adversely affect our reputation, revenue, and our results of operations.

 

20

 

 

Risks Related to Our Common Stock

 

We may need to raise additional capital to execute on our growth plan. If we are unable to raise additional capital, our business may fail.

 

Although our current financial resources are sufficient for us to sustain our existing operations, we may be required to raise additional capital to help finance our planned growth within the financial services sector; particularly, as we will be caused to fund the start-up operations and planned expansion of our newly acquired entities, Renu Labs and Opencash. If we find that we need, but are unable, to obtain adequate additional financing, we may not be able to successfully market and sell our products and our business operations will most likely be discontinued. To secure additional financing, we may need to borrow money or sell more securities. Under these circumstances, we may be unable to secure additional financing on favorable terms or at all. Selling additional stock, either privately or publicly, would dilute the equity interests of our stockholders. If we borrow money, we will have to pay interest and may also have to agree to restrictions that limit our operating flexibility. If we are unable to obtain adequate financing on terms acceptable to us, we may have to curtail business operations, which would have a material negative effect on operating results and most likely result in a lower stock price.

 

Our recent settlement with the SEC may limit our ability to access private financings.

 

Our recent January 17, 2025 settlement with the SEC, in as much as it causes us to cease and desist from committing any further violations of Sections 5(a) and 5(c) of the Securities Act, could, absent an SEC waiver, impair our efforts to raise private capital under a commonly used exemption from the SEC’s registration requirements, which could make our financing efforts more difficult and less efficient.

 

Our common stock price has been and may continue to be extremely volatile.

 

Our common stock has closed as low as $0.004 per share and as high as approximately $0.030 per share during the year ended December 31, 2024. We believe this volatility may be caused, in part, by variations in our quarterly operating results, delays in development of our technologies, changes in market valuations of similar companies, and the volume of our stock in the market.

 

Additionally, in recent years the stock market in general, and the OTC Markets and technology stocks in particular, have experienced extreme price and volume fluctuations. In some cases, these fluctuations are unrelated or disproportionate to the operating performance of the underlying company. These market and industry factors may materially and adversely affect our stock price regardless of our operating performance. The historical trading of our common stock is not necessarily an indicator of how it will trade in the future and our trading price as of the date of this report is not necessarily an indicator of what the trading price of our common stock might be in the future.

 

In the past, class action litigation has often been brought against companies following periods of volatility in the market price of those companies’ common stock. If we become involved in this type of litigation in the future it could result in substantial costs and diversion of management attention and resources, which could have a further negative effect on our stock price.

 

Sales of substantial amounts of our common stock in the public markets or the perception that sales might occur, could cause the trading price of our common stock to decline.

 

Our current and former officers, directors and certain of our significant shareholders will soon be permitted to sell in the market up to an aggregate of approximately 381,205,961 shares of our common stock, as well as 565 million shares of our common stock that may be issuable in the future upon the redemption, if at all, of shares of Class B Redeemable Units of our IFGH subsidiary, that were issued in September 2021 in connection with our acquisition of the algorithmic trading platform of MPower, as the lock-up agreement that prohibited any such market sales is scheduled to expire on April 25, 2025. Sales of substantial amounts of stock in the public markets following the expiration of the lock-up period, or the perception that sales might occur, could cause the trading price of our common stock to decline.

 

Conversion of existing convertible notes purchased by DBR Capital could cause additional substantial dilution to our stockholders.

 

Under the terms of its convertible notes, DBR Capital has the right to convert an aggregate of $3.3 million in principal of convertible notes into shares of our common stock at a conversion price of $0.007 per share. Exclusive of interest that could accrue on these notes, conversion of the outstanding principal of these notes would result in the issuance to DBR Capital of approximately 471 million additional shares of our common stock. Substantial additional dilution of up to an additional 1,100,000,000 shares of our common stock could be experienced by our shareholders should DBR Capital advance and ultimately convert additional notes of $7.7 million on or before December 31, 2026. The presence of these arrangements could make it difficult for the Company to attract third-party capital in the future.

 

21

 

 

Special Governance Rights included within DBR Capital’s investments enable DBR Capital to retain significant control of the Company for the foreseeable future.

 

In connection with its investment, DBR Capital, LLC, has been accorded certain special governance rights, including the right to appoint four of our seven directors, and to require that certain capital, financial and other material actions of our board of directors be approved by at least one DBR Capital-appointed director, who shall be David B. Rothrock if he is then serving as a director. The special governance rights shall remain in place for so long as DBR Capital holds a convertible note or any of our other securities. The presence of these governance rights could make it difficult for the Company to attract third-party capital in the future.

 

The trading price of shares of our common stock may increase or decrease as does the trading price of Bitcoin and other digital currencies, which subject investors to pricing risks, including “bubble” type risks, and volatility.

 

Because of our connection with Bitcoin, the trading prices of our common stock may at times be tied to the trading prices of Bitcoin and such other digital currencies. Specifically, we may experience adverse effects on our stock price when the value of Bitcoin or other digital currencies drops. Furthermore, if the market for Bitcoin or other digital currency company stocks or the stock market in general experiences a loss of investor confidence, the trading price of our stock could decline for reasons unrelated to our business, operating results or financial condition. The trading price of our common stock could be subject to arbitrary pricing factors that are not necessarily associated with traditional factors that influence stock prices or the value of non-cryptocurrency assets such as revenue, cash flows, profitability, growth prospects or business activity since the value and price, as determined by the investing public, may be influenced by uncertain contingencies such as future anticipated adoption or appreciation in value of cryptocurrencies or Blockchains generally, and other factors over which we have little or no influence or control.

 

Bitcoin and other cryptocurrency market prices, which have historically been volatile and are impacted by a variety of factors, are determined primarily using data from various exchanges, over-the-counter markets and derivative platforms. Furthermore, such prices may be subject to factors such as those that impact commodities, more so than business activities, which could be subjected to additional influence from fraudulent or illegitimate actors, real or perceived scarcity, and political, economic, regulatory or other conditions. Pricing may be the result of, and may continue to result in, speculation regarding future appreciation in the value of cryptocurrencies, or our share price, making their market prices more volatile or creating “bubble” type risks for the trading price of Bitcoin.

 

Conversion of exchangeable shares issued in connection with the acquisition of the assets of MPower.

 

During September 2021, we acquired, among other assets, a proprietary algorithmic trading platform from MPower, a business controlled by two members of our Board of Directors. The assets of MPower were acquired in consideration of the issuance of Class B Redeemable Units consisting of non-voting membership interests in our wholly owned subsidiary IFGH that are in the future redeemable for 565,000,000 Company common shares on a one-for-one basis. That could ultimately result in the issuance of 565,000,000 Company common shares, presently representing over 23% of the Company’s current fully-diluted shares.

 

Additional issuances of stock options and warrants, convertible notes, and stock grants will cause additional substantial dilution to our stockholders.

 

Given our growth plans, and given our current limited cash resources, it is possible that in the future we will need to issue additional warrants, stock grants, and convertible debt to finance our future business operations and acquisitions and strategic relationships. The issuance of additional shares of common stock, the exercise of warrants, and the conversion of debt to stock could cause additional dilution to our stockholders and could have further adverse effects on the market price for our securities or on our ability to obtain future financing. The 2018 increase in our authorized common shares from two billion to ten billion increased the magnitude of this risk substantially.

 

Shares of our common stock may never become eligible for trading on Nasdaq or a national securities exchange: we do not have a majority of independent directors.

 

We cannot assure that we will ever be listed on the Nasdaq Stock Market or on another national securities exchange. Listing on one of the Nasdaq markets or one of the national securities exchanges is subject to a variety of requirements, including, among others, us having a majority of independent directors, a minimum trading price and a minimum public “float” requirement. There are also continuing eligibility requirements for companies listed on national securities exchanges. If we are unable to satisfy the initial or continuing eligibility requirements of any such market, then our stock may not be listed or could be delisted. This could result in a lower trading price for our common stock and may limit the ability of our stockholders to sell their shares, which could result in a loss of some or all of their investments.

 

If we fail to file periodic reports with the U.S. Securities and Exchange Commission, our common stock will not be able to be traded on the OTCQB.

 

Although our common stock is quoted on the OTCQB, a regular trading market for our common stock may not be sustained in the future. OTC Markets limits quotation on the OTCQB to securities of issuers that are current in their reports filed with the Securities and Exchange Commission. If we fail to remain current in the filing of our reports with the Securities and Exchange Commission, our common stock will not be able to be quoted on the OTCQB. The OTCQB is an inter-dealer market that provides significantly less liquidity than a national securities exchange or automated quotation system.

 

22

 

 

Because we have no plans to pay dividends on our common stock, stockholders must look solely to appreciation of our common stock to realize a gain on their investments.

 

We do not anticipate paying any dividends on our common stock in the foreseeable future. First, because we intend to retain earnings, if any, to finance the development and expansion of our business. Next, we are subject to certain restrictions on declaring dividends under our existing convertible note financing arrangements with DBR Capital, LLC and the Certificate of Designation of our Series B Preferred Stock. Our future dividend policy is within the discretion of our board of directors and will depend upon numerous factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities. Accordingly, stockholders must look solely to appreciation of our common stock to realize a gain on their investment. This appreciation may not occur.

 

Certain provisions of Nevada law and of our governing documents may inhibit a potential acquisition of our company, and this could negatively impact our stock price.

 

Nevada corporate law and our governing documents include provisions that could delay, defer, or prevent a change in control of our company or our management. These provisions could discourage information contests and make it more difficult for our stockholders to elect directors and take other corporate actions. As a result, these provisions could limit the price that investors are willing to pay in the future for shares of our common stock. For example:

 

  without prior stockholder approval, our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of our common stock and to determine the rights, privileges, and preferences of that preferred stock;
     
  there is no cumulative voting in the election of directors, which would otherwise allow less than a majority of stockholders to elect director candidates; and
     
  only our board of directors or stockholders holding at least 25% of the outstanding capital stock of the Company can call a special meeting of stockholders.

 

Our indemnification of our directors and officers may limit the rights of our stockholders.

 

While our board of directors and officers are generally accountable to our stockholders and us, the liability of our directors and officers to all parties is limited in certain respects under applicable state law and our articles of incorporation and bylaws, as in effect. Further, we have agreed or may agree to indemnify our directors and officers against liabilities not attributable to certain limited circumstances. This limitation of liability and indemnity may limit rights that our stockholders would otherwise have to seek redress against our directors and officers.

 

We may be caused to issue a substantial number of shares of our common stock to our former Chief Executive Officer if our attempts to retire his note in cash are unsuccessful.

 

We owe payment on a promissory note in the principal amount of $1,550,000 to our former Chief Executive Officer, Joseph Cammarata, (the “Cammarata Note”). Further, the Cammarata Note is convertible into shares of our common stock at $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period, and citing certain other damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and instead during 2022 asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares, although we believe his attempted conversion was not timely, nor in compliance with the conversion features of the note. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and otherwise at law, and Mr. Cammarata’s attempt to convert the note were ineffective, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note.

 

23

 

 

The amount of authorized common stock may result in management implementing anti-takeover procedures by issuing new securities.

 

The proportion of unissued authorized shares to issued shares could, under certain circumstances, have an anti-takeover effect, for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of our board of directors or contemplating a tender offer or other transaction for the combination of our company with another entity. Although, we have no current plans to issue additional stock for this purpose, management could use the additional shares that are now available or that may be available after a possible further recapitalization to resist or frustrate a third-party transaction. Generally, no stockholder approval would be necessary for the issuance of all or any portion of the additional shares of common stock unless required by law or any rules or regulations to which we are subject.

 

Our stockholders may not recoup all or any portion of their investment upon our dissolution.

 

In the event of a liquidation, dissolution, or winding-up of our company, whether voluntary or involuntary, our net remaining proceeds and/or assets, after paying all of our debts and liabilities, will be distributed to the holders of common stock on a pro-rata basis. We cannot assure that we will have available assets to pay to the holders of common stock any amounts upon such a liquidation, dissolution, or winding-up of our company. In this event, our stockholders could lose some or all of their investment.

 

Item 1B. Unresolved Staff Comments

 

None.

 

Item 1C. CYBERSECURITY

 

Risk Management and Strategy

 

The Company’s cybersecurity risk management practices are intended to assess, identify and manage risks from threats to the security of our information, systems, products and network. Our cybersecurity program is a key component of our broader risk management strategy in which cyber risk has been identified and is actively managed with preventive and mitigating measures. We design and assess our cybersecurity program based on the National Institute of Standards and Technology’s Cybersecurity Framework, ISO 27001, and industry-specific regulations. This does not imply that we meet any particular technical standards, specifications or requirements, but rather that we use them as a guide to help us identify, assess and manage cybersecurity risks relevant to our business.

 

Cybersecurity incidents could result from unintentional events, or from deliberate attacks by unauthorized entities or individuals attempting to gain access to Investview’s System Technology for the purposes of misappropriating assets or information or causing operational disruption and damage. To mitigate the risk of an impact to our business operations and/or damage from cybersecurity incidents or cyberattacks, Investview invests in multiple forms of cybersecurity and operational safeguards.

 

On an ongoing basis, we assess our people, processes, and technology, and when necessary, modify the overall program in order to meet the demands of the ever-changing cyber risk environment. As part of our regular training and readiness program, we conduct phishing and penetration testing campaigns in order to ensure that our employees are familiar with all types of phishing emails and similar threats.

 

Our data is dynamically backed up to mitigate against data loss. To prevent unauthorized access and data breaches, we encrypt sensitive data both in transit and at rest. We have also implemented access controls and multi-factor authentication to ensure that only authorized personnel can access sensitive information. We also utilize third-party information technology systems vendors to conduct regular network and endpoint monitoring.

 

Our risk management program is comprised of, among other things, policies that are designed to identify, assess, manage, and mitigate cybersecurity risk, and is based on applicable laws and regulations, derived from industry standards and best practices. These policies are intended to identify cybersecurity threats that may be associated with both internally managed systems and systems managed by third-party service providers.

 

We conduct risk assessments to evaluate the effectiveness of our systems and processes in addressing threats and to identify opportunities for enhancements. Additionally, we conduct privacy and cybersecurity reviews, as well as annual employee training, and monitor emerging laws and regulations related to information security and data protection. We utilize third party tools and techniques to test and enhance our security controls, perform annual cybersecurity framework assessments, conduct ongoing penetration testing of our systems, and benchmark against best practices. Our internal audit function provides an independent assessment on the overall operations of our cybersecurity program and the supporting framework.

 

Our cybersecurity team engages and utilizes third-party services as it monitors and actively responds to cybersecurity threats. We utilize an Endpoint Detection and Response (EDR) platform, an anti-virus application, through which incoming electronic communications are filtered, and an email security platform which seeks out identifiers in communications that disguise, impersonate, or otherwise misrepresent the source of the communication. If such a communication is detected, it is subject to quarantine or removal depending on the severity of issue. Additionally, we use a Security Information and Event Management (SIEM) system, which allows us to store logs off the system of record to prevent log tampering and provides the cybersecurity team functionality to build alerts on specific use cases that are important and unique to our business. If our applications fail or our software does not successfully block a malicious electronic communication, employees are required to notify an immediate supervisor or the cybersecurity team promptly, but in no circumstances later than twenty-four (24) hours after such occurrence.

 

24

 

 

Upon detection of a cybersecurity incident and initial intake and validation by our cybersecurity team, our incident response team triages and evaluates the cybersecurity incident, and, depending on the severity, escalates the incident to management and a cross-functional working group. Any incident assessed as potentially being or potentially becoming material is immediately escalated for further assessment and reported to executive management. Determination of what resources are needed to address the incident, prioritizing of response activities, forming of action plans, and notification of external parties as needed are then undertaken by executive management and the cross-functional working group, led by our Senior Information Officer (SIO). We consult with outside counsel as appropriate, including on materiality analysis and disclosure matters, and our executive management makes the final materiality and disclosure determinations, among other compliance decisions.

 

Governance

 

Our board, Senior Information Officer (“SIO”) and management actively assess the Company’s cybersecurity and data privacy risk management practices with the goal of being proactive rather than reactive. Our SIO and management regularly review the Company’s cybersecurity and data privacy risks, including our policies, controls and procedures for identifying, managing and mitigating such risks. Our SIO provides management with periodic reports regarding cybersecurity and data privacy measures and procedures, the identification of security gaps and compliance with applicable cybersecurity and data privacy regulations. Management then briefs our board at scheduled meetings regarding cybersecurity and data privacy developments.

 

Management and our SIO are responsible for day-to-day monitoring of the prevention, detection, mitigation and remediation of cybersecurity incidents. Our SIO, who reports to our Chief Operating Officer, has primary oversight of the material risks from cybersecurity and data privacy matters. Our SIO has more than 20 years of experience across various information technology, information security and management roles, including leading the development and implementation of cybersecurity and data privacy strategies for the employee and customer-facing aspects of our business.

 

In 2024, we did not identify any cybersecurity incidents or threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations or financial condition. However, despite our efforts, we may not be successful in eliminating all risks from cybersecurity threats and can provide no assurances that undetected cybersecurity incidents have not occurred. See Part I, Item 1A. “Risk Factors” of this Annual Report for more information regarding the cybersecurity risks we face.

 

Item 2. Properties

 

Our corporate headquarters consisting of approximately 7,102 square feet of office space are located at 521 West Lancaster Avenue, Second Floor, Haverford, Pennsylvania 19041 and are being leased under a one-year lease agreement that will expire in December 2025. Our iGenius LLC headquarters consisting of approximately 1,325 square feet of office space are located at 459 North 300 West, #15, Kaysville, Utah 84037 and is on a month-to-month lease. The manufacturing headquarters consisting of approximately 12,500 square feet of office and manufacturing space for Renu Laboratories LLC are located at 1836 Stout Drive, #1, 2, 5, 6, and 7, Warminster, Pennsylvania 18974 and are being leased under a 14-month lease that will expire in December 2025. Additionally, approximately 5,849 square feet of warehouse space for Renu Laboratories LLC located at 48 Vincent Circle, #48A, Ivyland, Pennsylvania 18974 is being leased for storage of materials and pre-finished goods under a 2-year lease agreement that will expire in December 2026. Our Opencash Securities LLC headquarters, consisting of approximately 134 square feet of office space, are located at 1120 NASA Parkway, #220C, Houston, Texas, 77058 and is on a one-year lease that will expire in December 2025. We lease administrative office space, which is located at 386 Main Street, #212, Wyckoff, New Jersey 07481 and is being leased under a two-year lease agreement that will expire in July 2025 with an option for the Company to terminate with 60 days’ written notice.

 

Item 3. Legal Proceedings

 

In the ordinary course of business, we may be or have been involved in legal proceedings from time to time; however, we do not anticipate that the outcome of such matters and disputes will materially affect our financial statements.

 

None of our directors, officers, or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

We are not currently involved in any material legal proceedings. However, during November 2021, we received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. The SEC order, the factual and legal findings of which we neither admit nor deny, relates to a program developed by prior management involving the sale/leaseback of high-performance server equipment primarily used for bitcoin mining to investors from July 2019 through June 2020. In its order, the SEC concluded that the interests of the Company offered in connection with the program were unregistered investment contracts sold in violation of Sections 5(a) and 5(c) of the Securities Act of 1933, as amended. On January 17, 2025, we reached an agreement and entered into a settlement with the SEC to resolve the inquiry. As part of the settlement, we agreed to pay the SEC a penalty of $375,000 and to cease and desist from continuing any further violations of Sections 5(a) and 5(c) of the Securities Act of 1933, as amended.

 

25

 

 

Item 4. Mine Safety Disclosure

 

Not applicable

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Our common stock is quoted on the OTCQB under the symbol “INVU.” You should be aware that over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not necessarily represent actual transactions.

 

As of March 20, 2025, we had approximately 624 stockholders of record of our common stock and 1,858,525,896 shares of common stock issued and outstanding.

 

Dividends

 

Holders of shares of common stock are entitled to share pro rata in dividends and distributions for the common stock when, as, and if declared by the board of directors out of funds legally available therefor. We have not paid any dividends on our common stock. Other than payment of a dividend of $3.25 per annum, paid quarterly, on our 13% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), we intend to retain earnings, if any, to finance the development and expansion of our business. In addition, we and our subsidiaries are subject to certain restrictions on declaring dividends under our existing Convertible Note Financing Arrangements with DBR Capital, LLC and the Certificate of Designation of our Series B Preferred Stock. Future dividend policy is subject to the discretion of the board of directors and will depend upon a number of factors, including future revenues, capital requirements, overall financial condition, and such other factors as our board of directors deems relevant.

 

Recent Sales of Unregistered Securities

 

None.

 

Item 6. [Reserved]

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with our consolidated financial statements and notes to our financial statements included elsewhere in this report. This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as noted by use of the words “believe,” “expect,” “plan,” “project,” “estimate,” and similar expressions are used, they identify forward-looking statements. These forward-looking statements are based on management’s current beliefs and assumptions and information currently available to management, and involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found elsewhere in this Report and in our periodic reports filed with the U.S. Securities and Exchange Commission. The forward-looking statements included are made only as of the date of this report. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of the report.

 

Overview

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion; an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

26

 

 

Recent Material Developments

 

Private Share Repurchase Transactions

 

We have attempted to repurchase shares privately, when the circumstances arise, as an opportunistic way to use our existing cash resources strategically to add shareholder value by significantly reducing our outstanding capitalization at a discounted price to the market. These opportunities have arisen for us on three occasions. First, on September 29, 2023, we purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock from two of our former Directors and executive officers, and a series of their family members and related entities. The shares were purchased for an aggregate consideration of $2,922,380, equating to a price of $0.00964739 per share; representing a discount of approximately 52.5% to the average market price at the time of closing. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. See Item 13 of this Form 10-K for additional details on the transaction.

 

Next, further private purchases were effectuated on February 7, 2024, when we repurchased for surrender and cancellation an aggregate of 472,374,710 shares of the Company’s common stock from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. These shares were purchased for an aggregate purchase price of $3,571,146, equating to a price of $0.007559985 per share; representing a discount of approximately 57.6% to the average market price at the time of the closing. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. See Item 13 of this Form 10-K for additional details on the transaction.

 

Finally, on October 25, 2024, we announced that we entered into an agreement to purchase from certain non-affiliated shareholders, in a private transaction, a total of 121 million shares of our common stock. Closing under the share purchase transaction, however, was subject to certain customary and standard closing conditions, including, primarily, the delivery of the purchased shares to the Company at a closing to be conducted on or before an outside termination date of February 23, 2025. As of the date of this Report, the sellers in the transaction have been unable to arrange delivery of the shares. Accordingly, we cannot assure that the transaction will occur as announced. We have reserved our rights under the agreement.

 

Acquisition of Business of Opencash

 

On March 18, 2024, we announced the acquisition of Opencash, an early-stage registered broker-dealer that plans to offer investors an online platform to enable self-directed retail brokerage and other related services.

 

Acquisition of Business of Renu

 

On October 11, 2024, we acquired substantially all of the business and assets of Renu Labs. The total purchase price of Renu Labs was $1,780,000. As part of this acquisition, we also issued 5,000,0000 stock options to the principal of Renu Labs, which options are scheduled to vest in equal amounts over a five-year period, at an exercise price of $0.05 per share with a ten-year life.

 

Settlement of Outstanding Matter with the SEC

 

During November 2021, we received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. The SEC order, the factual and legal findings of which we neither admit nor deny, relates to a program developed by prior management involving the sale/leaseback of high-performance server equipment primarily used for bitcoin mining to investors from July 2019 through June 2020. In its order, the SEC concluded that the interests of the Company offered in connection with the program were unregistered investment contracts sold in violation of Sections 5(a) and 5(c) of the Securities Act of 1933, as amended. On January 17, 2025, we reached an agreement and entered into a settlement with the SEC to resolve the inquiry. As part of the settlement, we agreed to pay the SEC a penalty of $375,000 and to cease and desist from continuing any further violations of Sections 5(a) and 5(c) of the Securities Act of 1933, as amended.

 

Amendment of Credit Arrangements with DBR Capital

 

On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”), approved by the disinterested members of the Company’s Board of Directors. Pursuant to the Amendment, DBR has been given until August 31,2025 to lend to the Company a minimum of $2.0 million, and until December 31, 2026 to lend to the Company balance of up to $5.7 million. The Amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million.

 

Announcement of Stock Repurchase Program

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. As of the date of this filing, 705,890 shares have been repurchased for $16,618. These shares are being held by the Company in Treasury.

 

Results of Operations

 

Year Ended December 31, 2024, Compared to Year Ended December 31, 2023

 

Revenues

 

   Year Ended December 31,   Increase 
   2024   2023   (Decrease) 
             
Membership revenue, net of refunds, incentives, credits, and chargebacks  $47,061,290   $56,036,052   $(8,974,762)
Mining revenue   5,186,606    11,348,156    (6,161,550)
Health and wellness product sales   110,671    -    110,671 
Cryptocurrency revenue   -    513,285    (513,285)
Mining equipment repair revenue   23,404    23,378    26 
Total revenue, net  $52,381,971   $67,920,871   $(15,538,900)

 

Total revenue, net, decreased $15,538,900, or 23%, from $67,920,871 for the year ended December 31, 2023, to $52,381,971 for the year ended December 31, 2024. The decreases of $9.0 million, $6.2 million, and $513 thousand pertain to a contraction in our membership revenue, mining revenue, and cryptocurrency revenue, respectively. The $9.0 million (16%) decrease in membership revenue was largely attributable to a combination of shifts in consumer behavior and demand following the COVID-19 pandemic as individuals re-evaluated their spending priorities, lifestyle habits, and engagement preferences, as well as broader global macroeconomic changes that have caused a general slowdown in direct sales and home-based business. This trend reflects broader market changes and has impacted overall participation and retention rates. The $6.1 million (54%) decrease in mining revenue was a result of “Bitcoin Halving” which occurred on April 19th, 2024, decreasing the reward to 3.125 Bitcoin per block solved from the previous reward rate of 6.25 Bitcoin per block solved, an increase in Bitcoin Network Difficulty and a mandated power curtailment enforced by the government-controlled utility companies in Northern Europe, partially offset by an increase in the price of Bitcoin; and the $513 thousand decrease in cryptocurrency revenue was due to the discontinuation of our distribution of NDAU during the year ended December 31, 2023. These decreases were offset by a $111 thousand increase in health and wellness product sales which can be explained by the purchase of the business and assets of Renu Laboratories, Inc. in October 2024.

 

27

 

 

Operating Costs

 

   Year Ended December 31,   Increase 
   2024   2023   (Decrease) 
             
Cost of sales and service  $6,056,491   $10,736,709   $(4,680,218)
Commissions   25,913,260    31,716,399    (5,803,139)
Selling and marketing   569,491    560,065    9,426 
Salary and related   6,626,588    7,112,954    (486,366)
Professional fees   1,547,288    1,378,367    168,921 
Impairment expense   1,771,891    2,056,386    (284,495)
Loss (gain) on disposal of assets   180,223    223,630    (43,307)
General and administrative   8,022,020    9,531,431    (1,509,411)
Total operating costs and expenses  $50,687,252   $63,315,941   $(12,628,689)

 

Operating costs decreased $12,628,689, or (20%), from $63,315,941 for the year ended December 31, 2023, to $50,687,252 for the year ended December 31, 2024. The decrease can be explained by a reduction in commissions of $5.8 million, which was a result of a decrease in our membership revenue, a decrease in cost of sales and services of $4.7 million, which was a result of a power curtailment mandated by the government-controlled utility companies in Northern Europe, a decrease in salary and related of $486 thousand, which was a result of a decrease in stock based compensation, a decrease in general and administrative expenses, which was a result of decreases in credit card processing fees due to the decreases in our membership revenue and decreases in costs related to our mining operations, and a decrease in impairment expense of $285 thousand due to impairment of our data processing equipment during the current year being slightly less than the impairment of other assets in the prior year.

 

Other Income (Expense)

 

   Year Ended December 31,     
   2024   2023   Change 
             
Loss on Settlement  $(375,000)  $-   $(375,000)
Gain (loss) on fair value of derivative liability   4,974    18,691    (13,717)
Realized gain (loss) on cryptocurrency   452,450    255,268    197,182 
Interest expense   (18,801)   (18,750)   (51)
Interest expense, related parties   (1,240,529)   (1,239,603)   (926)
Other income (expense)   1,567,543    1,389,796    177,747 
Total other income (expense)  $390,637   $405,402   $(14,765)

 

We recorded other income of $390,637 for the year ended December 31, 2024, which was a decrease of $14,765, or 4%, from the prior year other income of $405,402. The change is due to a realized gain on cryptocurrency in the current period of $452 thousand compared to a realized gain of $255 thousand in the prior year and an increase in other income in the current period of $178 thousand, as we recognized more interest income in the current period due to our cash balances being held in higher interest-bearing accounts, as compared to the equivalent prior year period, and as a result of an increase in ticket sales from certain promotional events iGenius held during the years ended December 31, 2024 and 2023. These increases were offset by a loss on settlement in the current year with the SEC to resolve the SEC inquiry previously disclosed by the Company in November 2021.

 

Liquidity and Capital Resources

 

During the year ended December 31, 2024, we met our short-and long-term working capital and capital expenditure requirements. Our net cash provided by operating activities for the year ended December 31, 2024, was $8.3 million. We used our cash provided by operating activities for the acquisition of substantially all the assets of Renu Labs for $1.1 million, the purchase of fixed assets in the amount of $0.5 million, principal and interest payments on debt of $1.3 million, the repurchase of common shares totaling $3.4 million, total dividend payments on our preferred stock of $0.7 million and added $1.3 million to our cash balance, which totaled $22.5 million at December 31, 2024. We believe we will have sufficient resources, including cash flow from operations and access to capital markets, to meet debt service and other obligations in a timely manner and be able to meet our objectives.

 

Trends, Risks, and Uncertainties

 

During 2024, we experienced a material contraction in the revenues generated by our Financial Education and Technology, and our Blockchain Technology and Crypto Mining Products and Services, business units. In the case of our Financial Education and Technology business unit, the contraction was largely attributable to a combination of shifts in consumer behavior and demand following the COVID-19 pandemic as individuals re-evaluated their spending priorities, lifestyle habits, and engagement preferences, as well as broader global macroeconomic changes that have caused a general slowdown in the direct sales and home-based business industry. In the case of our Blockchain Technology and Crypto Mining Products and Services business unit, the contraction was largely attributable to a combination of the “Bitcoin Halving” which occurred on April 19th, 2024, decreasing the reward to 3.125 Bitcoin per block solved from the previous reward rate of 6.25 Bitcoin per block solved, an increase in Bitcoin Network Difficulty and a mandated power curtailment enforced by the government-controlled utility companies in Northern Europe, partially offset by an increase in the price of Bitcoin. As we have seen no material change during 2025 in the underlying macroeconomic conditions that caused these contractions in 2024, we have reason to believe that trends we experienced in 2024 will likely continue in 2025. Against these headwinds, in 2025, we believe that as we start to commercialize our Opencash business, and as we start to experience some of the growth we expect from our health and wellness business unit, we may start to experience revenue growth that was not available during 2024, although we do not expect that these possible lines of growth will in the short-term suffice to offset the contraction in revenue we experience during 2024. We have otherwise sought to identify in our Risk factors discussion and elsewhere in this Annual Report on Form 10-K, what we believe to be the most significant risks to our business, but we cannot predict whether, or to what extent, any of such risks may be realized nor can we guarantee that we have identified all possible risks that might arise. Investors should carefully consider all such risk factors before making an investment decision with respect to our common stock.

 

28

 

 

Commitments and Contingencies

 

Related Party Debt

 

At December 31, 2024, we had related party debt of approximately $2.7 million and debt of approximately $520 thousand.

 

Third-Party Vendor Buy-Back Program

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program.

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

Debt and Equity Transactions with Former Officer

 

Beginning in March 2021, we engaged in certain debt and equity transactions with Joseph Cammarata, who served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021, certain of which have exposed the Company to the uncertainty of possible claims in the future. For additional information, please see Note 10, “Commitments and Contingencies” to our audited consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K.

 

Critical Accounting Policies

 

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are several significant accounting policies affecting our consolidated financial statements; we believe the following critical accounting policies involve the most complex, difficult, and subjective estimates and judgments.

 

29

 

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Long-Lived Assets – Intangible Assets & License Agreement

 

We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $1,127,891 and $585,632, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($5,186,606 and $11,348,156 for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $452,450 and $255,268, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $2,056,386. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $0 due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.

 

Impairment of Long-Lived Assets

 

We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.

 

During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $1,771,891. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, no impairment was recorded.

 

30

 

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $1,905,734 and $2,703,398, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $1,014,164.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania, are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

Cryptocurrency Revenue

 

During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.

 

During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.

 

During 2024, we generated no revenue from the sale of cryptocurrency packages.

 

31

 

 

Mining Equipment Repair Revenue

 

Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.

 

Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2024, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $50,086,839   $5,186,606   $110,856   $23,404   $55,407,705 
Refunds, incentives, credits, and chargebacks   (3,025,549)   -    (185)   -    (3,025,734)
Net revenue  $47,061,290   $5,186,606   $110,671   $23,404   $52,381,971 

 

Foreign revenues for the year ended December 31, 2024 were approximately $42.9 million while domestic revenue for the year ended December 31, 2024 was approximately $9.5 million.

 

Revenue generated for the year ended December 31, 2023

 

Revenue generated for the year ended December 31, 2023, was as follows:

 

  

Membership

Revenue

   Cryptocurrency Revenue   Mining Revenue   Miner Repair Revenue   Total 
Gross billings/receipts  $60,516,836   $990,785   $11,348,156   $23,378   $72,879,156 
Refunds, incentives, credits, and chargebacks   (4,480,784)   -    -    -    (4,480,784)
Amounts paid to supplier   -    (477,500)   -    -    (477,500)
Net revenue  $56,036,052   $513,285   $11,348,156   $23,378   $67,920,871 

 

Foreign revenues for the year ended December 31, 2023 were approximately $51.0 million while domestic revenue for the year ended December 31, 2023 was approximately $16.9 million.

 

Recent Accounting Pronouncements

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued (or made available for issuance). If an entity adopts the amendments in an interim period, it must adopt them as of the beginning of the fiscal year that includes that interim period. ASU No. 2023-08 requires a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company has not yet adopted ASU No. 2023-08 and is currently evaluating the impact that the adoption will have on the Company’s financial statement presentation and disclosures.

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company did not elect early adoption and is currently evaluating the impact the updated guidance will have on its 2025 disclosures.

 

32

 

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance reportable segment disclosures by requiring disclosures of significant segment expenses regularly provided to the CODM, requiring disclosure of the title and position of the CODM and explanation of how the reported measures of segment profit and loss are used by the CODM in assessing segment performance and allocation of resources. ASU 2023-07 is effective for the Company for annual periods beginning after December 31, 2023. The Company adopted ASU 2023-07 for the year ended December 31, 2024. As a result of the adoption, the Company added this disclosure in Note 11. Segment Information, to present significant expenses that are included within cost of revenue, by reportable segment, which are presented to the CODM.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

Cautionary Factors That May Affect Future Results

 

We have sought to identify what we believe are significant risks to our business, but we cannot predict whether, or to what extent, any of such risks may be realized nor can we guarantee that we have identified all possible risks that might arise.

 

Potential Fluctuations in Annual Operating Results

 

Our annual operating results may fluctuate significantly in the future as a result of a variety of factors, most of which are outside our control, including: the demand for our products and services; seasonal trends in purchasing, the amount and timing of capital expenditures; price competition or pricing changes in the market; technical difficulties or system downtime; and general economic conditions.

 

Our annual results may also be significantly impacted by the accounting treatment of acquisitions, financing transactions, or other matters. Particularly at our early stage of development, such accounting treatment can have a material impact on the results for any quarter. Due to the foregoing factors, among others, it is likely that our operating results may fall below our expectations or those of investors in some future quarter.

 

Management of Growth

 

Although we have recently experienced a decrease in our revenues and net income, we believe that as we start to commercialize our Opencash business, and as we start to experience some of the growth we expect from our health and wellness business unit, we may start to experience growth, which will place a strain on our managerial, operational, and financial systems resources. To accommodate our current size and manage growth if it occurs, we must devote management attention and resources to improve our financial strength and our operational systems. Further, we will need to expand, train, and manage our sales and distribution base. There is no guarantee that we will be able to effectively manage our existing operations or the growth of our operations, or that our facilities, systems, procedures, or controls will be adequate to support any future growth. Our ability to manage our operations and any future growth will have a material effect on our stockholders.

 

Companies quoted on the OTCQB tier of OTC Markets, such as us, must be reporting issuers under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and must be current in their reports under Section 13, to maintain price quotation privileges on the OTCQB tier. If we fail to remain current on our reporting requirements, we could be removed from the OTCQB tier. As a result, the market liquidity for our securities could be severely adversely affected by limiting the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.

 

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

 

We are not required to provide the information required by this item.

 

Item 8. Financial Statements and Supplementary Data

 

The financial statements begin on Page F-1.

 

33

 

 

Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including the principal executive officer and the principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13(a)-15(e) under the Exchange Act, as of the end of the period covered by this report. Based on this evaluation management concluded that our disclosure controls and procedures were effective as of December 31, 2024.

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurances regarding the reliability of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles, or GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate.

 

With the participation of our Chief Executive Officer and Chief Financial Officer (principal financial officer), our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2024, based on the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our evaluation, management concluded that we maintained effective internal control over financial reporting as of December 31, 2024, based on the COSO framework criteria. Management believes our processes and controls are sufficient to ensure the consolidated financial statements for the year ended December 31, 2024, included in this Form 10-K, were fairly stated in accordance with U.S. GAAP.

 

Management’s report on internal control over financial reporting was not subject to attestation by our registered public accounting firm pursuant to Securities and Exchange Commission rules that permit us to provide only management’s report in this Annual Report on Form 10-K.

 

Limitations on Effectiveness of Controls and Procedures

 

Our management, including our Chief Executive Officer and Chief Financial Officer (principal financial officer), does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Changes in Internal Controls

 

During the fiscal quarter ended December 31, 2024, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

Item 9B. Other Information

 

During the fourth quarter of the fiscal year ended December 31, 2024, no director or “officer” as defined in Rule 16a-1(f) under the Exchange Act adopted or terminated any Rule 10b5-1 trading plan or arrangements or any non-Rule 10b5-1 trading plan or arrangements, in both cases as defined in Item 408(a) of Regulation S-K.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable.

 

34

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Directors and Executive Officers

 

The following table sets forth certain information with respect to our directors and executive officers:

 

Name   Age   Position   Serving Since
David B. Rothrock   60   Chairman   2020
Victor M. Oviedo   48   Chief Executive Officer and Director   2022
James Bell   59   President, Chief Operating Officer and Director   2020
Ralph R. Valvano   55   Chief Financial Officer   2021
Jayme L. McWidener   46   Chief Accounting Officer   2019

 

David B. Rothrock has extensive executive management, board, and operational expertise in the automobile industry, fintech, financial services, residential and commercial real estate, property management, corporate financing, private equity, utility technology, environmental remediation services, insurance, wine retail operations and distribution, and wealth management. Mr. Rothrock is the chief executive officer of DBR Capital, LLC, a family investment office. Through his leadership, guidance, and vision, in key roles as president and chief executive officer of DBR Capital LLC, MPower Trading Systems, LLC (a fintech firm), Cedar Crest Partners G.P. LLC (a real estate holding t company), and Rothrock Motors Sales, Inc. (a group of franchised automobile dealerships), these businesses collectively generated over $300 million in annual sales revenue. Mr. Rothrock is an active board member of charitable organizations that support breast cancer research and women’s health and fitness as well as the arts and theater in Lehigh Valley, PA. Mr. Rothrock has a B.S. in Business Management graduating Magna Cum Laude from Widener University and holds a J.D. from the New York Law School with bar admittance to New York, New Jersey, and Pennsylvania. Mr. Rothrock was appointed to the Board at the request of DBR Capital, LLC, pursuant to the terms of a Voting Agreement between DBR Capital and certain key holders of our common stock dated April 27, 2020 and amended November 9, 2020. Mr. Rothrock is the sole owner of DBR Capital, LLC. See Item 13. Certain Relationships and Related Transactions, and Director Independence. We believe Mr. Rothrock is qualified to serve as a director due to his executive management, board, and operational expertise across multiple disciplines and industries.

 

Victor M. Oviedo has served as our Chief Executive Officer since February 2022. Prior to joining Investview, Mr. Oviedo served since February 2018 as co-founder and Managing Partner for StageLight Group, a strategic capital and advisory firm which provides strategic capital to early and growth-stage companies. Before StageLight Group, he was a Partner at SkyBridge Capital, an alternative asset manager and investment advisor, and Global Head of Business Development & Strategy where he was directly responsible for the firm’s growth, international expansion, new business development and brand strategy initiatives. During his 12-year tenure, he was instrumental in growing the firm’s assets from $300M to $14B, acquiring their flagship fund-of-fund business and creating & launching the world-renowned SALT Conference. Prior to joining SkyBridge, Mr. Oviedo was a Senior Consultant within Oliver Wyman’s capital markets division where he focused on international acquisitions and growth strategies for major financial institutions. In addition, he was a Manager of Strategic Growth for Kozmo – a venture capital funded start-up. He began his career as an investment banker at Donaldson, Lufkin & Jenrette (DLJ) within the media & communications team. Mr. Oviedo received an MBA in Finance & Entrepreneurship from the Wharton School at the University of Pennsylvania and a MA in Advance International Studies from the Paul H. Nitze School of Advanced International Studies (SAIS) at Johns Hopkins University. He also graduated with honors with a BSFS in International Economics from the Edmund A. Walsh School of Foreign Service at Georgetown University. We believe Mr. Oviedo is qualified to serve as a director based on his role as our Chief Executive Officer and his extensive management experience in the financial industry.

 

James R. Bell has extensive experience in financial management and operations with more than 30 years of experience in the capital markets. Mr. Bell has served as our President and Chief Operating Officer since February 2022, after having served for a brief time as our Acting Chief Executive Officer. Previously, as co-founder and chief executive officer of MPower Trading Systems, LCC, a fintech firm, Mr. Bell was responsible for overseeing all principal functions of the firm, including corporate strategy and deployment of initiatives, product, and partnerships. Mr. Bell has been at the forefront of online trading since its infancy. Prior to co-founding MPower in 2004, Mr. Bell served as managing director of trading development of thinkorswim-TD Ameritrade, Inc. from 2002-2011, where he led the company’s product and technology team to develop client digital content. Mr. Bell is co-founder and passive investor of Shadow Trader Technologies, which provides real-time digital financial research and education content to TD Ameritrade/Charles Schwab (2004-December 31, 2023). Prior to MPower, Mr. Bell also co-founded B/C Interactive Trading Technologies in 2001, which was ultimately sold to MPower in 2004. Prior to B/C, Mr. Bell served as SVP of Janney Montgomery Scott, and before that position, with Morgan Stanley. Mr. Bell studied economics and business management at Frostburg State University. Mr. Bell holds multiple business accreditations and previously held securities licenses, including FINRA Series 7, FINRA Series 55, and FINRA Series 63. Mr. Bell was appointed to the Board at the request of DBR Capital, LLC, pursuant to the terms of a Voting Agreement between DBR Capital and certain key holders of our common stock dated April 27, 2020, and amended November 9, 2020. We believe Mr. Bell is qualified to serve as a director due to his extensive experience in financial management and operations.

 

35

 

 

Ralph R. Valvano has over 26 years of global finance and transformation experience in the financial services industry. Mr. Valvano has served as our Chief Financial Officer since June 2021. Mr. Valvano’s prior experience included the positions of CFO/COO of J.C. Flowers Asset Management, part of a $15 billion-dollar private equity firm, Financial Operations and Principal (FinOp) of J.C. Flowers Securities, a FINRA registered broker-dealer, and CFO of Flowers National Bank NA. Prior to that Mr. Valvano held various roles at JPMorgan Chase & Co. and ended his tenure as the Global Investment Bank Management Controller. Mr. Valvano began his career as a financial services auditor for PricewaterhouseCoopers. He earned a BS in Accounting from William Paterson University, a MS in Tax from Fairleigh Dickinson University and obtained his CPA license in 1994.

 

Jayme L. McWidener has served as our Chief Accounting Officer since June 2021 and prior to that, as our Chief Financial Officer, from September 2019. Ms. McWidener earned her bachelor’s degree and Masters of Business Administration from Drake University and became an auditor for Cahaba GBA in 2001 before joining HJ & Associates, LLC (“HJ”) in January 2004 as an audit staff member. She obtained her CPA license in 2007 and worked at HJ focusing on auditing SEC reporting companies, eventually being promoted to an audit senior and audit manager before she became a partner at HJ in January 2014. Ms. McWidener spent just over 2 years as a partner with HJ and with its successor, Haynie & Company. In April of 2016 she established Mac Accounting Group & CPAs, LLP, specializing in PCAOB audits for SEC reporting companies and AICPA audits for private companies in a variety of industries.

 

Our directors are elected for a term of one year and until their successors are qualified, nominated, and elected.

 

Role of the Board

 

It is the paramount duty of the board to oversee our management in the competent and ethical operation of the company on a day-to-day basis and to assure that the long-term interests of the shareholders are being served. To satisfy this duty, the directors take a proactive, focused approach to their position, and set standards to ensure that we are committed to business success through maintenance of ambitious standards of responsibility and ethics.

 

The board of directors met formally seven times and acted by written consent six times during the year ended December 31, 2024.

 

Special Governance Rights Associated with the Investment of DBR Capital, LLC

 

In connection with its investment, DBR Capital, LLC has been accorded certain special governance rights, including the right to appoint four of our seven director’s positions (of which, four remain vacant) so long as it holds a convertible note or any of our other securities. The investment agreements also require that certain capital, financial and other material actions of our board of directors be approved by at least one DBR Capital appointed director, who shall be David B. Rothrock if he is then serving as a director. DBR Capital appointed David B. Rothrock and James R. Bell to two of its four nominee positions, with the other two nominee positions remaining vacant. If we default under the investment agreements, DBR Capital, LLC, will have the right to remove any directors it did not appoint and appoint its designees to fill all seven positions on the board of directors.

 

Committees

 

Our business, property, and affairs are managed by or under the direction of the board of directors. Members of the board are kept informed of our business through discussion with the chief executive and financial officers and other officers, by reviewing materials provided to them, and by participating at meetings of the board and its committees.

 

Audit Committee

 

We currently do not have a designated audit committee. The OTCQB does not require us to have a designated audit committee, and our board of directors has determined that it is in the Company’s best interest to have the full board fulfill the functions that would be performed by an audit committee. Accordingly, our board of directors preapproves all audit and permissible non-audit services provided by the independent auditor, including audit, audit-related, tax, and other services. Preapproval is generally provided for up to one year, detailed as to the service or category of services, and subject to a specific budget. The independent auditor and management are required to periodically report to our board of directors regarding the extent of services provided by the independent auditor in accordance with this preapproval and the fees for the services performed to date. The board of directors may also preapprove particular services on a case-by-case basis. Additionally, since we are not currently required to have an audit committee, we currently do not have an audit committee “financial expert” as defined in Item 407(d)(5) of Regulation S-K.

 

Compensation Committee

 

We currently do not have a designated compensation committee. The OTCQB does not require us to have a designated compensation committee, and our board of directors has determined that it is in the Company’s best interest to have the full board fulfill the functions that would be performed by a compensation committee. Accordingly, our board of directors will approve all compensation matters until such committee is established and approved.

 

36

 

 

Code of Ethics

 

We have adopted a code of ethics that applies to all of our employees, including our principal executive officer, principal financial officer, principal accounting officer, and the directors, a copy of which is filed with the SEC as exhibit 14.01 to this Annual Report on Form 10-K. We intend to disclose any changes in or waivers from our code of ethics by posting such information on our website or by filing a Form 8-K.

 

Insider Trading Policy

 

We have adopted an insider trading policy governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees, among other insiders. We believe our insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations. Our insider trading policy is filed with the SEC as exhibit 19.01 to this Annual Report on Form 10-K.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our common stock to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of common stock and other of our equity securities. DBR Capital, LLC, MPower Trading Systems, LLC and Brian McMullen each own more than 10% of our common stock and have failed to file with the Securities and Exchange Commission initial reports of ownership on Form 3.

 

Item 11. Executive Compensation

 

Directors’ Compensation

 

Our directors were awarded compensation for their services as directors in 2024 as follows. Mr. Oviedo and Mr. Bell are not compensated separately for their service as directors, and all of their compensation is discussed under “Executive Officers’ Compensation.”

 

Name  Fees Earned or Paid in Cash   Total 
   ($)   ($) 
David Rothrock   96,000[1]    96,000 

 

 

[1] Mr. Rothrock’s board fees were paid in monthly installments of $8,000.

 

Executive Officers’ Compensation

 

The following table sets forth information concerning the annual and long-term compensation earned by our chief executive officer and to other persons who served as executive officers as, at, or during the years ended December 31, 2024 and 2023 (the “named executive officers”), for services as executive officers for the last two periods.

 

Summary Compensation Table

 

Name and Principal Position  Year   Salary   Bonus   All Other Compensation [2]   Total 
       ($)   ($)   ($)   ($) 
Victor Oviedo [1]   2024    440,384    1,000    12,319    453,703 
Chief Executive Officer and Director   2023    427,548    1,000    10,858    439,406 
James Bell   2024    354,704    72,500    38,188    465,392 
President, Chief Operating Officer, and Director   2023    345,877    2,500    33,659    382,036 
Ralph Valvano   2024    301,730    72,500    38,188    412,418 
Chief Financial Officer   2023    293,008    6,000    33,659    332,667 

 

 

[1] On February 23, 2022, Victor Oviedo was appointed as Chief Executive Officer.
[2] These other compensation amounts are for medical and other fringe benefits.

 

37

 

 

Outstanding Equity Awards at Fiscal Year-End

 

On February 2, 2022, the Company’s board of directors approved and adopted the Investview, Inc. 2022 Incentive Plan. Although the 2022 Incentive Plan has been adopted by the board of directors, it has not yet been approved by the Company’s stockholders. Accordingly, those provisions of the 2022 Incentive Plan that for federal tax purposes require approval of the stockholders of the Company (i.e., the granting of incentive stock options) shall not become effective until adopted by the stockholders, however, the Company reserves the right to grant Incentive Stock Options provided stockholder approval is secured within one (1) year from the date thereof.

 

As of December 31, 2024, the following stock option awards were issued and exercisable for the Company’s executive officers pursuant to the 2022 Incentive Plan.

 

    Option Awards
   

Option grant

    Number of securities underlying unexercised options exercisable     Number of securities underlying unexercised options unexercisable     Option exercise price     Option expiration
Name   date     (#)     (#)     ($)     date
David Rothrock     6/24/2022       41,666,665             -        0.05     6/24/2029
Chairman     6/24/2022       17,500,000       26,250,000 [1]     0.05     6/24/2029
Victor Oviedo     6/24/2022       30,000,000       45,000,000  [1]     0.05     6/24/2029
Chief Executive Officer and Director     6/24/2022       10,000,000       15,000,000 [1]     0.05     6/24/2029
James Bell     6/24/2022       37,500,000             0.05     6/24/2029
President, Chief Operating Officer, and Director     6/24/2022       30,000,000       45,000,000 [1]     0.05     6/24/2029
Ralph Valvano     6/24/2022       4,875,000       3,250,000  [1]     0.05     6/24/2029
Chief Financial Officer     6/24/2022       11,750,000       17,625,000 [1]     0.05     6/24/2029

 

[1] Vest annually over a five-year period following grant.

 

Employment Agreements

 

On September 6, 2019, the Company entered into an Employment Agreement with Jayme McWidener that became effective September 15, 2019, appointing her as Chief Financial Officer. The Employment Agreement has a term of two years commencing on the effective date and automatically renews for one-year periods for three consecutive years, unless terminated prior to the 90th day following the expiration of the applicable term. Compensation for the position is $175,000 per year plus expenses. Other consideration is 20,000,000 restricted shares of the Company’s common stock vesting over a two-year period with one third vesting upon issuance and one third vesting on each of the next two anniversaries. On June 7, 2021, the Company amended the September 6, 2019 Employment Agreement to appoint Ms. McWidener as Chief Accounting Officer.

 

On June 4, 2021, we entered into an Employment Agreement with Ralph Valvano to take effect June 7, 2021, appointing him as the Chief Financial Officer of Investview, Inc. The contract has a term of one year commencing on the effective date and automatically renews for one-year periods for four consecutive years, unless terminated. Compensation for the position is $225,000 per year. Other consideration was 6,500,000 restricted shares of the Company’s common stock vesting over a five-year period with 20% vesting upon each annual anniversary of employment. On or about June 24, 2022, we entered into an amended and restated employment agreement with Mr. Valvano pursuant to which he will receive an annual salary of $285,000 with additional quarterly incentive cash and common stock bonuses to be paid if certain target key performance indicators are achieved. In addition, Mr. Valvano shall be eligible to receive: (i) periodic cash and common stock “Market Capitalization” bonuses once we achieve certain pre-determined minimum levels of market capitalization, share price and trading volume; and (ii) a one-time cash “Up-Listing” bonus upon our shares being listed on the Nasdaq Stock Market, the New York Stock Exchange, the NYSE American or such other national stock exchange as approved by the board of directors (or committee thereof). We have also agreed to grant Mr. Valvano options to purchase 37,500,000 shares of common stock at an exercise price of $0.05 per share, subject to a seven-year term and vesting over a five-year period. Mr. Valvano surrendered all rights in and to the prior grant of restricted shares he had received.

 

38

 

 

On February 10, 2022, we entered into an employment agreement with Victor M. Oviedo, our new Chief Executive Officer. Mr. Oviedo will receive an annual salary of $415,000 with additional quarterly incentive cash and common stock bonuses to be paid if certain target key performance indicators are achieved. In addition, Mr. Oviedo shall be eligible to receive: (i) periodic cash and common stock “Market Capitalization” bonuses once we achieve certain pre-determined minimum levels of market capitalization, share price and trading volume; and (ii) a one-time cash “Up-Listing” bonus upon our shares being listed on the Nasdaq Stock Market, the New York Stock Exchange, the NYSE American or such other national stock exchange as approved by the board of directors (or committee thereof). During June 2022, in connection with his services to the Company as an executive officer, we awarded to Mr. Oviedo options to purchase an aggregate of 100 million shares of our common stock at an exercise price of $0.05 per share. The options are subject to a seven-year term and vest over a five-year period following the date of grant. Additional options were granted to Mr. Oviedo in connection with his service to the Company as a member of its Board of Directors. See “Directors’ Compensation” above.

 

On February 22, 2022, we entered into an employment with our President and Chief Operating Officer, James R. Bell. Mr. Bell will receive an annual salary of $335,000 with additional quarterly incentive cash and common stock bonuses to be paid if certain target key performance indicators are achieved. In addition, Mr. Bell shall be eligible to receive: (i) periodic cash and common stock “Market Capitalization” bonuses once we achieve certain pre-determined minimum levels of market capitalization, share price and trading volume; and (ii) a one-time cash “Up-Listing” bonus upon our shares being listed on the Nasdaq Stock Market, the New York Stock Exchange, the NYSE American or such other national stock exchange as approved by the board of directors (or committee thereof). During June 2022, in connection with his services to the Company as an executive officer, we awarded to Mr. Bell options to purchase an aggregate of 75 million shares of our common stock at an exercise price of $0.05 per share. The options are subject to a seven-year term and vest over a five-year period following the date of grant. Additional options were granted to Mr. Bell in connection with his service to the Company as a member of its Board of Directors. See “Directors’ Compensation” above.

 

We have also entered into indemnification agreements with our current named executive officers and directors.

 

Potential Payments Upon Termination of Employment or Change in Control

 

Employment Agreements

 

The employment agreements with our named executive officers contain severance provisions, including in connection with a change of control, intended to induce these executives to continue employment with our Company and to retain them and provide consideration to them for certain restrictive covenants that apply following a termination of employment.

 

Under each of our employment agreements with Messrs. Oviedo, Bell, and Valvano, we may terminate the agreement at any time. If we terminate the agreement due to the executive’s disability or death, the executive’s unvested options that are scheduled to vest during the period from the date of termination through the next scheduled vesting date will immediately vest and the remaining unvested options shall terminate and be forfeited, and we must pay to the executive or his estate, no later than 90 days following his termination, any quarterly cash bonuses, market capitalization bonuses, up-listing cash bonuses that he earned for any fiscal quarters prior to the termination of his employment, as well as a lump sum amount in cash equal to 6 months base salary. If the executive terminates the agreement for good reason or we terminate for any reason other than for cause, (i) we must pay to the executive an amount equal to his base salary as salary continuation payments over six months if his termination occurs on or before the first anniversary of his employment or, for Mr. Oviedo, over twelve months if his termination occurs after the first anniversary of his employment; (ii) his unvested options that are scheduled to vest during the severance period will immediately vest and the remaining unvested options shall terminate and be forfeited; (iii) we must pay to the executive, no later than 90 days following his termination, any quarterly cash bonuses, market capitalization bonuses, up-listing cash bonuses that he earned for any fiscal quarters prior to the termination of his employment; and (iv) we shall pay or reimburse him for his and his covered dependents continued coverage under our group medical, dental and health plans during the applicable severance period. The employment agreements with Messrs. Oviedo, Bell and Valvano also contain a change of control provision whereby the executive’s unvested options shall immediately vest if his employment is terminated without cause or for good reason within 12 months of a change in control. For purposes of these employment agreements, the term “change in control” is as defined in our 2022 Incentive Plan. The receipt of any severance by these executives is conditioned upon his execution of a broad release of claims.

 

Other Change in Control Arrangements

 

The Investview, Inc. 2022 Incentive Plan under which awards have been issued to our named executive officers and directors contains “change in control” provisions. Under the 2022 Incentive Plan, without limiting the authority of the Board or a committee delegated authority by the Board to adjust awards, if a “change in control” of the Company occurs, then, unless otherwise provided in the award or other agreement, if an award is continued, assumed or substituted by the successor entity, the award will not vest or lapse solely as a result of the change of control but will instead remain outstanding under the terms pursuant to which it has been continued, assumed or substituted and will continue to vest or lapse pursuant to such terms.

 

39

 

 

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information

 

During fiscal 2024, we granted 16,000,000 stock options or similar awards as part of our equity compensation program. When granting equity awards, we do not grant equity awards in anticipation of the release of material nonpublic information, and we do not time the release of material nonpublic information based on equity award grant dates or for the purpose of affecting the value of executive compensation. In addition, we do not take material nonpublic information into account when determining the timing and terms of such awards.

 

Item 12. Security Ownership of Certain Beneficial Owners, Management and Related Stockholder Matters

 

The following table sets forth certain information, as of March 20, 2025, respecting the beneficial ownership of our outstanding common stock by: (i) any holder of more than 5%; (ii) each of the Named Executive Officers and directors; and (iii) our directors and Named Executive Officers as a group, based on 1,859,231,786 shares of common stock outstanding as of March 20, 2025. Except as otherwise indicated, each stockholder listed below has sole voting and investment power over the shares beneficially owned:

 

Name and Address of Beneficial Owner (1)  Amount and Nature of Beneficial Ownership   Percent of Class (2) 
Principal Stockholders:          

DBR Capital, LLC (3)

1645 Kecks Road

Breinigsville, PA 18031

   471,428,572    20.23%

MPower Trading Systems, LLC (4)

521 W Lancaster Ave.

Haverford, PA 19041

   565,000,000    23.31%

Brian McMullen (5)

5348 Vegas Drive #1342

Las Vegas NV 89108

   290,000,000    15.60%

Joseph Hagan (6)

745 Hope Road

Eatontown NY 07724

   203,981,945    10.97%
Directors and Officers:          
David B. Rothrock, Chairman (7)   1,115,811,903    37.65%
Victor M. Oviedo, CEO and Director (8)   40,020,000    2.11%
James R. Bell, President, COO, and Director (9)   92,820,000    4.78%
Ralph R. Valvano, CFO (10)   22,500,000    1.20%
Jayme L. McWidener, CAO (11)   13,333,334    * 
All Officers and Directors as a group (5 persons) (7)(8)(9)(10)(11)   1,284,485,237    41.32%

 

* Less than 1%.
(1) Except as otherwise indicated, the address of each beneficial owner is c/o Investview Inc., 521 W. Lancaster Avenue, 2nd Floor, Haverford, PA 19041.
(2) Applicable percentage ownership is based on 1,859,231,786 shares of common stock outstanding as of March 20, 2025, together with securities exercisable or convertible into shares of common stock within 60 days of that date, for each stockholder.
(3) Reflects the shares issuable, if at all, upon the conversion of $3.3 million of convertible notes issued to DBR Capital in 2020. DBR Capital is controlled by Company Chairman, David Rothrock.
(4) Reflects 565 million non-voting membership interests in our wholly owned subsidiary IFGH, which are redeemable in the future for 565 million shares of the Company.
(5) Brian McMullen beneficially owns 90,000,000 shares through an entity he controls, plus 200,000,000 shares owned personally.
(6) Joseph Hagan owns 199,683,274 shares through two entities he controls, plus 4,298,671 shares owned personally.
(7) David B. Rothrock is deemed to be the beneficial owner of 471,428,572 shares issuable upon the conversion of Convertible Notes in the amount of $3,300,000 issued to DBR Capital, LLC, because Mr. Rothrock is the sole owner of DBR Capital. As the managing member of MPower Trading Systems, LLC and as part of the acquisition of the operating assets and intellectual property rights of MPower Trading Systems, LLC, Mr. Rothrock is also deemed the beneficial owner of 565 million non-voting membership interests in our wholly owned subsidiary IFGH, which are redeemable in the future for 565 million shares of the Company. Mr. Rothrock also owns 11,466,666 shares and vested options to purchase 67,916,665 shares.
(8) Includes vested options to purchase 40,020,000 shares.
(9) Includes 10,320,000 shares and vested options to purchase 82,500,000 shares.
(10) Includes vested options to purchase 22,500,000 shares.
(11) Ms. McWidener personally owns 13,333,334 shares of common stock.

 

No director, executive officer, affiliate, or any owner of record or beneficial owner of more than 5% of any class of our voting securities is a party adverse to us or has a material interest adverse to us.

 

40

 

 

Material Agreement Regarding Stock Ownership

 

We have entered into a Lock-Up agreement dated March 22, 2021, with all of our current and former officers, directors, and certain of our significant shareholders, covering an aggregate of approximately 381,205,961 shares of our common stock. The Lock-Up agreement will run through the earlier of April 25, 2025, the date we complete a liquidation, merger, stock exchange, or similar transaction resulting in all our shareholders having the right to exchange their shares of common stock for cash, securities, or other property, or the date we determine to release some or all of the shares of common stock from the Lock-Up Agreement. The Lock-Up Agreement does provide for limited resale provisions if certain price per share and trading volume benchmarks are met.

 

Equity Compensation Plans

 

The following table summarizes the equity compensation plans under which our securities may be issued as of December 31, 2024:

 

   Number of Securities to Be Issued upon Exercise of Outstanding Options, Warrants and Rights   Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights   Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (excluding securities reflected in column (a)) 
Plan Category  (a)   (b)   (c) 
             
Equity compensation plans approved by security holders            
Equity compensation plans not approved by security holders   351,416,665    0.05    248,583,335 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Convertible Note Financing Arrangements with DBR Capital, LLC

 

On April 27, 2020, we entered into a Securities Purchase Agreement and related agreements with DBR Capital, LLC (“DBR Capital”), a company wholly owned by David B. Rothrock, the Chairman of our Board of Directors. Pursuant to the Securities Purchase Agreement, which was subsequently amended and restated on November 9, 2020, between April 27 and November 9, 2020, we received aggregate proceeds of $3,300,000 from DBR Capital and entered into three convertible promissory notes in support thereof. Each note is secured by collateral of the Company and its subsidiaries. The notes bear interest at rates between 20% and 38.5% per annum, payable monthly, with the principal for each note due and payable on April 27, 2030. Each note is convertible into our common stock at a conversion price of $0.007 per share by DBR Capital at any time prior to their maturity or by the Company if certain benchmarks relating to the trading price and volume of the common stock are met. During the years ended December 31, 2024 and December 31, 2023 we made aggregate payments of interest to DBR Capital in the amounts of $900,516 and $900,516, respectively.

 

In addition, the Securities Purchase Agreement, as amended, under which the first three loans were issued, gave DBR Capital the right to lend to the Company up to an additional $7.7 million, on substantially the same terms as the prior loans, through December 31, 2024. On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”), pursuant to which DBR Capital has been given until August 31, 2025 to lend to the Company a minimum of $2.0 million, and until December 31, 2026 to lend to the Company the balance of up to $5.7 million. The Amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million. Funding of the additional loan amounts remain at the sole discretion of DBR Capital as the Company has no right to call the loan amounts. In electing to enter into the Amendment, which was approved by the disinterested members of our board of directors, we took into consideration, among other things, the avoidance of additional interest charges under the current lending arrangement that we would have been caused to incur in the immediate term were DBR Capital to have put the additional loans to the Company during December 2024, as well as our need for expansion capital in the future.

 

41

 

 

Messrs. Rothrock and Bell were appointed as DBR Capital’s designees to our Board of Directors pursuant to the April 2020 Securities Purchase Agreement. The Securities Purchase Agreement and related transaction documents, as amended in November 2020, among other things, expanded our Board of Directors to seven members, leaving two seats vacant, and granted DBR Capital the right to fill those vacancies and remove directors in the event of default under the transaction documents.

 

Separation, Stock Purchase, and Release Agreements with Two Former Officers and Directors

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement, dated September 18, 2023 (the “2023 Agreement”). Under the 2023 Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “2023 Purchased Shares”) from sellers consisting of Mario Romano and Annette Raynor, two of the Company’s founders and former members of management and the Board of Directors, and a series of their family members and related entities (collectively, the 2023 “Sellers”). The 2023 Purchased Shares were purchased for aggregate consideration of $2,922,380, equating to a price of $0.00964739 per share, representing a discount of approximately 52.5% to the average market price at the time of the closing. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

 

In addition to the cash consideration for the 2023 Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the 2023 Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380.

 

Purchase of Company Shares in a Private Transaction

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement, dated February 6, 2024 (the “2024 Agreement”). Under the 2024 Agreement, the Company repurchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “2024 Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members (collectively, the “2024 Sellers”). The 2024 Purchased Shares were purchased for an aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share, representing a discount of approximately 57.6% to the average market price at the time of the closing. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

 

Director Independence

 

Our common stock is currently quoted on the OTCQB maintained by OTC Markets. The OTCQB does not require us to have independent members of our Board of Directors. Accordingly, we do not identify the members of our board of directors as independent.

 

Item 14. Principal Accountant Fees and Services

 

The following is a summary of the fees billed to us for professional services rendered for the following periods:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Audit Fees  $187,500   $165,000 
Audit Related Fees   -    - 
Tax Fees   -    - 
All Other Fees   -    - 
Total  $187,500   $165,000 

 

Audit Fees. Consists of fees billed for professional services rendered for the audit of our consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports and services in connection with statutory and regulatory filings or engagements.

 

42

 

 

Audit-Related Fees. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under “Audit Fees.”

 

Tax Fees. Consists of fees billed for professional services for tax compliance, tax advice, and tax planning.

 

All Other Fees. Consists of fees for products and services other than the services reported above.

 

Policy on Audit Committee Preapproval of Audit and Permissible Non-Audit Services of Independent Auditors

 

We do not have a designated Audit Committee, and accordingly, our board of directors’ policy is to preapprove all audit and permissible non-audit services provided by the independent auditors. These services may include audit services, audit-related services, tax services, and other services. Preapproval is generally provided for up to one year and any preapproval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent auditors and management are required to periodically report to the Company’s board of directors regarding the extent of services provided by the independent auditors in accordance with this pre-approval, and the fees for the services performed to date. The board of directors may also preapprove particular services on a case-by-case basis.

 

Item 15. Exhibits and Financial Statement Schedules

 

Financial Statements

 

Our consolidated financial statements are included in “Part II, Item 8. Financial Statements and Supplementary Data.”

 

Financial Statement Schedules

 

All financial statement schedules are omitted because they are inapplicable since we are a smaller reporting company.

 

Exhibits

 

The exhibits being filed or furnished with this report are listed below, along with an indication as to each management contract or compensatory plan or arrangement.

 

Exhibit

Number*

  Title of Document   Location
         
Item 2   Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession    
         
2.01   Contribution Agreement between Investview, Inc., Wealth Generators, LLC, and the members of Wealth Generators, LLC dated March 31, 2017   Incorporated by reference to the Current Report on Form 8-K filed April 6, 2017
         
Item 3   Articles of Incorporation and Bylaws    
         
3.01   Articles of Incorporation   Incorporated by reference to the Form 10-SB filed August 12, 1999
         
3.02   Articles of Amendments to the Articles of Incorporation   Incorporated by reference to the Form 10-SB filed August 12, 1999
         
3.03   Bylaws   Incorporated by reference to the Form 10-SB filed August 12, 1999
         
3.04   Certificate of Change filed pursuant to NRS 78.209   Incorporated by reference to the Current Report on Form 8-K filed April 6, 2012

 

43

 

 

Exhibit

Number*

  Title of Document  

Location

         
3.05   Articles of Merger filed pursuant to NRS 92.A.200   Incorporated by reference to the Current Report on Form 8-K filed April 6, 2012
         
3.06   Certificate of Amendment to Articles of Incorporation   Incorporated by reference to the Annual Report on Form 10-K filed March 29, 2024
         
3.07   Certificate of Amendment to Articles of Incorporation   Incorporated by reference to the Annual Report on Form 10-K filed March 29, 2024
         
3.08   Certificate of Amendment to the Bylaws   Incorporated by reference to the Current Report on Form 8-K filed April 30, 2020
         
3.09   Certificate of Designation of 13% Series B Cumulative Redeemable Perpetual Preferred Stock   Incorporated by reference to the Form S-1/A Registration Statement filed with the SEC on March 3, 2020.
         
3.10   Certificate of Amendment of Certificate of Designation of Designation of 13% Series B Cumulative Redeemable Perpetual Preferred Stock, dated May 12, 2020   Incorporated by reference to the POS AM as filed with the SEC on June 2, 2020.
         
3.11   Certificate of Amendment of Certificate of Designation of Designation of 13% Series B Cumulative Redeemable Perpetual Preferred Stock, dated November 23, 2020   Incorporated by reference to the POS AM as filed with the SEC on December 17, 2020.
         
Item 4   Instruments Defining the Rights of Security Holders, including indentures    
         
4.01   Common Stock Specimen   Incorporated by reference to the Registration Statement on Form S-1 filed January 12, 2018
         
4.02   Description of Securities   This filing
         
Item 10   Material Contracts    
         
10.50   Convertible Promissory Note, dated as of July 23, 2019   Incorporated by reference to the Current Report on Form 8-K filed August 1, 2019
         
10.51†   Employment Agreement between Investview, Inc. and Jayme McWidener, effective as of September 15, 2019   Incorporated by reference to the Current Report on Form 8-K filed September 12, 2019
         
10.57   Common Stock Purchase Warrant   Filed with the S-1/A on March 3, 2020.
         
10.58   Form of Warrant Exercise   Filed as part of Exhibit 10.57.
         
10.63.1   Securities Purchase Agreement between Investview, Inc., and DBR Capital, LLC dated as of April 27, 2020   Incorporated by reference to the Current Report on Form 8-K filed on April 30, 2020
         
10.63.2   Voting Rights Agreement between certain Investview, Inc. stockholders and DBR Capital, LLC dated as of April 27, 2020   Incorporated by reference to the Current Report on Form 8-K filed on April 30, 2020
         
10.63.3   Lock-up Agreement between certain Investview, Inc., stockholders and DBR Capital, LLC dated as of April 27, 2020   Incorporated by reference to the Current Report on Form 8-K filed on April 30, 2020

 

44

 

 

Exhibit

Number*

  Title of Document   Location
         
10.63.4   Investor Rights Agreement between Investview, Inc., and DBR Capital, LLC dated as of April 27, 2020   Incorporated by reference to the Current Report on Form 8-K filed on April 30, 2020
         
10.63.5   Convertible Secured Promissory Note by Investview, Inc., and DBR Capital, LLC dated as of April 27, 2020   Incorporated by reference to the Current Report on Form 8-K filed on April 30, 2020
         
10.64   Consent of Holders of Series B Preferred   Filed with the POS AM as filed with the SEC on June 2, 2020
         
10.65   Convertible Secured Promissory Note by Investview, Inc., and DBR Capital, LLC, dated as of May 27, 2020   Incorporated by reference to the Current Report on form 8-K filed on June 2, 2020
         
10.66   Amended and Restated Securities Purchase Agreement dated November 9, 2020   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.67   Convertible Promissory Note dated November 9, 2020   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.68   Amended and Restated Convertible Secured Promissory Note in the Amount of $1,300,000 dated November 9, 2020 (originally dated April 27, 2020)   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.69   Amended and Restated Convertible Secured Promissory Note in the Amount of $700,000 dated November 9, 2020 (originally dated May 27, 2020)   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.70   First Amendment to Investor Rights Agreement of April 27, 2020, dated November 9, 2020   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.71   First Amendment to Voting Agreement of April 27, 2020, dated November 9, 2020   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.72   Guaranty and Collateral Agreement dated May 15, 2020   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.74   Cover Letter and Restricted Shares Award Agreement for David Rothrock   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020
         
10.75   Cover Letter and Restricted Shares Award Agreement for James Bell   Incorporated by reference to the Current Report on form 8-K filed on November 13, 2020

 

45

 

 

Exhibit

Number*

  Title of Document  

Location

         
10.78   Joinder Agreement dated December 23, 2020   Incorporated by reference to the Current Report on form 8-K filed on December 31, 2020
         
10.79   Promissory Note in the Amount of $1,000,000 with Joe Cammarata, dated January 30, 2020, First Amendment to the $1,000,000 Promissory Note dated January 31, 2020 and Second Amendment to the $1,000,000 Promissory Note dated January 30, 2020   Incorporated by reference to the periodic report on Form 10-Q filed February 26, 2021
         
10.81   Securities Purchase Agreement between Investview Financial Group Holdings, LLC, Investview, Inc., and the Purchasers Listed on Schedule A dated as of March 22, 2021.   Incorporated by reference to the Current Report on Form 8-K filed on March 26, 2021
         
10.82   Securities Purchase Agreement between Investview MTS, LLC, Investview Financial Group Holdings, LLC, Investview, Inc., and MPower Trading Systems LLC dated as of March 22, 2021.   Incorporated by reference to the Current Report on Form 8-K filed on March 26, 2021
         
10.83   Working Capital Promissory Note by Investview, Inc., dated as of March 22, 2021.   Incorporated by reference to the Current Report on Form 8-K filed on March 26, 2021
         
10.87   Lock-Up Agreement   Incorporated by reference to the periodic report on Form 10-K filed on June 29, 2021
         
10.88   Second Amendment to Amended and Restated Securities Purchase Agreement dated as of November 9, 2020   Incorporated by reference to the Current Report on Form 8-K filed on June 2, 2021
         
10.89†   Employment Agreement between Investview, Inc., and Ralph R. Valvano, effective as of June 7, 2021   Incorporated by reference to the Current Report on Form 8-K filed on June 9, 2021
         
10.90†   Amendment to Employment Agreement between Investview, Inc., and Jayme McWidener, effective as of June 7, 2021   Incorporated by reference to the Current Report on Form 8-K filed on June 9, 2021

 

46

 

 

Exhibit

Number*

  Title of Document   Location
         
10.91   Amended and Restated Securities Purchase Agreement between and among Investview MTS, LLC, Investview Financial Group Holdings, LLC, Investview, Inc., and MPower Trading Systems, LLC dated as of September 3, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 10, 2021
         
10.92   Bill of Sale, Assignment and Assumption between Investview MTS, LLC, and MPower Trading Systems, LLC dated as of September 3, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 10, 2021
         
10.93   Registration Rights Agreement dated as of September 3, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 10, 2021
         
10.94   Debt Conversion Agreement between Investview, Inc. and Joseph Cammarata, effective as of March 30, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 29, 2021
         
10.95   Convertible Promissory Note due March 30, 2022, dated March 30, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 29, 2021
         
10.96   Amendment One to Convertible Promissory Note dated March 30, 2021   Incorporated by reference to the Current Report on Form 8-K filed on September 29, 2021
         
10.97   Third Amendment to Amended and Restated Securities Purchase Agreement dated as of November 9, 2020   Incorporated by reference to the Quarterly Report on Form 10-Q filed on November 22, 2021
         
10.98†   Separation and Release Agreement by and among Investview, Inc., and Mario Romano and Wealth Engineering, LLC, dated as of January 6, 2022   Incorporated by reference to the Current Report on Form 8-K filed on January 10, 2022
         
10.99†   Separation and Release Agreement by and among Investview, Inc., and Annette Raynor and Wealth Engineering, LLC, dated as of January 6, 2022   Incorporated by reference to the Current Report on Form 8-K filed on January 10, 2022
         
10.100†   Employment Agreement between Investview, Inc., and Victor M. Oviedo, dated as of February 10, 2022   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022

 

47

 

 

Exhibit

Number*

  Title of Document   Location
         
10.101†   Indemnification Agreement between Investview, Inc., and Victor M. Oviedo, dated as of February 10, 2022   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.102   Victor M. Oviedo Joinder to Lock-Up Agreement dated March 22, 2021   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.103†   Employment Agreement between Investview, Inc., and James R. Bell, dated as of February 22, 2022   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.104†   Employment Agreement between Investview, Inc., and Myles Gill, dated as of February 21, 2022   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.105   Myles Gill Joinder to Lock-Up Agreement dated March 22, 2021   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.106†   Form of Executive Indemnification Agreement in Use as of February 2022   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.107†   Investview, Inc., 2022 Incentive Plan   Incorporated by reference to the Current Report on Form 8-K filed on February 23, 2022
         
10.110   Non-Statutory Option Award and Non-Statutory Option Award Agreement for David B. Rothrock #1   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.111   Non-Statutory Option Award and Non-Statutory Option Award Agreement for David B. Rothrock #2   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.112†   Amendment to Employment Agreement with Victor Oviedo   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.113†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for Victor Oviedo #1   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.114†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for Victor Oviedo #2   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.115†   Amendment to Employment Agreement with James R. Bell   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.116†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for James R. Bell #1   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022

 

48

 

 

Exhibit

Number*

  Title of Document   Location
         
10.117†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for James R. Bell #2   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.118†   Amendment to Employment Agreement with Myles Gill   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.119†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for Myles P Gill   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.120†   Amended and Restated Employment Agreement with Ralph Valvano   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.121†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for Ralph Valvano #1   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.122†   Non-Statutory Option Award and Non-Statutory Option Award Agreement for Ralph Valvano #2   Incorporated by reference to the Current Report on Form 8-K filed on June 30, 2022
         
10.123   Fourth Amendment to Amended and Restated Securities Purchase Agreement dated as of November 9, 2020   Incorporated by reference to the Quarterly Report on Form 10-Q filed on August 15, 2022
         
10.124   Stock Purchase and Release Agreement dated September 18, 2023   Incorporated by reference to the Current Report on Form 8-K filed on October 4, 2023
         
10.125   Stock Purchase and Release Agreement dated February 6, 2024   Incorporated by reference to the Current Report on Form 8-K filed on February 9, 2024
         
10.126   Fifth Amendment to Amended and Restated Securities Purchase Agreement between Investview, Inc. and DBR Capital, LLC, dated as of February 28, 2025   Incorporated by reference to the Current Report on Form 8-K filed on March 4, 2025
         
10.127   Separation Agreement and General Release by and between Investview, Inc. and Myles P. Gill, dated as of August 19, 2024   This filing.
         
10.128   First Amendment to Amended and Restated Securities Purchase Agreement between Investview, Inc. and DBR Capital, LLC dated as of November 9, 2020   Incorporated by reference to the Current Report on Form 8-K filed on March 26, 2021
         
Item 14   Code of Ethics    
         
14.01   Code of Ethics   This filing.
         
Item 19   Insider Trading Policies and Procedures    
         
19.01   Insider Trading Policy   This filing.
         
Item 21   Subsidiaries of the Registrant    
         
21.01   Schedule of Subsidiaries   This filing.

 

49

 

 

Exhibit

Number*

  Title of Document   Location
         
Item 23   Consents of Experts and Counsel    
         
23.01   Consent of M&K CPAs   This filing.
         
Item 24   Power of Attorney    
         
24.01   Power of Attorney   This filing – included on signature page.
         
Item 31   Rule 13a-14(a)/15d-14(a) Certifications    
         
31.01   Rule 13a-14(a) Certification of Principal Executive Officer   This filing.
         
31.02   Rule 13a-14(a) Certification of Principal Financial Officer   This filing.
         
Item 32   Section 1350 Certifications    
         
32.01   Section 1350 Certification of the Principal Executive Officer   This filing.
         
32.02   Section 1350 Certification of the Principal Financial Officer   This filing.
         
Item 97   Policy Relating to Recovery of Erroneously Awarded Compensation    
         
97.01   Clawback Policy   This filing.
         
Item 101   Interactive Data Files***    
         
101.INS   XBRL Instance Document   This filing.
         
101.SCH   XBRL Taxonomy Extension Schema   This filing.
         
101.CAL   XBRL Taxonomy Extension Calculation Linkbase   This filing.
         
101.DEF   XBRL Taxonomy Extension Definition Linkbase   This filing.
         
101.LAB   XBRL Taxonomy Extension Label Linkbase   This filing.
         
101.PRE   XBRL Taxonomy Extension Presentation Linkbase   This filing.
         
Item 104   Cover Page Interactive Data File    
         
    Cover Page Interactive Data File (formatted as Inline XBRL and continued in Exhibit 101).   This filing.

 

Indicates a management contract or compensatory plan.
*All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.
**Identifies each management contract or compensatory plan or arrangement required to be filed as an exhibit, as required by Item 15(a)(3) of Form 10-K.
***Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of this annual report for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act and otherwise are not subject to liability.

 

Item 16. Form 10-K Summary

 

Not included.

 

50

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Investview Inc.
     
Dated: March 28, 2025 By: /s/ Victor M. Oviedo
    Victor M. Oviedo
    Chief Executive Officer
    (Principal Executive Officer)
     
Dated: March 28, 2025 By: /s/ Ralph R. Valvano
    Ralph R. Valvano
    Chief Financial Officer
    (Principal Financial Officer and Accounting Officer)

 

POWER OF ATTORNEY

 

Each person whose signature appears below constitutes and appoints Victor M. Oviedo and Ralph R. Valvano, or either of them, as such person’s true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and any documents related to this report and filed pursuant to the Securities Exchange Act of 1934, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This power of attorney shall be governed by and construed with the laws of the State of Delaware and applicable federal securities laws.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

SIGNATURE   TITLE   DATE
         
/s/ Victor M. Oviedo   Chief Executive Officer and Director   March 28, 2025
Victor M. Oviedo   (Principal Executive Officer)    
         
/s/ Ralph R. Valvano   Chief Financial Officer   March 28, 2025
Ralph R. Valvano   (Principal Financial and Accounting Officer)    
         
/s/ James Bell   President, Chief Operating Officer   March 28, 2025
James Bell   and Director    
         
/s/ David B. Rothrock   Chairman   March 28, 2025
David B. Rothrock        

 

51

 

 

DECEMBER 31, 2024 AND 2023

 

FORMING A PART OF ANNUAL REPORT

PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934

 

INVESTVIEW, INC.

 

Index to Consolidated Financial Statements

 

  Page
   
Report of Independent Registered Public Accounting Firm (PCAOB ID: 2738) F-2
   
Consolidated Balance Sheets as of December 31, 2024 and 2023 F-3
   
Consolidated Statements of Operations and Other Comprehensive Income (Loss) for the years ended December 31, 2024 and 2023 F-4
   
Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2024 and 2023 F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 F-6
   
Notes to Consolidated Financial Statements F-7

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Shareholders of Investview, Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Investview, Inc. (the Company) as of December 31, 2024 and 2023, and the related consolidated statements of operations and other comprehensive income (loss), stockholders’ equity (deficit), and cash flows for the years ended and the related notes to the consolidated financial statements. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the year ended in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

 

Revenue Recognition

 

The Company generates revenues from the mining of Bitcoin that requires significant judgements with regard to how the revenues are recognized. As discussed in the notes to the financial statements, management’s estimate of the consideration received and recognized from its cryptocurrency mining activities is considered variable.

 

Given the intricate technological considerations and complexities inherent in cryptocurrency transactions, the assessment of mining revenues requires a nuanced understanding of cryptocurrency technology, transaction processes, verification procedures, and valuation methodologies. As such, Auditing management’s evaluation of the accounting for mining revenues recognized involved significant judgement and subjectivity due to technological considerations and complexity of cryptocurrency transactions.

 

We evaluated the appropriateness and accuracy of management’s assessment in relation to our understanding of cryptocurrency technology, evaluation of transaction processes, verification of transactions, and assessment of valuation methods.

 

/s/ M&K CPAS, PLLC

We have served as the Company’s auditor since 2021.

The Woodlands, TX

March 28, 2025

 

F-2

 

 

INVESTVIEW, INC.

CONSOLIDATED BALANCE SHEETS

 

   December 31,   December 31, 
   2024   2023 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $22,467,710   $20,912,276 
Restricted cash, current   -    230,354 
Prepaid assets   497,620    492,607 
Deposits, current   936,434    - 
Receivables   2,534,727    2,232,725 
Inventory   495,865    - 
Income tax paid in advance   459,872    - 
Other current assets   1,127,891    585,632 
Total current assets   28,520,119    24,453,594 
           
Fixed assets, net   1,868,441    6,536,823 
           
Other assets:          
Goodwill   873,701    - 
Intangible assets, net   40,310    - 
Operating lease right-of-use asset   211,996    110,427 
Deposits   57,028    2,588,127 
Total other assets   1,183,035    2,698,554 
           
Total assets  $31,571,595   $33,688,971 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable and accrued liabilities  $7,139,684   $5,854,093 
Payroll liabilities   271,606    187,419 
Income tax payable   202,573    1,004,535 
Deferred revenue   3,029,145    2,703,398 
Derivative liability   758    5,732 
Dividend liability   245,101    256,392 
Operating lease liability, current   165,707    109,628 
Related party debt, net of discounts, current   1,204,567    1,203,247 
Debt, net of discounts, current   29,244    715,127 
Total current liabilities   12,288,385    12,039,571 
           
Operating lease liability, long term   46,433    6,048 
Accrued liabilities, long term   45,532    1,189,643 
Related party debt, net of discounts, long term   1,501,041    1,162,349 
Debt, net of discounts, long term   490,619    501,062 
Total long-term liabilities   2,083,625    2,859,102 
           
Total liabilities   14,372,010    14,898,673 
           
Commitments and contingencies   -    - 
           
Stockholders’ equity (deficit):          
Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively   252    252 
Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 2,333,356,496 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively   1,859,231    2,333,356 
Additional paid in capital   102,560,320    104,056,807 
Accumulated other comprehensive income (loss)   (23,218)   (23,218)
Accumulated noncontrolling interest   8,070    - 
Accumulated deficit   (87,205,070)   (87,576,899)
Total stockholders’ equity (deficit)   17,199,585    18,790,298 
           
Total liabilities and stockholders’ equity (deficit)  $31,571,595   $33,688,971 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 


INVESTVIEW, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

 

   Year Ended   Year Ended 
   December 31, 2024   December 31, 2023 
         
Revenue:          
Membership revenue, net of refunds, incentives, credits, and chargebacks  $47,061,290   $56,036,052 
Mining revenue   5,186,606    11,348,156 
Health and wellness product sales   110,671    - 
Cryptocurrency revenue   -    513,285 
Mining equipment repair revenue   -    23,378 
Other revenue   23,404    - 
Total revenue, net   52,381,971    67,920,871 
           
Operating costs and expenses:          
Cost of sales and service   6,056,491    10,736,709 
Commissions   25,913,260    31,716,399 
Selling and marketing   569,491    560,065 
Salary and related   6,626,588    7,112,954 
Professional fees   1,547,288    1,378,367 
Impairment expense   1,771,891    2,056,386 
Loss (gain) on disposal of assets   180,223    223,630 
General and administrative   8,022,020    9,531,431 
Total operating costs and expenses   50,687,252    63,315,941 
           
Net income (loss) from operations   1,694,719    4,604,930 
           
Other income (expense):          
Loss on Settlement   (375,000)   - 
Gain (loss) on fair value of derivative liability   4,974    18,691 
Realized gain (loss) on cryptocurrency   452,450    255,268 
Interest expense   (18,801)   (18,750)
Interest expense, related parties   (1,240,529)   (1,239,603)
Other income (expense)   1,567,543    1,389,796 
Total other income (expense)   390,637    405,402 
           
Income (loss) before income taxes   2,085,356    5,010,332 
Income tax expense   (894,940)   (2,178,412)
           
Net income (loss)   1,190,416    2,831,920 
Net income (loss) attributable to noncontrolling interest   (753)   - 
Net income (loss) attributable to Investview, Inc.   1,191,169    2,831,920 
           
Dividends on Preferred Stock   (819,340)   (819,340)
           
Net income (loss) applicable to common shareholders  $371,829   $2,012,580 
           
Basic income (loss) per common share  $0.00   $0.00 
Diluted income (loss) per common share  $0.00   $0.00 
           
Basic weighted average number of common shares outstanding   1,908,219,120    2,559,093,504 
Diluted weighted average number of common shares outstanding   2,944,647,691    3,595,522,075 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

INVESTVIEW, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

 

                                     
                       Accumulated             
                   Additional   Other             
   Preferred Stock   Common Stock   Paid in   Comprehensive   Accumulated   Noncontrolling     
   Shares   Amount   Shares   Amount   Capital   Income (Loss)   Deficit   Interest   Total 
Balance, December 31, 2022   252,192   $252    2,636,275,489   $2,636,275   $104,350,746   $(23,218)  $(89,589,479)  $-   $17,374,576 
Common stock issued for services and other stock-based compensation   -    -    -    -    2,575,496    -    -    -    2,575,496 
Warrant Exercise   -    -    230    -    23    -    -    -    23 
Derivative liability extinguished with warrant exercise   -    -    -    -    3    -    -    -    3 
Common stock repurchased from related parties and canceled   -    -    (302,919,223)   (302,919)   (2,869,461)   -    -    -    (3,172,380)
Dividends   -    -    -    -    -    -    (819,340)   -    (819,340)
Net income (loss)   -    -    -    -    -    -    2,831,920    -    2,831,920 
Balance, December 31, 2023   252,192    252    2,333,356,496    2,333,356    104,056,807    (23,218)   (87,576,899)   -    18,790,298 
Common stock issued for services and other stock-based compensation   -    -    -    -    1,600,534    -    -    -    1,600,534 
Common stock repurchased from related parties and canceled   -    -    (472,374,710)   (472,375)   (3,098,771)   -    -    -    (3,571,146)
Common stock canceled   -    -    (1,750,000)   (1,750)   1,750    -    -    -    - 
Recognition of noncontrolling interest in acquisition   -    -    -    -    -    -    -    8,823    8,823 
Dividends   -    -    -    -    -    -    (819,340)   -    (819,340)
Net income (loss)   -    -    -    -    -    -    1,191,169    (753)   1,190,416 
Balance, December 31, 2024   252,192   $252    1,859,231,786   $1,859,231   $102,560,320   $(23,218)  $(87,205,070)  $8,070   $17,199,585 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

INVESTVIEW INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Year Ended   Year Ended 
   December 31, 2024   December 31, 2023 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $1,190,416   $2,831,920 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation   3,875,614    4,450,466 
Amortization of debt discount   338,691    337,767 
Stock issued for services and other stock-based compensation   1,600,534    2,575,496 
Lease cost, net of repayment   (5,105)   1,283 
(Gain) loss on disposal of assets   180,223    223,630 
Loss on fair value of derivative liability   (4,974)   (18,691)
Realized (gain) loss on cryptocurrency   (452,450)   (255,268)
Impairment expense   1,771,891    2,056,386 
Changes in operating assets and liabilities:          
Receivables   (302,002)   (977,183)
Inventory   (326,986)   74,645 
Prepaid assets   (5,013)   (126,046)
Income tax paid in advance   (459,872)   535,932 
Other current assets   (535,461)   (5,396,521)
Deposits   (2,439)   (2,114,529)
Accounts payable and accrued liabilities   1,559,877    (350,764)
Income tax payable   (801,962)   763,932 
Customer advance   -    (96,609)
Deferred revenue   (239,279)   628,824 
Accrued interest   18,801    18,750 
Accrued interest, related parties   901,837    901,837 
Net cash provided by (used in) operating activities   8,302,341    6,065,257 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash acquired in acquisition   1,495    - 
Cash paid for purchase of Renu   (1,144,426)   - 
Cash received from the disposal of fixed assets   -    23,278 
Cash paid for fixed assets   (461,945)   (2,561,001)
Net cash provided by (used in) investing activities   (1,604,876)   (2,537,723)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayments for related party debt   (900,516)   (900,516)
Repayments for debt   (441,086)   (1,948,906)
Payments for shares repurchased from related parties   (3,371,763)   (396,547)
Dividends paid   (659,020)   (627,856)
Proceeds from the exercise of warrants   -    23 
Net cash provided by (used in) financing activities   (5,372,385)   (3,873,802)
           
Effect of exchange rate translation on cash   -    - 
           
Net increase (decrease) in cash, cash equivalents, and restricted cash   1,325,080    (346,268)
Cash, cash equivalents, and restricted cash - beginning of period   21,142,630    21,488,898 
Cash, cash equivalents, and restricted cash - end of period  $22,467,710   $21,142,630 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $929,760   $932,197 
Income taxes  $2,156,774   $2,178,412 
Non-cash investing and financing activities:          
Common stock repurchased for payables  $3,571,146   $2,775,833 
Application of deposit to payables  $1,597,104   $- 
Dividends declared  $819,340   $819,340 
Recognition of lease liability and ROU asset at lease commencement  $223,364   $23,520 
Debt extinguished in exchange for cryptocurrency  $274,041   $5,322,058 
Dividends paid with cryptocurrency  $171,611   $171,722 
Common stock cancelled  $1,750   $- 
Cryptocurrency received from sale of fixed assets  $-   $9,913 
Derivative liability extinguished with warrant exercise  $-   $3 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 


NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Investview, Inc. was incorporated on January 30, 1946, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.

 

Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.

 

On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $419,139 in pre-merger liabilities.

 

On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).

 

On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.

 

On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.

 

On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.

 

Nature of Business

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion: an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

F-7

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of December 31, 2024 and 2023, cash balances that exceeded FDIC limits were $10,837,830 and $3,778,085, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents and Restricted Cash

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2024 and 2023, we had no cash equivalents.

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.

 

   December 31,   December 31, 
   2024   2023 
Cash and cash equivalents  $22,467,710   $20,912,276 
Restricted cash, current   -    230,354 
Total cash, cash equivalents, and restricted cash shown on the statement of cash flows  $22,467,710   $21,142,630 

 

Amount included in restricted cash represent funds required to be held in an escrow account by a contractual agreement and will be used for paying dividends to our Series B Preferred Stockholders and funds required to be held in an account as collateral for business charges on our Company credit card.

 

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

F-8

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   December 31,   December 31, 
   2024   2023 
Due from merchant processors  $318,921   $1,732,456 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,219,342 
Due from payout service providers   296,558    3,251 
Accounts and other receivables   47,213    - 
 Receivable, gross   2,534,727    2,955,049 
Allowance for doubtful accounts   -    (722,324)
Receivables  $2,534,727   $2,232,725 

 

[1]We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

   Estimated        
   Useful        
   Life  December 31,   December 31, 
   (years)  2024   2023 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   28,571    11,308 
Data processing equipment  3   11,824,560    14,084,670 
Manufacturing equipment  3-25   1,161,701    - 
       13,015,549    14,096,695 
Accumulated depreciation      (11,147,108)   (7,559,872)
Net book value     $1,868,441   $6,536,823 

 

Total depreciation expense for the years ended December 31, 2024 and 2023, was $3,875,614 and $4,450,466, respectively, all of which was recorded in our general and administrative expenses on our statement of operations. During the year ended December 31, 2024, we disposed of assets with a net book value of $180,223. During the year ended December 31, 2023, we sold assets with a total net book value of $26,731 for cash of $23,278 and bitcoin worth $9,913, therefore recognized a gain on disposal of assets of $6,460. This gain was offset by loss on disposal of assets with a net book value of $55,255.

 

Long-Lived Assets – Cryptocurrencies & Intangible Assets

 

We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $1,127,891 and $585,632, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($5,186,606 and $11,348,156 for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $452,450 and $255,268, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $2,056,386. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $0 due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.

 

F-9

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Impairment of Long-Lived Assets

 

We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.

 

During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $1,771,891. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, no impairment was recorded.

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

-quoted prices for similar assets or liabilities in active markets;
-quoted prices for identical or similar assets or liabilities in markets that are not active;
-inputs other than quoted prices that are observable for the asset or liability; and
-inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable, and accounts payable. We have determined that the book value of our outstanding financial instruments as of December 31, 2024 and 2023, approximates the fair value due to their short-term nature.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

F-10

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $5,732   $5,732 
Total Liabilities  $-   $-   $5,732   $5,732 

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $1,905,734 and $2,703,398, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $1,014,164.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

F-11

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cryptocurrency Revenue

 

During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.

 

During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.

 

During 2024, we generated no revenue from the sale of cryptocurrency packages.

 

Mining Equipment Repair Revenue

 

Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.

 

Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2024, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $50,086,839   $5,186,606   $110,856   $23,404   $55,407,705 
Refunds, incentives, credits, and chargebacks   (3,025,549)   -    (185)   -    (3,025,734)
Net revenue  $47,061,290   $5,186,606   $110,671   $23,404   $52,381,971 

 

Foreign revenues for the year ended December 31, 2024 were approximately $42.9 million while domestic revenue for the year ended December 31, 2024 was approximately $9.5 million.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2023, was as follows:

 

   Membership
Revenue
   Cryptocurrency Revenue   Mining Revenue   Miner Repair Revenue   Total 
Gross billings/receipts  $60,516,836   $990,785   $11,348,156   $23,378   $72,879,155 
Refunds, incentives, credits, and chargebacks   (4,480,784)   -    -    -    (4,480,784)
Amounts paid to supplier   -    (477,500)   -    -    (477,500)
Net revenue  $56,036,052   $513,285   $11,348,156   $23,378   $67,920,871 

 

Foreign revenues for the year ended December 31, 2023 were approximately $51.0 million while domestic revenue for the year ended December 31, 2023 was approximately $16.9 million.

 

Advertising, Selling, and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the year ended December 31, 2024 and 2023, totaled $569,491 and $560,065, respectively.

 

F-12

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the year ended December 31, 2024 and 2023, totaled $6,056,491 and $10,736,709, respectively.

 

Inventory

 

As of December 31, 2024, inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Due to the discontinuation of our miner repair business during the quarter ended June 30, 2023, all related inventory was sold. During the year ended December 31, 2023, we recognized a loss on disposal of assets of $174,835.

 

As of December 31, 2024 and 2023 the net realizable value of our inventory was $495,865 and $0, respectively.

 

Income Taxes

 

We have adopted ASC Subtopic 740-10, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.

 

   December 31,
2024
   December 31,
2023
 
Net income  $1,190,416    2,831,920 
Less: preferred dividends   (819,340)   (819,340)
Add: interest expense on convertible debt   900,516    900,516 
Net income available to common shareholders (numerator)  $1,271,592    2,913,096 
           
Basic weighted average number of common shares outstanding   1,908,219,120    2,559,093,504 
Dilutive impact of convertible notes   471,428,571    471,428,571 
Dilutive impact of non-voting membership interest   565,000,000    565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   2,944,647,691    3,595,522,075 
           
Diluted income per common share  $0.00    0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

   December 31,
2024
   December 31,
2023
 
Options to purchase common stock   359,698,857    360,416,665 
Warrants to purchase common stock   1,178,090    1,178,129 

 

F-13

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued (or made available for issuance). If an entity adopts the amendments in an interim period, it must adopt them as of the beginning of the fiscal year that includes that interim period. ASU No. 2023-08 requires a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company has not yet adopted ASU No. 2023-08 and is currently evaluating the impact that the adoption will have on the Company’s financial statement presentation and disclosures.

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company did not elect early adoption and is currently evaluating the impact the updated guidance will have on its 2025 disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance reportable segment disclosures by requiring disclosures of significant segment expenses regularly provided to the CODM, requiring disclosure of the title and position of the CODM and explanation of how the reported measures of segment profit and loss are used by the CODM in assessing segment performance and allocation of resources. ASU 2023-07 is effective for the Company for annual periods beginning after December 31, 2023. The Company adopted ASU 2023-07 for the year ended December 31, 2024. As a result of the adoption, the Company added this disclosure in Note 11. Segment Information, to present significant expenses that are included within cost of revenue, by reportable segment, which are presented to the CODM.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

F-14

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

NOTE 4 – LIQUIDITY

 

Our financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

During the year ended December 31, 2024, we met our short-and long-term working capital and capital expenditure requirements. Our net cash provided by operating activities for the year ended December 31, 2024, was $8.3 million. We used our cash provided by operating activities for the acquisition of substantially all the assets of Renu Labs for $1.1 million, the purchase of fixed assets in the amount of $0.5 million, principal and interest payments on debt of $1.3 million, the repurchase of common shares totaling $3.4 million, total dividend payments on our preferred stock of $0.7 million and added $1.3 million to our cash balance, which totaled $22.5 million at December 31, 2024. We believe we will have sufficient resources, including cash flow from operations and access to capital markets, to meet debt service and other obligations in a timely manner and be able to meet our objectives.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Related Party Debt

 

Our related party debt consisted of the following:

 

   December 31,   December 31, 
   2024   2023 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $692,004 as of December 31, 2024 [1]  $607,996   $477,711 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $375,700 as of December 31, 2024 [2]   324,304    253,566 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $731,254 as of December 31, 2024 [3]   568,742    431,072 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,567    1,203,247 
Total related-party debt   2,705,608    2,365,596 
Less: Current portion   (1,204,567)   (1,203,247)
Related-party debt, long term  $1,501,041   $1,162,349 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $130,285 of the debt discount into interest expense, as well as expensed an additional $260,016 of interest expense on the note, all of which was repaid during the period.
  
[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the year ended December 31, 2024, we recognized $70,738 of the debt discount into interest expense as well as expensed an additional $140,000 of interest expense on the note, all of which was repaid during the period.
  
[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $137,670 of the debt discount into interest expense as well as expensed an additional $500,500 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $1,320 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.

 

F-15

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

 

On February 28, 2025, we and DBR Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated or ever.

 

Other Related Party Arrangements

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $1,189,643 under the Romano/Raynor Agreement of which $1,189,643 is included in Accounts payable and accrued liabilities.

 

In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380 (see NOTE 9).

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $1,785,573 under the Smith/Miller Agreement of which $1,785,572 is included in Accounts payable and accrued liabilities.

 

The consideration paid for the Purchased Shares of $3,571,146 was allocated to the share purchase (see NOTE 9).

 

F-16

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

NOTE 6 – DEBT

 

Our debt consisted of the following:

 

   December 31,
2024
   December 31,
2023
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $519,863   $530,306 
Long term notes for APEX lease buyback [2]   -    685,883 
Total debt   519,863    1,216,189 
Less: Current portion   29,244    715,127 
Debt, long term portion  $490,619   $501,062 

 

[1]In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $18,801 and $18,750 worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $29,244 and $31,681.
  
[2]In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until December 31, 2024, when the last monthly payment will be made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $411,842 and issuances of cryptocurrency then valued at $274,041. As of December 31, 2024, the debt was paid in full.

 

NOTE 7 – DERIVATIVE LIABILITY

 

During the year ended December 31, 2024 and 2023, we had the following activity in our derivative liability account:

 

   Total 
Derivative liability at December 31, 2022  $24,426 
Derivative extinguished with warrant exercise (see NOTE 9)   (3)
Change in fair value   (18,691)
Derivative liability at December 31, 2023   5,732 
Change in fair value   (4,974)
Derivative liability at December 31, 2024  $758 

 

We use the binomial option pricing model to estimate fair value for those instruments, at inception, at warrant exercise, and at each reporting date. During the years ended December 31, 2024 and 2023, the assumptions used in our binomial option pricing model were in the following range:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Risk free interest rate   4.16 - 4.25%   4.01 - 4.23%
Expected life in years   0.58 - 1.50    1.58 - 2.50 
Expected volatility   122% - 142%   116% - 122%

 

NOTE 8 – OPERATING LEASES

 

In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the MPower acquisition. This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (“the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered for use by our newly formed subsidiary Renu Laboratories LLC.

 

F-17

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

At commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $22,034. The original 24.5-month term of the Wyckoff Lease was extended through July 2025 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2024. The earliest termination date is July 31, 2024. At the extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $23,520.

 

At date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $172,042. On August 7, 2024, the term of the Haverford Lease was extended through December 31, 2025.

 

At commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327. The Warminster Lease will automatically terminate after the 14-month term.

 

At commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037. The Ivyland Lease will automatically terminate after the 24-month term.

 

Operating lease expense was $130,710 for the year ended December 31, 2024. Operating cash flows used for the operating leases during the year ended December 31, 2024, was $135,809. As of December 31, 2024, the weighted average remaining lease term was 1.48 years, and the weighted average discount rate was 12%.

 

Future minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:

 

      
2025  $171,148 
2026   61,057 
Total   232,205 
Less: Interest   (20,065)
Present value of lease liability   212,140 
Operating lease liability, current [1]   (165,707)
Operating lease liability, long term  $46,433 

 

[1] Represents lease payments to be made in the next 12 months.

 

NOTE 9 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

We are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.

 

Our Board of Directors approved the designation of 2,000,000 of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $25 per share. Our Series B Preferred Stockholders are entitled to receive cumulative dividends at the annual rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.

 

During the year ended March 31, 2021, we commenced an offering to sell a total of 2,000,000 units at $25 per unit (“Unit Offering”), with each unit consisting of: (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 7). The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of 252,192 Units.

 

As of December 31, 2024 and 2023, we had 252,192 shares of preferred stock issued and outstanding.

 

F-18

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Preferred Stock Dividends

 

During the year ended December 31, 2024, we recorded $819,340 for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $659,020 in cash and issued $171,611 worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $245,101 as a dividend liability on our balance sheet as of December 31, 2024.

 

During the year ended December 31, 2023, we recorded $819,340 for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $627,856 in cash and issued $171,722 worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $256,392 as a dividend liability on our balance sheet as of December 31, 2023.

 

Common Stock Transactions

 

During the year ended December 31, 2024, we repurchased 472,374,710 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $446,391 and payables of $3,124,755 (see NOTE 5). Also, during the year ended December 31, 2024, we cancelled 1,750,000 shares that had been issued but were forfeited by choice. As a result, we decreased common stock by $1,750 and increased additional paid in capital by the same. The forfeiture also resulted in the reversal of previously recorded expense resulting in a net $10,002 reduction in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

During the year ended December 31, 2023, we issued 230 shares of common stock as a result of warrants exercised, resulting in proceeds of $23 and an increase in additional paid in capital of $3 for the derivative liability extinguished with the exercise (see NOTE 7). Also, during the year ended December 31, 2023, we repurchased 302,919,223 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $396,547 and payables of $2,775,833 (see NOTE 5). We also recognized $20,341 in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

As of December 31, 2024 and 2023, we had 1,859,231,786 and 2,333,356,496 shares of common stock issued and outstanding, respectively.

 

Options

 

The 2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to 600,000,000 shares of the Company’s common stock.

 

During the year ended December 31, 2024, we issued 1,000,000 stock options as part of the acquisition of Opencash Finance, Inc., 10,000,000 stock options as part of a compensation package offered to a new officer of the Company, and 5,000,000 stock options as part of the purchase of the business and assets of Renu Laboratories, Inc. The options vest in equal amounts over a five-year period, at an exercise price of $0.05 per share, with a seven-year life. We utilized the Black Scholes Model to value these options, and the expense related to these options is being recognized over the vesting term. Also, during the year ended December 31, 2024, we cancelled 15,000,000 unvested options and 10,000,000 vested options expired upon the resignation of an officer of the Company.

 

Transactions involving our options are summarized as follows:

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2023   360,416,665   $0.05   $0.03 
Granted   16,000,000   $0.05   $0.01 
Canceled/Expired   (25,000,000)  $0.05   $0.03 
Exercised   -   $-   $- 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 

 

Details of our options outstanding as of December 31, 2024, is as follows:

 

Options Exercisable   Weighted Average
Exercise Price of Options
Exercisable
   Weighted Average
Contractual Life of Options
Exercisable (Years)
   Weighted Average
Contractual Life of Options
Outstanding (Years)
 
 183,291,665    0.05    4.48    4.62 

 

F-19

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Total stock compensation expense related to the options for the year ended December 31, 2024 and 2023, was $1,610,536 and $2,555,155, respectively. As of December 31, 2024 there was approximately $3.3 million of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 1.2 years.

 

Warrants

 

Transactions involving our warrants are summarized as follows:

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2022   1,178,320   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   (230)  $0.10 
Warrants outstanding at December 31, 2023   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 

 

Details of our warrants outstanding as of December 31, 2024 is as follows:

 

Warrants Exercisable   Weighted Average Contractual Life (Years) 
 1,178,090    1.14 

 

Class B Units of Investview Financial Group Holdings, LLC

 

As of December 31, 2024, and December 31, 2023, there were 565,000,000 Units of Class B Investview Financial Group Holdings, LLC issued and outstanding. These units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement. In order to properly account for the purchase transaction on the Company’s financial statements, we were required by applicable financial reporting standards to value the Class B Units issued to MPower in the transaction as of the closing date of the MPower sale transaction (September 3, 2021). For these accounting purposes, we concluded that the “fair value” of the consideration for financial accounting purposes, at the if-converted market value of the underlying common shares was $58.9 million, based on the closing market price of $0.1532 on the closing date of September 3, 2021, as discounted from $86.6 million by 32% (or $27.7 million) to reflect the significant lock up period. The “fair value” valuation of the Class B Units, however, was completed relying on a certain set of methodologies that are accepted for accounting purposes and is not necessarily indicative of the “fair market value” that may be implied relative to such Units in a commercial transaction not governed by financial reporting standards. In particular, the methodology used to value the Class B Units at their “fair value” did not take into account any blockage discounts that may otherwise apply after the expiration of the lock-up period in 2025; while other valuation methodologies, not bound by financial reporting codifications, would possibly determine that the blockage discount associated with the resale of 565 million shares after the expiration of the lock-up period, into a marketplace that has limited market liquidity, could possibly have a material downward influence on the valuation.

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

In the ordinary course of business, we may be, or have been, involved in legal proceedings. On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted, however, agreed to pay a civil monetary penalty of $375,000 to conclude the inquiry. The Company considers this matter to be closed. As of December 31, 2024, the penalty of $375,000 was in escrow with our SEC attorney.

 

F-20

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $19 million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a 25% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled the approximately $19 million of promissory notes.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program.

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

F-21

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The Company’s financial statements as of December 31, 2024, reflect a receivables balance of $2.53 million. Of that balance, $2.19 million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $1.87 million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $1.87 million. Furthermore, the Company may be caused under generally accepted accounting principles, to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $1.87 million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.

 

Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.

 

Prior to his termination, Mr. Cammarata and the Company engaged in certain transactions as described below:

 

We issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $1,550,000 (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $0.02 per share, Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA has only provided advances of $1,200,000 to date. The note bears interest at the rate of 0.11% per annum therefore we recognized $990 worth of interest expense on the loan during the nine months ended September 30, 2024. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

F-22

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

NOTE 11 – SEGMENT REPORTING

 

The company has three reportable segments, Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products. The reportable segments are identified based on the types of products that generate revenue.

 

The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.

 

For the years ended December 2024 and 2023, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.

 

The Financial Education and Technology segment generates revenue through membership fees. The Blockchain Technology and Crypto Mining segment generates revenue primarily through its Bitcoin mining operation. The Manufacturing and Development of Health, Beauty and Wellness Products generates revenue primarily through the sale of health and wellness products manufactured to wholesale and retail customers.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2024.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $47,061,290   $5,186,606   $134,075   $52,381,971 
                     
Less:                    
Commissions   25,913,260    -    -    25,913,260 
Market experts   1,065,350    -    -    1,065,350 
Credit card processing   1,949,087    -    -    1,949,087 
Salary and related   2,051,064    980,302    251,632    3,282,998 
Selling and marketing   565,437    1,803    1,000    568,240 
Energy and hosting   -    4,924,717    -    4,924,717 
Depreciation   1,565    3,871,740    -    3,873,305 
Impairment expense   -    1,771,891    -    1,771,891 
Cost of sales   -    -    56,521    56,521 
Loss (gain) on disposal of assets   -    180,223    -    180,223 
General and administrative [2]   1,491,652    391,040    116,221    1,998,913 
                     
Segment net income (loss) from operations  $14,023,875   $(6,935,110)  $(291,299)  $6,797,466 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

F-23

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2023.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $56,549,336   $11,371,535   $67,920,871 
                
Less:               
Commissions   31,498,098    -    31,498,098 
Market experts   1,239,347    -    1,239,347 
Credit card processing   2,390,922    -    2,390,922 
Salary and related   2,132,340    1,178,908    3,311,248 
Selling and marketing   549,776    1,174    550,950 
Energy and hosting   -    9,475,908    9,475,908 
Depreciation   2,606    4,446,940    4,449,546 
Loss (gain) on disposal of assets   1,096    201,512    202,608 
General and administrative [1]   845,457    844,664    1,690,121 
                
Segment income (loss) from operations  $17,889,694   $(4,777,571)  $13,112,123 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.

 

The following table illustrates the reconciliation of segment operating income to net income before taxes for the years ended December 31, 2024 and 2023.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   December 31,
2024
   December 31,
2023
 
Segment income from operations  $6,797,466   $13,112,123 
           
Reconciling items          
Bank interest   64,376    56,258 
Event ticket sales   350,635    288,454 
Leasing income   391,985    446,667 
Gain on winddown of operations [1]   -    56,422 
All other, net   3,684    (11,500)
           
Net income before taxes  $7,608,146   $13,948,314 

 

[1] Represents a gain on the winddown of SAFETek’s North American operations.

 

F-24

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

NOTE 12 – ACQUISITION

 

On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

 

The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

 

      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
 Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2]This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

 

Renu Laboratories LLC recorded revenue of $110,671 and net loss of $291,227 since the October 11, 2024 acquisition date, which were included in our consolidated statement of operations for the year ended December 31, 2024.

 

The table below represents the pro forma revenue and net income (loss) for the years ended December 31, 2023 and 2024, assuming the acquisition had occurred on January 1, 2023, pursuant to ASC Subtopic 805-10-50. This pro forma information does not purport to represent what the actual results of our operations would have been had the acquisition occurred on this date nor does it purport to predict the results of operations for future periods.

 

   December 31, 2024   December 31, 2023 
Revenue  $1,327,940   $1,534,369 
Net (loss)  $(325,257)  $(43,736)
Loss per common share  $(0.00)  $(0.00)

 

F-25

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

NOTE 13 – INCOME TAXES

 

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company used an effective tax rate of 21% when calculating the deferred tax assets and liabilities and income tax provision below.

 

The Company’s income (loss) before income taxes were broken down as follows:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Domestic  $2,085,356   $5,010,332 
Foreign   -    - 
Total Income (loss) before income taxes  $2,085,356   $5,010,332 

 

The Company’s tax provision (benefit) as of December 31, 2024 and 2023 is summarized as follows:

 

   December 31, 2024   December 31, 2023 
Current          
Federal  $903,347   $2,138,412 
State   (8,407)   40,000 
Foreign   -    - 
Total current income tax expense   894,940    2,178,412 
           
Total income tax expense  $894,940   $2,178,412 

 

Net deferred tax assets consist of the following components as of December 31, 2024 and 2023:

 

   December 31, 2024   December 31, 2023 
Deferred tax assets          
NOL carryover  $2,417,161   $2,982,071 
Amortization   1,850,667    1,771,645 
Other accruals   1,988,821    1,800,662 
Depreciation   862,384    562,982 
Investment in partnership   10,985,183    10,964,704 
Deferred tax liabilities   -    - 
Valuation allowance   (18,104,216)   (18,082,064)
Net deferred tax liability  $-   $- 

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the year ended December 31, 2024 and 2023, due to the following:

 

  

Year ended

December 31, 2024

  

Year ended

December 31, 2023

 
Income taxes at statutory rate  $437,925   $1,052,169 
State taxes – net of federal benefit   (6,641)   31,600 
Valuation allowance   581,800    1,809,765 
Foreign derived intangible income   (420,033)   (781,561)
Interest   260,511    260,317 
Other   41,378    (193,878)
Total income tax provision (benefit)  $894,940   $2,178,412 

 

F-26

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

At December 31, 2024 and December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $2.4 million (tax effected) and $3.0 million (tax effected), portions of which will begin to expire in 2025. Utilization of some of the federal and state net operating losses carryforwards are subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.

 

The Company will recognize penalties and interest accrued related to unrecognized tax benefits as a component of income taxes. As of December 31, 2024, the Company had $18,764 of accrued interest and penalties related to state income tax uncertain tax positions, in which $4,144 has been recognized in the Company’s statements of operations in the current year.

 

The Company is required to file income tax returns in various States. The Company is subject to income tax examinations by federal and state taxing authorities. The taxable years that are open under federal and state statute of limitations are 2020 through 2024. Due to net operating loss carryforwards that remain unutilized, such loss carryforwards remain subject to review until utilized.

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

  

Year ended

 December 31, 2024

  

Year ended

December 31, 2023

 
Balance at the beginning of the year   -    - 
Increases related to positions taken in prior years   26,768      - 
Balance at the end of the year  $26,768   $- 

 

NOTE 14 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.

 

On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”), approved by the disinterested members of the Company’s Board of Directors. Pursuant to the Amendment, DBR has been given until August 31,2025 to lend to the Company a minimum of $2.0 million, and until December 31, 2026 to lend to the Company the balance of up to $5.7 million. The Amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million.

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. As of the date of this filing, 705,890 shares have been repurchased for $16,618. These shares are being held by the Company in Treasury.

 

F-27

 

 

EX-4.02 2 ex4-02.htm

 

Exhibit 4.02

 

INVESTVIEW, INC.

DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

The following is a summary of information concerning the capital stock of Investview, Inc., a Nevada corporation (the “Company,” “we,” “us” and “our”). The summaries and descriptions below do not purport to be complete and are subject to and qualified in their entirety by reference to our Articles of Incorporation, as amended (our “Charter”), our Bylaws as amended (our “Bylaws”), our Certificate of Designation of 13% Series B Cumulative Redeemable Perpetual Preferred Stock, as amended (our “Certificate of Designation”), and our Common Stock Purchase Warrant (“Warrant”), which are filed as exhibits to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and are incorporated by reference herein. We encourage you to read our Charter, our Bylaws, our Certificate of Designation, our Warrant and the applicable provisions of the Nevada Revised Statutes (“NRS”) for additional information.

 

General

 

Our Charter authorizes us to issue 10,050,000,000 shares of capital stock, consisting of 10,000,000,000 shares of common stock, par value $0.001 (“common stock”), and 50,000,000,000 shares of preferred stock, par value $0.001 (“preferred stock”).

 

Common Stock

 

As of March 20, 2025, we had 1,859,231,786 shares of common stock issued and outstanding.

 

Voting Rights

 

The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and do not have cumulative voting rights.

 

Dividends

 

Holders of shares of our common stock are entitled to share pro rata in dividends and distributions when, as, and if declared by the board of directors out of funds legally available therefor. We have not paid any dividends on our common stock. Other than payment of a dividend of $3.25 per annum, paid quarterly, on our Series B preferred stock, we intend to retain earnings, if any, to finance the development and expansion of our business. In addition, we and our subsidiaries are subject to certain restrictions on declaring dividends under our existing Convertible Note Financing Arrangements with DBR Capital, LLC and the Certificate of Designation of our Series B Preferred Stock. Future dividend policy is subject to the discretion of our board of directors and will depend upon a number of factors, including future revenues, capital requirements, overall financial condition, and such other factors as our board of directors deems relevant.

 

Liquidation

 

Subject to any preferential rights of any then outstanding preferred stock, in the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in the assets remaining after payment of liabilities and the liquidation preferences of any then outstanding preferred stock.

 

Rights and Preferences

 

Our common stock does not carry any preemptive rights enabling a holder to subscribe for, or receive shares of, any class of our common stock or any other securities convertible into shares of any class of our common stock, or any redemption rights. Our common stock also does not have any conversion rights, and there are no sinking fund provisions applicable to our common stock.

 

 

 

 

Stock Exchange Listing

 

Our common stock is quoted on the OTCQB under the symbol “INVU.”

 

Units

 

During the year ended March 31, 2021, we commenced an offering to sell a total of 2,000,000 units at $25 per unit (“Unit Offering”), with each unit consisting of: (i) one share of our Series B preferred stock (as hereinafter defined) and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share (each, a “Warrant”). The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of 252,192 Units. The shares of Series B preferred stock and the Warrants comprising the Units were immediately separable upon issuance and were issued separately upon the closing of the Unit Offering.

 

Preferred Stock

 

We are authorized to issue 50,000,000 shares of preferred stock, $0.001 par value per share, of which 2,000,000 have been designated “13% Series B Preferred Cumulative Redeemable Perpetual Preferred Stock” (“Series B preferred stock”). As of March 20, 2025, we had 252,192 shares of Series B preferred stock issued and outstanding.

 

The Series B preferred stock has a stated value of $25 per share. The Series B preferred stock is not convertible into our common stock and earns cumulative dividends at a fixed rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred has no stated maturity and will not be subject to any sinking fund or mandatory redemption. The Series B preferred stock is redeemable at our option or upon certain change of control events.

 

The Series B preferred stock ranks, with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up, senior to all classes or series of our common stock and to all other equity securities issued by us other than equity securities on a parity with all equity securities issued by us with terms specifically providing that those equity securities rank on a parity with the Series B preferred stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; junior to all equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series B preferred stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up, including any other series of preferred stock; and effectively junior to all of our existing and future indebtedness (including indebtedness convertible into our common stock or preferred stock) and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing subsidiaries and any future subsidiaries.

 

Holders of Series B preferred stock have no voting rights except for the limited instance where the Series B Preferred may vote, which is with respect to any amendments to our Series B Preferred Certificate of Designation that materially and adversely affect the rights of the holders of Series B preferred stock or authorize, increase or create additional classes or series of our capital stock that are senior to the Series B preferred stock.

 

Our Series B preferred stock is quoted on the OTCQB under the symbol “INVUB.”

 

Warrants

 

The Warrants issued in the Unit Offering are exercisable during the period commencing on the date of their issuance and ending five years from such date (the “Warrant Expiration Date”) at an exercise price of $0.10 per Warrant Share. The exercise price of the Warrants is subject to adjustment if, during the five-year exercise period from the original issuance of the Warrants, we sell any shares of our common stock or securities exchangeable or exercisable or convertible into our common stock, subject to certain exceptions, at a price per share less than the exercise price of the Warrants then in effect or without consideration. As of March 20, 2025, we had 1,178,090 Warrants outstanding.

 

2

 

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our common stock, Series B preferred stock and Warrants is Vstock Transfer LLC. The transfer agent and registrar’s address is 18 Lafayette Place Woodmere, NY 11598.

 

Anti-Takeover Effects of Certain Provisions of our Charter and Bylaws and Nevada Law

 

No Cumulative Voting. The holders of our common stock do not have cumulative voting rights in the election of our directors, which makes it more difficult for minority stockholders to be represented on our board of directors.

 

Authorized but Unissued Shares of Common Stock. Our authorized but unissued shares of common stock will be available for future issuance without approval by the holders of common stock. We may use additional shares for a variety of corporate purposes, including future public offerings to raise additional capital, employee benefit plans and as consideration for or to finance future acquisitions, investments or other purposes. The existence of authorized but unissued shares of common stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

Undesignated Preferred Stock. Our certificate of incorporation authorizes undesignated preferred stock. As a result, our board may, without the approval of our stockholders, issue shares of preferred stock with super voting, special approval, dividend or other rights or preferences on a discriminatory basis that could impede the success of any attempt to acquire us. These and other provisions may have the effect of deferring, delaying or discouraging hostile takeovers, or changes in control or management of the Company.

 

Special Governance Rights included within DBR Capital’s investments enable DBR Capital to retain significant control of the Company for the foreseeable future. In connection with a convertible note financing arrangement we have with DBR Capital, LLC (“DBR Capital”) (see “ITEM 13. Certain Relationships and Related Transactions, and Director Independence” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024), an affiliate of our Chairman, David B. Rothrock, DBR Capital has been accorded certain special governance rights, including the right to appoint four of our seven directors, and to require that certain capital, financial and other material actions of our board of directors be approved by at least one DBR Capital-appointed director, who shall be David B. Rothrock if he is then serving as a director. The special governance rights shall remain in place for so long as DBR Capital holds a convertible note or any of our other securities. The presence of these governance rights makes it more difficult for minority stockholders to be represented on our board of directors and could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

Conversion of existing convertible notes purchased by DBR Capital could cause additional substantial dilution to our stockholders. Under the terms of its convertible notes, DBR Capital has the right to convert an aggregate of $3.3 million in principal of convertible notes into shares of our common stock at a conversion price of $0.007 per share. Exclusive of interest that could accrue on these notes, conversion of the outstanding principal of these notes would result in the issuance to DBR Capital of approximately 471 million additional shares of our common stock. Substantial additional dilution of up to an additional 1,100,000,000 shares of our common stock could be experienced by our shareholders should DBR Capital advance and ultimately convert additional notes of $7.7 million on or before December 31, 2026. The presence of these arrangements could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

3

 

EX-10.127 3 ex10-127.htm

 

Exhibit 10.127

 

GENERAL RELEASE AGREEMENT

 

THIS SEPARATION AGREEMENT AND GENERAL RELEASE (this “AGREEMENT”) is made by and between Investview, Inc., a Nevada corporation, with an address of 521 W. Lancaster Ave., Second Floor, Haverford, PA., 19041 (“INVESTVIEW”) and Myles P. Gill, an individual residing at 4827 Bethel Creek Drive, Vero Beach, FL 32963 (“GILL”). For purposes of this AGREEMENT, “COMPANY” shall include INVESTVIEW and all of its divisions, parents, subsidiaries, affiliates or related entities, its and their past, present and future officers, directors, trustees, members, shareholders, partners, insurers, attorneys, legal representatives, employees and agents and all of its and their respective heirs, executors, administrators, successors and assigns.

 

WHEREAS, GILL had been employed by INVESTVIEW since February, 2022; and

 

WHEREAS, GILL and INVESTVIEW are parties to an employment agreement dated February 21, 2022 (the “EMPLOYMENT AGREEMENT”) and a non-statutory option award agreement dated June 24, 2022 (the “OPTION AGREEMENT”); and

 

WHEREAS, GILL voluntarily resigned his employment with INVESTVIEW effective August 14, 2024 (the “SEPARATION DATE”); and

 

WHEREAS, INVESTVIEW desires to provide GILL with a separation package that both INVESTVIEW and GILL deem fair, reasonable and equitable; and

 

WHEREAS, INVESTVIEW and GILL deem it to be in their mutual interest to amicably resolve any disputes which may exist between them concerning GILL’s employment and its cessation and to provide for the manner in which they will hereafter conduct themselves in relation to each other.

 

NOW, THEREFORE, in consideration of their mutual promises as set forth herein and intending to be legally bound hereby, INVESTVIEW and GILL agree as follows:

 

1. The foregoing recitals are incorporated herein as if set forth at length.

 

2. In settlement of all RELEASED CLAIMS (as defined below) GILL had, has or may have against COMPANY, as well as in exchange for the representations, warranties and covenants made by GILL in this AGREEMENT, INVESTVIEW shall: (i) agree to accept GILL’S resignation absent any notice requirement, and to characterize Gill’s separation from service as being in response to his voluntary resignation from his employment with the Company; and (ii) grant GILL an extension of the exercise rights set forth in the OPTION AGREEMENT in paragraph 6(b) from ninety (90) days to one hundred and twenty (120) days and in accordance with the terms set forth therein (the “EXERCISE EXTENSION”). As INVESTVIEW makes no representation or warranties regarding any tax obligations arising out of the EXERCISE EXTENSION, GILL acknowledges that he has not relied upon any tax advice from INVESTVIEW regarding any tax obligations with respect to the EXERCISE EXTENSION. GILL shall indemnify and hold harmless INVESTVIEW from any and all claims and/or liability resulting from any failure by INVESTVIEW to withhold any taxes related to the EXERCISE EXTENSION, and/or GILL’s or his counsel’s failure to pay any and all taxes for which GILL or his counsel are responsible for relating to said EXERCISE EXTENSION.

 

Separation Agreement1Initial Here: ___/___

 

 

3. In consideration of the promises and undertakings of INVESTVIEW under this AGREEMENT, GILL makes the following representations, warranties and covenants:

 

(a)that for purposes of this AGREEMENT, COMPANY shall have no further obligation to pay or reimburse any amounts in connection with GILL’s benefits, including health benefits; and

 

(b)that he has been afforded by COMPANY any and all rights he had or may have had under any and all family or medical leave law including, but not limited to, the federal Family and Medical Leave Act (“FMLA”) and/or any state or local family or medical leave law, if applicable; and

 

(c)that he has been paid all wages, commissions and bonuses due him including, but not limited to, any monies under any bonus, severance and/or incentive compensation plan and that he has received all sums due him under the federal Fair Labor Standards Act (“FLSA”) and/or any state or local wage and hour law, if applicable; and

 

(d)that he shall make himself available and cooperate in any reasonable manner in providing reasonable assistance to COMPANY in concluding any business and/or legal matters which are presently pending and in connection with any such matters that may arise in the future which relate to his employment and or consulting employment with COMPANY and COMPANY shall have no obligation to compensate GILL for said time other than as set forth in this AGREEMENT. Notwithstanding the foregoing sentence of this Subparagraph (d), GILL shall be reimbursed by INVESTVIEW for all reasonable and necessary out-of-pocket expenses actually incurred by him as a result of his performance of his obligations under this Subparagraph (d), provided GILL receives the prior written approval for the expenses from INVESTVIEW prior to incurring any such expenses. In the event INVESTVIEW requests GILL to perform services pursuant to this Subparagraph (d), such work shall not be deemed a violation or breach of Subparagraph 3(i) of this AGREEMENT; and

 

(e)that he has returned to COMPANY all property of COMPANY in his possession or control which refer or relate to COMPANY’s business, or which are otherwise the property of COMPANY, including, but not limited to, all confidential and proprietary business information, papers, documents, letters, invoices, sales records and reports, notes, memoranda, keys, security cards, records, employee and human resource records, customer and supplier lists, customer and supplier materials or documents, computers, smartphone/Android/iPhone device, computer data, office equipment, and employment records, which were created by GILL or other employees, agents and customers or suppliers of COMPANY in the course of their employment and/or consulting relationship with COMPANY, as well as copies or multiple versions thereof, regardless of the form or medium retained or stored in (including hard copy or electronic or digital form). GILL further agrees and acknowledges that prior to the SEPARATION DATE, he has provided a list of all passwords and/or login information for all INVESTVIEW accounts and/or devices; and

 

Separation Agreement2Initial Here: ___/___

 

 

(f)that as an employee of COMPANY he had access to and was entrusted with COMPANY’s confidential and proprietary business information and trade secrets. At all times prior to, during, and following GILL’s separation he has maintained and will maintain such information in strict confidence and has not disclosed and will not disclose the information to any third party without the prior written consent of INVESTVIEW; and

 

(g)that he shall not receive any other payment from COMPANY other than that set forth in this AGREEMENT including, but not limited to, any wages, bonuses, compensation, incentive compensation, and/or commissions; and

 

(h)that he shall cooperate with COMPANY in the defense of any claim currently pending or hereinafter pursued against COMPANY without the payment of any additional compensation other than as set forth in this AGREEMENT. Such cooperation includes, but is not limited to, meeting with internal INVESTVIEW employees to discuss and review issues which GILL was directly or indirectly involved with during his employment with INVESTVIEW, participating in any investigation conducted by INVESTVIEW either internally or by outside counsel or consultants, signing declarations or witness statements, preparing for and serving as a witness in any civil or administrative proceeding by both depositions or a witness at trial, reviewing documents and similar activities that INVESTVIEW deems necessary. In the event INVESTVIEW requests GILL to perform services pursuant to this Subparagraph of this AGREEMENT, such work shall not be deemed a violation or breach of Subparagraph 3(i) of this AGREEMENT. Furthermore, GILL has not and shall not initiate, commence, voluntarily cooperate with or provide assistance including, but not limited to, testimony or consultative services, in any claim, lawsuit, administrative proceeding, investigation, inquiry, or similar activity, whether governmental or private, whether pending or otherwise, without obtaining the prior written consent of INVESTVIEW. In the case of legal proceedings, GILL shall notify INVESTVIEW, in writing, of any subpoena or other similar notice to give testimony or provide documentation (“NOTICE”) within two business days of receipt of said NOTICE and prior to providing any response to said NOTICE such that COMPANY may have an opportunity to seek and obtain, among other things, an appropriate protective order or seek intervention in the matter; and

 

(i)that he shall not be reemployed by COMPANY as an employee, independent contractor, consultant or otherwise and that he shall not apply for or otherwise seek employment with COMPANY at any time hereinafter except as may be specifically authorized in writing by COMPANY; and

 

(j)that he has not and will not access or attempt to access any property, computer systems, networks, password protected data or other property of the COMPANY on or after the SEPARATION DATE; and

 

Separation Agreement3Initial Here: ___/___

 

 

(k)that he has not sustained any injuries and/or illnesses/diseases as a result of his employment with or by COMPANY that would otherwise be covered by any otherwise applicable workers’ compensation insurance benefit plan; and

 

(l)that this AGREEMENT does not have the purpose or effect of concealing details relating to claims of or for discrimination, retaliation, harassment, fair labor standards, family and medical, or wage and hour; and

 

(m)that neither he nor anyone under GILL’S direction or control shall take, support, encourage, induce or voluntarily participate in any action or attempted action that would negatively comment on, disparage, or call into question the business operations, policies, or conduct of COMPANY or otherwise take any action, verbal or otherwise, in retaliation against COMPANY, or act in any way that could likely damage COMPANY’S reputation, business relationships, or present or future business. In addition, neither GILL nor anyone under GILL’S direction or control shall blog, tweet or comment on Facebook, Instagram, Twitter, Snapchat, GlassDoor or any other social or public media platform or forum about COMPANY (whether or not anonymously) in any manner that violates this AGREEMENT. Nothing in this AGREEMENT is intended in any way to interfere with, coerce, or restrain GILL from exercising his rights under any state or federal labor law, including the National Labor Relations Act; and

  

(n)that he unconditionally releases and forever discharges COMPANY (whether individually or collectively) from any and all causes of action, suits, damages, grievances, demands, liabilities, defenses, debts, dues, sums of monies, accounts, covenants, controversies, promises, variances, claims, judgments, interest, attorneys’ fees, liquidated damages, costs and expenses whatsoever relating to, or in connection with, GILL’s employment by COMPANY or cessation thereof, either directly or indirectly, whether known or unknown, contingent or fixed, liquidated or un-liquidated, matured or un-matured, in law, equity or otherwise, for, upon or by reason of any matter, cause or thing whatsoever, including, but not limited to, any breach of contract claims (whether written or oral, express or implied); claims arising out of any offer letter or similar document; claims arising out of any employee handbook, personnel manual or employment policy; estoppel claims; tort claims; claims of discrimination; claims for compensatory and/or punitive damages; public policy claims; defamation claims; claims of retaliation; claims of wrongful discharge or termination; claims for breach of promise; claims of negligence; claims of impairment of economic opportunity or loss of business opportunity; claims of fraud or misrepresentation (negligent or intentional); claims for severance offers made prior to the date GILL signs this AGREEMENT other than as set forth in this AGREEMENT; claims for abuse of process; claims for workers’ compensation benefits; claims of promissory estoppel; claims for quantum meruit; claims for unjust enrichment; claims for breach of the covenant of good faith and fair dealing; claims of unfair labor practices; claims under Title VII of the Civil Rights Act of 1964, as amended (“TITLE VII”); claims under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) (excluding claims for vested benefits); claims under the Immigration Reform and Control Act of 1986 (“IRCA”); claims under the Americans With Disabilities Act (“ADA”); claims under the Family and Medical Leave Act (“FMLA”); claims under the Fair Labor Standards Act (“FLSA”); claims under the Uniformed Services Employment and Reemployment Rights Act (“USERRA”); claims under the National Labor Relations Act (“NLRA”); claims under the Worker Adjustment and Retraining Notification Act (“WARN”); claims under the Genetic Information Nondiscrimination Act of 2008 (“GINA”); claims under the Families First Coronavirus Response Act (“FFCRA”); claims under the Constitution of the United States of America; claims under the New Jersey Law Against Discrimination (“NJLAD”); claims under the New Jersey Conscientious Employee Protection Act (“CEPA”); claims under the New Jersey Family Leave Act (“FLA”); claims under the New Jersey Millville Dallas Airmotive Plant Job Loss Notification Act (“NJMDAP”) or any other New Jersey plant closing or mass lay off law; claims under the New Jersey Wage and Hour laws; claims under the Constitution of the State of New Jersey: claims under the Pennsylvania Human Relations Act (“PHRA”); claims under the Pennsylvania Minimum Wage Act (“PMWA”); claims under the Pennsylvania Wage Payment and Collection law (“PAWPCL”); claims under the Pennsylvania Whistleblower Law, the Pennsylvania Public Employee Relations Act; claims under the Pennsylvania Medical Marijuana Law; claims under the Philadelphia Fair Practices Ordinance; claims under Philadelphia’s ordinances relating to earned sick time; claims under the Philadelphia Wage Theft Ordinance; claims under the Constitution of the Commonwealth of Pennsylvania; claims under the Florida Civil Rights Act (“FRCRA”); claims under the Florida Private Whistle-Blower’s Act (“FWA”); claims under the Florida Equal Pay Act (“FEPA”); claims under the Florida Equal Wage Law (“FEWL”); claims under the Florida Alien Discrimination Law (“FADL”); claims under the Florida AIDS Discrimination Law (“FADL”); claims under the Florida Sickle-Cell Trait Discrimination Law (“FSCTDL”); claims under the Florida Genetic Testing Law (“FGTL”); claims under the Florida Private Drug-Free Workplace Law (FDFWL”); claims under the Florida Jury Service Law (“FJSL”); claims under the Florida Military Discrimination in Employment Law (“FMDEL”); claims under the Florida Clean Indoor Air Act (“FCIAA”); claims under the Florida Wage Garnishment Law (“FWGL”); claims under the Florida Wage and Hour Laws (“FWHL”); claims under any other federal, state or local anti-discrimination law, whistle-blowing law, family and/or medical leave law and wage and hour law; claims for benefits including, but not limited to, life insurance, accidental death & disability insurance, sick leave or other employer provided plan or program; claims for distributions of income or profit; claims for ownership, stock, stock options, equity or otherwise; claims for reimbursement; claims for wages, commissions or bonuses; claims for incentive compensation; claims for salary continuation benefits; claims for vacation or other leave time; claims for royalties or license fees; claims for patent, copyright or trademark infringement; claims relating to retirement, pension and/or profit sharing plans (excluding claims for vested benefits); claims arising from the EMPLOYMENT AGREEMENT; claims arising from the OPTIONS AGREEMENT; claims for, or arising out of the offering of, group health insurance coverage (excluding claims for COBRA or similar state mandated continuation coverage) or the use of information obtained by COMPANY as a result of the offering of group health insurance coverage; claims against the Employer Health Plan as defined under the Health Insurance Portability and Accountability Act (“HIPAA”); claims relating to GILL’s application for hire, employment, or termination thereof, as well as any claims which GILL may have arising under or in connection with any and all local, state or federal ordinances, statutes, rules, regulations, executive orders or common law, from the beginning of the world up to and including the date of GILL’s execution of this AGREEMENT (collectively the above releases and discharges to be hereafter known as the “RELEASED CLAIMS”). The only exclusions from this release provision is a claim that some term of this AGREEMENT has been materially violated; and

 

Separation Agreement4Initial Here: ___/___

 

 

(o)that in giving the general release as set forth in Subparagraph 3(n) of this AGREEMENT, GILL acknowledges that he understands the significance and consequence of such release and waiver. Furthermore, that in giving the general release as set forth in Subparagraph 3(n) of this AGREEMENT, GILL specifically acknowledges that he may hereafter discover claims or facts in addition to or different from those which he now knows or believes to exist with respect to the subject matter of this AGREEMENT and which, if known or suspected at the time of executing this AGREEMENT, may have materially affected this AGREEMENT. Nevertheless, GILL hereby waives any right, claim or cause of action that might arise as a result of such different or additional claims or facts. GILL acknowledges that he understands the significance and consequence of such general release and waiver; and

 

(p)that neither GILL nor anyone on GILL’S behalf has filed an action in any court of law against COMPANY in connection with GILL’S employment with COMPANY, and that there is no pending charge or complaint filed with any state, federal, or local agency, including, but not limited to, the U.S. Equal Employment Opportunity Commission or the U.S. Department of Labor.

 

4. GILL acknowledges and confirms that he is waiving any claim under the Age Discrimination in Employment Act of 1967 (“ADEA”) as amended by the Older Workers Benefit Protection Act (“OWBPA”) and that:

 

(a)he is receiving consideration which is in addition to anything of value to which s/he otherwise would have been entitled; and

 

(b)this AGREEMENT is written in a manner understood by GILL and that he fully understands the terms of this AGREEMENT and enters into it voluntarily without any coercion on the part of any person or entity; and

 

(c)he was given adequate time to consider all implications and to freely and fully consult with and seek the advice of counsel or whomever else he deemed appropriate and has done so; and

 

(d)the consideration paid or provided to GILL under this AGREEMENT is and shall be deemed to be adequate consideration for the representations, warranties and covenants made by GILL under this AGREEMENT; and

 

Separation Agreement5Initial Here: ___/___

 

 

(e)he was advised in writing, by way of this AGREEMENT, to consult an attorney before signing this AGREEMENT; and

 

(f)he was advised, in writing, by way of this AGREEMENT, that he has at least 21 calendar days within which to consider this AGREEMENT before signing it and, in the event that he signs this AGREEMENT during this time period, said signing constitutes a knowing and voluntary waiver of this time period; and

 

(g)he has seven calendar days after executing this AGREEMENT within which to revoke this AGREEMENT. If the seventh day is a weekend or national holiday, GILL has until the next business day to revoke. If GILL elects to revoke this AGREEMENT, he shall notify Jonathan D. Ash, Esq. of Fox Rothschild LLP, 212 Carnegie Center, Suite 400, Princeton, NJ 08540 (“ASH”) in writing sent by Federal Express Priority Overnight delivery, or by hand delivery with written receipt, of his revocation. Any determination of whether GILL’s revocation was timely sent shall be determined by the date of actual receipt by ASH. In the event of revocation, INVESTVIEW reserves the right to reject GILL’s resignation and proceed as it deems appropriate.

 

5. GILL represents, warrants and covenants that neither he nor anyone on his behalf has filed any suits, claims or the like regarding his employment with COMPANY and/or its termination. To the extent that GILL or any third party seeks redress for a RELEASED CLAIM covered and released and discharged by this AGREEMENT and a settlement or judgment of said RELEASED CLAIM is reached or entered, GILL shall designate INVESTVIEW as the recipient and or payee of any such monies allocated to him by the payor or, if that is not possible, GILL shall pay to INVESTVIEW the amount received from the payor within 72 hours of GILL’s receipt of said monies.

 

6. GILL has not and shall not, without the prior written consent of INVESTVIEW, disclose the terms of this AGREEMENT, including, but not by way of limitation, the amount or fact of any payment to be made under this AGREEMENT or any of the facts or events surrounding or leading to this AGREEMENT (including any characterization thereof) to any person (including, but not limited to, current or former employees of COMPANY) or entity other than his spouse, attorneys, tax or financial advisors, or lenders for the purpose of confidential legal or financial counseling, or as otherwise required by law, or for purposes of enforcement of this AGREEMENT. In the event that GILL makes a disclosure permitted by this provision, he shall inform the individual or entity to whom disclosure is made of this confidentiality provision, and instruct such individual or entity that any breach of confidentiality by them would constitute a breach of this AGREEMENT. GILL understands and acknowledges that, as a publicly-held corporation, the COMPANY may have an obligation under law to file one or more reports with the Securities and Exchange Commission that includes a copy of this AGREEMENT and discloses the terms of this AGREEMENT.

 

7. In the event of a breach of this AGREEMENT, including without limitation, paragraphs 3 and 6, COMPANY, in addition to any other rights it may have at law or in equity, shall have the right to seek enforcement of this AGREEMENT in an action at law or in equity and COMPANY shall have the right to recover its legal fees, costs and expenses in such action to enforce this AGREEMENT, to the extent permitted by law and to the extent that such recovery does not result in the invalidation of this AGREEMENT. GILL acknowledges that any breach or threatened breach of this AGREEMENT, including, but not limited to Paragraphs 3 and 6, will cause irreparable injury to COMPANY, that money damages shall not provide an adequate remedy, and COMPANY shall therefore be entitled, in addition to any other relief available to it, to preliminary, temporary and permanent injunctive relief without the necessity of proving irreparable harm or posting a bond. If provisions of this AGREEMENT are ever determined by a court of competent jurisdiction to exceed limitations permitted by law, then such provisions shall be reformed automatically to set forth the maximum limitations permissible by law.

 

Separation Agreement6Initial Here: ___/___

 

 

8. This AGREEMENT shall not in any manner be deemed or construed as an admission by COMPANY that it has acted wrongfully and/or illegally in any manner with respect to GILL, but is made solely to avoid any potential disputes for and in consideration of the EXERCISE EXTENSION hereunder.

 

9. COMPANY shall be entitled to plead this AGREEMENT as a complete defense to RELEASED CLAIMS and or any other claim or entitlement relating to GILL’s employment with COMPANY or cessation thereof which hereafter may be asserted by GILL or other persons, entities or agencies acting on his behalf in any suit or claim against COMPANY.

 

10. The captions herein are for convenience and reference only, and the words contained therein shall not be used to explain, modify or amplify the meaning of any of the provisions or terms of this AGREEMENT. The parties hereto agree that this AGREEMENT shall be fairly interpreted in accordance with its provisions and terms without any strict construction in favor of or against either party, and that an ambiguity shall not be interpreted against the drafting party, rather such provision shall be modified to the minimum extent necessary to make it or its application valid and enforceable, and the remainder of this Agreement shall not be affected thereby and shall be valid and enforceable to the fullest extent provided by law. Each provision of this AGREEMENT is severable and, if any term or provision is held to be invalid, void or unenforceable by a court of competent jurisdiction or by an administrative agency for any reason whatsoever, such provision (i) shall be modified to the minimum extent necessary to make it or its application valid and enforceable, if possible, and if not possible, (ii) such provision or provisions shall be stricken from this AGREEMENT and the remainder of this AGREEMENT shall not be affected thereby and shall be valid and enforceable to the fullest extent provided by law. Notwithstanding the foregoing, if the release provisions (or any portion thereof) as set forth in Subparagraph (n) or otherwise contained herein this AGREEMENT are held to be invalid, void or unenforceable by a court of competent jurisdiction or by an administrative agency for any reason whatsoever, as a result of actions or inactions by GILL or anyone on his behalf, such ruling shall render this AGREEMENT void and GILL shall repay to INVESTVIEW all monies paid to or on behalf of GILL as set forth in this AGREEMENT within 72 hours of such determination, to the extent permitted by law and to the extent that such repayment does not result in the invalidation of this AGREEMENT.

 

11. This AGREEMENT supersedes and voids all previous agreements, policies and practices between GILL and COMPANY, whether written or oral, including, but not limited to, any severance offer or settlements made prior to the date GILL signs this AGREEMENT other than as set forth in this AGREEMENT. Notwithstanding the foregoing sentence of this Paragraph of this AGREEMENT, GILL continues to be bound by any and all post-employment obligations of GILL that are contained in any agreement, contract, or other document that GILL has already signed, including but not limited to the EMPLOYMENT AGREEMENT and those terms are hereby deemed incorporated herein by reference and shall continue in full force and effect as if set forth in their entirety as they are considered an integral part of this AGREEMENT. GILL further acknowledges that the consideration provided to GILL under this AGREEMENT including but not limited to the EXERCISE EXTENSION is and shall be deemed to be adequate consideration for the representations, warranties and covenants made by GILL under this AGREEMENT. This AGREEMENT sets forth the entire understanding of the parties as to the subject matter contained herein and may be modified solely by a writing executed by INVESTVIEW and GILL.

 

Separation Agreement7Initial Here: ___/___

 

 

12. This AGREEMENT shall be governed by, construed and enforced under the laws of the State of New Jersey (without regard to conflict of laws principles). Any dispute pertaining to this AGREEMENT or between the parties hereto shall be brought only in the Federal or State courts located in the County of Mercer, State of New Jersey. This AGREEMENT shall be interpreted without the aid of any canon, custom or rule of law requiring construction against the draftsman. GILL hereby irrevocably waives personal service of process and consents to process served in any such suit, action or proceeding by service of a copy thereof to him by certified mail, return receipt requested, postage pre-paid or by federal express/ups letter package, postage pre-paid, signature/receipt requested and sent for overnight delivery with service being effective upon receipt, delivery or refusal of receipt or delivery to GILL’s address first set forth above herein this AGREEMENT. Such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.

 

13. ANY DISPUTE ARISING OUT OF THIS AGREEMENT OR ANY DISPUTE BETWEEN THE PARTIES TO THIS AGREEMENT ON ANY SUBJECT MATTER SHALL BE TRIED WITHOUT A JURY. THE PARTIES RECOGNIZE THAT WITH THIS PROVISION THEY ARE EXPRESSLY AND VOLUNTARILY WAIVING THEIR RESPECTIVE RIGHTS TO A JURY TRIAL AND DO SO IN ORDER TO RESOLVE ANY FUTURE DISPUTES IN A MORE EFFICIENT AND COST-EFFECTIVE MANNER.

 

14. GILL and INVESTVIEW shall each bear his and its own costs and expenses, including but not limited to attorneys’ fees incurred in connection with the drafting, preparation, negotiation and execution of this AGREEMENT.

 

15. GILL and INVESTVIEW shall take all steps necessary or required to effectuate the intent and/or terms of this AGREEMENT in a timely manner including, but not limited to, the execution of any appropriate tax reporting documentation.

 

16. INVESTVIEW represents, warrants and covenants that it has reviewed this AGREEMENT carefully, understands it and has the authority to act on behalf of it and to execute, deliver, perform and bind INVESTVIEW to this AGREEMENT. GILL represents, warrants and covenants that he has reviewed this AGREEMENT carefully, understands it and that he has the capacity to act on his own behalf and to execute, deliver, perform and bind himself/herself to this AGREEMENT.

 

17. The failure of COMPANY to insist upon the performance of any of the terms and conditions of this AGREEMENT or the failure of COMPANY to prosecute any breach of this AGREEMENT, nor any customary or course of conduct shall not be construed or considered a waiver of any such term or condition of this AGREEMENT; to wit, the entire AGREEMENT shall remain in full force and effect as if no such forbearance or failure of performance had occurred. All rights, powers and remedies specified in this AGREEMENT are cumulative and are in addition to, and not in limitation of, such other rights, powers and remedies as may be available to a party under applicable law, by agreement among the parties or otherwise.

 

Separation Agreement8Initial Here: ___/___

 

 

18. Except as otherwise herein expressly provided, this AGREEMENT shall inure to the benefit of and be binding upon GILL, his heirs, successors and executors and shall inure to the benefit of COMPANY. GILL represents, warrants and covenants that he has not assigned or in any other manner conveyed any right or claim that he has or may have with respect to the subject matter of this AGREEMENT to any third party person or entity, and GILL shall not assign or convey to any assignee for any reason any right or claim covered by this AGREEMENT, or the consideration, monetary or other, to be received by him hereunder. INVESTVIEW may assign its rights and obligations under this AGREEMENT to any third party person or entity in its sole discretion.

 

19. The parties hereto represent, warrant and covenant that they entered into and signed this AGREEMENT voluntarily, without coercion and based upon their own judgment and not in reliance on any oral or written statements, representations or promises made by the other party or their agent(s) except as specifically set forth herein; further, each party represents, warrants and covenants that prior to signing this AGREEMENT, each has had an opportunity to, or has voluntarily chose not to, have this AGREEMENT reviewed by legal counsel, tax and/or other professional advisors of the party’s own choice, are satisfied with such advice, as applicable, and are signing this AGREEMENT fully intending to be legally bound hereby based upon the valuable benefits each party will receive hereunder. This AGREEMENT may be executed in counterparts, each executed AGREEMENT, when taken together, shall constitute a complete AGREEMENT. Any party may execute this AGREEMENT by signing, including by electronic means and transmitting that signature page via facsimile or e-mail to the other party. Any signature made and transmitted by facsimile or e-mail for the purpose of executing this AGREEMENT shall be deemed an original signature for purposes of this AGREEMENT. GILL hereby acknowledges and certifies that he is fully aware that Fox Rothschild LLP represents the COMPANY as its legal counsel.

 

20. In the event that any of the Parties hereto shall commence any proceeding, at law or in equity, against the other party, or institute any claims or counterclaims against the other party in any such proceeding, which proceeding, claims or counterclaims arise out of, under, in connection with or relates to, this AGREEMENT, the representations, warranties and covenants thereof or the RELEASED CLAIMS, the non-prevailing party in such proceeding or counterclaim shall pay to the prevailing Party the prevailing party’s reasonable attorneys’ fees and costs, expenses and disbursements incurred in connection with such proceeding or counterclaim and in connection with any post judgment collection efforts.

 

21. All notices and communications required, necessary or permitted hereunder shall be in writing and shall be delivered: (a) by registered or certified mail, postage prepaid, return receipt requested; or (b) by a generally recognized commercial courier service or overnight delivery service, (Federal Express or UPS), sent for next Business Day delivery, postage prepaid, with delivery receipt requested. All such notices sent in accordance with this Paragraph 21 shall be deemed “Delivered” three (3) Business Days after the same is deposited in the U.S. Mail if sent by registered or certified mail or one (1) Business Day after payment and receipt of mailing if sent by a commercial courier service or overnight delivery service for next Business Day delivery. Such communications must be sent to the respective parties at the addresses first above written or a different address as specified by a party in accordance with this Paragraph 21.

 

22. The obligations, representations, warranties and covenants of each party to the other, which are to be performed after termination, shall survive the termination of this Agreement indefinitely.

 

*** Signature page to follow

 

Separation Agreement9Initial Here: ___/___

 

  

PLEASE READ CAREFULLY THE ENTIRE AGREEMENT BEFORE SIGNING. THIS SEPARATION AGREEMENT AND GENERAL RELEASE INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN, FORESEEN AND UNFORESEEN, AND SUSPECTED AND UNSUSPECTED CLAIMS REGARDLESS OF ANY POTENTIAL FOR FUTURE DISCOVERY OF UNKNOWN FACTS.

 

IN WITNESS WHEREOF, the parties hereto have made and signed this AGREEMENT as follows:

 

INVESTVIEW, INC.   MYLES P. GILL
         
BY: /s/ James R. Bell     /s/ Myles P. Gill
Name: James R. Bell   Name:   Myles P. Gill
Title: President/COO    

 

DATED: August 19, 2024   DATED: August 19, 2024

  

Separation Agreement10Initial Here: ___/___

 

 

EX-14.01 4 ex14-01.htm

 

Exhibit 14.01

 

INVESTVIEW, INC.

 

___________________

 

CODE OF ETHICS 

___________________

 

Effective as of November 14, 2022

 

 

 

 

Investview, Inc.

 

Code of Ethics

 

1. Introduction.

 

1.1 Investview, Inc. and each of its operating subsidiaries and affiliates (collectively referred to herein as the “Company”) is committed to the highest ethical standards and to conducting its business with the highest level of integrity, honesty, fairness, accountability and respect in dealing with its employees, customers, suppliers, investors and the general public. An uncompromising adherence to ethical excellence is integral to creating, sustaining and increasing the goodwill and reputation of the Company. In support thereof, the Company has adopted this Code of Ethics (the “Code”) for all of its directors, officers and employees to guide them in assessing and addressing legal and ethical obligations. Compliance with this Code is considered a condition of employment, where violations of this Code will be investigated and may subject the violator to disciplinary action up to and including termination of employment where appropriate. No code or policy can anticipate every situation which may arise. Accordingly, this Code is intended to serve as a source of guiding principles.

 

1.2 The Board has adopted this Code in order to:

 

(a) promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest;

 

(b) promote full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with, or submits to, the SEC and in other public communications made by the Company;

 

(c) promote compliance with applicable governmental laws, rules and regulations;

 

(d) promote the protection of Company assets, including corporate opportunities and confidential information;

 

(e) promote fair dealing practices;

 

(f) deter wrongdoing; and

 

(g) ensure accountability for adherence to the Code.

 

1.3 All directors, officers and employees are required to be familiar with the Code, comply with its provisions and report any suspected violations as described below in Section 17, Reporting and Enforcement.

 

 2 

 

  

2. Honest and Ethical Conduct.

 

2.1 The Company’s policy is to promote high standards of integrity by conducting its affairs honestly and ethically.

 

2.2 Each director, officer and employee must act with integrity and observe the highest ethical standards of business conduct in his or her dealings with the Company’s customers, suppliers, partners, service providers, competitors, employees, contractors and anyone else with whom he or she has contact in the course of performing his or her job.

 

3. Employment Practices. The Company promotes the potential of every individual and values everyone’s diversity. The Company is an equal opportunity employer and does not tolerate discrimination or harassment because of race, sex, age, color, religion, creed, marital status, sexual orientation, gender identity, gender expression, national origin, veteran’s status, disability or any other characteristic protected under applicable law.

 

4. Conflicts of Interest.

 

4.1 A conflict of interest occurs when an individual’s private interest (or the interest of a member of his or her family) interferes, or even appears to interfere, with the interests of the Company as a whole. A conflict of interest can arise when an employee, contractor, officer or director (or a member of his or her family) takes actions or has interests that may make it difficult to perform his or her work for the Company objectively and effectively. Conflicts of interest also arise when an employee, contractor, officer or director (or a member of his or her family) receives improper personal benefits as a result of his or her position in the Company.

 

4.2 Loans by the Company to, or guarantees by the Company of obligations of, employees or their family members are of special concern and could constitute improper personal benefits to the recipients of such loans or guarantees, depending on the facts and circumstances. Loans by the Company to, or guarantees by the Company of obligations of, any director or executive officer are expressly prohibited.

 

4.3 Conflicts of interest should be avoided unless specifically authorized as described in Section 4.5. Further, the Company’s Related Party Transactions Policy requires preapproval for certain conflicts of interest. Whether or not a conflict of interest exists or will exist can be unclear. For example, there is likely a conflict of interest if an individual:

 

(a) Causes the Company to engage in business transactions with relatives or friends;

 

(b) Uses non-public Company, customer or vendor information for personal gain by such individual or his relatives or friends (including securities transactions based on such information);

 

 3 

 

 

(c) Has more than a modest financial interest in the Company’s vendors, customers or competitors (see below for guidelines);

 

(d) Receives a loan, or guarantee of any obligation, from the Company or a third party as a result of his position at the Company;

 

(e) Receives any payments or gifts, other than gifts of nominal value, from any third party as a result of his position with the Company; or

 

(f) Competes, or prepares to compete, with the Company while still employed by the Company.

 

4.4 Employees, officers and directors must understand the potential for conflicts of interest in investing in the Company’s vendors, customers, partners or competitors. The Company’s employees, officers and directors must always serve the Company’s stockholders first, and investing in companies with which the Company does business may not be in our stockholders’ best interests. The following guidelines apply with respect to such investments:

 

(a) Public Companies. Passive investments of less than 1% of the outstanding shares of such companies that are listed on a U.S. or international stock exchange or quoted on Nasdaq, are permitted without the Company’s approval, provided that the investment is not so large financially in either absolute dollars or percentage of the individual’s total investment portfolio as to create the appearance of a conflict of interest. No investment may involve any confidential inside or proprietary information, such as information that may have been learned about the other company as a result of the Company’s relationship with the other company. Passive investments of 1% or more of the outstanding shares of such companies that are listed on a U.S. or international stock exchange or quoted on Nasdaq require disclosure to the Compliance Officer (as hereinafter defined).

 

(b) Private Companies. Any investment in the Company’s vendors, partners, customers or competitors that are privately held requires disclosure to the Compliance Officer.

 

4.5 Persons other than directors and executive officers who have questions about a potential conflict of interest or who become aware of an actual or potential conflict should discuss the matter with, and seek a determination and prior authorization or approval from, their supervisor or the Chief Financial Officer (as such, the “Compliance Officer”). A supervisor may not authorize or approve conflict of interest matters or make determinations as to whether a problematic conflict of interest exists without first providing the Compliance Officer with a written description of the activity and seeking the Compliance Officer’s written approval. If the supervisor is themself involved in the potential or actual conflict, the matter should instead be discussed directly with the Compliance Officer.

 

 4 

 

 

Directors and executive officers must seek determinations and prior authorizations or approvals of potential conflicts of interest exclusively from the Board of Directors, or if the Board so delegates, an independent committee of the Board.

 

5. Gifts, Bribes and Kickbacks.

 

5.1 Other than modest gifts given or received in the normal course of business (including travel or entertainment), no director, officer or employee nor any of their relatives may give gifts to, or receive gifts from, the Company’s customers or vendors. Other gifts may be given or accepted only with prior approval of their supervisor or the Compliance Officer, and in no event should a director, officer or employee put the Company or himself in a position that would be embarrassing if information about the gift was made public.

 

5.2 When dealing with governmental agencies and public officials, directors, officers and employees must avoid any activity that is or appears illegal or unethical. Many federal, state and local governmental bodies strictly prohibit the receipt of any gratuities by their employees, including meals, transportation, lodging and entertainment. Directors, officers and employees must be aware of and strictly follow these prohibitions.

 

5.3 Any employee, director or officer who pays or receives bribes or kickbacks will be immediately terminated and may be reported to the appropriate authorities. A kickback or bribe includes any item intended to improperly obtain favorable treatment, including a bribe to guarantee that the Company will use the services of a particular vendor when such use is not advantageous to the Company.

 

5.4 In addition, the U.S. Foreign Corrupt Practices Act (“FCPA”) prohibits giving anything of value, directly or indirectly, to officials of foreign governments or foreign political candidates to obtain or retain business. This prohibition also extends to payments to sales representatives or agents if there is reason to believe that the payment will be used indirectly for a prohibited payment to a foreign official. Violation of the FCPA can result in severe fines and criminal penalties, as well as disciplinary action by the Company, up to and including termination of employment. Questions regarding whether certain payments are prohibited by the FCPA should be directed to the Compliance Officer.

 

6. Community Activities and Political Contributions. The Company encourages all employees, directors, and officers to participate on an individual basis in community and political activities. Those who do participate in community and political activities do so as individual citizens and not as representatives of the Company. Employees, directors, and officers are not authorized to use the Company’s name or premises for (or contribute the Company’s funds in support of) political or campaign purposes. The Company does not support or endorse political parties or individual candidates.

 

 5 

 

 

7. Compliance

 

7.1 Employees, officers and directors should comply, both in letter and spirit, with all applicable laws, rules and regulations in the cities, states and countries in which the Company operates.

 

7.2 Although not all employees, officers and directors are expected to know the details of all applicable laws, rules and regulations, it is important to know enough to determine when to seek advice from appropriate personnel. Questions about compliance should be addressed to the Compliance Officer.

 

8. Security Laws and Insider Trading.

 

8.1  It is usually illegal to buy or sell securities using material information not available to the public. Persons who give such undisclosed “inside” information to others may be as liable as persons who trade securities while possessing such information. Securities laws may be violated if any employees, officers and directors, or any of their relatives or friends, trade in securities of the Company, or any of its customers or vendors, while possessing inside information or unpublished knowledge. For additional information, please refer to the Company’s “Insider Trading Policy”. If uncertain about the legality of a particular trade, directors, officers and employees should consult with the Compliance Officer before making any such purchase or sale.

 

 6 

 

  

9. Disclosure.

 

9.1 The Company’s periodic reports and other documents filed with the SEC, including all financial statements and other financial information, must comply with applicable federal securities laws and SEC rules.

 

9.2 Each director, officer, and employee who contributes in any way to the preparation or verification of the Company’s financial statements and other financial information must ensure that the Company’s books, records and accounts are accurately maintained. Each director, officer and employee must cooperate fully with the Company’s accounting and internal audit departments, as well as the Company’s independent public accountants and counsel.

 

9.3 Each director, officer and employee who is involved in the Company’s disclosure process must:

 

(a) be familiar with and comply with the Company’s disclosure controls and procedures and its internal control over financial reporting; and

 

(b) take all necessary steps to ensure that all filings with the SEC and all other public communications about the financial and business condition of the Company provide full, fair, accurate, timely and understandable disclosure.

 

10. Protection and Proper Use of Company Assets.

 

10.1 All directors, officers and employees should protect the Company’s assets and ensure their efficient use. Theft, carelessness and waste have a direct impact on the Company’s profitability and are prohibited.

 

10.2 All Company assets should be used only for legitimate business purposes. Any suspected incident of fraud or theft should be reported for investigation immediately.

 

10.3 The obligation to protect Company assets includes the Company’s proprietary information. Proprietary information includes intellectual property such as trade secrets, patents, trademarks, and copyrights, as well as business and marketing plans, engineering and manufacturing ideas, designs, databases, records and any nonpublic financial data or reports. Unauthorized use or distribution of this information is prohibited and could also be illegal and result in civil or criminal penalties.

 

11. Corporate Opportunities.

 

11.1 All directors, officers and employees owe a duty to the Company to advance its interests when the opportunity arises. Directors, officers and employees are prohibited from taking for themselves personally (or for the benefit of friends or family members) opportunities that are discovered through the use of Company assets, property, information or position. Directors, officers and employees may not use Company assets, property, information or position for personal gain (including gain of friends or family members).

 

 7 

 

 

11.2 Other than with the prior written consent of the Compliance Officer, simultaneous employment with any other entity where such entity is a competitor of the Company, or where such employment interferes with the ability of a director, officer or employee to perform or carry out job responsibilities, serving as a director/trustee of a significant competitor of the Company, serving as a director/trustee of any entity in which the Company is invested or engaging in any activity that a director, officer or employee should reasonably expect to advance a competitor’s interests is strictly prohibited. It is the responsibility of such person to consult with the Compliance Officer to determine whether a planned activity will compete impermissibly with any of the Company’s business activities before pursuing the activity in question.

 

12. Confidentiality. In carrying out the Company’s business, directors, officers and employees often learn confidential or proprietary information about the Company, its customers, vendors or joint venture parties. Directors, officers and employees may not use or reveal Company, customer or vendor confidential or proprietary information to others, except when disclosure is authorized or legally mandated. Additionally, directors, officers and employees must take appropriate steps, including without limitation, securing documents, limiting access to computers and electronic media, and proper disposal methods, to prevent unauthorized access to such information. Proprietary and/or confidential information, among other things, includes: business methods; sales, pricing and marketing data; strategy; computer code; information regarding the Company’s intellectual property, including its technology and products; screens; forms; experimental research; and information about, or received from, the Company’s current, former and prospective customers, vendors and employees. Any questions regarding the securing or disclosing of confidential information should be referred to the Compliance Officer.

 

13. Privacy and Data Protection.

 

13.1 The Company respects the general right to privacy of all individuals regarding their personally identifiable information (“PII”) and follows all applicable laws on the use of PII. In carrying out the Company’s business, directors, officers and employees may collect, use, or have access to PII belonging to our employees, customers, and third-party service providers. The Company takes seriously its responsibilities related to the collection, use, and disclosure of this information. The Company is committed to respecting the privacy of any PII we collect, use, or otherwise process. The kind of information that can be PII varies by country. PII often means all data that relates to a natural person (for example, an employee, a customer contact, or a third-party service provider representative), including name, physical address, phone number, and e-mail address. PII can also include business contact information (such as job title, department, and name of employer); country information; and other personal information as may be provided by the customer or third-party service provider representative.

 

 8 

 

 

13.2 Directors, officers and employees should be aware of and comply with local laws, regulations, and all applicable Company policies. In general:

 

(a) PII may only be collected, used, or otherwise processed by lawful means and for lawful purposes and, where required, with the knowledge and/or consent of the person to whom it pertains.

 

(b) PII may be used only for business purposes and only in accordance with applicable law and, where necessary, with appropriate consent.

 

(c) There are legal restrictions on transferring PII to another party, including to other persons or entities within the Company’s network. There may be additional legal restrictions on transferring PII outside its country of origin.

 

14. Document Retention. The Company’s records are important to the proper functioning of the Company and are valuable business assets. Knowing what documents and information to keep—and for how long—is an important part of the job. Directors, officers and employees should follow the Company’s record retention and destruction procedures. Documents that are the subject of any pending or threatened proceeding, dispute, or regulatory inquiry should never be destroyed or altered.

 

15. Computer and Communication Resources. The Company’s computer and communication resources, including computers, voicemail and e-mail, provide substantial benefits, but they also present significant security and liability risks to individuals and the Company. It is extremely important that Company personnel take all necessary measures to secure their computer and any computer or voicemail passwords. All sensitive, confidential or restricted electronic information must be password protected, and, if sent across the Internet, must be protected by Company-approved encryption software. If an individual has any reason to believe that his or her password or the security of a Company computer or communication resource has in any manner been compromised, he or she must change the password immediately and report the incident to the Compliance Officer.

 

16. Fair Dealing. Each director, officer and employee must deal fairly with the Company’s customers, suppliers, partners, service providers, competitors, employees, contractors and anyone else with whom he or she has contact in the course of performing his or her job. No director, officer or employee may take unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of facts or any other unfair dealing practice.

 

17. Reporting and Enforcement.

 

17.1 Reporting and Investigation of Violations.

 

(a) Actions prohibited by this Code involving directors or executive officers must be reported to the Board of Directors, or if the Board so delegates, an independent committee of the Board.

 

 9 

 

 

(b) Actions prohibited by this Code involving anyone other than a director or executive officer must be reported to the reporting person’s supervisor or the Compliance Officer. Reporting may also be made via email notification at ralph@investview.com. This email is available twenty-four (24) hours daily, seven (7) days a week or via hardcopy mailed to:

 

Investview, Inc.
Attn: Compliance Officer
521 West Lancaster Avenue, Second Floor

Haverford, Pennsylvania 19041

  

(c) After receiving a report of an alleged prohibited action, the Board of Directors (or if the Board so delegates, an independent committee of the Board), the relevant supervisor, or the Compliance Officer must promptly take all appropriate actions necessary to investigate.

 

(d) All directors, officers and employees are expected to cooperate in any internal investigation of misconduct.

 

17.2 Enforcement.

 

(a) The Company must ensure prompt and consistent action against violations of this Code.

 

(b) If, after investigating a report of an alleged prohibited action, the relevant supervisor or the Compliance Officer determines that a violation of this Code has occurred, the relevant supervisor or Compliance Officer will report such determination to the Board of Directors, or if the Board so delegates, an independent committee of the Board.

 

(c) Upon receipt of a determination that there has been a violation of this Code, the Board of Directors, or if the Board so delegates, an independent committee of the Board or the Compliance Officer will take such preventative or disciplinary action as it deems appropriate, including, but not limited to, reassignment, demotion, dismissal and, in the event of criminal conduct or other serious violations of the law, notification of appropriate governmental authorities.

 

17.3 Waivers.

 

(a) Each of the Board of Directors, or if the Board so delegates, an independent committee of the Board (in the case of a violation by a director or executive officer) and the Compliance Officer (in the case of a violation by any other person) may, in its discretion, waive any violation of this Code.

 

(b) Any waiver for a director or an executive officer shall be disclosed as required by SEC, OTC and any other applicable rules.

 

17.4 Prohibition on Retaliation. 

 

The Company does not tolerate acts of retaliation against any director, officer, employee or contractor who makes a good faith report of known or suspected acts of misconduct or other violations of this Code.

 

 10 

 

  

code of ethics

 

Acknowledgment of Receipt and Review

 

Please sign below to indicate that you have read and understand the Code of Ethics and that you agree to comply with the policies and procedures set out in the Code. Please return the signed copy to HR. This page will be kept in your file.

 

Employee Name: __________________________________________

 

Employee Signature: __________________________________________

 

Date: __________________________________________

 

 11 

 

EX-19.01 5 ex19-01.htm

 

Exhibit 19.01

 

INVESTVIEW, INC. 

___________________

 

INSIDER TRADING POLICY

and

Guidelines with Respect to

Certain Transactions in Securities 

___________________

 

Effective as of November 14, 2022

 

 

 

 

TABLE OF CONTENTS

 

  Page
   
INTRODUCTION 1
Legal prohibitions on insider trading 1
Detection and prosecution of insider trading 1
Penalties for violation of insider trading laws and this Policy 1
Compliance Officer 2
Reporting violations 2
Personal responsibility 2
   
PERSONS AND TRANSACTIONS COVERED BY THIS POLICY 3
Persons covered by this Policy 3
Types of transactions covered by this Policy 3
Responsibilities regarding the nonpublic information of other companies 3
Applicability of this Policy after your departure 3
No exceptions based on personal circumstances 3
   
MATERIAL NONPUBLIC INFORMATION 4
“Material” information 4
“Nonpublic” information 4
   
POLICIES REGARDING MATERIAL NONPUBLIC INFORMATION 5
Confidentiality of nonpublic information 5
No trading on material nonpublic information 5
No disclosing material nonpublic information for the benefit of others 5
Obligation to disclose material nonpublic information to the Company 5
Responding to outside inquiries for information 5
   
TRADING BLACKOUT PERIODS 6
Quarterly blackout periods 6
Special blackout periods 6
Regulation BTR blackouts 6
No “safe harbors” 6
   
PRE-CLEARANCE OF TRADES 7
   
ADDITIONAL RESTRICTIONS AND GUIDANCE 8
Short sales 8
Derivative securities and hedging transactions 8
Using Company securities as collateral for loans 8
Holding Company securities in margin accounts 8
Placing open orders with brokers 8
   
LIMITED EXCEPTIONS 9
Transactions pursuant to a trading plan that complies with SEC rules 9
Receipt and vesting of stock options, restricted stock and stock appreciation rights 9
Exercise of stock options for cash 10
Stock splits, stock dividends and similar transactions 10
Bona fide gifts and inheritance 10

 

 

 

 

Change in form of ownership 10
Other exceptions 10
   
COMPLIANCE WITH SECTION 16 OF THE SECURITIES EXCHANGE ACT 11
Obligations under Section 16 11
Notification requirements to facilitate Section 16 reporting 11
Personal responsibility 11
   
ADDITIONAL INFORMATION 12
Delivery of Policy 12
Amendments 12

  

SCHEDULE I (Individuals subject to pre-clearance requirements)

 

ii

 

 

INTRODUCTION

 

Investview, Inc. (together with its subsidiaries, the “Company”) opposes the unauthorized disclosure of any nonpublic information acquired in the course of your service with the Company and the misuse of material nonpublic information in securities trading. Any such actions will be deemed violations of this Insider Trading Policy (the “Policy”).

 

Legal prohibitions on insider trading

 

The antifraud provisions of U.S. federal securities laws prohibit directors, officers, employees and other individuals who possess material nonpublic information from trading on the basis of that information. Transactions will be considered “on the basis of” material nonpublic information if the person engaged in the transaction was aware of the material nonpublic information at the time of the transaction. It is not a defense that the person did not “use” the information for purposes of the transaction.

 

Disclosing material nonpublic information directly or indirectly to others who then trade based on that information or making recommendations or expressing opinions as to transactions in securities while aware of material nonpublic information (which is sometime referred to as “tipping”) is also illegal. Both the person who provides the information, recommendation or opinion and the person who trades based on it may be liable.

 

These illegal activities are commonly referred to as “insider trading”. State securities laws and securities laws of other jurisdictions also impose restrictions on insider trading.

 

In addition, a company, as well as individual directors, officers and other supervisory personnel, may be subject to liability as “controlling persons” for failure to take appropriate steps to prevent insider trading by those under their supervision, influence or control.

 

Detection and prosecution of insider trading

 

The U.S. Securities and Exchange Commission (the “SEC”), the Financial Industry Regulatory Authority, Inc. and stock exchanges use sophisticated electronic surveillance techniques to investigate and detect insider trading, and the SEC and the U.S. Department of Justice pursue insider trading violations vigorously. Cases involving trading through foreign accounts, trading by family members and friends and trading involving only a small number of shares have been successfully prosecuted.

 

Penalties for violation of insider trading laws and this Policy

 

Civil and criminal penalties. As of the effective date of this Policy, potential penalties for insider trading violations under U.S. federal securities laws include:

 

·damages in a private lawsuit;

 

·disgorging any profits made or losses avoided;

 

·imprisonment for up to 20 years;

 

·criminal fines of up to $5 million for individuals and $25 million for entities;

 

·civil fines of up to three times the profit gained or loss avoided;

 

·a bar against serving as an officer or director of a public company; and

 

 - 1 - 

 

  

·an injunction against future violations.

 

Civil and criminal penalties also apply to tipping. The SEC has imposed large penalties in tipping cases even when the disclosing person did not trade or gain any benefit from another person’s trading.

 

Company disciplinary actions. If the Company has a reasonable basis to conclude that you have failed to comply with this Policy, you may be subject to disciplinary action by the Company, up to and including dismissal for cause, regardless of whether or not your failure to comply with this Policy results in a violation of law. It is not necessary for the Company to wait for the filing or conclusion of any civil or criminal action against an alleged violator before taking disciplinary action. In addition, the Company may give stop transfer and other instructions to the Company’s transfer agent to enforce compliance with this Policy.

 

Compliance Officer

 

Please direct any questions, requests or reports as to any of the matters discussed in this Policy to the Company’s Chief Financial Officer (the “Compliance Officer”). The Compliance Officer is generally responsible for the administration of this Policy. The Compliance Officer may select others to assist with the execution of his or her duties.

 

Reporting violations

 

It is your responsibility to help enforce this Policy. You should be alert to possible violations and promptly report violations or suspected violations of this Policy to the Compliance Officer. If your situation requires that your identity be kept secret, your anonymity will be preserved to the greatest extent reasonably possible. If you wish to remain anonymous, send a letter addressed to the Compliance Officer at 521 West Lancaster Avenue, Second Floor, Haverford, Pennsylvania 19041. If you make an anonymous report, please provide as much detail as possible, including any evidence that you believe may be relevant to the issue.

 

Personal responsibility

 

The ultimate responsibility for complying with this Policy and applicable laws and regulations rests with you. You should use your best judgment at all times and consult with your legal and financial advisors, as needed. We advise you to seek assistance if you have any questions at all. The rules relating to insider trading can be complex, and a violation of insider trading laws can carry severe consequences.

 

 - 2 - 

 

 

PERSONS AND TRANSACTIONS COVERED BY THIS POLICY

 

Persons covered by this Policy

 

This Policy applies to all directors, officers, employees and agents (such as consultants and independent contractors) of the Company. References in this Policy to “you” (as well as general references to directors, officers, employees and agents of the Company) should also be understood to include members of your immediate family, persons with whom you share a household, persons that are your economic dependents and any other individuals or entities whose transactions in securities you influence, direct or control (including, for example, a venture or other investment fund, if you influence, direct or control transactions by the fund). You are responsible for making sure that these other individuals and entities comply with this Policy.

 

Types of transactions covered by this Policy

 

Except as discussed in the section entitled “Limited Exceptions”, this Policy applies to all transactions involving the securities of the Company or the securities of other companies as to which you possess material nonpublic information obtained in the course of your service with the Company. This Policy therefore applies to purchases, sales and other transfers of common stock, options, warrants, preferred stock, debt securities (such as debentures, bonds and notes) and other securities. This Policy also applies to any arrangements that affect economic exposure to changes in the prices of these securities. These arrangements may include, among other things, transactions in derivative securities (such as exchange-traded put or call options), hedging transactions, short sales and certain decisions with respect to participation in benefit plans. This Policy also applies to any offers with respect to the transactions discussed above.

 

Responsibilities regarding the nonpublic information of other companies

 

This Policy prohibits the unauthorized disclosure or other misuse of any nonpublic information of other companies, such as the Company’s vendors, customers, collaborators, suppliers and competitors. This Policy also prohibits insider trading and tipping based on the material nonpublic information of other companies.

 

Applicability of this Policy after your departure

 

You are expected to comply with this Policy until such time as you are no longer affiliated with the Company and you no longer possess any material nonpublic information subject to this Policy. In addition, if you are subject to a trading blackout under this Policy at the time you cease to be affiliated with the Company, you are expected to abide by the applicable trading restrictions until at least the end of the relevant blackout period.

 

No exceptions based on personal circumstances

 

There may be instances where you suffer financial harm or other hardship or are otherwise required to forego a planned transaction because of the restrictions imposed by this Policy. Personal financial emergency or other personal circumstances are not mitigating factors under securities laws and will not excuse a failure to comply with this Policy.

 

 - 3 - 

 

 

MATERIAL NONPUBLIC INFORMATION

 

“Material” information

 

Information should be regarded as material if there is a substantial likelihood that a reasonable investor would consider it important in deciding whether to buy, hold or sell securities or would view the information as significantly altering the total mix of information in the marketplace about the issuer of the security. In general, any information that could reasonably be expected to affect the market price of a security is likely to be material. Either positive or negative information may be material.

 

It is not possible to define all categories of “material” information. However, some examples of information that would often be regarded as material include information with respect to:

 

·Financial results, financial condition, earnings pre-announcements, guidance, projections or forecasts, particularly if inconsistent with the expectations of the investment community;

 

·Restatements of financial results, or material impairments, write-offs or restructurings;

 

·Changes in independent auditors, or notification that the Company may no longer rely on an audit report;

 

·Business plans or budgets;

 

·Creation of significant financial obligations, or any significant default under or acceleration of any financial obligation;

 

·Impending bankruptcy or financial liquidity problems;

 

·Significant developments involving business relationships, including execution, modification or termination of significant agreements or orders with customers, suppliers, distribution partners or other business partners;

 

·Product introductions, modifications, defects or significant pricing changes or other product announcements of a significant nature;

 

·Significant developments in research and development or relating to intellectual property;

 

·Significant legal or regulatory developments, whether actual or threatened;

 

·Major events involving the Company’s securities, including calls of securities for redemption, adoption of stock repurchase programs, option repricings, stock splits, changes in dividend policies, public or private securities offerings, modification to the rights of security holders or notice of delisting;

 

·Significant corporate events, such as a pending or proposed merger, joint venture or tender offer, a significant investment, the acquisition or disposition of a significant business or asset or a change in control of the company; and

 

·Major personnel changes, such as changes in senior management or lay-offs.

 

If you have any questions as to whether information should be considered “material”, you should consult with the Compliance Officer. In general, it is advisable to resolve any close questions as to the materiality of any information by assuming that the information is material. 

  

“Nonpublic” information

 

Information is considered nonpublic if the information has not been broadly disseminated to the public for a sufficient period to be reflected in the price of the security. As a general rule, information should be considered nonpublic until at least two (2) full trading days have elapsed after the information is broadly distributed to the public in a press release, a public filing with the SEC, a pre-announced public webcast or another broad, non-exclusionary form of public communication. Any questions as to whether information is nonpublic should be directed to the Compliance Officer.

 

The term “trading day” means a day on which national stock exchanges are open for trading. A “full” trading day has elapsed when, after the public disclosure, trading in the relevant security has opened and then closed.

 

 - 4 - 

 

 

POLICIES REGARDING MATERIAL NONPUBLIC INFORMATION

 

Confidentiality of nonpublic information

 

The unauthorized use or disclosure of nonpublic information relating to the Company or other companies is prohibited. All nonpublic information you acquire in the course of your service with the Company may only be used for legitimate Company business purposes. In addition, nonpublic information of others should be handled in accordance with the terms of any relevant nondisclosure agreements, and the use of any such nonpublic information should be limited to the purpose for which it was disclosed.

 

All directors, officers, employees and agents of the Company are required to sign and comply with the confidentiality agreement entered into with the Company.

 

No trading on material nonpublic information

 

Except as discussed in the section entitled “Limited Exceptions”, you may not, directly or indirectly through others, engage in any transaction involving the Company’s securities while aware of material nonpublic information relating to the Company. It is not an excuse that you did not “use” the information in your transaction.

 

Similarly, you may not engage in transactions involving the securities of any other company if you are aware of material nonpublic information about that company (except to the extent the transactions are analogous to those presented in the section entitled “Limited Exceptions”).

 

No disclosing material nonpublic information for the benefit of others

 

You may not disclose material nonpublic information concerning the Company or any other company to friends, family members or any other person or entity not authorized to receive such information where such person or entity may benefit by trading on the basis of such information. In addition, you may not make recommendations or express opinions on the basis of material nonpublic information as to trading in the securities of companies to which such information relates. You are prohibited from engaging in these actions whether or not you derive any profit or personal benefit from doing so.

 

Obligation to disclose material nonpublic information to the Company

 

You may not enter into any transaction, including those discussed in the section entitled “Limited Exceptions”, unless you have disclosed any material nonpublic information that you become aware of in the course of your service with the Company, and that senior management is not aware of, to the Compliance Officer. If you are a member of senior management, the information must be disclosed to the Chief Executive Officer, and if you are the Chief Executive Officer or a director, you must disclose the information to the board of directors, before any transaction is permissible.

 

Responding to outside inquiries for information

 

In the event you receive an inquiry from someone outside of the Company, such as a stock analyst, for information, you should refer the inquiry to the Chief Financial Officer. The Company is required under Regulation FD (Fair Disclosure) of the U.S. federal securities laws to avoid the selective disclosure of material nonpublic information. In general, the regulation provides that when a public company discloses material nonpublic information, it must provide broad, non-exclusionary access to the information. Violations of this regulation can subject the company to SEC enforcement actions, which may result in injunctions and severe monetary penalties. The Company has established procedures for releasing material information in a manner that is designed to achieve broad public dissemination of the information immediately upon its release in compliance with applicable law.

 

 - 5 - 

 

  

TRADING BLACKOUT PERIODS

 

To limit the likelihood of trading at times when there is a significant risk of insider trading exposure, the Company has instituted quarterly trading blackout periods for Company Insiders. Company Insiders include all directors and officers of the Company, employees specifically designated as a Company Insider by the Compliance Officer and shareholders who beneficially own more than 10% of the Company’s stock, as well as their immediate family members. Officers include persons who occupy the principal executive offices of the Company such as the chief executive officer, chief operating officer, president, chief financial officer, as well as any vice presidents in charge of a principal business unit, division or function. In addition to quarterly trading blackout periods, we may institute special trading blackout periods from time to time.

 

It is important to note that whether or not you are subject to blackout periods, you remain subject to the prohibitions on trading on the basis of material nonpublic information and any other applicable restrictions in this Policy.

 

Quarterly blackout periods

 

Except as discussed in the section entitled “Limited Exceptions”, all Company Insiders of the Company must refrain from conducting transactions involving the Company’s securities during quarterly blackout periods.

 

Quarterly blackout periods begin after the market closes on the last day of each fiscal quarter and end at the start of the third full trading day following the date of public disclosure of the financial results for that fiscal quarter. This period is a particularly sensitive time for transactions involving the Company’s securities from the perspective of compliance with applicable securities laws due to the fact that, during this period, individuals may often possess or have access to material nonpublic information relevant to the expected financial results for the quarter.

 

Special blackout periods

 

From time to time, the Company may also prohibit Company Insiders from engaging in transactions involving the Company’s securities when, in the judgment of the Compliance Officer, a trading blackout is warranted. The Company will generally impose special blackout periods when there are material developments known to the Company that have not yet been disclosed to the public.

 

The Company will notify those persons subject to a special blackout period. Each person who has been so identified and notified by the Company may not engage in any transaction involving the Company’s securities until instructed otherwise by the Compliance Officer, and should not disclose to others the fact of such suspension of trading.

 

Regulation BTR blackouts

 

Directors and executive officers may also be subject to trading blackouts pursuant to Regulation Blackout Trading Restriction, or Regulation BTR, under U.S. federal securities laws. In general, Regulation BTR prohibits any director or executive officer from engaging in certain transactions involving Company securities during periods when participants in certain employee benefits plans are prevented from purchasing, selling or otherwise acquiring or transferring an interest in certain securities held in individual account plans. Any profits realized from a transaction that violates Regulation BTR are recoverable by the Company, regardless of the intentions of the director or officer effecting the transaction. In addition, individuals who engage in such transactions are subject to sanction by the SEC as well as potential criminal liability. 

  

Failure to comply with an applicable trading blackout in accordance with Regulation BTR is a violation of law and this Policy.

 

No “safe harbors”

 

There are no unconditional “safe harbors” for trades made at particular times, and all persons subject to this Policy should exercise good judgment at all times. Even when a quarterly blackout period is not in effect, you may be prohibited from engaging in transactions involving the Company’s securities because you possess material nonpublic information, are subject to a special blackout period or are otherwise restricted under this Policy.

 

 - 6 - 

 

 

PRE-CLEARANCE OF TRADES

 

Except as discussed in the section entitled “Limited Exceptions”, Company Insiders should refrain from engaging in any transaction involving the Company’s securities without first obtaining pre-clearance of the transaction from the Compliance Officer. In addition, the Company has determined that certain other employees and agents of the Company that may have regular or special access to material nonpublic information should refrain from engaging in any transaction involving the Company’s securities without first obtaining pre-clearance of the transaction from the Compliance Officer. The Compliance Officer may not engage in a transaction involving the Company’s securities unless the Chief Executive Officer has pre-cleared the transaction. Individuals subject to pre-clearance requirements are set forth on Schedule I. From time to time, the Company may identify other persons who should be subject to the pre-clearance requirements set forth above, and the Compliance Officer may update and revise Schedule I as appropriate.

 

These pre-clearance procedures are intended to decrease insider trading risks associated with transactions by individuals with regular or special access to material nonpublic information. In addition, requiring pre-clearance of transactions by directors and officers facilitates compliance with Rule 144 resale restrictions under the Securities Act, the liability and reporting provisions of Section 16 under the Exchange Act and Regulation BTR. Pre-clearance of a trade, however, is not a defense to a claim of insider trading and does not excuse you from otherwise complying with insider trading laws or this Policy.

 

The Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance, and may determine not to permit the transaction.

 

 - 7 - 

 

 

ADDITIONAL RESTRICTIONS AND GUIDANCE

 

This section addresses certain types of transactions that may expose you and the Company to significant risks. You should understand that, even though a transaction may not be expressly prohibited by this section, you are responsible for ensuring that the transaction otherwise complies with other provisions in this Policy that may apply to the transaction, such as the general prohibition against insider trading as well as pre-clearance procedures and blackout periods, to the extent applicable.

 

Short sales

 

Short sales (i.e., the sale of a security that must be borrowed to make delivery) and “selling short against the box” (i.e., a sale with a delayed delivery) with respect to Company securities are prohibited under this Policy. Short sales may signal to the market possible bad news about the Company or a general lack of confidence in the Company’s prospects, and an expectation that the value of the Company’s securities will decline. In addition, short sales are effectively a bet against the Company’s success and may reduce the seller’s incentive to improve the Company’s performance. Short sales may also create a suspicion that the seller is engaged in insider trading.

 

Derivative securities and hedging transactions

 

You are prohibited from engaging in transactions in publicly-traded options, such as puts and calls, and other derivative securities with respect to the Company’s securities. This prohibition extends to any hedging or similar transaction designed to decrease the risks associated with holding Company securities. Stock options, stock appreciation rights and other securities issued pursuant to Company benefit plans or other compensatory arrangements with the Company are not subject to this prohibition.

 

Using Company securities as collateral for loans

 

Unless approved in advance by the Company’s Board of Directors, you may not pledge Company securities as collateral for loans. If you default on the loan, the lender may sell the pledged securities as collateral in a foreclosure sale. The sale, even though not initiated at your request, is still considered a sale for your benefit and, if made at a time when you are aware of material nonpublic information or otherwise are not permitted to trade in Company securities, may result in inadvertent insider trading violations, Section 16 and Reg. BTR violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company.

 

Holding Company securities in margin accounts

 

Unless approved in advance by the Company’s Board of Directors, you may not hold Company securities in margin accounts. Under typical margin arrangements, if you fail to meet a margin call, the broker may be entitled to sell securities held in the margin account without your consent. The sale, even though not initiated at your request, is still considered a sale for your benefit and, if made at a time when you are aware of material nonpublic information or are otherwise not permitted to trade, may result in inadvertent insider trading violations, Section 16 and Reg. BTR violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company. 

  

Placing open orders with brokers

 

Except in accordance with an approved trading plan (as discussed below), you should exercise caution when placing open orders, such as limit orders or stop orders, with brokers, particularly where the order is likely to remain outstanding for an extended period of time. Open orders may result in the execution of a trade at a time when you are aware of material nonpublic information or otherwise are not permitted to trade in Company securities, which may result in inadvertent insider trading violations, Section 16 and Reg. BTR violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company. If you are subject to blackout periods or pre-clearance requirements, you should so inform any broker with whom you place any open order at the time it is placed.

 

 - 8 - 

 

 

LIMITED EXCEPTIONS

 

The following are certain limited exceptions to the restrictions imposed by the Company under this Policy. Please be aware that even if a transaction is subject to an exception to this Policy, you will need to separately assess whether the transaction complies with applicable law. For example, even if a transaction is indicated as exempt from this Policy, you may need to comply with the “short-swing” trading restrictions under Section 16 of the Exchange Act, to the extent applicable. You are responsible for complying with applicable law at all times.

 

Transactions pursuant to a trading plan that complies with SEC rules

 

The SEC has enacted rules that provide an affirmative defense against alleged violations of U.S. federal insider trading laws for transactions pursuant to trading plans that meet certain requirements. In general, these rules, as set forth in Rule 10b5-1 under the Securities Exchange Act, provide for an affirmative defense if you enter into a contract, provide instructions or adopt a written plan for trading securities when you are not aware of material nonpublic information. The contract, instructions or plan must (i) specify the amount, price and date of the transaction, (ii) specify an objective method for determining the amount, price and date of the transaction and/or (iii) place any subsequent discretion for determining the amount, price and date of the transaction in another person who is not, at the time of the transaction, aware of material nonpublic information.

 

Transactions made pursuant to a written trading plan that (i) complies with the affirmative defense set forth in Rule 10b5-1 and (ii) is approved by the Compliance Officer, are not subject to the restrictions in this Policy against trades made while aware of material nonpublic information or to the pre-clearance procedures or blackout periods established under this Policy. In approving a trading plan, the Compliance Officer may, in furtherance of the objectives expressed in this Policy, impose criteria in addition to those set forth in Rule 10b5-1. You should therefore confer with the Compliance Officer prior to entering into any trading plan.

 

The SEC rules regarding trading plans are complex and must be complied with completely to be effective. The description provided above is only a summary, and the Company strongly advises that you consult with your legal advisor if you intend to adopt a trading plan. While trading plans are subject to review and approval by the Company, the individual adopting the trading plan is ultimately responsible for compliance with Rule 10b5-1 and ensuring that the trading plan complies with this Policy.

 

Trading plans must be filed with the Compliance Officer and must be accompanied with an executed certificate stating that the trading plan complies with Rule 10b5-1 and any other criteria established by the Company. The Company may publicly disclose information regarding trading plans that you may enter.

 

Receipt and vesting of stock options, restricted stock and stock appreciation rights

 

The trading restrictions under this Policy do not apply to the acceptance or purchase of stock options, restricted stock or stock appreciation rights issued or offered by the Company. The trading restrictions under this Policy also do not apply to the vesting, cancellation or forfeiture of stock options, restricted stock or stock appreciation rights in accordance with applicable plans and agreements.

 

 - 9 - 

 

 

Exercise of stock options for cash

 

The trading restrictions under this Policy do not apply to the exercise of stock options for cash under the Company’s stock option plans. Likewise, the trading restrictions under this Policy do not apply to the exercise of stock options in a stock-for-stock exercise with the Company or an election to have the Company withhold securities to cover tax obligations in connection with an option exercise. However, the trading restrictions under this Policy do apply to (i) the sale of any securities issued upon the exercise of a stock option, (ii) a cashless exercise of a stock option through a broker, since this involves selling a portion of the underlying shares to cover the costs of exercise, and (iii) any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.

 

Stock splits, stock dividends and similar transactions

 

The trading restrictions under this Policy do not apply to a change in the number of securities held as a result of a stock split or stock dividend applying equally to all securities of a class, or similar transactions.

 

Bona fide gifts and inheritance

 

The trading restrictions under this Policy do not apply to bona fide gifts involving Company securities or transfers by will or the laws of descent and distribution.

 

Change in form of ownership

 

Transactions that involve merely a change in the form in which you own securities are permissible. For example, you may transfer shares to an inter vivos trust of which you are the sole beneficiary during your lifetime.

 

Other exceptions

 

Any other exception from this Policy must be approved by the Compliance Officer, in consultation with the Board of Directors or an independent committee of the Board of Directors.

 

 - 10 - 

 

 

COMPLIANCE WITH SECTION 16 OF THE SECURITIES EXCHANGE ACT

 

Obligations under Section 16

 

Section 16 of the Securities Exchange Act of 1934, and the related rules and regulations, set forth (i) reporting obligations, (ii) limitations on “short-swing” transactions and (iii) limitations on short sales and other transactions applicable to directors, officers, large shareholders and certain other persons. The Company has provided, or will provide, memoranda and other materials addressing these matters.

 

All of the Company’s directors and certain of the Company’s officers, employees and stockholders are required to comply with Section 16 of the Securities Exchange Act of 1934, and the related rules and regulations, because of their positions with the Company or because of their stockholdings.

 

Notification requirements to facilitate Section 16 reporting

 

To facilitate timely reporting of transactions pursuant to Section 16 requirements, each person subject to Section 16 reporting requirements must provide, or must ensure that his or her broker provides, the Company with detailed information (e.g., trade date, number of shares, exact price, etc.) regarding his or her transactions involving the Company’s securities, including gifts, transfers, pledges and transactions pursuant to a trading plan, both prior to (to confirm compliance with pre-clearance procedures, if applicable) and promptly following execution.

 

Personal responsibility

 

The obligation to file Section 16 reports, and to otherwise comply with Section 16, is personal. The Company is not responsible for the failure to comply with Section 16 requirements.

 

 - 11 - 

 

 

ADDITIONAL INFORMATION

 

Delivery of Policy

 

This Policy will be delivered to all directors, officers, employees and agents of the Company when they commence service with the Company. In addition, this Policy (or a summary of this Policy) will be circulated periodically and will be available on the Company’s website. Each director, officer, employee and agent of the Company is required to acknowledge that he or she understands, and agrees to comply with, this Policy.

 

Amendments

 

We are committed to continuously reviewing and updating our policies and procedures. The Company therefore reserves the right to amend, alter or terminate this Policy at any time and for any reason, subject to applicable law. A current copy of the Company’s policies regarding insider trading may be obtained by contacting the Compliance Officer.

 

* * *

 

Nothing in this Insider Trading Policy creates or implies an employment contract or term of employment. In addition, all employees should understand that this Insider Trading Policy does not modify their employment relationship, whether at-will or governed by contract.

 

The policies in this Insider Trading Policy do not constitute a complete list of Company policies or a complete list of the types of conduct that can result in discipline, up to and including discharge.

 

 - 12 - 

 

 

SCHEDULE I

 

INDIVIDUALS SUBJECT TO
PRE-CLEARANCE REQUIREMENTS

 

1.All of the Company’s directors.
2.All of the Company’s officers (including officers who are also directors).

 

 - 13 - 

 

EX-21.01 6 ex21-01.htm

 

Exhibit 21.01

 

Schedule of Subsidiaries

 

Name   State of Organization
iGenius, LLC   Utah
iGenius Global LTD   Ireland
Investview Financial Group Holdings, LLC   Delaware
Opencash Finance, Inc.   Delaware
Opencash Securities, LLC   Delaware
Investview MTS, LLC   Delaware
SAFETek LLC   Utah
myLife Wellness Company   Delaware
myLife Wellness LLC   Delaware
Goldman’s Pharmaceuticals LLC   Pennsylvania
ELRT Technologies, LLC (1)   Pennsylvania

 

(1) Investview, Inc. owns 50% of the ownership interests in ELRT Technologies, LLC

 

 

 

EX-23.01 7 ex23-01.htm

 

Exhibit 23.01

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation, by reference, in the Registration Statement of Investview, Inc. (the “Company”) on Form S-8 (File No. 333-265778) of our report dated March 28, 2025 relating to the consolidated balance sheets of the Company as of December 31, 2024 and 2023, and the related consolidated statements of operations and comprehensive income (loss), stockholders’ equity (deficit) and cash flows for each of the years in the two-year periods ended December 31, 2024, and the related notes, as appearing in the Annual Report on Form 10-K of the Company for the years ended December 31, 2024 and 2023. We also consent to the reference to us under the heading “Experts” in such Registration Statements.

 

/s/ M&K CPA’s, PLLC

 

The Woodlands, TX

March 28, 2025

 

 

 

EX-31.1 8 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Victor M. Oviedo, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2024, of Investview, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: March 28, 2025  
   
/s/ Victor M. Oviedo  
Victor M. Oviedo  
Chief Executive Officer (Principal Executive Officer)  

 

 

 

 

EX-31.2 9 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Ralph R. Valvano, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2024, of Investview, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: March 28, 2025  
   
/s/ Ralph R. Valvano  
Ralph R. Valvano  
Chief Financial Officer (Principal Financial and Accounting Officer)  

 

 

 

 

EX-32.1 10 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report on Form 10-K of Investview, Inc. (the “Company”) for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Victor M. Oviedo, the Chief Executive Officer, of the Company, do hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 28, 2025

 

/s/ Victor M. Oviedo  
Victor M. Oviedo  
Chief Executive Officer (Principal Executive Officer)  

 

 

 

EX-32.2 11 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report on Form 10-K of Investview, Inc. (the “Company”) for the year ended December, 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ralph R. Valvano, the Chief Financial Officer, of the Company, do hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 28, 2025

 

/s/ Ralph R. Valvano  
Ralph R. Valvano  
Chief Financial Officer (Principal Financial and Accounting Officer)  

 

 

 

 

EX-97.01 12 ex97-01.htm

 

Exhibit 97.01

 

INVESTVIEW, INC.
CLAWBACK AND FORFEITURE POLICY

 

Purpose

 

Investview, Inc. (the “Company”) is committed to conducting business with integrity in accordance with high ethical standards and in compliance with all applicable laws, rules and regulations. This includes the Company’s commitment to comply with all laws, rules and regulations, including those applicable to the presentation of the Company’s financial information to the public. As a result, the Board of Directors of the Company (the “Board”) has adopted this Clawback and Forfeiture Policy (this “Policy”), which provides for the recoupment and/or forfeiture or cancellation of certain executive officer incentive compensation in the event of an accounting restatement.

 

Administration

 

This Policy will be administered by the Board of Directors, or if the Board so delegates, an independent committee of the Board (either of which shall be referred to herein as the “Committee”). Except as limited by law, the Committee will have full power, authority, and sole and exclusive discretion to reasonably construe, interpret and administer this Policy. Any determinations made by the Committee will be made in its reasonable discretion and will be final, conclusive and binding on all affected individuals.

 

In the event of any change in any federal or state law, rule or regulation, or rule, regulation, policy or listing standard of the Securities and Exchange Commission or any securities exchange on which the Company’s securities are listed, which requires the Company to recoup certain compensation from a Covered Executive (as defined below), the Committee will be required to seek recoupment under this Policy to the fullest extent required by such laws, rules, regulations or listing standards.

 

Covered Executives; Compensation Covered

 

This Policy will cover the Company’s current and former officers as determined by the Board from time to time in accordance with Rule 16a-1 under the Securities Exchange Act of 1934, as amended, or as otherwise determined in the discretion of the Committee (the “Covered Executives”).

 

The Policy will apply to all incentive compensation paid, granted, earned, vested or otherwise awarded to a Covered Executive, including annual bonuses and other short and long term cash incentive awards, stock options and other equity-based awards (“Incentive Compensation”).

 

Authority to Recoup Incentive Compensation

 

In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirement under applicable securities laws, the Committee may require reimbursement or forfeiture of any excess Incentive Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement.

 

In addition, if the Committee determines that a Covered Executive has engaged in egregious conduct that is substantially detrimental to the Company, the Committee may require the Covered Executive to reimburse the Company for all or a portion of Incentive Compensation previously vested or paid to such Covered Executive during the one-year period preceding the date on which the Company discovers such conduct and/or authorize the cancellation of unpaid or unvested Incentive Compensation, as determined by the Committee pursuant to this Policy. “Egregious conduct substantially detrimental to the Company” will mean any one of the following:

 

 

 

  

·any act or omission which would constitute grounds, in the discretion of the Committee, for termination for “Cause” under the terms of the Covered Executive’s employment agreement or other employment arrangements if no employment agreement was in place;

 

·the material breach of a written policy applicable to the Covered Executive, including, but not limited to, the Company’s Code of Ethics;

 

·egregious misconduct by the Covered Executive including, but not limited to, fraud, criminal activities, falsification of Company records, theft, violent acts or threats of violence, or a violation of law, unethical conduct or inappropriate behavior that causes substantial reputational harm to the Company or exposes the Company to substantial legal liability; or

 

·the commission of an act or omission which causes the Covered Executive or the Company to be in violation of federal or state securities laws, rules or regulations.

 

Recoupment Amount

 

In the event the recoupment is triggered by a requirement to prepare an accounting restatement, then the amount to be recovered will be the excess of the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have been paid to the Covered Executive had it been based on the restated results, as determined by the Committee in its reasonable discretion. If the Committee cannot determine the amount of excess Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make its determination based on a reasonable estimate of the effect of the accounting restatement.

 

In the event the recoupment is triggered by egregious conduct substantially detrimental to the Company by the Covered Executive, then the Committee will determine the amount of Incentive Compensation to recoup from such Covered Executive based on the following factors:

 

·the amount of Incentive Compensation received by the Covered Executive that exceeds the amount of Incentive Compensation that otherwise would have been received or granted had the Covered Executive’s egregious conduct substantially detrimental to the Company been known;

 

·the relative fault or degree of involvement by the Covered Executive;

 

·the overall work performance of the Covered Executive;

 

·the relative impact of the Covered Executive’s conduct on the Company and the magnitude of any restatement, loss or variance from budget or plan;

 

·the cost or difficulty of obtaining recoupment, including but not limited to whether the Covered Executive has any outstanding equity-based awards that may be cancelled, whether the Covered Executive continues to be employed by the Company or its subsidiaries, and the language of this Policy in effect on the relevant date; and/or

 

·any other facts and circumstances determined relevant by the Committee, in its sole discretion.

 

 2 

 

  

Method of Recoupment and/or Forfeiture

 

The Committee will determine, in its reasonable discretion, the method for recouping or cancelling, as the case may be, Incentive Compensation hereunder, which may include, without limitation, any one or more of the following:

 

·requiring reimbursement of cash Incentive Compensation previously paid;

 

·seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards;

 

·cancelling or rescinding some or all outstanding vested or unvested equity-based awards;

 

·adjusting or withholding from unpaid compensation or other set-off;

 

·cancelling or setting-off against planned future grants of equity-based awards; and/or

 

·any other method authorized by applicable law or contract.

 

Not Exclusive

 

Any recoupment, forfeiture, or cancellation under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, incentive or equity compensation plan or award or other agreement and any other legal rights or remedies available to the Company. Notwithstanding the generality of the foregoing, to the extent that the requirements under the provisions of Section 304 of the Sarbanes-Oxley Act of 2002 are broader than the provisions in this Policy, the provisions of such law will apply to the Company’s Chief Executive Officer and Chief Financial Officer.

 

No Indemnification

 

The Company will not indemnify or agree to indemnify any Covered Executive against the loss of erroneously awarded compensation subject to this Policy nor will the Company pay or agree to pay any insurance premium to cover the loss of erroneously awarded compensation.

 

Effective Date

 

The effective date of this Policy is March 29, 2024 and will apply to all Incentive Compensation that is approved, awarded or granted to Covered Executives on or after the effective date, except as otherwise agreed by any Covered Executive or pursuant to the terms of any Company plan regarding Incentive Compensation.

 

Amendments

 

The Board may amend, modify or terminate this Policy in whole or in part at any time in its sole discretion and may adopt such rules and procedures that it deems necessary or appropriate to implement this Policy or to comply with applicable laws and regulations.

 

 3 

 

 

GRAPHIC 13 ex23-01_001.jpg begin 644 ex23-01_001.jpg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invu-20241231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 999014 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 999016 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 999017 - Disclosure - LIQUIDITY link:presentationLink link:calculationLink link:definitionLink 999018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 999019 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 999020 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:calculationLink link:definitionLink 999021 - Disclosure - OPERATING LEASES link:presentationLink link:calculationLink link:definitionLink 999022 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 999023 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 999024 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 999025 - Disclosure - ACQUISITION link:presentationLink link:calculationLink link:definitionLink 999026 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 999027 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999030 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 999031 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 999032 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 999033 - Disclosure - OPERATING LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 999034 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 999035 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 999036 - Disclosure - ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 999037 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 999038 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) link:presentationLink link:calculationLink link:definitionLink 999040 - Disclosure - SCHEDULE OF RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 999041 - Disclosure - SCHEDULE OF RECEIVABLES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999042 - Disclosure - SCHEDULE OF FIXED ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 999044 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details) link:presentationLink link:calculationLink link:definitionLink 999045 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 999046 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999048 - Disclosure - LIQUIDITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999049 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999051 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999052 - Disclosure - SCHEDULE OF DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 999053 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999054 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 999055 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) link:presentationLink link:calculationLink link:definitionLink 999056 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 999057 - Disclosure - OPERATING LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999058 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 999059 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 999060 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details) link:presentationLink link:calculationLink link:definitionLink 999061 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 999062 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999064 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 999065 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 999066 - Disclosure - SEGMENT REPORTING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999067 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) link:presentationLink link:calculationLink link:definitionLink 999068 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 999069 - Disclosure - SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 999070 - Disclosure - ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999071 - Disclosure - SCHEDULE OF INCOME BEFORE INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 999072 - Disclosure - SCHEDULE OF TAX PROVISION BENEFIT (Details) link:presentationLink link:calculationLink link:definitionLink 999073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999074 - Disclosure - SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 999075 - Disclosure - SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details) link:presentationLink link:calculationLink link:definitionLink 999076 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 invu-20241231_cal.xml XBRL CALCULATION FILE EX-101.DEF 16 invu-20241231_def.xml XBRL DEFINITION FILE EX-101.LAB 17 invu-20241231_lab.xml XBRL LABEL FILE Related and Nonrelated Parties [Axis] Related Party [Member] Nonrelated Party [Member] Product and Service [Axis] Membership Revenue [Member] Mining [Member] Health and Wellness Revenue [Member] Cryptocurrency Revenue [Member] Mining Equipment Repair Revenue [Member] Other [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Contribution Agreement [Member] Business Acquisition [Axis] Wealth Generators LLC [Member] Acquisition Agreement [Member] Market Trend Strategies LLC [Member] Crypto Asset [Axis] Bitcoin [Member] Mining Revenue [Member] Foreign Revenue [Member] Domestic Revenue [Member] Long-Lived Tangible Asset [Axis] Furniture, Fixtures and Equipment [Member] Computer Equipment [Member] Data Processing Equipment [Member] Manufacturing Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Miner Repair Revenue [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Long-Term Debt, Type [Axis] Convertible Promissory Note [Member] Convertible Promissory Note One [Member] Convertible Promissory Note Two [Member] Convertible Promissory Note Three [Member] Debt Instrument [Axis] Title and Position [Axis] Chairman [Member] Related Party Transaction [Axis] DBR Capital LLC [Member] Securities Purchase Agreements [Member] SSA Technologies LLC [Member] Stock Purchase And Release Agreement [Member] Mario Romano and Annette Raynor [Member] Ryan Smith And Chand Miller [Member] US Small Business Administration [Member] APEX Tex LLC [Member] Legal Entity [Axis] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Measurement Input, Price Volatility [Member] Lease Contractual Term [Axis] Wyckoff Lease [Member] Haverford Lease [Member] Warminster Lease [Member] Ivyland Lease [Member] Class of Stock [Axis] Series B Preferred Stock [Member] Board Of Directors [Member] Sale of Stock [Axis] Unit Offering [Member] Cryptocurrency [Member] Award Type [Axis] Restricted Stock [Member] Officer [Member] Investview Financial Group Holding LLC [Member] David B Rothrock And James R Bell [Member] Class B Units [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Promissory Note [Member] Consolidated Entities [Axis] iGenius, LLC [Member] Joseph Cammarata [Member] Subsegments Consolidation Items [Axis] Reportable Subsegments [Member] Subsegments [Axis] Financial Education and Technology [Member] Blockchain Technology and Crypto Mining Products and Services [Member] Manufacturing and Development of Health Beauty and Wellness Products [Member] Ownership [Axis] Goldman's Pharmaceuticals LLC [Member] ELRT Technologies, LLC [Member] Renu Laboratories, Inc [Member] DBR Capital [Member] Securities Purchase Agreement [Member] Share Repurchase Program [Axis] Share Repurchase Program [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Listing, Par Value Per Share Description of non-controlling interest Auditor Firm ID Auditor Name Auditor Location Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets: Cash and cash equivalents Restricted cash, current Prepaid assets Deposits, current Receivables Inventory Income tax paid in advance Other current assets Total current assets Fixed assets, net Other assets: Goodwill Intangible assets, net Operating lease right-of-use asset Deposits Total other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Current liabilities: Accounts payable and accrued liabilities Payroll liabilities Income tax payable Deferred revenue Derivative liability Dividend liability Operating lease liability, current Debt, net of discounts, current Total current liabilities Operating lease liability, long term Accrued liabilities, long term Debt, net of discounts, long term Total long-term liabilities Total liabilities Commitments and contingencies Stockholders’ equity (deficit): Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 2,333,356,496 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively Additional paid in capital Accumulated other comprehensive income (loss) Accumulated noncontrolling interest Accumulated deficit Total stockholders’ equity (deficit) Total liabilities and stockholders’ equity (deficit) Statement of Financial Position [Abstract] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Revenue: Total revenue, net Operating costs and expenses: Cost of sales and service Commissions Selling and marketing Salary and related Professional fees Impairment expense Loss (gain) on disposal of assets General and administrative Total operating costs and expenses Net income (loss) from operations Other income (expense): Loss on Settlement Gain (loss) on fair value of derivative liability Realized gain (loss) on cryptocurrency Interest expense Other income (expense) Total other income (expense) Income (loss) before income taxes Income tax expense Net income (loss) Net income (loss) attributable to noncontrolling interest Net income (loss) attributable to Investview, Inc. Dividends on Preferred Stock Net income (loss) applicable to common shareholders Basic income (loss) per common share Diluted income (loss) per common share Basic weighted average number of common shares outstanding Diluted weighted average number of common shares outstanding Balance Balance, shares Common stock issued for services and other stock-based compensation Warrant Exercise Warrant Exercise, shares Derivative liability extinguished with warrant exercise Common stock repurchased from related parties and canceled Common stock repurchased from related parties and canceled, shares Dividends Net income (loss) Common stock issued for services and other stock-based compensation Common stock canceled Common stock cancelled, shares Recognition of noncontrolling interest in acquisition Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation Amortization of debt discount Stock issued for services and other stock-based compensation Lease cost, net of repayment (Gain) loss on disposal of assets Loss on fair value of derivative liability Realized (gain) loss on cryptocurrency Changes in operating assets and liabilities: Receivables Inventory Prepaid assets Income tax paid in advance Other current assets Deposits Accounts payable and accrued liabilities Income tax payable Customer advance Deferred revenue Accrued interest Accrued interest, related parties Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Cash acquired in acquisition Cash paid for purchase of Renu Cash received from the disposal of fixed assets Cash paid for fixed assets Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Repayments for related party debt Repayments for debt Payments for shares repurchased from related parties Dividends paid Proceeds from the exercise of warrants Net cash provided by (used in) financing activities Effect of exchange rate translation on cash Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, cash equivalents, and restricted cash - beginning of period Cash, cash equivalents, and restricted cash - end of period SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid during the period for: Interest Income taxes Non-cash investing and financing activities: Common stock repurchased for payables Application of deposit to payables Dividends declared Recognition of lease liability and ROU asset at lease commencement Debt extinguished in exchange for cryptocurrency Dividends paid with cryptocurrency Common stock cancelled Cryptocurrency received from sale of fixed assets Derivative liability extinguished with warrant exercise Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Disclosure - Insider Trading Policies and Procedures Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND NATURE OF BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Changes and Error Corrections [Abstract] RECENT ACCOUNTING PRONOUNCEMENTS LIQUIDITY Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Debt Disclosure [Abstract] DEBT Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITY Operating Leases OPERATING LEASES Equity [Abstract] STOCKHOLDERS’ EQUITY Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT REPORTING Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] ACQUISITION Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Accounting Principles of Consolidation Operating Segments Financial Statement Reclassification Use of Estimates Concentration of Credit Risk Cash Equivalents and Restricted Cash Receivables Fixed Assets Long-Lived Assets – Cryptocurrencies & Intangible Assets Impairment of Long-Lived Assets Fair Value of Financial Instruments Revenue Recognition Advertising, Selling, and Marketing Costs Cost of Sales and Service Inventory Income Taxes Net Income (Loss) per Share Lease Obligation SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH SCHEDULE OF RECEIVABLES SCHEDULE OF FIXED ASSETS SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS SCHEDULE OF REVENUE GENERATED SCHEDULE OF DILUTED EARNINGS PER SHARE SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES SCHEDULE OF RELATED PARTY PAYABLES SCHEDULE OF DEBT SCHEDULE OF DERIVATIVE LIABILITY SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES SCHEDULE OF OPTIONS ACTIVITY SCHEDULE OF OPTIONS OUTSTANDING SCHEDULE OF WARRANTS ISSUED SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS SCHEDULE OF INCOME BEFORE INCOME TAXES SCHEDULE OF TAX PROVISION BENEFIT SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF INCOME FROM CONTINUING OPERATIONS SCHEDULE OF UNRECOGNIZED TAX BENEFITS Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Entity incorporation, date of incorporation Percentage of shares contributed Number of shares exchanged for common stock Value pre-merger liabilities Total cash, cash equivalents, and restricted cash shown on the statement of cash flows Due from merchant processors Held in reserve by merchant processors for future returns and chargebacks Due from payout service providers Accounts and other receivables  Receivable, gross Allowance for doubtful accounts Receivables Credit card receivables Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful life of fixed assets Property, plant and equipment, gross Accumulated depreciation Net book value Platform Operator, Crypto Asset [Table] Platform Operator, Crypto Asset [Line Items] Total Assets Derivative liability Total Liabilities Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Gross billings/receipts Refunds, incentives, credits, and chargebacks Amounts paid to supplier Net revenue Net income Less: preferred dividends Add: interest expense on convertible debt Net income available to common shareholders (numerator) Dilutive impact of convertible notes Dilutive impact of non-voting membership interest Diluted weighted average number of common shares outstanding (denominator) Diluted income per common share Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities Cash, FDIC insured amount Cash balances exceeded FDIC limits Cash equivalents Depreciation expense Gain loss on disposal of assets Net book value Bitcoin received from sale of fixed assets Loss on disposal of assets Cryptocurrencies Revenues Realized gains (losses) on cryptocurrency Asset impairment charges Crypto Impairment expense Asset impairment charges Deferred revenues deposits collected from customers for orders to be filled at future date Advertising, selling, and marketing expenses Loss on disposal on assets Inventory, entirely finished goods Net cash provided by operating activities Cash paid for purchase Cash paid for fixed assets Repayments for debt Payments for shares repurchased from related parties Dividends paid Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, cash equivalents, and restricted cash Related Party Transaction [Table] Related Party Transaction [Line Items] Total related-party debt Less: Current portion Related-party debt, long term Debt Instrument, Unamortized Discount Received proceeds from related party debt Debt interest rate Debt instrument maturity date Debt conversion price per share Beneficial conversion feature and debt discount Debt discount into interest expense Interest expenses Debt interest rate Facility fee percentage Acquired percentage Debt instrument face amount Interest expense Debt instrument conversion feature Related party transaction amounts of advance Number of shares repurchased Shares purchased value Share price Shares purchased value Legal fees Consideration paid for purchased shares Consideration paid for purchased shares and expenses Shares cancelled Purchase price Purchase price per share Short-Term Debt [Table] Short-Term Debt [Line Items] Total debt Current portion Debt, long term portion Proceeds from debt Debt instrument interest percentage Monthly installment payments Debt Instrument, interest Repayments on the loan Other liabilities Common stock shares issued Preferred stock shares issued Debt instrument, maturity date Payment percentage Repayments of debt Issuances of cryptocurrency value Derivative liability Derivative extinguished with warrant exercise Change in fair value Derivative liability Derivative [Table] Derivative [Line Items] Derivative liability measurement input Schedule Of Future Minimum Lease Payments Under Non-cancellable Leases 2025 2026 Total Less: Interest Present value of lease liability Operating lease liability, current Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Operating lease right of use asset Lease term Exchange for new operating lease liability Operating lease liability Operating lease expense Operating lease cost Weighted average discount rate Number of Options, Options outstanding, beginning Weighted Average Exercise Price, Options outstanding, beginning Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning Number of Options, Granted Weighted Average Exercise Price, Granted Weighted Average Grant-Date Per Share Fair Value, Granted Number of Options, Canceled/Expired Weighted Average Exercise Price, Canceled/Expired Weighted Average Grant-Date Per Share Fair Value, Canceled/Expired Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Options outstanding, ending Weighted Average Exercise Price, Options outstanding, ending Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending Options Exercisable Weighted Average Exercise Price of Options Exercisable Weighted Average Contractual Life of Options Exercisable (Years) Weighted Average Contractual Life of Options Outstanding (Years) Number of Warrants Outstanding, Beginning Weighted Average Exercise Price Outstanding, Beginning Number of Warrants Granted Weighted Average Exercise Price Granted Number of Warrants Canceled/Expired Weighted Average Exercise Price Canceled Number of Warrants Exercised Weighted Average Exercise Price Exercised Number of Warrants Outstanding, Ending Weighted Average Exercise Price Outstanding, Ending Warrants Exercisable Weighted Average Contractual Life (Years) Stock, Class of Stock [Table] Class of Stock [Line Items] Preferred stock designated Cumulative dividends annual rate percentage Number of shares issued in transaction Sale of stock, price per share Description of offering Dividends, cash Payments to preferred stock dividend cash Payments to preferred stock dividend crypto Dividend liability Exchange for cash Consideration payable for purchased shares and expenses Number of common stock shares cancelled Value of common stock shares decreased Share based compensation expenses Proceeds from warrant exercised Stock-based compensation based on grant Number of options to purchase shares of common stock Number of options to purchase shares of common stock, stock options Number of options to purchase shares of common stock Vest over period Exercise price increase Number of options, canceled Number of options, vested Stock compensation expense Unrecognized compensation cost Weighted average vesting period Common unit, outstanding Common stock, voting rights Converted market value Closing market price per share Transaction cost Fair value discounted percentage Business acquisition, transaction costs discount value Number of exchange shares issuable Litigation Settlement, Fee Expense Escrow deposit Repayment of debt Debt premium percentage Repayment of debt Distribution of digital currencies prior to termination Receivable balances Receivable balance arise out of credit card transaction Debt instrument, principal amount Common stock, terms of conversion Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Market experts Credit card processing Energy and hosting Cost of sales Loss (gain) on disposal of assets Segment income from operations Bank interest Event ticket sales Leasing income Gain on winddown of operations All other, net Number of reportable segments Description of Products and Services Factors used to identify entity's reportable segments Cash Customer deposits – intercompany Domain names Raw materials Manufacturing equipment Total assets acquired Accounts payable Customer deposits Total liabilities assumed Net assets acquired Consideration Fair value of noncontrolling interest in ELRT Technologies, LLC  Total Payments to Acquire Businesses, Gross Customer deposits Revenue Net (loss) Loss per common share - Basic Loss per common share - Diluted Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Ownership interest, percentage Purchase price Revenue Net loss Domestic Foreign Federal State Foreign Total current income tax expense Total income tax expense NOL carryover Amortization Other accruals Depreciation Investment in partnership Deferred tax liabilities Valuation allowance Net deferred tax liability Income taxes at statutory rate State taxes – net of federal benefit Valuation allowance Foreign derived intangible income Interest Other Total income tax provision (benefit) Balance at the beginning of the year Increases related to positions taken in prior years Balance at the end of the year Effective tax rate Net operating loss carryforwards Income tax accrued interest and penalties Unrecognized tax benefits Subsequent Event [Table] Subsequent Event [Line Items] Debt amount Debt instrument interest rate Debt instrument, reduced interest rate Repurchase of common stock, value Number of shares repurchased, value Income tax paid in advance. Accrued liabilities long term. Accumulated noncontrolling interest. Other [Member] Health and Wellness Revenue [Member] Commissions. Loss on Settlement. Common stock canceled. Common stock cancelled, shares. Adjustments to additional paid in capital derivative liability extinguished for warrants exercised. Adjustments to additional paid in capital, warrant issued, shares. Gain loss on lease cost net of repayment. Increase decrease in income tax paid in advance. Increase decrease customer advances. Increase decrease in interest payable related parties net. Cash Paid During The Period For [Abstract] Common stock repurchased for payables. Dividends declared. Application of deposit to payables. Recognition of lease liability and ROU assets at lease commencement. Debt and related party debt extinguished in exchange for cryptocurrency. Dividends paid with cryptocurrency. Common stock cancelled. Cryptocurrency received from sale of fixed assets. Derivative liability extinguished with warrant exercise. Contribution Agreement [Member] Wealth Generators LLC [Member] Acquisition Agreement [Member] Market Trend Strategies LLC [Member] Furniture, Fixtures and Equipment [Member] Data Processing Equipment [Member] Manufacturing Equipment [Member] Bitcoin [Member] Mining Revenue [Member] Wyckoff Lease [Member] Haverford Lease [Member] Cryptocurrency Revenue [Member] Gross billings/receipts. Represents the monetary amount of Refunds, Incentives, Credits, and Chargebacks, during the indicated time period. Miner Repair Revenue [Member] Foreign Revenue [Member] Domestic Revenue [Member] Preferred stock designated. Board Of Directors [Member] Cumulative dividends annual rate percentage. Unit Offering [Member] Convertible Promissory Note [Member] Convertible Promissory Note One [Member] Convertible Promissory Note Two [Member] Cryptocurrency [Member] Chairman [Member] DBR Capital LLC [Member] Stock Purchase And Release Agreement [Member] Ryan Smith And Chand Miller [Member] Mario Romano and Annette Raynor [Member] Value of common stock shares decreased. Securities Purchase Agreements [Member] Convertible Promissory Note Three [Member] SSA Technologies LLC [Member] Share based compensation arrangement by share based payment award options outstanding weighted average remaining vesting period contractual term. Payments for repurchase of equity and legal fee. US Small Business Administration [Member] APEX Tex LLC [Member] Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price granted. Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price canceled. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price exercised. Summary Of Warrants Outstanding [Table Text Block] Warrants exercisable. Investview Financial Group Holding LLC [Member] David B Rothrock And James R Bell [Member] Class B Units [Member] Debt instrument periodic payment terms balloon payment percentage. Issuances of cryptocurrency value. Fair value discounted percentage. Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount. Derivative extinguished with warrant exercise. Promissory Note [Member] Membership Revenue [Member] Warminster Lease [Member] Ivyland Lease [Member] Debt discount current. Debt premium percentage. iGenius, LLC [Member] Joseph Cammarata [Member] Mining [Member] Mining Equipment Repair Revenue [Member] Deferred tax assets amortization. Deferred tax liabilities depreciation. Deferred Tax Assets Tax Deferred Expense Reserves And Investment In Partnership. Schedule Of Income From Continuing Operations [Table Text Block] Income tax reconciliation interest. Goldman's Pharmaceuticals LLC [Member] ELRT Technologies, LLC [Member] Renu Laboratories, Inc [Member] Business combination recognized identifiable assets acquired and liabilities assumed customer deposits inter company. Business combination recognized identifiable assets acquired and liabilities assumed domain names. Business combination recognized identifiable assets acquired and liabilities assumed raw materials. Business combination recognized identifiable assets acquired and liabilities assumed manufacturing equipment. Business combination recognized identifiable assets acquired and liabilities assumed current liabilities customer deposits. Securities Purchase Agreement [Member] Due from merchant processors. Held in reserve by merchant processors for future returns and charge backs. Due from payout service providers. Distribution of digital currencies prior to termination. DBR Capital [Member] Share Repurchase Program [Member] Deposits collected from customers for orders to be filled at future date. Financial Education and Technology [Member] Blockchain Technology and Crypto Mining Products and Services [Member] Manufacturing and Development of Health Beauty and Wellness Products [Member] Market experts. Credit card processing. Energy and Hosting. Segment reporting reconciling item bank interest. Segment reporting reconciling item event ticket sales. Segment reporting reconciling item leasing income. Segment reporting reconciling item gain on winddown of operations. Segment reporting reconciling item all other net. Assets, Current Other Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) LossOnSettlement Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Preferred Stock Dividends, Income Statement Impact Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Stock Issued During Period, Value, Other Stock Issued During Period, Shares, Other Dividends Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture GainLossonLeaseCostNetofRepayment Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInIncomeTaxPaidInAdvance Increase (Decrease) in Other Current Assets Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Income Taxes Payable Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Investing Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities DerivativeLiabilityExtinguishedWithWarrantExercise Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Receivable [Policy Text Block] Inventory, Policy [Policy Text Block] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accounts Receivable, before Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss Accounts Receivable, after Allowance for Credit Loss Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Derivative Liability Payments to Suppliers Dividends, Preferred Stock Net Income (Loss) Available to Common Stockholders, Diluted Debt Instrument, Interest Rate During Period Stock Issued During Period, Value, Purchase of Assets Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Dividends Payable SegmentReportingReconcilingItemBankInterest SegmentReportingReconcilingItemEventTicketSales SegmentReportingReconcilingItemLeasingIncome SegmentReportingReconcilingItemGainOnWinddownOfOperations SegmentReportingReconcilingItemAllOtherNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Revenue from Contract with Customer, Including Assessed Tax Current Foreign Tax Expense (Benefit) Current Income Tax Expense (Benefit) DeferredTaxLiabilitiesDepreciation Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net Effective Income Tax Rate Reconciliation, FDII, Amount IncomeTaxReconciliationInterest Unrecognized Tax Benefits EX-101.PRE 18 invu-20241231_pre.xml XBRL PRESENTATION FILE XML 20 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2024
Mar. 20, 2025
Jun. 28, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 000-27019    
Entity Registrant Name INVESTVIEW, INC.    
Entity Central Index Key 0000862651    
Entity Tax Identification Number 87-0369205    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 521 West Lancaster Avenue    
Entity Address, Address Line Two Second Floor    
Entity Address, City or Town Haverford    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 19041    
City Area Code 732    
Local Phone Number 889-4300    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 26,798,138
Entity Common Stock, Shares Outstanding   1,859,231,786  
Documents Incorporated by Reference NONE    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 0.001    
Description of non-controlling interest The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own.    
Auditor Firm ID 2738    
Auditor Name M&K CPAS, PLLC    
Auditor Location The Woodlands, TX    
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 22,467,710 $ 20,912,276
Restricted cash, current 230,354
Prepaid assets 497,620 492,607
Deposits, current 936,434
Receivables 2,534,727 2,232,725
Inventory 495,865
Income tax paid in advance 459,872
Other current assets 1,127,891 585,632
Total current assets 28,520,119 24,453,594
Fixed assets, net 1,868,441 6,536,823
Other assets:    
Goodwill 873,701
Intangible assets, net 40,310
Operating lease right-of-use asset 211,996 110,427
Deposits 57,028 2,588,127
Total other assets 1,183,035 2,698,554
Total assets 31,571,595 33,688,971
Current liabilities:    
Accounts payable and accrued liabilities 7,139,684 5,854,093
Payroll liabilities 271,606 187,419
Income tax payable 202,573 1,004,535
Deferred revenue 3,029,145 2,703,398
Derivative liability 758 5,732
Dividend liability 245,101 256,392
Operating lease liability, current 165,707 [1] 109,628
Total current liabilities 12,288,385 12,039,571
Operating lease liability, long term 46,433 6,048
Accrued liabilities, long term 45,532 1,189,643
Total long-term liabilities 2,083,625 2,859,102
Total liabilities 14,372,010 14,898,673
Commitments and contingencies
Stockholders’ equity (deficit):    
Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 252 252
Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 2,333,356,496 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 1,859,231 2,333,356
Additional paid in capital 102,560,320 104,056,807
Accumulated other comprehensive income (loss) (23,218) (23,218)
Accumulated noncontrolling interest 8,070
Accumulated deficit (87,205,070) (87,576,899)
Total stockholders’ equity (deficit) 17,199,585 18,790,298
Total liabilities and stockholders’ equity (deficit) 31,571,595 33,688,971
Related Party [Member]    
Current liabilities:    
Debt, net of discounts, current 1,204,567 1,203,247
Debt, net of discounts, long term 1,501,041 1,162,349
Nonrelated Party [Member]    
Current liabilities:    
Debt, net of discounts, current 29,244 715,127
Debt, net of discounts, long term $ 490,619 $ 501,062
[1] Represents lease payments to be made in the next 12 months.
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 252,192 252,192
Preferred stock, shares outstanding 252,192 252,192
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 10,000,000,000 10,000,000,000
Common stock, shares issued 1,859,231,786 2,333,356,496
Common stock, shares outstanding 1,859,231,786 2,333,356,496
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Other Comprehensive Income (Loss) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue:    
Total revenue, net $ 52,381,971 $ 67,920,871
Operating costs and expenses:    
Cost of sales and service 6,056,491 10,736,709
Commissions 25,913,260 31,716,399
Selling and marketing 569,491 560,065
Salary and related 6,626,588 7,112,954
Professional fees 1,547,288 1,378,367
Impairment expense 1,771,891 2,056,386
Loss (gain) on disposal of assets 180,223 223,630
General and administrative 8,022,020 9,531,431
Total operating costs and expenses 50,687,252 63,315,941
Net income (loss) from operations 1,694,719 4,604,930
Other income (expense):    
Loss on Settlement (375,000)
Gain (loss) on fair value of derivative liability 4,974 18,691
Realized gain (loss) on cryptocurrency 452,450 255,268
Other income (expense) 1,567,543 1,389,796
Total other income (expense) 390,637 405,402
Income (loss) before income taxes 2,085,356 5,010,332
Income tax expense (894,940) (2,178,412)
Net income (loss) 1,190,416 2,831,920
Net income (loss) attributable to noncontrolling interest (753)
Net income (loss) attributable to Investview, Inc. 1,191,169 2,831,920
Dividends on Preferred Stock (819,340) (819,340)
Net income (loss) applicable to common shareholders $ 371,829 $ 2,012,580
Basic income (loss) per common share $ 0.00 $ 0.00
Diluted income (loss) per common share $ 0.00 $ 0.00
Basic weighted average number of common shares outstanding 1,908,219,120 2,559,093,504
Diluted weighted average number of common shares outstanding 2,944,647,691 3,595,522,075
Nonrelated Party [Member]    
Other income (expense):    
Interest expense $ (18,801) $ (18,750)
Related Party [Member]    
Other income (expense):    
Interest expense (1,240,529) (1,239,603)
Membership Revenue [Member]    
Revenue:    
Total revenue, net 47,061,290 56,036,052
Mining [Member]    
Revenue:    
Total revenue, net 5,186,606 11,348,156
Health and Wellness Revenue [Member]    
Revenue:    
Total revenue, net 110,671
Cryptocurrency Revenue [Member]    
Revenue:    
Total revenue, net 513,285
Mining Equipment Repair Revenue [Member]    
Revenue:    
Total revenue, net 23,378
Other [Member]    
Revenue:    
Total revenue, net $ 23,404
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2022 $ 252 $ 2,636,275 $ 104,350,746 $ (23,218) $ (89,589,479) $ 17,374,576
Balance, shares at Dec. 31, 2022 252,192 2,636,275,489          
Common stock issued for services and other stock-based compensation 2,575,496 2,575,496
Warrant Exercise 23 23
Warrant Exercise, shares   230          
Derivative liability extinguished with warrant exercise 3 3
Common stock repurchased from related parties and canceled $ (302,919) (2,869,461) (3,172,380)
Common stock repurchased from related parties and canceled, shares   (302,919,223)          
Dividends (819,340) (819,340)
Net income (loss) 2,831,920 2,831,920
Balance at Dec. 31, 2023 $ 252 $ 2,333,356 104,056,807 (23,218) (87,576,899) 18,790,298
Balance, shares at Dec. 31, 2023 252,192 2,333,356,496          
Warrant Exercise, shares   230          
Common stock repurchased from related parties and canceled $ (472,375) (3,098,771) (3,571,146)
Common stock repurchased from related parties and canceled, shares   (472,374,710)          
Dividends (819,340) (819,340)
Net income (loss) 1,191,169 (753) 1,190,416
Common stock issued for services and other stock-based compensation 1,600,534 1,600,534
Common stock canceled $ (1,750) 1,750
Common stock cancelled, shares   (1,750,000)          
Recognition of noncontrolling interest in acquisition 8,823 8,823
Balance at Dec. 31, 2024 $ 252 $ 1,859,231 $ 102,560,320 $ (23,218) $ (87,205,070) $ 8,070 $ 17,199,585
Balance, shares at Dec. 31, 2024 252,192 1,859,231,786          
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 1,190,416 $ 2,831,920
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 3,875,614 4,450,466
Amortization of debt discount 338,691 337,767
Stock issued for services and other stock-based compensation 1,600,534 2,575,496
Lease cost, net of repayment (5,105) 1,283
(Gain) loss on disposal of assets 180,223 223,630
Loss on fair value of derivative liability (4,974) (18,691)
Realized (gain) loss on cryptocurrency (452,450) (255,268)
Impairment expense 1,771,891 2,056,386
Changes in operating assets and liabilities:    
Receivables (302,002) (977,183)
Inventory (326,986) 74,645
Prepaid assets (5,013) (126,046)
Income tax paid in advance (459,872) 535,932
Other current assets (535,461) (5,396,521)
Deposits (2,439) (2,114,529)
Accounts payable and accrued liabilities 1,559,877 (350,764)
Income tax payable (801,962) 763,932
Customer advance (96,609)
Deferred revenue (239,279) 628,824
Accrued interest 18,801 18,750
Accrued interest, related parties 901,837 901,837
Net cash provided by (used in) operating activities 8,302,341 6,065,257
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash acquired in acquisition 1,495
Cash paid for purchase of Renu (1,144,426)
Cash received from the disposal of fixed assets 23,278
Cash paid for fixed assets (461,945) (2,561,001)
Net cash provided by (used in) investing activities (1,604,876) (2,537,723)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments for related party debt (900,516) (900,516)
Repayments for debt (441,086) (1,948,906)
Payments for shares repurchased from related parties (3,371,763) (396,547)
Dividends paid (659,020) (627,856)
Proceeds from the exercise of warrants 23
Net cash provided by (used in) financing activities (5,372,385) (3,873,802)
Effect of exchange rate translation on cash
Net increase (decrease) in cash, cash equivalents, and restricted cash 1,325,080 (346,268)
Cash, cash equivalents, and restricted cash - beginning of period 21,142,630 21,488,898
Cash, cash equivalents, and restricted cash - end of period 22,467,710 21,142,630
Cash paid during the period for:    
Interest 929,760 932,197
Income taxes 2,156,774 2,178,412
Non-cash investing and financing activities:    
Common stock repurchased for payables 3,571,146 2,775,833
Application of deposit to payables 1,597,104
Dividends declared 819,340 819,340
Recognition of lease liability and ROU asset at lease commencement 223,364 23,520
Debt extinguished in exchange for cryptocurrency 274,041 5,322,058
Dividends paid with cryptocurrency 171,611 171,722
Common stock cancelled 1,750
Cryptocurrency received from sale of fixed assets 9,913
Derivative liability extinguished with warrant exercise $ 3
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ 1,191,169 $ 2,831,920
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Disclosure - Insider Trading Policies and Procedures true
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Abstract]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Risk Management and Strategy

 

The Company’s cybersecurity risk management practices are intended to assess, identify and manage risks from threats to the security of our information, systems, products and network. Our cybersecurity program is a key component of our broader risk management strategy in which cyber risk has been identified and is actively managed with preventive and mitigating measures. We design and assess our cybersecurity program based on the National Institute of Standards and Technology’s Cybersecurity Framework, ISO 27001, and industry-specific regulations. This does not imply that we meet any particular technical standards, specifications or requirements, but rather that we use them as a guide to help us identify, assess and manage cybersecurity risks relevant to our business.

 

Cybersecurity incidents could result from unintentional events, or from deliberate attacks by unauthorized entities or individuals attempting to gain access to Investview’s System Technology for the purposes of misappropriating assets or information or causing operational disruption and damage. To mitigate the risk of an impact to our business operations and/or damage from cybersecurity incidents or cyberattacks, Investview invests in multiple forms of cybersecurity and operational safeguards.

 

On an ongoing basis, we assess our people, processes, and technology, and when necessary, modify the overall program in order to meet the demands of the ever-changing cyber risk environment. As part of our regular training and readiness program, we conduct phishing and penetration testing campaigns in order to ensure that our employees are familiar with all types of phishing emails and similar threats.

 

Our data is dynamically backed up to mitigate against data loss. To prevent unauthorized access and data breaches, we encrypt sensitive data both in transit and at rest. We have also implemented access controls and multi-factor authentication to ensure that only authorized personnel can access sensitive information. We also utilize third-party information technology systems vendors to conduct regular network and endpoint monitoring.

 

Our risk management program is comprised of, among other things, policies that are designed to identify, assess, manage, and mitigate cybersecurity risk, and is based on applicable laws and regulations, derived from industry standards and best practices. These policies are intended to identify cybersecurity threats that may be associated with both internally managed systems and systems managed by third-party service providers.

 

We conduct risk assessments to evaluate the effectiveness of our systems and processes in addressing threats and to identify opportunities for enhancements. Additionally, we conduct privacy and cybersecurity reviews, as well as annual employee training, and monitor emerging laws and regulations related to information security and data protection. We utilize third party tools and techniques to test and enhance our security controls, perform annual cybersecurity framework assessments, conduct ongoing penetration testing of our systems, and benchmark against best practices. Our internal audit function provides an independent assessment on the overall operations of our cybersecurity program and the supporting framework.

 

Our cybersecurity team engages and utilizes third-party services as it monitors and actively responds to cybersecurity threats. We utilize an Endpoint Detection and Response (EDR) platform, an anti-virus application, through which incoming electronic communications are filtered, and an email security platform which seeks out identifiers in communications that disguise, impersonate, or otherwise misrepresent the source of the communication. If such a communication is detected, it is subject to quarantine or removal depending on the severity of issue. Additionally, we use a Security Information and Event Management (SIEM) system, which allows us to store logs off the system of record to prevent log tampering and provides the cybersecurity team functionality to build alerts on specific use cases that are important and unique to our business. If our applications fail or our software does not successfully block a malicious electronic communication, employees are required to notify an immediate supervisor or the cybersecurity team promptly, but in no circumstances later than twenty-four (24) hours after such occurrence.

Upon detection of a cybersecurity incident and initial intake and validation by our cybersecurity team, our incident response team triages and evaluates the cybersecurity incident, and, depending on the severity, escalates the incident to management and a cross-functional working group. Any incident assessed as potentially being or potentially becoming material is immediately escalated for further assessment and reported to executive management. Determination of what resources are needed to address the incident, prioritizing of response activities, forming of action plans, and notification of external parties as needed are then undertaken by executive management and the cross-functional working group, led by our Senior Information Officer (SIO). We consult with outside counsel as appropriate, including on materiality analysis and disclosure matters, and our executive management makes the final materiality and disclosure determinations, among other compliance decisions.

Cybersecurity Risk Management Processes Integrated [Flag] false
Cybersecurity Risk Management Processes Integrated [Text Block] The Company’s cybersecurity risk management practices are intended to assess, identify and manage risks from threats to the security of our information, systems, products and network. Our cybersecurity program is a key component of our broader risk management strategy in which cyber risk has been identified and is actively managed with preventive and mitigating measures. We design and assess our cybersecurity program based on the National Institute of Standards and Technology’s Cybersecurity Framework, ISO 27001, and industry-specific regulations. This does not imply that we meet any particular technical standards, specifications or requirements, but rather that we use them as a guide to help us identify, assess and manage cybersecurity risks relevant to our business.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Board of Directors Oversight [Text Block] GovernanceOur board, Senior Information Officer (“SIO”) and management actively assess the Company’s cybersecurity and data privacy risk management practices with the goal of being proactive rather than reactive. Our SIO and management regularly review the Company’s cybersecurity and data privacy risks, including our policies, controls and procedures for identifying, managing and mitigating such risks. Our SIO provides management with periodic reports regarding cybersecurity and data privacy measures and procedures, the identification of security gaps and compliance with applicable cybersecurity and data privacy regulations. Management then briefs our board at scheduled meetings regarding cybersecurity and data privacy developments.

 

Management and our SIO are responsible for day-to-day monitoring of the prevention, detection, mitigation and remediation of cybersecurity incidents. Our SIO, who reports to our Chief Operating Officer, has primary oversight of the material risks from cybersecurity and data privacy matters. Our SIO has more than 20 years of experience across various information technology, information security and management roles, including leading the development and implementation of cybersecurity and data privacy strategies for the employee and customer-facing aspects of our business.

 

In 2024, we did not identify any cybersecurity incidents or threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations or financial condition. However, despite our efforts, we may not be successful in eliminating all risks from cybersecurity threats and can provide no assurances that undetected cybersecurity incidents have not occurred. See Part I, Item 1A. “Risk Factors” of this Annual Report for more information regarding the cybersecurity risks we face.

 
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board, Senior Information Officer (“SIO”) and management actively assess the Company’s cybersecurity and data privacy risk management practices with the goal of being proactive rather than reactive. Our SIO and management regularly review the Company’s cybersecurity and data privacy risks, including our policies, controls and procedures for identifying, managing and mitigating such risks. Our SIO provides management with periodic reports regarding cybersecurity and data privacy measures and procedures, the identification of security gaps and compliance with applicable cybersecurity and data privacy regulations. Management then briefs our board at scheduled meetings regarding cybersecurity and data privacy developments
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF BUSINESS
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND NATURE OF BUSINESS


NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Investview, Inc. was incorporated on January 30, 1946, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.

 

Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.

 

On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $419,139 in pre-merger liabilities.

 

On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).

 

On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.

 

On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.

 

On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.

 

Nature of Business

 

We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion: an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.

 

XML 31 R12.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of December 31, 2024 and 2023, cash balances that exceeded FDIC limits were $10,837,830 and $3,778,085, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents and Restricted Cash

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2024 and 2023, we had no cash equivalents.

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.

 

   December 31,   December 31, 
   2024   2023 
Cash and cash equivalents  $22,467,710   $20,912,276 
Restricted cash, current   -    230,354 
Total cash, cash equivalents, and restricted cash shown on the statement of cash flows  $22,467,710   $21,142,630 

 

Amount included in restricted cash represent funds required to be held in an escrow account by a contractual agreement and will be used for paying dividends to our Series B Preferred Stockholders and funds required to be held in an account as collateral for business charges on our Company credit card.

 

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   December 31,   December 31, 
   2024   2023 
Due from merchant processors  $318,921   $1,732,456 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,219,342 
Due from payout service providers   296,558    3,251 
Accounts and other receivables   47,213    - 
 Receivable, gross   2,534,727    2,955,049 
Allowance for doubtful accounts   -    (722,324)
Receivables  $2,534,727   $2,232,725 

 

[1]We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

   Estimated        
   Useful        
   Life  December 31,   December 31, 
   (years)  2024   2023 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   28,571    11,308 
Data processing equipment  3   11,824,560    14,084,670 
Manufacturing equipment  3-25   1,161,701    - 
       13,015,549    14,096,695 
Accumulated depreciation      (11,147,108)   (7,559,872)
Net book value     $1,868,441   $6,536,823 

 

Total depreciation expense for the years ended December 31, 2024 and 2023, was $3,875,614 and $4,450,466, respectively, all of which was recorded in our general and administrative expenses on our statement of operations. During the year ended December 31, 2024, we disposed of assets with a net book value of $180,223. During the year ended December 31, 2023, we sold assets with a total net book value of $26,731 for cash of $23,278 and bitcoin worth $9,913, therefore recognized a gain on disposal of assets of $6,460. This gain was offset by loss on disposal of assets with a net book value of $55,255.

 

Long-Lived Assets – Cryptocurrencies & Intangible Assets

 

We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $1,127,891 and $585,632, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($5,186,606 and $11,348,156 for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $452,450 and $255,268, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $2,056,386. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $0 due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Impairment of Long-Lived Assets

 

We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.

 

During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $1,771,891. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, no impairment was recorded.

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

-quoted prices for similar assets or liabilities in active markets;
-quoted prices for identical or similar assets or liabilities in markets that are not active;
-inputs other than quoted prices that are observable for the asset or liability; and
-inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable, and accounts payable. We have determined that the book value of our outstanding financial instruments as of December 31, 2024 and 2023, approximates the fair value due to their short-term nature.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $5,732   $5,732 
Total Liabilities  $-   $-   $5,732   $5,732 

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $1,905,734 and $2,703,398, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $1,014,164.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cryptocurrency Revenue

 

During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.

 

During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.

 

During 2024, we generated no revenue from the sale of cryptocurrency packages.

 

Mining Equipment Repair Revenue

 

Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.

 

Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2024, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $50,086,839   $5,186,606   $110,856   $23,404   $55,407,705 
Refunds, incentives, credits, and chargebacks   (3,025,549)   -    (185)   -    (3,025,734)
Net revenue  $47,061,290   $5,186,606   $110,671   $23,404   $52,381,971 

 

Foreign revenues for the year ended December 31, 2024 were approximately $42.9 million while domestic revenue for the year ended December 31, 2024 was approximately $9.5 million.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2023, was as follows:

 

   Membership
Revenue
   Cryptocurrency Revenue   Mining Revenue   Miner Repair Revenue   Total 
Gross billings/receipts  $60,516,836   $990,785   $11,348,156   $23,378   $72,879,155 
Refunds, incentives, credits, and chargebacks   (4,480,784)   -    -    -    (4,480,784)
Amounts paid to supplier   -    (477,500)   -    -    (477,500)
Net revenue  $56,036,052   $513,285   $11,348,156   $23,378   $67,920,871 

 

Foreign revenues for the year ended December 31, 2023 were approximately $51.0 million while domestic revenue for the year ended December 31, 2023 was approximately $16.9 million.

 

Advertising, Selling, and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the year ended December 31, 2024 and 2023, totaled $569,491 and $560,065, respectively.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the year ended December 31, 2024 and 2023, totaled $6,056,491 and $10,736,709, respectively.

 

Inventory

 

As of December 31, 2024, inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Due to the discontinuation of our miner repair business during the quarter ended June 30, 2023, all related inventory was sold. During the year ended December 31, 2023, we recognized a loss on disposal of assets of $174,835.

 

As of December 31, 2024 and 2023 the net realizable value of our inventory was $495,865 and $0, respectively.

 

Income Taxes

 

We have adopted ASC Subtopic 740-10, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.

 

   December 31,
2024
   December 31,
2023
 
Net income  $1,190,416    2,831,920 
Less: preferred dividends   (819,340)   (819,340)
Add: interest expense on convertible debt   900,516    900,516 
Net income available to common shareholders (numerator)  $1,271,592    2,913,096 
           
Basic weighted average number of common shares outstanding   1,908,219,120    2,559,093,504 
Dilutive impact of convertible notes   471,428,571    471,428,571 
Dilutive impact of non-voting membership interest   565,000,000    565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   2,944,647,691    3,595,522,075 
           
Diluted income per common share  $0.00    0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

   December 31,
2024
   December 31,
2023
 
Options to purchase common stock   359,698,857    360,416,665 
Warrants to purchase common stock   1,178,090    1,178,129 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

XML 32 R13.htm IDEA: XBRL DOCUMENT v3.25.1
RECENT ACCOUNTING PRONOUNCEMENTS
12 Months Ended
Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS

NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued (or made available for issuance). If an entity adopts the amendments in an interim period, it must adopt them as of the beginning of the fiscal year that includes that interim period. ASU No. 2023-08 requires a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company has not yet adopted ASU No. 2023-08 and is currently evaluating the impact that the adoption will have on the Company’s financial statement presentation and disclosures.

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company did not elect early adoption and is currently evaluating the impact the updated guidance will have on its 2025 disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance reportable segment disclosures by requiring disclosures of significant segment expenses regularly provided to the CODM, requiring disclosure of the title and position of the CODM and explanation of how the reported measures of segment profit and loss are used by the CODM in assessing segment performance and allocation of resources. ASU 2023-07 is effective for the Company for annual periods beginning after December 31, 2023. The Company adopted ASU 2023-07 for the year ended December 31, 2024. As a result of the adoption, the Company added this disclosure in Note 11. Segment Information, to present significant expenses that are included within cost of revenue, by reportable segment, which are presented to the CODM.

 

In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

XML 33 R14.htm IDEA: XBRL DOCUMENT v3.25.1
LIQUIDITY
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
LIQUIDITY

NOTE 4 – LIQUIDITY

 

Our financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

During the year ended December 31, 2024, we met our short-and long-term working capital and capital expenditure requirements. Our net cash provided by operating activities for the year ended December 31, 2024, was $8.3 million. We used our cash provided by operating activities for the acquisition of substantially all the assets of Renu Labs for $1.1 million, the purchase of fixed assets in the amount of $0.5 million, principal and interest payments on debt of $1.3 million, the repurchase of common shares totaling $3.4 million, total dividend payments on our preferred stock of $0.7 million and added $1.3 million to our cash balance, which totaled $22.5 million at December 31, 2024. We believe we will have sufficient resources, including cash flow from operations and access to capital markets, to meet debt service and other obligations in a timely manner and be able to meet our objectives.

 

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Related Party Debt

 

Our related party debt consisted of the following:

 

   December 31,   December 31, 
   2024   2023 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $692,004 as of December 31, 2024 [1]  $607,996   $477,711 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $375,700 as of December 31, 2024 [2]   324,304    253,566 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $731,254 as of December 31, 2024 [3]   568,742    431,072 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,567    1,203,247 
Total related-party debt   2,705,608    2,365,596 
Less: Current portion   (1,204,567)   (1,203,247)
Related-party debt, long term  $1,501,041   $1,162,349 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $130,285 of the debt discount into interest expense, as well as expensed an additional $260,016 of interest expense on the note, all of which was repaid during the period.
  
[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the year ended December 31, 2024, we recognized $70,738 of the debt discount into interest expense as well as expensed an additional $140,000 of interest expense on the note, all of which was repaid during the period.
  
[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $137,670 of the debt discount into interest expense as well as expensed an additional $500,500 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $1,320 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

 

On February 28, 2025, we and DBR Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated or ever.

 

Other Related Party Arrangements

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $1,189,643 under the Romano/Raynor Agreement of which $1,189,643 is included in Accounts payable and accrued liabilities.

 

In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380 (see NOTE 9).

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $1,785,573 under the Smith/Miller Agreement of which $1,785,572 is included in Accounts payable and accrued liabilities.

 

The consideration paid for the Purchased Shares of $3,571,146 was allocated to the share purchase (see NOTE 9).

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

XML 35 R16.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
DEBT

NOTE 6 – DEBT

 

Our debt consisted of the following:

 

   December 31,
2024
   December 31,
2023
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $519,863   $530,306 
Long term notes for APEX lease buyback [2]   -    685,883 
Total debt   519,863    1,216,189 
Less: Current portion   29,244    715,127 
Debt, long term portion  $490,619   $501,062 

 

[1]In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $18,801 and $18,750 worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $29,244 and $31,681.
  
[2]In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until December 31, 2024, when the last monthly payment will be made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $411,842 and issuances of cryptocurrency then valued at $274,041. As of December 31, 2024, the debt was paid in full.

 

XML 36 R17.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVE LIABILITY
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY

NOTE 7 – DERIVATIVE LIABILITY

 

During the year ended December 31, 2024 and 2023, we had the following activity in our derivative liability account:

 

   Total 
Derivative liability at December 31, 2022  $24,426 
Derivative extinguished with warrant exercise (see NOTE 9)   (3)
Change in fair value   (18,691)
Derivative liability at December 31, 2023   5,732 
Change in fair value   (4,974)
Derivative liability at December 31, 2024  $758 

 

We use the binomial option pricing model to estimate fair value for those instruments, at inception, at warrant exercise, and at each reporting date. During the years ended December 31, 2024 and 2023, the assumptions used in our binomial option pricing model were in the following range:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Risk free interest rate   4.16 - 4.25%   4.01 - 4.23%
Expected life in years   0.58 - 1.50    1.58 - 2.50 
Expected volatility   122% - 142%   116% - 122%

 

XML 37 R18.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASES
12 Months Ended
Dec. 31, 2024
Operating Leases  
OPERATING LEASES

NOTE 8 – OPERATING LEASES

 

In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the MPower acquisition. This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (“the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered for use by our newly formed subsidiary Renu Laboratories LLC.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

At commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $22,034. The original 24.5-month term of the Wyckoff Lease was extended through July 2025 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2024. The earliest termination date is July 31, 2024. At the extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $23,520.

 

At date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $172,042. On August 7, 2024, the term of the Haverford Lease was extended through December 31, 2025.

 

At commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327. The Warminster Lease will automatically terminate after the 14-month term.

 

At commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037. The Ivyland Lease will automatically terminate after the 24-month term.

 

Operating lease expense was $130,710 for the year ended December 31, 2024. Operating cash flows used for the operating leases during the year ended December 31, 2024, was $135,809. As of December 31, 2024, the weighted average remaining lease term was 1.48 years, and the weighted average discount rate was 12%.

 

Future minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:

 

      
2025  $171,148 
2026   61,057 
Total   232,205 
Less: Interest   (20,065)
Present value of lease liability   212,140 
Operating lease liability, current [1]   (165,707)
Operating lease liability, long term  $46,433 

 

[1] Represents lease payments to be made in the next 12 months.

 

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

We are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.

 

Our Board of Directors approved the designation of 2,000,000 of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $25 per share. Our Series B Preferred Stockholders are entitled to receive cumulative dividends at the annual rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.

 

During the year ended March 31, 2021, we commenced an offering to sell a total of 2,000,000 units at $25 per unit (“Unit Offering”), with each unit consisting of: (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 7). The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of 252,192 Units.

 

As of December 31, 2024 and 2023, we had 252,192 shares of preferred stock issued and outstanding.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Preferred Stock Dividends

 

During the year ended December 31, 2024, we recorded $819,340 for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $659,020 in cash and issued $171,611 worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $245,101 as a dividend liability on our balance sheet as of December 31, 2024.

 

During the year ended December 31, 2023, we recorded $819,340 for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $627,856 in cash and issued $171,722 worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $256,392 as a dividend liability on our balance sheet as of December 31, 2023.

 

Common Stock Transactions

 

During the year ended December 31, 2024, we repurchased 472,374,710 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $446,391 and payables of $3,124,755 (see NOTE 5). Also, during the year ended December 31, 2024, we cancelled 1,750,000 shares that had been issued but were forfeited by choice. As a result, we decreased common stock by $1,750 and increased additional paid in capital by the same. The forfeiture also resulted in the reversal of previously recorded expense resulting in a net $10,002 reduction in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

During the year ended December 31, 2023, we issued 230 shares of common stock as a result of warrants exercised, resulting in proceeds of $23 and an increase in additional paid in capital of $3 for the derivative liability extinguished with the exercise (see NOTE 7). Also, during the year ended December 31, 2023, we repurchased 302,919,223 shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $396,547 and payables of $2,775,833 (see NOTE 5). We also recognized $20,341 in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.

 

As of December 31, 2024 and 2023, we had 1,859,231,786 and 2,333,356,496 shares of common stock issued and outstanding, respectively.

 

Options

 

The 2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to 600,000,000 shares of the Company’s common stock.

 

During the year ended December 31, 2024, we issued 1,000,000 stock options as part of the acquisition of Opencash Finance, Inc., 10,000,000 stock options as part of a compensation package offered to a new officer of the Company, and 5,000,000 stock options as part of the purchase of the business and assets of Renu Laboratories, Inc. The options vest in equal amounts over a five-year period, at an exercise price of $0.05 per share, with a seven-year life. We utilized the Black Scholes Model to value these options, and the expense related to these options is being recognized over the vesting term. Also, during the year ended December 31, 2024, we cancelled 15,000,000 unvested options and 10,000,000 vested options expired upon the resignation of an officer of the Company.

 

Transactions involving our options are summarized as follows:

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2023   360,416,665   $0.05   $0.03 
Granted   16,000,000   $0.05   $0.01 
Canceled/Expired   (25,000,000)  $0.05   $0.03 
Exercised   -   $-   $- 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 

 

Details of our options outstanding as of December 31, 2024, is as follows:

 

Options Exercisable   Weighted Average
Exercise Price of Options
Exercisable
   Weighted Average
Contractual Life of Options
Exercisable (Years)
   Weighted Average
Contractual Life of Options
Outstanding (Years)
 
 183,291,665    0.05    4.48    4.62 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Total stock compensation expense related to the options for the year ended December 31, 2024 and 2023, was $1,610,536 and $2,555,155, respectively. As of December 31, 2024 there was approximately $3.3 million of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 1.2 years.

 

Warrants

 

Transactions involving our warrants are summarized as follows:

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2022   1,178,320   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   (230)  $0.10 
Warrants outstanding at December 31, 2023   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 

 

Details of our warrants outstanding as of December 31, 2024 is as follows:

 

Warrants Exercisable   Weighted Average Contractual Life (Years) 
 1,178,090    1.14 

 

Class B Units of Investview Financial Group Holdings, LLC

 

As of December 31, 2024, and December 31, 2023, there were 565,000,000 Units of Class B Investview Financial Group Holdings, LLC issued and outstanding. These units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement. In order to properly account for the purchase transaction on the Company’s financial statements, we were required by applicable financial reporting standards to value the Class B Units issued to MPower in the transaction as of the closing date of the MPower sale transaction (September 3, 2021). For these accounting purposes, we concluded that the “fair value” of the consideration for financial accounting purposes, at the if-converted market value of the underlying common shares was $58.9 million, based on the closing market price of $0.1532 on the closing date of September 3, 2021, as discounted from $86.6 million by 32% (or $27.7 million) to reflect the significant lock up period. The “fair value” valuation of the Class B Units, however, was completed relying on a certain set of methodologies that are accepted for accounting purposes and is not necessarily indicative of the “fair market value” that may be implied relative to such Units in a commercial transaction not governed by financial reporting standards. In particular, the methodology used to value the Class B Units at their “fair value” did not take into account any blockage discounts that may otherwise apply after the expiration of the lock-up period in 2025; while other valuation methodologies, not bound by financial reporting codifications, would possibly determine that the blockage discount associated with the resale of 565 million shares after the expiration of the lock-up period, into a marketplace that has limited market liquidity, could possibly have a material downward influence on the valuation.

 

XML 39 R20.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

In the ordinary course of business, we may be, or have been, involved in legal proceedings. On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted, however, agreed to pay a civil monetary penalty of $375,000 to conclude the inquiry. The Company considers this matter to be closed. As of December 31, 2024, the penalty of $375,000 was in escrow with our SEC attorney.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $19 million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a 25% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled the approximately $19 million of promissory notes.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, iGenius members who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $16.6 million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.

 

To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program.

 

We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The Company’s financial statements as of December 31, 2024, reflect a receivables balance of $2.53 million. Of that balance, $2.19 million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $1.87 million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $1.87 million. Furthermore, the Company may be caused under generally accepted accounting principles, to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $1.87 million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.

 

Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.

 

Prior to his termination, Mr. Cammarata and the Company engaged in certain transactions as described below:

 

We issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $1,550,000 (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $0.02 per share, Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA has only provided advances of $1,200,000 to date. The note bears interest at the rate of 0.11% per annum therefore we recognized $990 worth of interest expense on the loan during the nine months ended September 30, 2024. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

XML 40 R21.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 11 – SEGMENT REPORTING

 

The company has three reportable segments, Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products. The reportable segments are identified based on the types of products that generate revenue.

 

The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.

 

For the years ended December 2024 and 2023, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.

 

The Financial Education and Technology segment generates revenue through membership fees. The Blockchain Technology and Crypto Mining segment generates revenue primarily through its Bitcoin mining operation. The Manufacturing and Development of Health, Beauty and Wellness Products generates revenue primarily through the sale of health and wellness products manufactured to wholesale and retail customers.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2024.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $47,061,290   $5,186,606   $134,075   $52,381,971 
                     
Less:                    
Commissions   25,913,260    -    -    25,913,260 
Market experts   1,065,350    -    -    1,065,350 
Credit card processing   1,949,087    -    -    1,949,087 
Salary and related   2,051,064    980,302    251,632    3,282,998 
Selling and marketing   565,437    1,803    1,000    568,240 
Energy and hosting   -    4,924,717    -    4,924,717 
Depreciation   1,565    3,871,740    -    3,873,305 
Impairment expense   -    1,771,891    -    1,771,891 
Cost of sales   -    -    56,521    56,521 
Loss (gain) on disposal of assets   -    180,223    -    180,223 
General and administrative [2]   1,491,652    391,040    116,221    1,998,913 
                     
Segment net income (loss) from operations  $14,023,875   $(6,935,110)  $(291,299)  $6,797,466 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2023.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $56,549,336   $11,371,535   $67,920,871 
                
Less:               
Commissions   31,498,098    -    31,498,098 
Market experts   1,239,347    -    1,239,347 
Credit card processing   2,390,922    -    2,390,922 
Salary and related   2,132,340    1,178,908    3,311,248 
Selling and marketing   549,776    1,174    550,950 
Energy and hosting   -    9,475,908    9,475,908 
Depreciation   2,606    4,446,940    4,449,546 
Loss (gain) on disposal of assets   1,096    201,512    202,608 
General and administrative [1]   845,457    844,664    1,690,121 
                
Segment income (loss) from operations  $17,889,694   $(4,777,571)  $13,112,123 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.

 

The following table illustrates the reconciliation of segment operating income to net income before taxes for the years ended December 31, 2024 and 2023.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   December 31,
2024
   December 31,
2023
 
Segment income from operations  $6,797,466   $13,112,123 
           
Reconciling items          
Bank interest   64,376    56,258 
Event ticket sales   350,635    288,454 
Leasing income   391,985    446,667 
Gain on winddown of operations [1]   -    56,422 
All other, net   3,684    (11,500)
           
Net income before taxes  $7,608,146   $13,948,314 

 

[1] Represents a gain on the winddown of SAFETek’s North American operations.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITION

NOTE 12 – ACQUISITION

 

On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

 

The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

 

      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
 Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2]This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

 

Renu Laboratories LLC recorded revenue of $110,671 and net loss of $291,227 since the October 11, 2024 acquisition date, which were included in our consolidated statement of operations for the year ended December 31, 2024.

 

The table below represents the pro forma revenue and net income (loss) for the years ended December 31, 2023 and 2024, assuming the acquisition had occurred on January 1, 2023, pursuant to ASC Subtopic 805-10-50. This pro forma information does not purport to represent what the actual results of our operations would have been had the acquisition occurred on this date nor does it purport to predict the results of operations for future periods.

 

   December 31, 2024   December 31, 2023 
Revenue  $1,327,940   $1,534,369 
Net (loss)  $(325,257)  $(43,736)
Loss per common share  $(0.00)  $(0.00)

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

XML 42 R23.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 13 – INCOME TAXES

 

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company used an effective tax rate of 21% when calculating the deferred tax assets and liabilities and income tax provision below.

 

The Company’s income (loss) before income taxes were broken down as follows:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Domestic  $2,085,356   $5,010,332 
Foreign   -    - 
Total Income (loss) before income taxes  $2,085,356   $5,010,332 

 

The Company’s tax provision (benefit) as of December 31, 2024 and 2023 is summarized as follows:

 

   December 31, 2024   December 31, 2023 
Current          
Federal  $903,347   $2,138,412 
State   (8,407)   40,000 
Foreign   -    - 
Total current income tax expense   894,940    2,178,412 
           
Total income tax expense  $894,940   $2,178,412 

 

Net deferred tax assets consist of the following components as of December 31, 2024 and 2023:

 

   December 31, 2024   December 31, 2023 
Deferred tax assets          
NOL carryover  $2,417,161   $2,982,071 
Amortization   1,850,667    1,771,645 
Other accruals   1,988,821    1,800,662 
Depreciation   862,384    562,982 
Investment in partnership   10,985,183    10,964,704 
Deferred tax liabilities   -    - 
Valuation allowance   (18,104,216)   (18,082,064)
Net deferred tax liability  $-   $- 

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the year ended December 31, 2024 and 2023, due to the following:

 

  

Year ended

December 31, 2024

  

Year ended

December 31, 2023

 
Income taxes at statutory rate  $437,925   $1,052,169 
State taxes – net of federal benefit   (6,641)   31,600 
Valuation allowance   581,800    1,809,765 
Foreign derived intangible income   (420,033)   (781,561)
Interest   260,511    260,317 
Other   41,378    (193,878)
Total income tax provision (benefit)  $894,940   $2,178,412 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

At December 31, 2024 and December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $2.4 million (tax effected) and $3.0 million (tax effected), portions of which will begin to expire in 2025. Utilization of some of the federal and state net operating losses carryforwards are subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.

 

The Company will recognize penalties and interest accrued related to unrecognized tax benefits as a component of income taxes. As of December 31, 2024, the Company had $18,764 of accrued interest and penalties related to state income tax uncertain tax positions, in which $4,144 has been recognized in the Company’s statements of operations in the current year.

 

The Company is required to file income tax returns in various States. The Company is subject to income tax examinations by federal and state taxing authorities. The taxable years that are open under federal and state statute of limitations are 2020 through 2024. Due to net operating loss carryforwards that remain unutilized, such loss carryforwards remain subject to review until utilized.

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

  

Year ended

 December 31, 2024

  

Year ended

December 31, 2023

 
Balance at the beginning of the year   -    - 
Increases related to positions taken in prior years   26,768      - 
Balance at the end of the year  $26,768   $- 

 

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.

 

On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”), approved by the disinterested members of the Company’s Board of Directors. Pursuant to the Amendment, DBR has been given until August 31,2025 to lend to the Company a minimum of $2.0 million, and until December 31, 2026 to lend to the Company the balance of up to $5.7 million. The Amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million.

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. As of the date of this filing, 705,890 shares have been repurchased for $16,618. These shares are being held by the Company in Treasury.

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Accounting

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Operating Segments

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.

 

Financial Statement Reclassification

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $250,000. As of December 31, 2024 and 2023, cash balances that exceeded FDIC limits were $10,837,830 and $3,778,085, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents and Restricted Cash

Cash Equivalents and Restricted Cash

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2024 and 2023, we had no cash equivalents.

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.

 

   December 31,   December 31, 
   2024   2023 
Cash and cash equivalents  $22,467,710   $20,912,276 
Restricted cash, current   -    230,354 
Total cash, cash equivalents, and restricted cash shown on the statement of cash flows  $22,467,710   $21,142,630 

 

Amount included in restricted cash represent funds required to be held in an escrow account by a contractual agreement and will be used for paying dividends to our Series B Preferred Stockholders and funds required to be held in an account as collateral for business charges on our Company credit card.

 

Receivables

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   December 31,   December 31, 
   2024   2023 
Due from merchant processors  $318,921   $1,732,456 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,219,342 
Due from payout service providers   296,558    3,251 
Accounts and other receivables   47,213    - 
 Receivable, gross   2,534,727    2,955,049 
Allowance for doubtful accounts   -    (722,324)
Receivables  $2,534,727   $2,232,725 

 

[1]We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”

 

Fixed Assets

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

   Estimated        
   Useful        
   Life  December 31,   December 31, 
   (years)  2024   2023 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   28,571    11,308 
Data processing equipment  3   11,824,560    14,084,670 
Manufacturing equipment  3-25   1,161,701    - 
       13,015,549    14,096,695 
Accumulated depreciation      (11,147,108)   (7,559,872)
Net book value     $1,868,441   $6,536,823 

 

Total depreciation expense for the years ended December 31, 2024 and 2023, was $3,875,614 and $4,450,466, respectively, all of which was recorded in our general and administrative expenses on our statement of operations. During the year ended December 31, 2024, we disposed of assets with a net book value of $180,223. During the year ended December 31, 2023, we sold assets with a total net book value of $26,731 for cash of $23,278 and bitcoin worth $9,913, therefore recognized a gain on disposal of assets of $6,460. This gain was offset by loss on disposal of assets with a net book value of $55,255.

 

Long-Lived Assets – Cryptocurrencies & Intangible Assets

Long-Lived Assets – Cryptocurrencies & Intangible Assets

 

We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $1,127,891 and $585,632, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($5,186,606 and $11,348,156 for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $452,450 and $255,268, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $2,056,386. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $0 due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.

 

During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $1,771,891. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, no impairment was recorded.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

-quoted prices for similar assets or liabilities in active markets;
-quoted prices for identical or similar assets or liabilities in markets that are not active;
-inputs other than quoted prices that are observable for the asset or liability; and
-inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable, and accounts payable. We have determined that the book value of our outstanding financial instruments as of December 31, 2024 and 2023, approximates the fair value due to their short-term nature.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $5,732   $5,732 
Total Liabilities  $-   $-   $5,732   $5,732 

 

Revenue Recognition

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $1,905,734 and $2,703,398, respectively.

 

Mining Revenue

 

We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $1,014,164.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cryptocurrency Revenue

 

During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.

 

During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.

 

During 2024, we generated no revenue from the sale of cryptocurrency packages.

 

Mining Equipment Repair Revenue

 

Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.

 

Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2024, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $50,086,839   $5,186,606   $110,856   $23,404   $55,407,705 
Refunds, incentives, credits, and chargebacks   (3,025,549)   -    (185)   -    (3,025,734)
Net revenue  $47,061,290   $5,186,606   $110,671   $23,404   $52,381,971 

 

Foreign revenues for the year ended December 31, 2024 were approximately $42.9 million while domestic revenue for the year ended December 31, 2024 was approximately $9.5 million.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2023, was as follows:

 

   Membership
Revenue
   Cryptocurrency Revenue   Mining Revenue   Miner Repair Revenue   Total 
Gross billings/receipts  $60,516,836   $990,785   $11,348,156   $23,378   $72,879,155 
Refunds, incentives, credits, and chargebacks   (4,480,784)   -    -    -    (4,480,784)
Amounts paid to supplier   -    (477,500)   -    -    (477,500)
Net revenue  $56,036,052   $513,285   $11,348,156   $23,378   $67,920,871 

 

Foreign revenues for the year ended December 31, 2023 were approximately $51.0 million while domestic revenue for the year ended December 31, 2023 was approximately $16.9 million.

 

Advertising, Selling, and Marketing Costs

Advertising, Selling, and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the year ended December 31, 2024 and 2023, totaled $569,491 and $560,065, respectively.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Cost of Sales and Service

Cost of Sales and Service

 

Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the year ended December 31, 2024 and 2023, totaled $6,056,491 and $10,736,709, respectively.

 

Inventory

Inventory

 

As of December 31, 2024, inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Due to the discontinuation of our miner repair business during the quarter ended June 30, 2023, all related inventory was sold. During the year ended December 31, 2023, we recognized a loss on disposal of assets of $174,835.

 

As of December 31, 2024 and 2023 the net realizable value of our inventory was $495,865 and $0, respectively.

 

Income Taxes

Income Taxes

 

We have adopted ASC Subtopic 740-10, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Net Income (Loss) per Share

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.

 

   December 31,
2024
   December 31,
2023
 
Net income  $1,190,416    2,831,920 
Less: preferred dividends   (819,340)   (819,340)
Add: interest expense on convertible debt   900,516    900,516 
Net income available to common shareholders (numerator)  $1,271,592    2,913,096 
           
Basic weighted average number of common shares outstanding   1,908,219,120    2,559,093,504 
Dilutive impact of convertible notes   471,428,571    471,428,571 
Dilutive impact of non-voting membership interest   565,000,000    565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   2,944,647,691    3,595,522,075 
           
Diluted income per common share  $0.00    0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

   December 31,
2024
   December 31,
2023
 
Options to purchase common stock   359,698,857    360,416,665 
Warrants to purchase common stock   1,178,090    1,178,129 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Lease Obligation

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

XML 45 R26.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.

 

   December 31,   December 31, 
   2024   2023 
Cash and cash equivalents  $22,467,710   $20,912,276 
Restricted cash, current   -    230,354 
Total cash, cash equivalents, and restricted cash shown on the statement of cash flows  $22,467,710   $21,142,630 
SCHEDULE OF RECEIVABLES

Receivables were made up of the following as of each balance sheet date:

 

 SCHEDULE OF RECEIVABLES

   December 31,   December 31, 
   2024   2023 
Due from merchant processors  $318,921   $1,732,456 
Held in reserve by merchant processors for future returns and chargebacks [1]   1,872,035    1,219,342 
Due from payout service providers   296,558    3,251 
Accounts and other receivables   47,213    - 
 Receivable, gross   2,534,727    2,955,049 
Allowance for doubtful accounts   -    (722,324)
Receivables  $2,534,727   $2,232,725 

 

[1]We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”
SCHEDULE OF FIXED ASSETS

Fixed assets were made up of the following at each balance sheet date:

 

   Estimated        
   Useful        
   Life  December 31,   December 31, 
   (years)  2024   2023 
Furniture, fixtures, and equipment  10  $717   $717 
Computer equipment  3   28,571    11,308 
Data processing equipment  3   11,824,560    14,084,670 
Manufacturing equipment  3-25   1,161,701    - 
       13,015,549    14,096,695 
Accumulated depreciation      (11,147,108)   (7,559,872)
Net book value     $1,868,441   $6,536,823 
SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $758   $758 
Total Liabilities  $-   $-   $758   $758 

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:

 

   Level 1   Level 2   Level 3   Total 
Total Assets  $-   $-   $-   $- 
                     
Derivative liability  $-   $-   $5,732   $5,732 
Total Liabilities  $-   $-   $5,732   $5,732 
SCHEDULE OF REVENUE GENERATED

Revenue generated for the year ended December 31, 2024, was as follows:

 

   Membership
revenue
   Mining revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $50,086,839   $5,186,606   $110,856   $23,404   $55,407,705 
Refunds, incentives, credits, and chargebacks   (3,025,549)   -    (185)   -    (3,025,734)
Net revenue  $47,061,290   $5,186,606   $110,671   $23,404   $52,381,971 

 

Foreign revenues for the year ended December 31, 2024 were approximately $42.9 million while domestic revenue for the year ended December 31, 2024 was approximately $9.5 million.

 

Revenue generated for the year ended December 31, 2024

 

Revenue generated for the year ended December 31, 2023, was as follows:

 

   Membership
Revenue
   Cryptocurrency Revenue   Mining Revenue   Miner Repair Revenue   Total 
Gross billings/receipts  $60,516,836   $990,785   $11,348,156   $23,378   $72,879,155 
Refunds, incentives, credits, and chargebacks   (4,480,784)   -    -    -    (4,480,784)
Amounts paid to supplier   -    (477,500)   -    -    (477,500)
Net revenue  $56,036,052   $513,285   $11,348,156   $23,378   $67,920,871 
SCHEDULE OF DILUTED EARNINGS PER SHARE

The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.

 

   December 31,
2024
   December 31,
2023
 
Net income  $1,190,416    2,831,920 
Less: preferred dividends   (819,340)   (819,340)
Add: interest expense on convertible debt   900,516    900,516 
Net income available to common shareholders (numerator)  $1,271,592    2,913,096 
           
Basic weighted average number of common shares outstanding   1,908,219,120    2,559,093,504 
Dilutive impact of convertible notes   471,428,571    471,428,571 
Dilutive impact of non-voting membership interest   565,000,000    565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   2,944,647,691    3,595,522,075 
           
Diluted income per common share  $0.00    0.00 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.

 

   December 31,
2024
   December 31,
2023
 
Options to purchase common stock   359,698,857    360,416,665 
Warrants to purchase common stock   1,178,090    1,178,129 
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY PAYABLES

Our related party debt consisted of the following:

 

   December 31,   December 31, 
   2024   2023 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $692,004 as of December 31, 2024 [1]  $607,996   $477,711 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $375,700 as of December 31, 2024 [2]   324,304    253,566 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $731,254 as of December 31, 2024 [3]   568,742    431,072 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,204,567    1,203,247 
Total related-party debt   2,705,608    2,365,596 
Less: Current portion   (1,204,567)   (1,203,247)
Related-party debt, long term  $1,501,041   $1,162,349 

 

[1]On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $130,285 of the debt discount into interest expense, as well as expensed an additional $260,016 of interest expense on the note, all of which was repaid during the period.
  
[2]On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the year ended December 31, 2024, we recognized $70,738 of the debt discount into interest expense as well as expensed an additional $140,000 of interest expense on the note, all of which was repaid during the period.
  
[3]On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $137,670 of the debt discount into interest expense as well as expensed an additional $500,500 of interest expense on the note, all of which was repaid during the period.
  
[4]On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $1,320 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.25.1
DEBT (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
SCHEDULE OF DEBT

Our debt consisted of the following:

 

   December 31,
2024
   December 31,
2023
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $519,863   $530,306 
Long term notes for APEX lease buyback [2]   -    685,883 
Total debt   519,863    1,216,189 
Less: Current portion   29,244    715,127 
Debt, long term portion  $490,619   $501,062 

 

[1]In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $18,801 and $18,750 worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $29,244 and $31,681.
  
[2]In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until December 31, 2024, when the last monthly payment will be made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $411,842 and issuances of cryptocurrency then valued at $274,041. As of December 31, 2024, the debt was paid in full.
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVE LIABILITY (Tables)
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF DERIVATIVE LIABILITY

During the year ended December 31, 2024 and 2023, we had the following activity in our derivative liability account:

 

   Total 
Derivative liability at December 31, 2022  $24,426 
Derivative extinguished with warrant exercise (see NOTE 9)   (3)
Change in fair value   (18,691)
Derivative liability at December 31, 2023   5,732 
Change in fair value   (4,974)
Derivative liability at December 31, 2024  $758 
SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL

We use the binomial option pricing model to estimate fair value for those instruments, at inception, at warrant exercise, and at each reporting date. During the years ended December 31, 2024 and 2023, the assumptions used in our binomial option pricing model were in the following range:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Risk free interest rate   4.16 - 4.25%   4.01 - 4.23%
Expected life in years   0.58 - 1.50    1.58 - 2.50 
Expected volatility   122% - 142%   116% - 122%
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASES (Tables)
12 Months Ended
Dec. 31, 2024
Operating Leases  
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES

Future minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:

 

      
2025  $171,148 
2026   61,057 
Total   232,205 
Less: Interest   (20,065)
Present value of lease liability   212,140 
Operating lease liability, current [1]   (165,707)
Operating lease liability, long term  $46,433 

 

[1] Represents lease payments to be made in the next 12 months.
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
SCHEDULE OF OPTIONS ACTIVITY

Transactions involving our options are summarized as follows:

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2023   360,416,665   $0.05   $0.03 
Granted   16,000,000   $0.05   $0.01 
Canceled/Expired   (25,000,000)  $0.05   $0.03 
Exercised   -   $-   $- 
Options outstanding at December 31, 2024   351,416,665   $0.05   $0.03 
SCHEDULE OF OPTIONS OUTSTANDING

Details of our options outstanding as of December 31, 2024, is as follows:

 

Options Exercisable   Weighted Average
Exercise Price of Options
Exercisable
   Weighted Average
Contractual Life of Options
Exercisable (Years)
   Weighted Average
Contractual Life of Options
Outstanding (Years)
 
 183,291,665    0.05    4.48    4.62 
SCHEDULE OF WARRANTS ISSUED

Transactions involving our warrants are summarized as follows:

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2022   1,178,320   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   (230)  $0.10 
Warrants outstanding at December 31, 2023   1,178,090   $0.10 
Granted   -   $- 
Canceled/Expired   -   $- 
Exercised   -   $- 
Warrants outstanding at December 31, 2024   1,178,090   $0.10 
SCHEDULE OF WARRANTS OUTSTANDING

Details of our warrants outstanding as of December 31, 2024 is as follows:

 

Warrants Exercisable   Weighted Average Contractual Life (Years) 
 1,178,090    1.14 
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2024.

 

SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Manufacturing and Development of Health, Beauty and Wellness Products [1]   Total 
Revenue  $47,061,290   $5,186,606   $134,075   $52,381,971 
                     
Less:                    
Commissions   25,913,260    -    -    25,913,260 
Market experts   1,065,350    -    -    1,065,350 
Credit card processing   1,949,087    -    -    1,949,087 
Salary and related   2,051,064    980,302    251,632    3,282,998 
Selling and marketing   565,437    1,803    1,000    568,240 
Energy and hosting   -    4,924,717    -    4,924,717 
Depreciation   1,565    3,871,740    -    3,873,305 
Impairment expense   -    1,771,891    -    1,771,891 
Cost of sales   -    -    56,521    56,521 
Loss (gain) on disposal of assets   -    180,223    -    180,223 
General and administrative [2]   1,491,652    391,040    116,221    1,998,913 
                     
Segment net income (loss) from operations  $14,023,875   $(6,935,110)  $(291,299)  $6,797,466 

 

[1] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
   
[2] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.

 

 

INVESTVIEW, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2023.

 

   Financial Education and Technology   Blockchain Technology and Crypto Mining Products and Services   Total 
Revenue  $56,549,336   $11,371,535   $67,920,871 
                
Less:               
Commissions   31,498,098    -    31,498,098 
Market experts   1,239,347    -    1,239,347 
Credit card processing   2,390,922    -    2,390,922 
Salary and related   2,132,340    1,178,908    3,311,248 
Selling and marketing   549,776    1,174    550,950 
Energy and hosting   -    9,475,908    9,475,908 
Depreciation   2,606    4,446,940    4,449,546 
Loss (gain) on disposal of assets   1,096    201,512    202,608 
General and administrative [1]   845,457    844,664    1,690,121 
                
Segment income (loss) from operations  $17,889,694   $(4,777,571)  $13,112,123 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.
SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES

The following table illustrates the reconciliation of segment operating income to net income before taxes for the years ended December 31, 2024 and 2023.

 

SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

   December 31,
2024
   December 31,
2023
 
Segment income from operations  $6,797,466   $13,112,123 
           
Reconciling items          
Bank interest   64,376    56,258 
Event ticket sales   350,635    288,454 
Leasing income   391,985    446,667 
Gain on winddown of operations [1]   -    56,422 
All other, net   3,684    (11,500)
           
Net income before taxes  $7,608,146   $13,948,314 

 

[1] Represents a gain on the winddown of SAFETek’s North American operations.
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION (Tables)
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION

 

      
Cash  $1,495 
Customer deposits – intercompany   7,360 
Domain names [1]   40,310 
Raw materials   149,260 
Manufacturing equipment   717,020 
Total assets acquired  $915,445 
      
Accounts payable  $323 
Customer deposits   572,386 
Total liabilities assumed  $572,709 
      
Net assets acquired   342,736 
      
Consideration [2]  $1,207,614 
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823 
 Total   1,216,437 
      
Goodwill  $873,701 

 

[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
   
[2]This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.
SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS

 

   December 31, 2024   December 31, 2023 
Revenue  $1,327,940   $1,534,369 
Net (loss)  $(325,257)  $(43,736)
Loss per common share  $(0.00)  $(0.00)
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME BEFORE INCOME TAXES

The Company’s income (loss) before income taxes were broken down as follows:

 

  

Year Ended

December 31, 2024

  

Year Ended

December 31, 2023

 
Domestic  $2,085,356   $5,010,332 
Foreign   -    - 
Total Income (loss) before income taxes  $2,085,356   $5,010,332 
SCHEDULE OF TAX PROVISION BENEFIT

The Company’s tax provision (benefit) as of December 31, 2024 and 2023 is summarized as follows:

 

   December 31, 2024   December 31, 2023 
Current          
Federal  $903,347   $2,138,412 
State   (8,407)   40,000 
Foreign   -    - 
Total current income tax expense   894,940    2,178,412 
           
Total income tax expense  $894,940   $2,178,412 
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Net deferred tax assets consist of the following components as of December 31, 2024 and 2023:

 

   December 31, 2024   December 31, 2023 
Deferred tax assets          
NOL carryover  $2,417,161   $2,982,071 
Amortization   1,850,667    1,771,645 
Other accruals   1,988,821    1,800,662 
Depreciation   862,384    562,982 
Investment in partnership   10,985,183    10,964,704 
Deferred tax liabilities   -    - 
Valuation allowance   (18,104,216)   (18,082,064)
Net deferred tax liability  $-   $- 
SCHEDULE OF INCOME FROM CONTINUING OPERATIONS

 

  

Year ended

December 31, 2024

  

Year ended

December 31, 2023

 
Income taxes at statutory rate  $437,925   $1,052,169 
State taxes – net of federal benefit   (6,641)   31,600 
Valuation allowance   581,800    1,809,765 
Foreign derived intangible income   (420,033)   (781,561)
Interest   260,511    260,317 
Other   41,378    (193,878)
Total income tax provision (benefit)  $894,940   $2,178,412 
SCHEDULE OF UNRECOGNIZED TAX BENEFITS

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

  

Year ended

 December 31, 2024

  

Year ended

December 31, 2023

 
Balance at the beginning of the year   -    - 
Increases related to positions taken in prior years   26,768      - 
Balance at the end of the year  $26,768   $- 
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
12 Months Ended
Jun. 06, 2017
Apr. 01, 2017
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Entity incorporation, date of incorporation     Jan. 30, 1946
Contribution Agreement [Member] | Wealth Generators LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Percentage of shares contributed   100.00%  
Number of shares exchanged for common stock   1,358,670,942  
Acquisition Agreement [Member] | Market Trend Strategies LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Value pre-merger liabilities $ 419,139    
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
Cash and cash equivalents $ 22,467,710 $ 20,912,276
Restricted cash, current 230,354
Total cash, cash equivalents, and restricted cash shown on the statement of cash flows $ 22,467,710 $ 21,142,630
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECEIVABLES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
Due from merchant processors $ 318,921 $ 1,732,456
Held in reserve by merchant processors for future returns and chargebacks [1] 1,872,035 1,219,342
Due from payout service providers 296,558 3,251
Accounts and other receivables 47,213
 Receivable, gross 2,534,727 2,955,049
Allowance for doubtful accounts (722,324)
Receivables $ 2,534,727 $ 2,232,725
[1] We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECEIVABLES (Details) (Parenthetical)
$ in Thousands
Dec. 31, 2024
USD ($)
Accounting Policies [Abstract]  
Credit card receivables $ 1,870
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FIXED ASSETS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 13,015,549 $ 14,096,695
Accumulated depreciation (11,147,108) (7,559,872)
Net book value $ 1,868,441 6,536,823
Furniture, Fixtures and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 10 years  
Property, plant and equipment, gross $ 717 717
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Property, plant and equipment, gross $ 28,571 11,308
Data Processing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Property, plant and equipment, gross $ 11,824,560 14,084,670
Manufacturing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 1,161,701
Manufacturing Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 3 years  
Manufacturing Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of fixed assets 25 years  
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - Fair Value, Recurring [Member] - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Platform Operator, Crypto Asset [Line Items]    
Total Assets
Derivative liability 758 5,732
Total Liabilities 758 5,732
Fair Value, Inputs, Level 1 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Total Assets
Derivative liability
Total Liabilities
Fair Value, Inputs, Level 2 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Total Assets
Derivative liability
Total Liabilities
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto Asset [Line Items]    
Total Assets
Derivative liability 758 5,732
Total Liabilities $ 758 $ 5,732
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF REVENUE GENERATED (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]    
Gross billings/receipts $ 55,407,705 $ 72,879,155
Refunds, incentives, credits, and chargebacks (3,025,734) (4,480,784)
Amounts paid to supplier   (477,500)
Net revenue 52,381,971 67,920,871
Membership Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 50,086,839 60,516,836
Refunds, incentives, credits, and chargebacks (3,025,549) (4,480,784)
Amounts paid to supplier  
Net revenue 47,061,290 56,036,052
Mining Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 5,186,606 11,348,156
Refunds, incentives, credits, and chargebacks
Amounts paid to supplier  
Net revenue 5,186,606 11,348,156
Health and Wellness Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts 110,856  
Refunds, incentives, credits, and chargebacks (185)  
Net revenue 110,671
Other [Member]    
Product Information [Line Items]    
Gross billings/receipts 23,404  
Refunds, incentives, credits, and chargebacks  
Net revenue 23,404
Cryptocurrency Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts   990,785
Refunds, incentives, credits, and chargebacks  
Amounts paid to supplier   (477,500)
Net revenue 513,285
Miner Repair Revenue [Member]    
Product Information [Line Items]    
Gross billings/receipts   23,378
Refunds, incentives, credits, and chargebacks  
Amounts paid to supplier  
Net revenue   $ 23,378
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
Net income $ 1,190,416 $ 2,831,920
Less: preferred dividends (819,340) (819,340)
Add: interest expense on convertible debt 900,516 900,516
Net income available to common shareholders (numerator) $ 1,271,592 $ 2,913,096
Basic weighted average number of common shares outstanding 1,908,219,120 2,559,093,504
Dilutive impact of convertible notes 471,428,571 471,428,571
Dilutive impact of non-voting membership interest 565,000,000 565,000,000
Diluted weighted average number of common shares outstanding (denominator) 2,944,647,691 3,595,522,075
Diluted income per common share $ 0.00 $ 0.00
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) - shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 359,698,857 360,416,665
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 1,178,090 1,178,129
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]    
Cash, FDIC insured amount $ 250,000  
Cash balances exceeded FDIC limits 10,837,830 $ 3,778,085
Cash equivalents 0 0
Depreciation expense 3,875,614 4,450,466
Gain loss on disposal of assets 180,223 6,460
Net book value   26,731
Cash received from the disposal of fixed assets 23,278
Bitcoin received from sale of fixed assets 9,913
Loss on disposal of assets (180,223) (223,630)
Cryptocurrencies 1,127,891 585,632
Revenues 52,381,971 67,920,871
Realized gains (losses) on cryptocurrency 452,450 255,268
Asset impairment charges 1,771,891 2,056,386
Crypto Impairment expense   0
Asset impairment charges 1,771,891 0
Deferred revenues 1,905,734 2,703,398
deposits collected from customers for orders to be filled at future date 1,014,164  
Advertising, selling, and marketing expenses 569,491 560,065
Cost of sales and service 6,056,491 10,736,709
Loss on disposal on assets   174,835
Inventory, entirely finished goods 495,865
Mining Revenue [Member]    
Product Information [Line Items]    
Revenues 5,186,606 11,348,156
Cryptocurrency Revenue [Member]    
Product Information [Line Items]    
Revenues 513,285
Foreign Revenue [Member]    
Product Information [Line Items]    
Revenues 42,900,000 51,000,000.0
Domestic Revenue [Member]    
Product Information [Line Items]    
Revenues $ 9,500,000 16,900,000
Bitcoin [Member]    
Product Information [Line Items]    
Bitcoin received from sale of fixed assets   9,913
Loss on disposal of assets   $ 55,255
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.25.1
LIQUIDITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Net cash provided by operating activities $ 8,302,341 $ 6,065,257  
Cash paid for purchase 1,144,426  
Cash paid for fixed assets 461,945 2,561,001  
Repayments for debt 1,300,000    
Payments for shares repurchased from related parties 3,371,763 396,547  
Dividends paid 659,020 627,856  
Net increase (decrease) in cash, cash equivalents, and restricted cash 1,325,080 (346,268)  
Cash, cash equivalents, and restricted cash $ 22,467,710 $ 21,142,630 $ 21,488,898
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RELATED PARTY PAYABLES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Related Party [Member]    
Related Party Transaction [Line Items]    
Total related-party debt $ 2,705,608 $ 2,365,596
Less: Current portion (1,204,567) (1,203,247)
Related-party debt, long term 1,501,041 1,162,349
Convertible Promissory Note [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [1] 607,996 477,711
Convertible Promissory Note One [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [2] 324,304 253,566
Convertible Promissory Note Two [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [3] 568,742 431,072
Convertible Promissory Note Three [Member]    
Related Party Transaction [Line Items]    
Total related-party debt [4] $ 1,204,567 $ 1,203,247
[1] On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $130,285 of the debt discount into interest expense, as well as expensed an additional $260,016 of interest expense on the note, all of which was repaid during the period.
[2] On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the year ended December 31, 2024, we recognized $70,738 of the debt discount into interest expense as well as expensed an additional $140,000 of interest expense on the note, all of which was repaid during the period.
[3] On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $137,670 of the debt discount into interest expense as well as expensed an additional $500,500 of interest expense on the note, all of which was repaid during the period.
[4] On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $1,320 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) - USD ($)
9 Months Ended 12 Months Ended
Mar. 22, 2021
Nov. 09, 2020
May 27, 2020
Apr. 27, 2020
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]              
Debt discount into interest expense           $ 338,691 $ 337,767
Convertible Promissory Note [Member]              
Related Party Transaction [Line Items]              
Debt Instrument, Unamortized Discount           692,004  
Convertible Promissory Note [Member] | Chairman [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt       $ 1,300,000      
Debt interest rate       20.00%      
Debt instrument maturity date       Apr. 27, 2030      
Debt conversion price per share   $ 0.007   $ 0.01257      
Beneficial conversion feature and debt discount       $ 1,300,000      
Debt discount into interest expense           130,285  
Interest expenses           260,016  
Convertible Promissory Note One [Member]              
Related Party Transaction [Line Items]              
Debt Instrument, Unamortized Discount           375,700  
Convertible Promissory Note One [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt     $ 700,000        
Debt interest rate     20.00%        
Debt instrument maturity date     Apr. 27, 2030        
Debt conversion price per share   $ 0.007 $ 0.01257        
Beneficial conversion feature and debt discount     $ 700,000        
Debt discount into interest expense           70,738  
Interest expenses           140,000  
Convertible Promissory Note Two [Member]              
Related Party Transaction [Line Items]              
Debt Instrument, Unamortized Discount           731,254  
Interest expenses           500,500  
Convertible Promissory Note Two [Member] | DBR Capital LLC [Member]              
Related Party Transaction [Line Items]              
Received proceeds from related party debt   $ 1,300,000          
Debt interest rate   38.50%          
Debt instrument maturity date   Apr. 27, 2030          
Debt conversion price per share   $ 0.007          
Beneficial conversion feature and debt discount   $ 1,300,000          
Debt discount into interest expense           137,670  
Debt interest rate   25.00%          
Facility fee percentage   13.50%          
Convertible Promissory Note Three [Member] | Securities Purchase Agreements [Member] | SSA Technologies LLC [Member]              
Related Party Transaction [Line Items]              
Acquired percentage 100.00%            
Convertible Promissory Note Three [Member] | SSA Technologies LLC [Member] | Securities Purchase Agreements [Member]              
Related Party Transaction [Line Items]              
Debt interest rate 0.11%            
Debt instrument face amount $ 1,200,000            
Interest expense         $ 990 $ 1,320 $ 1,320
Debt instrument conversion feature 12,000,000            
Convertible Promissory Note Three [Member] | SSA Technologies LLC [Member] | Securities Purchase Agreements [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Debt instrument face amount $ 1,500,000            
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.25.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Feb. 07, 2024
Sep. 29, 2023
Apr. 27, 2020
Dec. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]          
Accounts payable and accrued liabilities       $ 7,139,684 $ 5,854,093
Consideration paid for purchased shares       3,371,763 396,547
Purchase price         2,575,496
Common Stock [Member]          
Related Party Transaction [Line Items]          
Purchase price        
Stock Purchase And Release Agreement [Member]          
Related Party Transaction [Line Items]          
Accounts payable and accrued liabilities       $ 1,189,643  
Stock Purchase And Release Agreement [Member] | Common Stock [Member]          
Related Party Transaction [Line Items]          
Number of shares repurchased       472,374,710  
DBR Capital LLC [Member] | Securities Purchase Agreements [Member]          
Related Party Transaction [Line Items]          
Related party transaction amounts of advance     $ 11,000,000    
Mario Romano and Annette Raynor [Member] | Stock Purchase And Release Agreement [Member]          
Related Party Transaction [Line Items]          
Number of shares repurchased   302,919,223     302,919,223
Shares purchased value   $ 2,922,380      
Share price   $ 0.00964739      
Shares purchased value       $ 1,189,643  
Legal fees   $ 250,000      
Consideration paid for purchased shares   2,922,380      
Consideration paid for purchased shares and expenses   $ 3,172,380      
Ryan Smith And Chand Miller [Member] | Stock Purchase And Release Agreement [Member]          
Related Party Transaction [Line Items]          
Accounts payable and accrued liabilities       1,785,572  
Ryan Smith And Chand Miller [Member] | Stock Purchase And Release Agreement [Member] | Common Stock [Member]          
Related Party Transaction [Line Items]          
Shares purchased value       $ 1,785,573  
Consideration paid for purchased shares and expenses $ 3,571,146        
Shares cancelled 472,374,710        
Purchase price $ 3,571,146        
Purchase price per share $ 0.007559985        
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Nonrelated Party [Member]    
Short-Term Debt [Line Items]    
Total debt $ 519,863 $ 1,216,189
Current portion 29,244 715,127
Debt, long term portion 490,619 501,062
US Small Business Administration [Member]    
Short-Term Debt [Line Items]    
Total debt [1] 519,863 530,306
APEX Tex LLC [Member]    
Short-Term Debt [Line Items]    
Total debt [2] $ 685,883
[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $18,801 and $18,750 worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $29,244 and $31,681.
[2] In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until December 31, 2024, when the last monthly payment will be made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $411,842 and issuances of cryptocurrency then valued at $274,041. As of December 31, 2024, the debt was paid in full.
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEBT (Details) (Parenthetical) - USD ($)
1 Months Ended 12 Months Ended
Apr. 30, 2020
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2021
Nov. 30, 2020
Short-Term Debt [Line Items]          
Common stock shares issued   1,859,231,786 2,333,356,496    
Preferred stock shares issued   252,192 252,192    
Repayments of debt   $ 441,086 $ 1,948,906    
APEX Tex LLC [Member]          
Short-Term Debt [Line Items]          
Repayments of debt   411,842      
Issuances of cryptocurrency value   274,041      
APEX Tex LLC [Member]          
Short-Term Debt [Line Items]          
Debt instrument interest percentage       75.00%  
Other liabilities         $ 19,089,500
Common stock shares issued       48,000,000  
Preferred stock shares issued       49,418  
Debt instrument, maturity date       Dec. 31, 2024  
Payment percentage       25.00%  
US Small Business Administration [Member]          
Short-Term Debt [Line Items]          
Proceeds from debt $ 500,000        
Debt instrument interest percentage 3.75%        
Monthly installment payments $ 2,437        
Debt Instrument, interest   18,801 18,750    
Repayments on the loan   $ 29,244 $ 31,681    
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DERIVATIVE LIABILITY (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Derivative liability $ 5,732 $ 24,426
Derivative extinguished with warrant exercise   (3)
Change in fair value (4,974) (18,691)
Derivative liability $ 758 $ 5,732
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) - Warrant [Member]
Dec. 31, 2024
Dec. 31, 2023
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 4.16 4.01
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 4.25 4.23
Measurement Input, Expected Term [Member] | Minimum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 0.58 1.58
Measurement Input, Expected Term [Member] | Maximum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 1.50 2.50
Measurement Input, Price Volatility [Member] | Minimum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 122 116
Measurement Input, Price Volatility [Member] | Maximum [Member]    
Derivative [Line Items]    
Derivative liability measurement input 142 122
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Operating Leases    
2025 $ 171,148  
2026 61,057  
Total 232,205  
Less: Interest (20,065)  
Present value of lease liability 212,140  
Operating lease liability, current (165,707) [1] $ (109,628)
Operating lease liability, long term $ 46,433 $ 6,048
[1] Represents lease payments to be made in the next 12 months.
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.25.1
OPERATING LEASES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Lessee, Lease, Description [Line Items]    
Operating lease right of use asset $ 211,996 $ 110,427
Lease term 1 year 5 months 23 days  
Operating lease liability $ 212,140  
Operating lease expense 130,710  
Operating lease cost $ 135,809  
Weighted average discount rate 12.00%  
Wyckoff Lease [Member]    
Lessee, Lease, Description [Line Items]    
Operating lease right of use asset $ 22,034  
Lease term 24 months 15 days  
Exchange for new operating lease liability $ 23,520  
Haverford Lease [Member]    
Lessee, Lease, Description [Line Items]    
Operating lease right of use asset 125,522  
Exchange for new operating lease liability 172,042  
Operating lease liability 152,961  
Warminster Lease [Member]    
Lessee, Lease, Description [Line Items]    
Operating lease right of use asset $ 108,327  
Lease term 14 months  
Ivyland Lease [Member]    
Lessee, Lease, Description [Line Items]    
Operating lease right of use asset $ 115,037  
Lease term 24 months  
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF OPTIONS ACTIVITY (Details)
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Equity [Abstract]  
Number of Options, Options outstanding, beginning | shares 360,416,665
Weighted Average Exercise Price, Options outstanding, beginning $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning $ 0.03
Number of Options, Granted | shares 16,000,000
Weighted Average Exercise Price, Granted $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Granted $ 0.01
Number of Options, Canceled/Expired | shares (25,000,000)
Weighted Average Exercise Price, Canceled/Expired $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Canceled/Expired $ 0.03
Number of Options, Exercised | shares
Weighted Average Exercise Price, Exercised
Number of Options, Options outstanding, ending | shares 351,416,665
Weighted Average Exercise Price, Options outstanding, ending $ 0.05
Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending $ 0.03
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF OPTIONS OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Equity [Abstract]  
Options Exercisable | shares 183,291,665
Weighted Average Exercise Price of Options Exercisable | $ / shares $ 0.05
Weighted Average Contractual Life of Options Exercisable (Years) 4 years 5 months 23 days
Weighted Average Contractual Life of Options Outstanding (Years) 4 years 7 months 13 days
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF WARRANTS ISSUED (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Equity [Abstract]    
Number of Warrants Outstanding, Beginning 1,178,090 1,178,320
Weighted Average Exercise Price Outstanding, Beginning $ 0.10 $ 0.10
Number of Warrants Granted
Weighted Average Exercise Price Granted
Number of Warrants Canceled/Expired
Weighted Average Exercise Price Canceled
Number of Warrants Exercised (230)
Weighted Average Exercise Price Exercised $ 0.10
Number of Warrants Outstanding, Ending 1,178,090 1,178,090
Weighted Average Exercise Price Outstanding, Ending $ 0.10 $ 0.10
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF WARRANTS OUTSTANDING (Details)
Dec. 31, 2024
shares
Equity [Abstract]  
Warrants Exercisable 1,178,090
Weighted Average Contractual Life (Years) 1 year 1 month 20 days
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
12 Months Ended
Sep. 29, 2023
Sep. 03, 2021
Aug. 17, 2021
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2021
Class of Stock [Line Items]            
Preferred stock, shares authorized       50,000,000 50,000,000  
Preferred stock, par value       $ 0.001 $ 0.001  
Preferred stock, shares issued       252,192 252,192  
Preferred stock, shares outstanding       252,192 252,192  
Payments to preferred stock dividend cash       $ 659,020    
Dividend liability       245,101 $ 256,392  
Consideration payable for purchased shares and expenses       3,571,146 2,775,833  
Share based compensation expenses       10,002 2,775,833  
Proceeds from warrant exercised         23  
Derivative liability extinguished with warrant exercise         3  
Stock-based compensation based on grant       $ 1,600,534 $ 2,575,496  
Common stock, shares issued       1,859,231,786 2,333,356,496  
Common stock, shares outstanding       1,859,231,786 2,333,356,496  
Number of options to purchase shares of common stock       1,000,000    
Number of options to purchase shares of common stock, stock options       10,000,000    
Number of options to purchase shares of common stock       16,000,000    
Vest over period       5 years    
Exercise price increase       $ 0.05 $ 0.05  
Number of options, canceled       15,000,000    
Number of options, vested       10,000,000    
Stock compensation expense       $ 1,610,536 $ 2,555,155  
Unrecognized compensation cost       $ 3,300,000    
Weighted average vesting period       1 year 2 months 12 days    
Investview Financial Group Holding LLC [Member]            
Class of Stock [Line Items]            
Converted market value   $ 58,900,000        
Closing market price per share   $ 0.1532        
Transaction cost   $ 86,600,000        
Fair value discounted percentage   32.00%        
Business acquisition, transaction costs discount value   $ 27,700,000        
Number of exchange shares issuable   565,000,000        
Restricted Stock [Member]            
Class of Stock [Line Items]            
Number of options to purchase shares of common stock       600,000,000    
Stock Purchase And Release Agreement [Member]            
Class of Stock [Line Items]            
Consideration payable for purchased shares and expenses       $ 3,124,755    
Stock Purchase And Release Agreement [Member] | Mario Romano and Annette Raynor [Member]            
Class of Stock [Line Items]            
Number of shares repurchased 302,919,223       302,919,223  
Consideration paid for purchased shares and expenses $ 3,172,380          
Common Stock [Member]            
Class of Stock [Line Items]            
Number of common stock shares cancelled       1,750,000    
Value of common stock shares decreased       $ 1,750    
Warrant Exercise, shares       230 230  
Proceeds from warrant exercised          
Derivative liability extinguished with warrant exercise          
Common Stock [Member] | Stock Purchase And Release Agreement [Member]            
Class of Stock [Line Items]            
Number of shares repurchased       472,374,710    
Exchange for cash       $ 446,391    
Additional Paid-in Capital [Member]            
Class of Stock [Line Items]            
Proceeds from warrant exercised         23  
Derivative liability extinguished with warrant exercise         3  
Unit Offering [Member]            
Class of Stock [Line Items]            
Number of shares issued in transaction     252,192     2,000,000
Sale of stock, price per share           $ 25
Description of offering           (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 7).
Mario Romano and Annette Raynor [Member] | Stock Purchase And Release Agreement [Member]            
Class of Stock [Line Items]            
Consideration paid for purchased shares and expenses         396,547  
Stock-based compensation based on grant         20,341  
Officer [Member]            
Class of Stock [Line Items]            
Number of options to purchase shares of common stock       5,000,000    
Series B Preferred Stock [Member]            
Class of Stock [Line Items]            
Preferred stock, par value       $ 3.25    
Cumulative dividends annual rate percentage       13.00%    
Dividends, cash       $ 819,340 819,340  
Payments to preferred stock dividend cash         627,856  
Series B Preferred Stock [Member] | Board Of Directors [Member]            
Class of Stock [Line Items]            
Preferred stock, par value       $ 25    
Preferred stock designated       2,000,000    
Cryptocurrency [Member]            
Class of Stock [Line Items]            
Payments to preferred stock dividend crypto       $ 171,611 $ 171,722  
Class B Units [Member] | David B Rothrock And James R Bell [Member] | Investview Financial Group Holding LLC [Member]            
Class of Stock [Line Items]            
Common unit, outstanding       565,000,000 565,000,000  
Common stock, voting rights       The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement.    
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jan. 17, 2025
Dec. 31, 2024
Aug. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Sep. 21, 2021
Mar. 30, 2021
Escrow deposit   $ 375,000   $ 375,000      
Repayment of debt       441,086 $ 1,948,906    
Distribution of digital currencies prior to termination     $ 16,600,000        
Receivable balances   2,530,000   2,530,000      
Receivable balance arise out of credit card transaction   2,534,727   2,534,727 $ 2,232,725    
Credit card receivables   1,870,000   $ 1,870,000      
Joseph Cammarata [Member]              
Debt instrument, principal amount             $ 1,550,000
Debt conversion price per share           $ 0.008 $ 0.02
Common stock, terms of conversion       As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.      
iGenius, LLC [Member]              
Receivable balance arise out of credit card transaction   2,190,000   $ 2,190,000      
Promissory Note [Member]              
Repayment of debt   $ 19,000,000          
Debt premium percentage   25.00%          
Repayment of debt   $ 19,000,000          
Subsequent Event [Member]              
Litigation Settlement, Fee Expense $ 375,000            
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Total revenue, net $ 52,381,971 $ 67,920,871
Commissions 25,913,260 31,716,399
Salary and related 6,626,588 7,112,954
Selling and marketing 569,491 560,065
Depreciation 3,875,614 4,450,466
Impairment expense 1,771,891 2,056,386
Loss (gain) on disposal of assets (180,223) (223,630)
General and administrative 8,022,020 9,531,431
Net income (loss) from operations 1,694,719 4,604,930
Reportable Subsegments [Member]    
Segment Reporting Information [Line Items]    
Total revenue, net 52,381,971 67,920,871
Commissions 25,913,260 31,498,098
Market experts 1,065,350 1,239,347
Credit card processing 1,949,087 2,390,922
Salary and related 3,282,998 3,311,248
Selling and marketing 568,240 550,950
Energy and hosting 4,924,717 9,475,908
Depreciation 3,873,305 4,449,546
Impairment expense 1,771,891  
Cost of sales 56,521  
Loss (gain) on disposal of assets 180,223 202,608
General and administrative 1,998,913 [1] 1,690,121 [2]
Net income (loss) from operations 6,797,466 13,112,123
Reportable Subsegments [Member] | Financial Education and Technology [Member]    
Segment Reporting Information [Line Items]    
Total revenue, net 47,061,290 56,549,336
Commissions 25,913,260 31,498,098
Market experts 1,065,350 1,239,347
Credit card processing 1,949,087 2,390,922
Salary and related 2,051,064 2,132,340
Selling and marketing 565,437 549,776
Energy and hosting
Depreciation 1,565 2,606
Impairment expense  
Cost of sales  
Loss (gain) on disposal of assets 1,096
General and administrative 1,491,652 [1] 845,457 [2]
Net income (loss) from operations 14,023,875 17,889,694
Reportable Subsegments [Member] | Blockchain Technology and Crypto Mining Products and Services [Member]    
Segment Reporting Information [Line Items]    
Total revenue, net 5,186,606 11,371,535
Commissions
Market experts
Credit card processing
Salary and related 980,302 1,178,908
Selling and marketing 1,803 1,174
Energy and hosting 4,924,717 9,475,908
Depreciation 3,871,740 4,446,940
Impairment expense 1,771,891  
Cost of sales  
Loss (gain) on disposal of assets 180,223 201,512
General and administrative 391,040 [1] 844,664 [2]
Net income (loss) from operations (6,935,110) $ (4,777,571)
Reportable Subsegments [Member] | Manufacturing and Development of Health Beauty and Wellness Products [Member]    
Segment Reporting Information [Line Items]    
Total revenue, net [3] 134,075  
Commissions [3]  
Market experts [3]  
Credit card processing [3]  
Salary and related [3] 251,632  
Selling and marketing [3] 1,000  
Energy and hosting [3]  
Depreciation [3]  
Impairment expense [3]  
Cost of sales [3] 56,521  
Loss (gain) on disposal of assets [3]  
General and administrative [1],[3] 116,221  
Net income (loss) from operations [3] $ (291,299)  
[1] General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.
[2] General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.
[3] The Development of Health, Beauty and Wellness Products business was acquired in October 2024.
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Income (loss) before income taxes $ 2,085,356 $ 5,010,332
Reportable Subsegments [Member]    
Segment Reporting Information [Line Items]    
Segment income from operations 6,797,466 13,112,123
Bank interest 64,376 56,258
Event ticket sales 350,635 288,454
Leasing income 391,985 446,667
Gain on winddown of operations [1] 56,422
All other, net 3,684 (11,500)
Income (loss) before income taxes $ 7,608,146 $ 13,948,314
[1] Represents a gain on the winddown of SAFETek’s North American operations.
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Details Narrative)
12 Months Ended
Dec. 31, 2024
Segments
Segment Reporting [Abstract]  
Number of reportable segments 3
Description of Products and Services Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products
Factors used to identify entity's reportable segments The reportable segments are identified based on the types of products that generate revenue.
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) - USD ($)
Dec. 31, 2024
Oct. 11, 2024
Dec. 31, 2023
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]      
Cash   $ 1,495  
Customer deposits – intercompany   7,360  
Domain names [1]   40,310  
Raw materials   149,260  
Manufacturing equipment   717,020  
Total assets acquired   915,445  
Accounts payable   323  
Customer deposits   572,386  
Total liabilities assumed   572,709  
Net assets acquired   342,736  
Consideration [2]   1,207,614  
Fair value of noncontrolling interest in ELRT Technologies, LLC   8,823  
 Total   1,216,437  
Goodwill $ 873,701 $ 873,701
[1] Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.
[2] This amount is equal to the $1,780,000
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)
Oct. 11, 2024
USD ($)
Customer deposits $ (572,386)
Renu Laboratories, Inc [Member]  
Payments to Acquire Businesses, Gross 1,780,000
Customer deposits $ 572,386
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]    
Revenue $ 1,327,940 $ 1,534,369
Net (loss) $ (325,257) $ (43,736)
Loss per common share - Basic $ (0.00) $ (0.00)
Loss per common share - Diluted $ (0.00) $ (0.00)
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITION (Details Narrative) - USD ($)
12 Months Ended
Oct. 11, 2024
Dec. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]      
Net loss   $ 1,191,169 $ 2,831,920
Renu Laboratories, Inc [Member]      
Business Acquisition [Line Items]      
Purchase price $ 1,780,000    
Revenue   110,671  
Net loss   $ 291,227  
Goldman's Pharmaceuticals LLC [Member]      
Business Acquisition [Line Items]      
Ownership interest, percentage 100.00%    
ELRT Technologies, LLC [Member]      
Business Acquisition [Line Items]      
Ownership interest, percentage 50.00%    
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INCOME BEFORE INCOME TAXES (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Domestic $ 2,085,356 $ 5,010,332
Foreign
Income (loss) before income taxes $ 2,085,356 $ 5,010,332
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF TAX PROVISION BENEFIT (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Federal $ 903,347 $ 2,138,412
State (8,407) 40,000
Foreign
Total current income tax expense 894,940 2,178,412
Total income tax expense $ 894,940 $ 2,178,412
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
NOL carryover $ 2,417,161 $ 2,982,071
Amortization 1,850,667 1,771,645
Other accruals 1,988,821 1,800,662
Depreciation (862,384) (562,982)
Investment in partnership 10,985,183 10,964,704
Deferred tax liabilities
Valuation allowance (18,104,216) (18,082,064)
Net deferred tax liability
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Income taxes at statutory rate $ 437,925 $ 1,052,169
State taxes – net of federal benefit (6,641) 31,600
Valuation allowance 581,800 1,809,765
Foreign derived intangible income (420,033) (781,561)
Interest 260,511 260,317
Other 41,378 (193,878)
Total income tax provision (benefit) $ 894,940 $ 2,178,412
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Balance at the beginning of the year
Increases related to positions taken in prior years 26,768
Balance at the end of the year $ 26,768
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Effective tax rate 21.00%  
Net operating loss carryforwards $ 2,400,000 $ 3,000,000.0
Income tax accrued interest and penalties 18,764  
Unrecognized tax benefits $ 4,144  
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.25.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
Mar. 06, 2025
Feb. 28, 2025
Dec. 31, 2024
Dec. 31, 2023
Subsequent Event [Line Items]        
Common stock, par value     $ 0.001 $ 0.001
Subsequent Event [Member] | Share Repurchase Program [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.001      
Subsequent Event [Member] | Share Repurchase Program [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Number of shares repurchased 705,890      
Number of shares repurchased, value $ 16,618      
Subsequent Event [Member] | Maximum [Member] | Share Repurchase Program [Member]        
Subsequent Event [Line Items]        
Repurchase of common stock, value $ 1,000,000      
Securities Purchase Agreements [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Debt instrument interest rate   38.50%    
Debt instrument, reduced interest rate   10.00%    
Securities Purchase Agreements [Member] | Subsequent Event [Member] | DBR Capital [Member]        
Subsequent Event [Line Items]        
Debt amount   $ 2,000,000    
Debt instrument interest rate   38.50%    
Debt instrument, reduced interest rate   18.75%    
Securities Purchase Agreements [Member] | Subsequent Event [Member] | Minimum [Member]        
Subsequent Event [Line Items]        
Debt amount   $ 2,000,000.0    
Securities Purchase Agreements [Member] | Subsequent Event [Member] | Maximum [Member]        
Subsequent Event [Line Items]        
Debt amount   5,700,000    
Securities Purchase Agreement [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Debt amount   $ 2,000,000    
EXCEL 94 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 95 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 96 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 98 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 210 440 1 true 88 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://investview.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://investview.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://investview.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Other Comprehensive Income (Loss) Sheet http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss Consolidated Statements of Operations and Other Comprehensive Income (Loss) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://investview.com/role/StatementsOfStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://investview.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 9 false false R10.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 10 false false R11.htm 999014 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS Sheet http://investview.com/role/OrganizationAndNatureOfBusiness ORGANIZATION AND NATURE OF BUSINESS Notes 11 false false R12.htm 999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://investview.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 12 false false R13.htm 999016 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS Sheet http://investview.com/role/RecentAccountingPronouncements RECENT ACCOUNTING PRONOUNCEMENTS Notes 13 false false R14.htm 999017 - Disclosure - LIQUIDITY Sheet http://investview.com/role/Liquidity LIQUIDITY Notes 14 false false R15.htm 999018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://investview.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 999019 - Disclosure - DEBT Sheet http://investview.com/role/Debt DEBT Notes 16 false false R17.htm 999020 - Disclosure - DERIVATIVE LIABILITY Sheet http://investview.com/role/DerivativeLiability DERIVATIVE LIABILITY Notes 17 false false R18.htm 999021 - Disclosure - OPERATING LEASES Sheet http://investview.com/role/OperatingLeases OPERATING LEASES Notes 18 false false R19.htm 999022 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://investview.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 19 false false R20.htm 999023 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://investview.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 999024 - Disclosure - SEGMENT REPORTING Sheet http://investview.com/role/SegmentReporting SEGMENT REPORTING Notes 21 false false R22.htm 999025 - Disclosure - ACQUISITION Sheet http://investview.com/role/Acquisition ACQUISITION Notes 22 false false R23.htm 999026 - Disclosure - INCOME TAXES Sheet http://investview.com/role/IncomeTaxes INCOME TAXES Notes 23 false false R24.htm 999027 - Disclosure - SUBSEQUENT EVENTS Sheet http://investview.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://investview.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 999030 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://investview.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://investview.com/role/RelatedPartyTransactions 27 false false R28.htm 999031 - Disclosure - DEBT (Tables) Sheet http://investview.com/role/DebtTables DEBT (Tables) Tables http://investview.com/role/Debt 28 false false R29.htm 999032 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://investview.com/role/DerivativeLiabilityTables DERIVATIVE LIABILITY (Tables) Tables http://investview.com/role/DerivativeLiability 29 false false R30.htm 999033 - Disclosure - OPERATING LEASES (Tables) Sheet http://investview.com/role/OperatingLeasesTables OPERATING LEASES (Tables) Tables http://investview.com/role/OperatingLeases 30 false false R31.htm 999034 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://investview.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://investview.com/role/StockholdersEquity 31 false false R32.htm 999035 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://investview.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://investview.com/role/SegmentReporting 32 false false R33.htm 999036 - Disclosure - ACQUISITION (Tables) Sheet http://investview.com/role/AcquisitionTables ACQUISITION (Tables) Tables http://investview.com/role/Acquisition 33 false false R34.htm 999037 - Disclosure - INCOME TAXES (Tables) Sheet http://investview.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://investview.com/role/IncomeTaxes 34 false false R35.htm 999038 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Sheet http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Details http://investview.com/role/OrganizationAndNatureOfBusiness 35 false false R36.htm 999039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) Sheet http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) Details 36 false false R37.htm 999040 - Disclosure - SCHEDULE OF RECEIVABLES (Details) Sheet http://investview.com/role/ScheduleOfReceivablesDetails SCHEDULE OF RECEIVABLES (Details) Details 37 false false R38.htm 999041 - Disclosure - SCHEDULE OF RECEIVABLES (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfReceivablesDetailsParenthetical SCHEDULE OF RECEIVABLES (Details) (Parenthetical) Details 38 false false R39.htm 999042 - Disclosure - SCHEDULE OF FIXED ASSETS (Details) Sheet http://investview.com/role/ScheduleOfFixedAssetsDetails SCHEDULE OF FIXED ASSETS (Details) Details 39 false false R40.htm 999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Sheet http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Details 40 false false R41.htm 999044 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details) Sheet http://investview.com/role/ScheduleOfRevenueGeneratedDetails SCHEDULE OF REVENUE GENERATED (Details) Details 41 false false R42.htm 999045 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) Sheet http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails SCHEDULE OF DILUTED EARNINGS PER SHARE (Details) Details 42 false false R43.htm 999046 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Sheet http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Details 43 false false R44.htm 999047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables 44 false false R45.htm 999048 - Disclosure - LIQUIDITY (Details Narrative) Sheet http://investview.com/role/LiquidityDetailsNarrative LIQUIDITY (Details Narrative) Details http://investview.com/role/Liquidity 45 false false R46.htm 999049 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) Sheet http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails SCHEDULE OF RELATED PARTY PAYABLES (Details) Details 46 false false R47.htm 999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical) Details 47 false false R48.htm 999051 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://investview.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://investview.com/role/RelatedPartyTransactionsTables 48 false false R49.htm 999052 - Disclosure - SCHEDULE OF DEBT (Details) Sheet http://investview.com/role/ScheduleOfDebtDetails SCHEDULE OF DEBT (Details) Details 49 false false R50.htm 999053 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfDebtDetailsParenthetical SCHEDULE OF DEBT (Details) (Parenthetical) Details 50 false false R51.htm 999054 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details) Sheet http://investview.com/role/ScheduleOfDerivativeLiabilityDetails SCHEDULE OF DERIVATIVE LIABILITY (Details) Details 51 false false R52.htm 999055 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) Sheet http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details) Details 52 false false R53.htm 999056 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Sheet http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details) Details 53 false false R54.htm 999057 - Disclosure - OPERATING LEASES (Details Narrative) Sheet http://investview.com/role/OperatingLeasesDetailsNarrative OPERATING LEASES (Details Narrative) Details http://investview.com/role/OperatingLeasesTables 54 false false R55.htm 999058 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details) Sheet http://investview.com/role/ScheduleOfOptionsActivityDetails SCHEDULE OF OPTIONS ACTIVITY (Details) Details 55 false false R56.htm 999059 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details) Sheet http://investview.com/role/ScheduleOfOptionsOutstandingDetails SCHEDULE OF OPTIONS OUTSTANDING (Details) Details 56 false false R57.htm 999060 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details) Sheet http://investview.com/role/ScheduleOfWarrantsIssuedDetails SCHEDULE OF WARRANTS ISSUED (Details) Details 57 false false R58.htm 999061 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) Sheet http://investview.com/role/ScheduleOfWarrantsOutstandingDetails SCHEDULE OF WARRANTS OUTSTANDING (Details) Details 58 false false R59.htm 999062 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://investview.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://investview.com/role/StockholdersEquityTables 59 false false R60.htm 999063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://investview.com/role/CommitmentsAndContingencies 60 false false R61.htm 999064 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) Sheet http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details) Details 61 false false R62.htm 999065 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) Sheet http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details) Details 62 false false R63.htm 999066 - Disclosure - SEGMENT REPORTING (Details Narrative) Sheet http://investview.com/role/SegmentReportingDetailsNarrative SEGMENT REPORTING (Details Narrative) Details http://investview.com/role/SegmentReportingTables 63 false false R64.htm 999067 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) Sheet http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) Details 64 false false R65.htm 999068 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) Sheet http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) Details 65 false false R66.htm 999069 - Disclosure - SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details) Sheet http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details) Details 66 false false R67.htm 999070 - Disclosure - ACQUISITION (Details Narrative) Sheet http://investview.com/role/AcquisitionDetailsNarrative ACQUISITION (Details Narrative) Details http://investview.com/role/AcquisitionTables 67 false false R68.htm 999071 - Disclosure - SCHEDULE OF INCOME BEFORE INCOME TAXES (Details) Sheet http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails SCHEDULE OF INCOME BEFORE INCOME TAXES (Details) Details 68 false false R69.htm 999072 - Disclosure - SCHEDULE OF TAX PROVISION BENEFIT (Details) Sheet http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails SCHEDULE OF TAX PROVISION BENEFIT (Details) Details 69 false false R70.htm 999073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 70 false false R71.htm 999074 - Disclosure - SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details) Sheet http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details) Details 71 false false R72.htm 999075 - Disclosure - SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details) Sheet http://investview.com/role/ScheduleOfUnrecognizedTaxBenefitsDetails SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details) Details 72 false false R73.htm 999076 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://investview.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://investview.com/role/IncomeTaxesTables 73 false false R74.htm 999077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://investview.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://investview.com/role/SubsequentEvents 74 false false All Reports Book All Reports form10-k.htm invu-20241231.xsd invu-20241231_cal.xml invu-20241231_def.xml invu-20241231_lab.xml invu-20241231_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/cyd/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 101 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "INVU", "nsuri": "http://investview.com/20241231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "invu-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "invu-20241231_cal.xml" ] }, "definitionLink": { "local": [ "invu-20241231_def.xml" ] }, "labelLink": { "local": [ "invu-20241231_lab.xml" ] }, "presentationLink": { "local": [ "invu-20241231_pre.xml" ] } }, "keyStandard": 375, "keyCustom": 65, "axisStandard": 27, "axisCustom": 0, "memberStandard": 25, "memberCustom": 53, "hidden": { "total": 165, "http://fasb.org/us-gaap/2024": 121, "http://investview.com/20241231": 41, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 210, "entityCount": 1, "segmentCount": 88, "elementCount": 754, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 915, "http://xbrl.sec.gov/dei/2024": 38, "http://xbrl.sec.gov/cyd/2024": 8, "http://xbrl.sec.gov/ecd/2024": 5 }, "report": { "R1": { "role": "http://investview.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://investview.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://investview.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R4": { "role": "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "longName": "00000004 - Statement - Consolidated Statements of Operations and Other Comprehensive Income (Loss)", "shortName": "Consolidated Statements of Operations and Other Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ProfessionalFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)", "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://investview.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "INVU:GainLossonLeaseCostNetofRepayment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-10-012024-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-10-012024-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc", "longName": "995447 - Disclosure - Insider Trading Policies and Procedures", "shortName": "Insider Trading Policies and Procedures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://investview.com/role/OrganizationAndNatureOfBusiness", "longName": "999014 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS", "shortName": "ORGANIZATION AND NATURE OF BUSINESS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPolicies", "longName": "999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://investview.com/role/RecentAccountingPronouncements", "longName": "999016 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS", "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://investview.com/role/Liquidity", "longName": "999017 - Disclosure - LIQUIDITY", "shortName": "LIQUIDITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://investview.com/role/RelatedPartyTransactions", "longName": "999018 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://investview.com/role/Debt", "longName": "999019 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://investview.com/role/DerivativeLiability", "longName": "999020 - Disclosure - DERIVATIVE LIABILITY", "shortName": "DERIVATIVE LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://investview.com/role/OperatingLeases", "longName": "999021 - Disclosure - OPERATING LEASES", "shortName": "OPERATING LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://investview.com/role/StockholdersEquity", "longName": "999022 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://investview.com/role/CommitmentsAndContingencies", "longName": "999023 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://investview.com/role/SegmentReporting", "longName": "999024 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://investview.com/role/Acquisition", "longName": "999025 - Disclosure - ACQUISITION", "shortName": "ACQUISITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://investview.com/role/IncomeTaxes", "longName": "999026 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://investview.com/role/SubsequentEvents", "longName": "999027 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://investview.com/role/RelatedPartyTransactionsTables", "longName": "999030 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://investview.com/role/DebtTables", "longName": "999031 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://investview.com/role/DerivativeLiabilityTables", "longName": "999032 - Disclosure - DERIVATIVE LIABILITY (Tables)", "shortName": "DERIVATIVE LIABILITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://investview.com/role/OperatingLeasesTables", "longName": "999033 - Disclosure - OPERATING LEASES (Tables)", "shortName": "OPERATING LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://investview.com/role/StockholdersEquityTables", "longName": "999034 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://investview.com/role/SegmentReportingTables", "longName": "999035 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://investview.com/role/AcquisitionTables", "longName": "999036 - Disclosure - ACQUISITION (Tables)", "shortName": "ACQUISITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://investview.com/role/IncomeTaxesTables", "longName": "999037 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "longName": "999038 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "shortName": "ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails", "longName": "999039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R37": { "role": "http://investview.com/role/ScheduleOfReceivablesDetails", "longName": "999040 - Disclosure - SCHEDULE OF RECEIVABLES (Details)", "shortName": "SCHEDULE OF RECEIVABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "INVU:DueFromMerchantProcessors", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "INVU:DueFromMerchantProcessors", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://investview.com/role/ScheduleOfReceivablesDetailsParenthetical", "longName": "999041 - Disclosure - SCHEDULE OF RECEIVABLES (Details) (Parenthetical)", "shortName": "SCHEDULE OF RECEIVABLES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CreditCardReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R39": { "role": "http://investview.com/role/ScheduleOfFixedAssetsDetails", "longName": "999042 - Disclosure - SCHEDULE OF FIXED ASSETS (Details)", "shortName": "SCHEDULE OF FIXED ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R40": { "role": "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "longName": "999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "shortName": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:DerivativeLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:DerivativeLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R41": { "role": "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "longName": "999044 - Disclosure - SCHEDULE OF REVENUE GENERATED (Details)", "shortName": "SCHEDULE OF REVENUE GENERATED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "INVU:GrossBillingsreceipts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "INVU:GrossBillingsreceipts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "longName": "999045 - Disclosure - SCHEDULE OF DILUTED EARNINGS PER SHARE (Details)", "shortName": "SCHEDULE OF DILUTED EARNINGS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DividendsPreferredStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R43": { "role": "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "longName": "999046 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "shortName": "SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R44": { "role": "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "999047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R45": { "role": "http://investview.com/role/LiquidityDetailsNarrative", "longName": "999048 - Disclosure - LIQUIDITY (Details Narrative)", "shortName": "LIQUIDITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RepaymentsOfLongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R46": { "role": "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "longName": "999049 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details)", "shortName": "SCHEDULE OF RELATED PARTY PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_RelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_RelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R47": { "role": "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "longName": "999050 - Disclosure - SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical)", "shortName": "SCHEDULE OF RELATED PARTY PAYABLES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_custom_ConvertiblePromissoryNoteMember36441703", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R48": { "role": "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "999051 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_custom_StockPurchaseAndReleaseAgreementMember", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R49": { "role": "http://investview.com/role/ScheduleOfDebtDetails", "longName": "999052 - Disclosure - SCHEDULE OF DEBT (Details)", "shortName": "SCHEDULE OF DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_NonrelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_NonrelatedPartyMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R50": { "role": "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "longName": "999053 - Disclosure - SCHEDULE OF DEBT (Details) (Parenthetical)", "shortName": " SCHEDULE OF DEBT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_APEXTexLLCMember", "name": "us-gaap:RepaymentsOfDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R51": { "role": "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails", "longName": "999054 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details)", "shortName": "SCHEDULE OF DERIVATIVE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DerivativeLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:DerivativeLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R52": { "role": "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "longName": "999055 - Disclosure - SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details)", "shortName": "SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R53": { "role": "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails", "longName": "999056 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R54": { "role": "http://investview.com/role/OperatingLeasesDetailsNarrative", "longName": "999057 - Disclosure - OPERATING LEASES (Details Narrative)", "shortName": "OPERATING LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R55": { "role": "http://investview.com/role/ScheduleOfOptionsActivityDetails", "longName": "999058 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details)", "shortName": "SCHEDULE OF OPTIONS ACTIVITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R56": { "role": "http://investview.com/role/ScheduleOfOptionsOutstandingDetails", "longName": "999059 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details)", "shortName": "SCHEDULE OF OPTIONS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R57": { "role": "http://investview.com/role/ScheduleOfWarrantsIssuedDetails", "longName": "999060 - Disclosure - SCHEDULE OF WARRANTS ISSUED (Details)", "shortName": "SCHEDULE OF WARRANTS ISSUED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R58": { "role": "http://investview.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "999061 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "INVU:WarrantsExercisable", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "INVU:SummaryOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "INVU:WarrantsExercisable", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "INVU:SummaryOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://investview.com/role/StockholdersEquityDetailsNarrative", "longName": "999062 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:DividendsPreferredStockCash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R60": { "role": "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "999063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:EscrowDeposit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-08-012023-08-31", "name": "INVU:DistributionOfDigitalCurrenciesPriorToTermination", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R61": { "role": "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "longName": "999064 - Disclosure - SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details)", "shortName": "SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_ReportableSubsegmentsMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R62": { "role": "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "longName": "999065 - Disclosure - SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_us-gaap_ReportableSubsegmentsMember", "name": "us-gaap:GrossProfit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R63": { "role": "http://investview.com/role/SegmentReportingDetailsNarrative", "longName": "999066 - Disclosure - SEGMENT REPORTING (Details Narrative)", "shortName": "SEGMENT REPORTING (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segments", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segments", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R64": { "role": "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails", "longName": "999067 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2024-10-11", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-11", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R65": { "role": "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical", "longName": "999068 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)", "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2024-10-11", "name": "INVU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-11_custom_RenuLaboratoriesIncMember", "name": "INVU:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R66": { "role": "http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails", "longName": "999069 - Disclosure - SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details)", "shortName": "SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://investview.com/role/AcquisitionDetailsNarrative", "longName": "999070 - Disclosure - ACQUISITION (Details Narrative)", "shortName": "ACQUISITION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_custom_RenuLaboratoriesIncMember", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R68": { "role": "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails", "longName": "999071 - Disclosure - SCHEDULE OF INCOME BEFORE INCOME TAXES (Details)", "shortName": "SCHEDULE OF INCOME BEFORE INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R69": { "role": "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails", "longName": "999072 - Disclosure - SCHEDULE OF TAX PROVISION BENEFIT (Details)", "shortName": "SCHEDULE OF TAX PROVISION BENEFIT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R70": { "role": "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "999073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R71": { "role": "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails", "longName": "999074 - Disclosure - SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details)", "shortName": "SCHEDULE OF INCOME FROM CONTINUING OPERATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "INVU:ScheduleOfIncomeFromContinuingOperationsTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "INVU:ScheduleOfIncomeFromContinuingOperationsTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R72": { "role": "http://investview.com/role/ScheduleOfUnrecognizedTaxBenefitsDetails", "longName": "999075 - Disclosure - SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details)", "shortName": "SCHEDULE OF UNRECOGNIZED TAX BENEFITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R73": { "role": "http://investview.com/role/IncomeTaxesDetailsNarrative", "longName": "999076 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R74": { "role": "http://investview.com/role/SubsequentEventsDetailsNarrative", "longName": "999077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-06_us-gaap_SubsequentEventMember_custom_ShareRepurchaseProgramMember", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "INVU_APEXTexLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "APEXTexLLCMember", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "APEX Tex LLC [Member]", "documentation": "APEX Tex LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingChangesAndErrorCorrectionsAbstract", "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndOtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts and other receivables", "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r90", "r91" ] }, "us-gaap_AccountsReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableGross", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Receivable, gross", "label": "Accounts Receivable, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r204", "r325", "r326", "r1076" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Receivables", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r701", "r763", "r830", "r1075", "r1076" ] }, "INVU_AccruedLiabilitiesLongTerm": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "AccruedLiabilitiesLongTerm", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities, long term", "documentation": "Accrued liabilities long term." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFixedAssetsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r45", "r196", "r625" ] }, "INVU_AccumulatedNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "AccumulatedNoncontrollingInterest", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated noncontrolling interest", "documentation": "Accumulated noncontrolling interest." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income (loss)", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r22", "r23", "r107", "r205", "r620", "r647", "r650" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r5", "r13", "r23", "r531", "r534", "r579", "r643", "r644", "r965", "r966", "r967", "r983", "r984", "r985", "r986" ] }, "INVU_AcquisitionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "AcquisitionAgreementMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition Agreement [Member]", "documentation": "Acquisition Agreement [Member]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r899" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r102", "r821", "r1109" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r664", "r983", "r984", "r985", "r986", "r1046", "r1112" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r905" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r905" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r905" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r905" ] }, "INVU_AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative liability extinguished with warrant exercise", "documentation": "Adjustments to additional paid in capital derivative liability extinguished for warrants exercised." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant Exercise", "verboseLabel": "Proceeds from warrant exercised", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r15", "r47", "r139" ] }, "INVU_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares": { "xbrltype": "sharesItemType", "nsuri": "http://investview.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant Exercise, shares", "documentation": "Adjustments to additional paid in capital, warrant issued, shares." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising, Selling, and Marketing Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r169" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r866", "r877", "r891", "r917" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r869", "r880", "r894", "r920" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r905" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r912" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r870", "r881", "r895", "r912", "r921", "r925", "r933" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r206", "r330", "r337", "r338", "r339", "r1076" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "verboseLabel": "Debt discount into interest expense", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r8", "r114", "r404", "r1057" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r873" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive securities", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r284" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r33" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r33" ] }, "INVU_ApplicationOfDepositToPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "ApplicationOfDepositToPayables", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Application of deposit to payables", "documentation": "Application of deposit to payables." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment expense", "verboseLabel": "Asset impairment charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r8", "r43" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r151", "r164", "r199", "r232", "r288", "r296", "r313", "r316", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r523", "r527", "r553", "r613", "r706", "r787", "r788", "r821", "r838", "r1024", "r1025", "r1063" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r191", "r211", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r523", "r527", "r553", "r821", "r1024", "r1025", "r1063" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Total Assets", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r544", "r545", "r813" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r873" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r850", "r852", "r873" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r850", "r852", "r873" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r850", "r852", "r873" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r928" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r929" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r924" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r924" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r927" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r926" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r925" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r925" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "INVU_BitcoinMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "BitcoinMember", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bitcoin [Member]", "documentation": "Bitcoin [Member]" } } }, "auth_ref": [] }, "INVU_BlockchainTechnologyAndCryptoMiningProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "BlockchainTechnologyAndCryptoMiningProductsAndServicesMember", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Blockchain Technology and Crypto Mining Products and Services [Member]", "documentation": "Blockchain Technology and Crypto Mining Products and Services [Member]" } } }, "auth_ref": [] }, "INVU_BoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "BoardOfDirectorsMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board Of Directors [Member]", "documentation": "Board Of Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r347", "r348", "r349", "r350", "r351", "r516", "r805", "r806" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r62", "r64", "r347", "r348", "r349", "r350", "r351", "r516", "r805", "r806" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction cost", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "INVU_BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business acquisition, transaction costs discount value", "documentation": "Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares exchanged for common stock", "verboseLabel": "Number of exchange shares issuable", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r145" ] }, "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock", "presentation": [ "http://investview.com/role/Acquisition" ], "lang": { "en-us": { "role": { "label": "ACQUISITION", "documentation": "The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs." } } }, "auth_ref": [ "r144" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r516" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage of shares contributed", "verboseLabel": "Acquired percentage", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r63" ] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "presentation": [ "http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Loss per common share - Basic", "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r951", "r952" ] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "presentation": [ "http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Loss per common share - Diluted", "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r951", "r952" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://investview.com/role/AcquisitionTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r951", "r952" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Closing market price per share", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Net (loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r514", "r515" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfProformaRevenueAndNetIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r514", "r515" ] }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of noncontrolling interest in ELRT Technologies, LLC", "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date." } } }, "auth_ref": [ "r67" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value pre-merger liabilities", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r1", "r2", "r68", "r518" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r66" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r66" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r66" ] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Customer deposits", "label": "Customer deposits", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities customer deposits." } } }, "auth_ref": [] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Customer deposits \u2013 intercompany", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer deposits inter company." } } }, "auth_ref": [] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDomainNames": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDomainNames", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Domain names", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed domain names." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r66" ] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedManufacturingEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedManufacturingEquipment", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Manufacturing equipment", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed manufacturing equipment." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Net assets acquired", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r65", "r66" ] }, "INVU_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRawMaterials", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed raw materials." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree." } } }, "auth_ref": [ "r66" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Consideration", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r66" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Converted market value", "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages." } } }, "auth_ref": [ "r19" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash acquired in acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r24" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r27", "r194", "r772" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents and Restricted Cash", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r28", "r149" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash, cash equivalents, and restricted cash shown on the statement of cash flows", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r27", "r121", "r228" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash - beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash - end of period", "label": "Cash, cash equivalents, and restricted cash", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r27", "r121", "r228" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash", "label": "Net increase (decrease) in cash, cash equivalents, and restricted cash", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r121" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "INVU_CashPaidDuringThePeriodForAbstract": { "xbrltype": "stringItemType", "nsuri": "http://investview.com/20241231", "localname": "CashPaidDuringThePeriodForAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for:", "documentation": "Cash Paid During The Period For [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash balances exceeded FDIC limits", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "INVU_ChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ChairmanMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Chairman [Member]", "documentation": "Chairman [Member]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r903" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "INVU_ClassBUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ClassBUnitsMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class B Units [Member]", "documentation": "Class B Units [Member]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r187", "r201", "r202", "r203", "r232", "r262", "r265", "r281", "r283", "r290", "r291", "r332", "r373", "r375", "r376", "r377", "r380", "r381", "r409", "r410", "r413", "r416", "r423", "r553", "r654", "r655", "r656", "r657", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r693", "r715", "r737", "r757", "r758", "r759", "r760", "r761", "r950", "r976", "r987" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r201", "r202", "r203", "r290", "r409", "r410", "r411", "r413", "r416", "r421", "r423", "r654", "r655", "r656", "r657", "r800", "r950", "r976" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r904" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r904" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r521" ] }, "INVU_Commissions": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "Commissions", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Commissions", "documentation": "Commissions." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r96", "r157", "r616", "r692" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://investview.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r132", "r365", "r366", "r764", "r1015", "r1020" ] }, "INVU_CommonStockCanceled": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "CommonStockCanceled", "crdr": "debit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock canceled", "documentation": "Common stock canceled." } } }, "auth_ref": [] }, "INVU_CommonStockCancelled": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "CommonStockCancelled", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common stock cancelled", "documentation": "Common stock cancelled." } } }, "auth_ref": [] }, "INVU_CommonStockCancelledShares": { "xbrltype": "sharesItemType", "nsuri": "http://investview.com/20241231", "localname": "CommonStockCancelledShares", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock cancelled, shares", "documentation": "Common stock cancelled, shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockConversionFeatures": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockConversionFeatures", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, terms of conversion", "documentation": "Description of common stock conversion feature. Includes, but is not limited to, conversion price; conversion right; timing of right; terms, event or change in circumstance causing contingency to be met or adjustment to conversion price or number of shares; manner of settlement upon conversion; and method of settlement." } } }, "auth_ref": [ "r180", "r181", "r182", "r424" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r827", "r828", "r829", "r831", "r832", "r833", "r834", "r983", "r984", "r986", "r1046", "r1106", "r1112" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r101" ] }, "INVU_CommonStockRepurchasedForPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "CommonStockRepurchasedForPayables", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock repurchased for payables", "verboseLabel": "Consideration payable for purchased shares and expenses", "documentation": "Common stock repurchased for payables." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r101", "r693" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r101" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r15", "r101", "r693", "r712", "r1112", "r1113" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,859,231,786 and 2,333,356,496 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r101", "r619", "r821" ] }, "us-gaap_CommonStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockVotingRights", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, voting rights", "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r50" ] }, "us-gaap_CommonUnitOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonUnitOutstanding", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common unit, outstanding", "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC)." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r909" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r908" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r910" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r907" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComputerEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r85", "r172" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r237", "r523", "r524", "r527", "r528", "r590", "r766", "r1023", "r1026", "r1027" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [ "r237", "r523", "r524", "r527", "r528", "r590", "r766", "r1023", "r1026", "r1027" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r70", "r776" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r426", "r427", "r438" ] }, "INVU_ContributionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ContributionAgreementMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contribution Agreement [Member]", "documentation": "Contribution Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument conversion feature", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r30", "r31", "r32" ] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Debt, net of discounts, long term", "verboseLabel": "Related-party debt, long term", "terseLabel": "Debt, long term portion", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Total related-party debt", "verboseLabel": "Total debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r21", "r156", "r1072" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Debt, net of discounts, current", "negatedLabel": "Less: Current portion", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r91" ] }, "INVU_ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ConvertiblePromissoryNoteMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note [Member]", "documentation": "Convertible Promissory Note [Member]" } } }, "auth_ref": [] }, "INVU_ConvertiblePromissoryNoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ConvertiblePromissoryNoteOneMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note One [Member]", "documentation": "Convertible Promissory Note One [Member]" } } }, "auth_ref": [] }, "INVU_ConvertiblePromissoryNoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ConvertiblePromissoryNoteThreeMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note Three [Member]", "documentation": "Convertible Promissory Note Three [Member]" } } }, "auth_ref": [] }, "INVU_ConvertiblePromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ConvertiblePromissoryNoteTwoMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note Two [Member]", "documentation": "Convertible Promissory Note Two [Member]" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r110", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r553", "r787", "r1024" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Sales and Service", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r956" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "INVU_CreditCardProcessing": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "CreditCardProcessing", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Credit card processing", "documentation": "Credit card processing." } } }, "auth_ref": [] }, "us-gaap_CreditCardReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditCardReceivables", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfReceivablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Credit card receivables", "documentation": "Amounts receivable from issuing a card to individuals or businesses that allows someone to make a purchase on borrowed money." } } }, "auth_ref": [ "r963" ] }, "srt_CryptoAssetAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CryptoAssetAxis", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Crypto Asset [Axis]" } } }, "auth_ref": [ "r353", "r354", "r355", "r356", "r357", "r359", "r1003", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "srt_CryptoAssetDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CryptoAssetDomain", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r353", "r354", "r355", "r356", "r357", "r359", "r1003", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "us-gaap_CryptoAssetRealizedGainLossNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetRealizedGainLossNonoperating", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Realized gain (loss) on cryptocurrency", "negatedLabel": "Realized (gain) loss on cryptocurrency", "documentation": "Amount of realized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r1004" ] }, "us-gaap_CryptoAssetRealizedGainLossOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CryptoAssetRealizedGainLossOperating", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Realized gains (losses) on cryptocurrency", "documentation": "Amount of realized gain (loss) from remeasurement of crypto asset, classified as operating. Excludes crypto asset held for platform user." } } }, "auth_ref": [ "r1004" ] }, "INVU_CryptocurrencyMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "CryptocurrencyMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cryptocurrency [Member]", "documentation": "Cryptocurrency [Member]" } } }, "auth_ref": [] }, "INVU_CryptocurrencyReceivedFromSaleOfFixedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "CryptocurrencyReceivedFromSaleOfFixedAssets", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cryptocurrency received from sale of fixed assets", "verboseLabel": "Bitcoin received from sale of fixed assets", "documentation": "Cryptocurrency received from sale of fixed assets." } } }, "auth_ref": [] }, "INVU_CryptocurrencyRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "CryptocurrencyRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cryptocurrency Revenue [Member]", "documentation": "Cryptocurrency Revenue [Member]" } } }, "auth_ref": [] }, "INVU_CumulativeDividendsAnnualRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20241231", "localname": "CumulativeDividendsAnnualRatePercentage", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cumulative dividends annual rate percentage", "documentation": "Cumulative dividends annual rate percentage." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r954", "r979", "r1044" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r954", "r979" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current income tax expense", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r499", "r979" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails" ], "lang": { "en-us": { "role": { "label": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r954", "r979", "r1044" ] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r860", "r943" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r860", "r943" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r862", "r945" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r862", "r945" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r855", "r938" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r856", "r939" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r856", "r939" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r854", "r937" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r857", "r940" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r859", "r942" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r859", "r942" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r860", "r943" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r861", "r944" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r858", "r941" ] }, "INVU_DBRCapitalLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "DBRCapitalLLCMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "DBR Capital LLC [Member]", "documentation": "DBR Capital LLC [Member]" } } }, "auth_ref": [] }, "INVU_DBRCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "DBRCapitalMember", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DBR Capital [Member]", "documentation": "DBR Capital [Member]" } } }, "auth_ref": [] }, "INVU_DataProcessingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "DataProcessingEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Data Processing Equipment [Member]", "documentation": "Data Processing Equipment [Member]" } } }, "auth_ref": [] }, "INVU_DavidBRothrockAndJamesRBellMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "DavidBRothrockAndJamesRBellMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "David B Rothrock And James R Bell [Member]", "documentation": "David B Rothrock And James R Bell [Member]" } } }, "auth_ref": [] }, "INVU_DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Debt extinguished in exchange for cryptocurrency", "documentation": "Debt and related party debt extinguished in exchange for cryptocurrency." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://investview.com/role/Debt" ], "lang": { "en-us": { "role": { "label": "DEBT", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r133", "r230", "r360", "r361", "r362", "r363", "r364", "r371", "r372", "r382", "r388", "r389", "r390", "r391", "r392", "r393", "r398", "r405", "r406", "r407", "r562" ] }, "INVU_DebtDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DebtDiscountCurrent", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Current portion", "documentation": "Debt discount current." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r21", "r90", "r91", "r152", "r156", "r237", "r383", "r384", "r385", "r386", "r387", "r389", "r394", "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r403", "r404", "r795", "r796", "r797", "r798", "r799", "r819", "r977", "r1016", "r1017", "r1018", "r1056", "r1058" ] }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Beneficial conversion feature and debt discount", "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt conversion price per share", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r134", "r385" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument face amount", "verboseLabel": "Debt instrument, principal amount", "terseLabel": "Debt amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r383", "r562", "r563", "r796", "r797", "r819" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt interest rate", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r93", "r401", "r1056" ] }, "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateIncreaseDecrease", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, reduced interest rate", "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt interest rate", "verboseLabel": "Debt instrument interest percentage", "terseLabel": "Debt instrument interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r93", "r384" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument maturity date", "verboseLabel": "Debt instrument, maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r200", "r795", "r1050", "r1051" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r21", "r237", "r383", "r384", "r385", "r386", "r387", "r389", "r394", "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r403", "r404", "r795", "r796", "r797", "r798", "r799", "r819", "r977", "r1016", "r1017", "r1018", "r1056", "r1058" ] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Monthly installment payments", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r21", "r84" ] }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPaymentInterest", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, interest", "documentation": "Amount of the required periodic payments applied to interest." } } }, "auth_ref": [ "r21" ] }, "INVU_DebtInstrumentPeriodicPaymentTermsBalloonPaymentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20241231", "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentPercentage", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Payment percentage", "documentation": "Debt instrument periodic payment terms balloon payment percentage." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1029", "r1055", "r1056", "r1058" ] }, "INVU_DebtPremiumPercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20241231", "localname": "DebtPremiumPercentage", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt premium percentage", "documentation": "Debt premium percentage." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r97", "r98", "r153", "r491" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred revenues", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r960" ] }, "INVU_DeferredTaxAssetsAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DeferredTaxAssetsAmortization", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Amortization", "documentation": "Deferred tax assets amortization." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Net deferred tax liability", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1041" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "NOL carryover", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r1042" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other accruals", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other." } } }, "auth_ref": [ "r1042" ] }, "INVU_DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment in partnership", "documentation": "Deferred Tax Assets Tax Deferred Expense Reserves And Investment In Partnership." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r492" ] }, "INVU_DeferredTaxLiabilitiesDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DeferredTaxLiabilitiesDepreciation", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation", "documentation": "Deferred tax liabilities depreciation.", "label": "DeferredTaxLiabilitiesDepreciation" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsAssetsCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits, current", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r964" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r959" ] }, "INVU_DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "deposits collected from customers for orders to be filled at future date", "documentation": "Deposits collected from customers for orders to be filled at future date." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation", "verboseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r44" ] }, "INVU_DerivativeExtinguishedWithWarrantExercise": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DerivativeExtinguishedWithWarrantExercise", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative extinguished with warrant exercise", "documentation": "Derivative extinguished with warrant exercise." } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain (loss) on fair value of derivative liability", "negatedLabel": "Loss on fair value of derivative liability", "negatedTerseLabel": "Change in fair value", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1045" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://investview.com/role/DerivativeLiability" ], "lang": { "en-us": { "role": { "label": "DERIVATIVE LIABILITY", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r148", "r529", "r537" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r212", "r213", "r544", "r545", "r550", "r552", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r707", "r709", "r710", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r775", "r1049", "r1050", "r1051", "r1107" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability", "periodStartLabel": "Derivative liability", "periodEndLabel": "Derivative liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r212" ] }, "INVU_DerivativeLiabilityExtinguishedWithWarrantExercise": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DerivativeLiabilityExtinguishedWithWarrantExercise", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability extinguished with warrant exercise", "documentation": "Derivative liability extinguished with warrant exercise.", "label": "DerivativeLiabilityExtinguishedWithWarrantExercise" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability measurement input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r546", "r547", "r548" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLineItems", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r537" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeTable", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Table]", "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date." } } }, "auth_ref": [ "r16", "r73", "r74", "r75", "r76", "r77", "r78", "r79", "r80", "r81", "r537" ] }, "us-gaap_DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues", "presentation": [ "http://investview.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of Products and Services", "documentation": "Description of the types of products and services from which the reportable segment derives its revenue." } } }, "auth_ref": [ "r126", "r782", "r789" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REVENUE GENERATED", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1032" ] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS ACTIVITY", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r10", "r60" ] }, "INVU_DisclosureOperatingLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://investview.com/20241231", "localname": "DisclosureOperatingLeasesAbstract", "lang": { "en-us": { "role": { "label": "Operating Leases", "verboseLabel": "Schedule Of Future Minimum Lease Payments Under Non-cancellable Leases" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net book value", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r4", "r86", "r88", "r130" ] }, "INVU_DistributionOfDigitalCurrenciesPriorToTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DistributionOfDigitalCurrenciesPriorToTermination", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Distribution of digital currencies prior to termination", "documentation": "Distribution of digital currencies prior to termination." } } }, "auth_ref": [] }, "us-gaap_Dividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Dividends", "crdr": "debit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Dividends", "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock." } } }, "auth_ref": [ "r6", "r139" ] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dividends, cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r6", "r139" ] }, "INVU_DividendsDeclared": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DividendsDeclared", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends declared", "documentation": "Dividends declared." } } }, "auth_ref": [] }, "INVU_DividendsPaidWithCryptocurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DividendsPaidWithCryptocurrency", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends paid with cryptocurrency", "documentation": "Dividends paid with cryptocurrency." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Dividend liability", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Dividend liability", "label": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r91", "r95", "r154", "r835", "r1071" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStock", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: preferred dividends", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r139" ] }, "us-gaap_DividendsPreferredStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStockCash", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments to preferred stock dividend cash", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r6", "r139" ] }, "us-gaap_DividendsPreferredStockPaidinkind": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStockPaidinkind", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments to preferred stock dividend crypto", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r139" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r852" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r850", "r852", "r873" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r850", "r852", "r873", "r913" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r851" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r839" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r852" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r852" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r898" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r842" ] }, "INVU_DomesticRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "DomesticRevenueMember", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Domestic Revenue [Member]", "documentation": "Domestic Revenue [Member]" } } }, "auth_ref": [] }, "INVU_DueFromMerchantProcessors": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DueFromMerchantProcessors", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Due from merchant processors", "documentation": "Due from merchant processors." } } }, "auth_ref": [] }, "INVU_DueFromPayoutServiceProviders": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "DueFromPayoutServiceProviders", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Due from payout service providers", "documentation": "Due from payout service providers." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Basic income (loss) per common share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r247", "r248", "r249", "r250", "r251", "r252", "r259", "r262", "r281", "r282", "r283", "r287", "r512", "r520", "r541", "r542", "r610", "r632", "r779" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Diluted income (loss) per common share", "verboseLabel": "Diluted income per common share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r247", "r248", "r249", "r250", "r251", "r252", "r262", "r281", "r282", "r283", "r287", "r512", "r520", "r541", "r542", "r610", "r632", "r779" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r258", "r284", "r285", "r286" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate translation on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1054" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://investview.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective tax rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r483", "r810", "r980", "r1036" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationFdiiAmount", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign derived intangible income", "label": "Effective Income Tax Rate Reconciliation, FDII, Amount", "documentation": "Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)." } } }, "auth_ref": [ "r810", "r1036", "r1038" ] }, "INVU_ElrtTechnologiesLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ElrtTechnologiesLLCMember", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ELRT Technologies, LLC [Member]", "documentation": "ELRT Technologies, LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Payroll liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation cost", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1034" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "INVU_EnergyAndHosting": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "EnergyAndHosting", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Energy and hosting", "documentation": "Energy and Hosting." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r845" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r841" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r841" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r949" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r841" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Entity incorporation, date of incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r946" ] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingParValuePerShare", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r873" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r841" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r841" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r841" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r841" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r947" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r15", "r188", "r217", "r218", "r219", "r238", "r239", "r240", "r244", "r251", "r253", "r255", "r289", "r333", "r336", "r358", "r425", "r500", "r501", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r531", "r532", "r533", "r534", "r536", "r540", "r554", "r555", "r556", "r557", "r558", "r559", "r564", "r566", "r579", "r631", "r643", "r644", "r645", "r664", "r737" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r906" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r866", "r877", "r891", "r917" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r863", "r874", "r888", "r914" ] }, "us-gaap_EscrowDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EscrowDeposit", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Escrow deposit", "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy." } } }, "auth_ref": [ "r150", "r765" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r912" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FactorsUsedToIdentifyEntitysReportableSegments": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FactorsUsedToIdentifyEntitysReportableSegments", "presentation": [ "http://investview.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Factors used to identify entity's reportable segments", "documentation": "Description of the factors used to identify reportable segments, including the basis of organization (for example, whether management has chosen to organize the enterprise around differences in products and services, geographic areas, regulatory environments, or a combination of factors and whether operating segments have been aggregated to reportable segments)." } } }, "auth_ref": [ "r125", "r786", "r792" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://investview.com/role/DerivativeLiabilityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r546", "r547", "r815" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r396", "r440", "r441", "r442", "r443", "r444", "r445", "r543", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r594", "r595", "r596", "r796", "r797", "r802", "r803", "r804", "r813", "r815" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r544", "r545", "r546", "r548", "r813", "r1050", "r1052" ] }, "INVU_FairValueDiscountedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://investview.com/20241231", "localname": "FairValueDiscountedPercentage", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value discounted percentage", "documentation": "Fair value discounted percentage." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r396", "r440", "r445", "r545", "r550", "r594", "r802", "r803", "r804", "r813" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r396", "r440", "r445", "r545", "r546", "r550", "r595", "r796", "r797", "r802", "r803", "r804", "r813" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r396", "r440", "r441", "r442", "r443", "r444", "r445", "r545", "r546", "r547", "r548", "r550", "r596", "r796", "r797", "r802", "r803", "r804", "r813", "r815" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [ "r544", "r545", "r546", "r548", "r813", "r1050", "r1052" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r396", "r440", "r441", "r442", "r443", "r444", "r445", "r543", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r594", "r595", "r596", "r796", "r797", "r802", "r803", "r804", "r813", "r815" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r813", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052" ] }, "INVU_FinancialEducationAndTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "FinancialEducationAndTechnologyMember", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Financial Education and Technology [Member]", "documentation": "Financial Education and Technology [Member]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r605", "r1002" ] }, "INVU_ForeignRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ForeignRevenueMember", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign Revenue [Member]", "documentation": "Foreign Revenue [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r870", "r881", "r895", "r921" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r870", "r881", "r895", "r921" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r870", "r881", "r895", "r921" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r870", "r881", "r895", "r921" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r870", "r881", "r895", "r921" ] }, "INVU_FurnitureFixturesAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "FurnitureFixturesAndEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Furniture, Fixtures and Equipment [Member]", "documentation": "Furniture, Fixtures and Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain loss on disposal of assets", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r974", "r1013", "r1014" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 }, "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss (gain) on disposal of assets", "negatedTerseLabel": "(Gain) loss on disposal of assets", "label": "Loss on disposal of assets", "verboseLabel": "Loss (gain) on disposal of assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r974" ] }, "us-gaap_GainLossOnSaleOfOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfOtherAssets", "crdr": "credit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loss on disposal on assets", "documentation": "Amount of gain (loss) on sale or disposal of other assets." } } }, "auth_ref": [ "r974" ] }, "INVU_GainLossonLeaseCostNetofRepayment": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "GainLossonLeaseCostNetofRepayment", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Lease cost, net of repayment", "documentation": "Gain loss on lease cost net of repayment.", "label": "GainLossonLeaseCostNetofRepayment" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r112", "r717" ] }, "INVU_GoldmansPharmaceuticalsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "GoldmansPharmaceuticalsLLCMember", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goldman's Pharmaceuticals LLC [Member]", "documentation": "Goldman's Pharmaceuticals LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r197", "r345", "r609", "r788", "r794", "r814", "r821", "r999", "r1000" ] }, "INVU_GrossBillingsreceipts": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "GrossBillingsreceipts", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails" ], "lang": { "en-us": { "role": { "label": "Gross billings/receipts", "documentation": "Gross billings/receipts." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Segment income from operations", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r108", "r110", "r163", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r553", "r781", "r787", "r989", "r991", "r992", "r993", "r994", "r1024" ] }, "INVU_HaverfordLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "HaverfordLeaseMember", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Haverford Lease [Member]", "documentation": "Haverford Lease [Member]" } } }, "auth_ref": [] }, "INVU_HealthAndWellnessRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "HealthAndWellnessRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Health and Wellness Revenue [Member]", "documentation": "Health and Wellness Revenue [Member]" } } }, "auth_ref": [] }, "INVU_HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Held in reserve by merchant processors for future returns and chargebacks", "documentation": "Held in reserve by merchant processors for future returns and charge backs." } } }, "auth_ref": [] }, "INVU_IGeniusLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "IGeniusLLCMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "iGenius, LLC [Member]", "documentation": "iGenius, LLC [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r850", "r852", "r873" ] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Crypto Impairment expense", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r8", "r346", "r352" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r131" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r233", "r480" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails", "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r109", "r159", "r163", "r611", "r627", "r781", "r787", "r989", "r991", "r992", "r993", "r994" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r233", "r480" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r234", "r475", "r481", "r484", "r485", "r486", "r489", "r494", "r502", "r504", "r505", "r506", "r659", "r810" ] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://investview.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income tax accrued interest and penalties", "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r1039" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails", "http://investview.com/role/ScheduleOfTaxProvisionBenefitDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "label": "Total income tax expense", "totalLabel": "Total income tax provision (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r166", "r183", "r254", "r255", "r288", "r300", "r316", "r479", "r481", "r503", "r633", "r810" ] }, "INVU_IncomeTaxPaidInAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IncomeTaxPaidInAdvance", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax paid in advance", "documentation": "Income tax paid in advance." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r216", "r477", "r478", "r489", "r490", "r493", "r498", "r653" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r483", "r810", "r1036" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Income taxes at statutory rate", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r481", "r810" ] }, "INVU_IncomeTaxReconciliationInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IncomeTaxReconciliationInterest", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest", "documentation": "Income tax reconciliation interest.", "label": "IncomeTaxReconciliationInterest" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r810", "r1036", "r1037" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfIncomeFromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "label": "State taxes \u2013 net of federal benefit", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r482", "r810", "r1036" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r29", "r227", "r495", "r496" ] }, "INVU_IncreaseDecreaseCustomerAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IncreaseDecreaseCustomerAdvances", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Customer advance", "documentation": "Increase decrease customer advances." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Receivables", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax payable", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue", "label": "Increase (Decrease) in Deferred Revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r769" ] }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDepositOtherAssets", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deposits", "label": "Increase (Decrease) in Deposit Assets", "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits." } } }, "auth_ref": [ "r7" ] }, "INVU_IncreaseDecreaseInIncomeTaxPaidInAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IncreaseDecreaseInIncomeTaxPaidInAdvance", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax paid in advance", "documentation": "Increase decrease in income tax paid in advance.", "label": "IncreaseDecreaseInIncomeTaxPaidInAdvance" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r7" ] }, "INVU_IncreaseDecreaseInInterestPayableRelatedPartiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IncreaseDecreaseInInterestPayableRelatedPartiesNet", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued interest, related parties", "documentation": "Increase decrease in interest payable related parties net." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r973" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Dilutive impact of non-voting membership interest", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met." } } }, "auth_ref": [ "r263", "r264", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r283" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Dilutive impact of convertible notes", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method." } } }, "auth_ref": [ "r270", "r271", "r283" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r870", "r881", "r895", "r912", "r921", "r925", "r933" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r931" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r853", "r936" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Disclosure - Insider Trading Policies and Procedures" } } }, "auth_ref": [ "r853", "r936" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r853", "r936" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Long-Lived Assets \u2013 Cryptocurrencies & Intangible Assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r601", "r602", "r603", "r605", "r777", "r1001" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Interest expenses", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r288", "r296", "r299", "r301", "r316", "r561", "r787", "r788" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseOther", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest expense", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestOnConvertibleDebtNetOfTax", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Add: interest expense on convertible debt", "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash." } } }, "auth_ref": [ "r261", "r267", "r283" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r222", "r225", "r226" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory", "verboseLabel": "Inventory, entirely finished goods", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r208", "r773", "r821" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r167", "r193", "r207", "r340", "r341", "r342", "r600", "r778" ] }, "INVU_InvestviewFinancialGroupHoldingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "InvestviewFinancialGroupHoldingLLCMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investview Financial Group Holding LLC [Member]", "documentation": "Investview Financial Group Holding LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued for services and other stock-based compensation", "verboseLabel": "Stock-based compensation based on grant", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r8" ] }, "INVU_IssuancesOfCryptocurrencyValue": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "IssuancesOfCryptocurrencyValue", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Issuances of cryptocurrency value", "documentation": "Issuances of cryptocurrency value." } } }, "auth_ref": [] }, "INVU_IvylandLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "IvylandLeaseMember", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ivyland Lease [Member]", "documentation": "Ivyland Lease [Member]" } } }, "auth_ref": [] }, "INVU_JosephCammarataMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "JosephCammarataMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Joseph Cammarata [Member]", "documentation": "Joseph Cammarata [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseContractualTermAxis", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r576", "r953" ] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseContractualTermDomain", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r576", "r953" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r955" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r569", "r576" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r569", "r576" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://investview.com/role/OperatingLeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1060" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r574" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r574" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r574" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r574" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://investview.com/role/OperatingLeases" ], "lang": { "en-us": { "role": { "label": "OPERATING LEASES", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r565" ] }, "us-gaap_LessorLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LessorLeasesPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lease Obligation", "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor." } } }, "auth_ref": [ "r176", "r177", "r178", "r577" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r21", "r90", "r91", "r92", "r94", "r95", "r96", "r99", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r524", "r527", "r528", "r553", "r691", "r780", "r838", "r1024", "r1063", "r1064" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r106", "r158", "r622", "r821", "r978", "r997", "r1053" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r92", "r192", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r524", "r527", "r528", "r553", "r821", "r1024", "r1063", "r1064" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Total Liabilities", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r545", "r1047" ] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total long-term liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r21", "r94", "r95", "r96", "r99", "r232", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r524", "r527", "r528", "r553", "r1024", "r1063", "r1064" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Facility fee percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LitigationSettlementExpense", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, Fee Expense", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [ "r955" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r21", "r1016", "r1017", "r1018" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r21", "r46", "r1016", "r1017", "r1018" ] }, "INVU_LossOnSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "LossOnSettlement", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on Settlement", "documentation": "Loss on Settlement.", "label": "LossOnSettlement" } } }, "auth_ref": [] }, "INVU_ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Manufacturing and Development of Health Beauty and Wellness Products [Member]", "documentation": "Manufacturing and Development of Health Beauty and Wellness Products [Member]" } } }, "auth_ref": [] }, "INVU_ManufacturingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ManufacturingEquipmentMember", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Manufacturing Equipment [Member]", "documentation": "Manufacturing Equipment [Member]" } } }, "auth_ref": [] }, "INVU_MarioRomanoAndAnnetteRaynorMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MarioRomanoAndAnnetteRaynorMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mario Romano and Annette Raynor [Member]", "documentation": "Mario Romano and Annette Raynor [Member]" } } }, "auth_ref": [] }, "INVU_MarketExperts": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "MarketExperts", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Market experts", "documentation": "Market experts." } } }, "auth_ref": [] }, "INVU_MarketTrendStrategiesLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MarketTrendStrategiesLLCMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Market Trend Strategies LLC [Member]", "documentation": "Market Trend Strategies LLC [Member]" } } }, "auth_ref": [] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r884", "r885" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r884", "r886" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r884", "r887" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r884", "r887" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r884", "r887" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r884", "r887" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/ScheduleOfFixedAssetsDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r367", "r368", "r369", "r370", "r447", "r474", "r548", "r599", "r641", "r642", "r651", "r683", "r684", "r745", "r746", "r747", "r748", "r756", "r767", "r768", "r793", "r800", "r807", "r815", "r816", "r817", "r818", "r823", "r1028", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r904" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r904" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r1049", "r1050", "r1051" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r815", "r1049", "r1050", "r1051" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r1049", "r1050", "r1051" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r546", "r547", "r548", "r815" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r546", "r547", "r548", "r815" ] }, "INVU_MembershipRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MembershipRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Membership Revenue [Member]", "documentation": "Membership Revenue [Member]" } } }, "auth_ref": [] }, "INVU_MinerRepairRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MinerRepairRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails" ], "lang": { "en-us": { "role": { "label": "Miner Repair Revenue [Member]", "documentation": "Miner Repair Revenue [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/ScheduleOfFixedAssetsDetails", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r367", "r368", "r369", "r370", "r447", "r474", "r548", "r599", "r641", "r642", "r651", "r683", "r684", "r745", "r746", "r747", "r748", "r756", "r767", "r768", "r793", "r800", "r807", "r815", "r816", "r817", "r823", "r1028", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "INVU_MiningEquipmentRepairRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MiningEquipmentRepairRevenueMember", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Mining Equipment Repair Revenue [Member]", "documentation": "Mining Equipment Repair Revenue [Member]" } } }, "auth_ref": [] }, "INVU_MiningMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MiningMember", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Mining [Member]", "documentation": "Mining [Member]" } } }, "auth_ref": [] }, "INVU_MiningRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "MiningRevenueMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mining Revenue [Member]", "documentation": "Mining Revenue [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestDescription", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Description of non-controlling interest", "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership interest, percentage", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r924" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r932" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r905" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NatureOfOperations", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusiness" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND NATURE OF BUSINESS", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r168", "r185" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net cash provided by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r121", "r122", "r123" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss) attributable to Investview, Inc.", "label": "Net Income (Loss)", "verboseLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r111", "r123", "r160", "r190", "r214", "r215", "r219", "r232", "r243", "r247", "r248", "r249", "r250", "r251", "r254", "r255", "r279", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r512", "r520", "r542", "r553", "r630", "r714", "r735", "r736", "r836", "r1024" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Net income (loss) attributable to noncontrolling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r72", "r147", "r214", "r215", "r251", "r254", "r255", "r629", "r967" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss) applicable to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r221", "r247", "r248", "r249", "r250", "r259", "r260", "r280", "r283", "r520" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders (numerator)", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r221", "r261", "r266", "r267", "r268", "r269", "r280", "r283" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://investview.com/role/RecentAccountingPronouncements" ], "lang": { "en-us": { "role": { "label": "RECENT ACCOUNTING PRONOUNCEMENTS", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r184", "r189", "r241", "r242", "r245", "r246", "r256", "r257", "r324", "r334", "r335", "r510", "r511", "r513", "r520", "r535", "r539", "r578", "r580", "r581", "r606", "r607", "r608", "r646", "r647", "r648", "r649", "r650" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r904" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r902" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r901" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r932" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r932" ] }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Recognition of noncontrolling interest in acquisition", "documentation": "Amount of increase in noncontrolling interest from a business combination." } } }, "auth_ref": [ "r12", "r54", "r67" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r69", "r425", "r983", "r984", "r985", "r986", "r1112" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r113" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonrelatedPartyMember", "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r981", "r982" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportableSegments", "presentation": [ "http://investview.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of reportable segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r782", "r792", "r990" ] }, "srt_OfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OfficerMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officer [Member]" } } }, "auth_ref": [ "r325", "r1108" ] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cost of sales and service", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating costs and expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Operating costs and expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss) from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r163", "r781", "r989", "r991", "r992", "r993", "r994" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r570", "r820" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1059" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative", "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Present value of lease liability", "verboseLabel": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r568" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, current", "negatedLabel": "Operating lease liability, current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r568" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfFutureMinimumLeasePaymentsUnderNon-cancellableLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, long term", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r568" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "verboseLabel": "Operating lease right of use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r567" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r573", "r820" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r572", "r820" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://investview.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r497" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets:" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other current assets", "verboseLabel": "Cryptocurrencies", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r210", "r821" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r198" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Other liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r155", "r614", "r687", "r688", "r838", "r1073", "r1108" ] }, "INVU_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "OtherMember", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other [Member]", "documentation": "Other [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other income (expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r115" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r904" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Receivable balances", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r852" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r868", "r879", "r893", "r919" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r871", "r882", "r896", "r922" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r871", "r882", "r896", "r922" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipAxis", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipDomain", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r900" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repurchase of common stock, value", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r119" ] }, "us-gaap_PaymentsForRepurchaseOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfEquity", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments for shares repurchased from related parties", "label": "Payments for shares repurchased from related parties", "verboseLabel": "Consideration paid for purchased shares", "documentation": "The cash outflow to reacquire common and preferred stock." } } }, "auth_ref": [ "r119", "r657" ] }, "INVU_PaymentsForRepurchaseOfEquityAndLegalFee": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "PaymentsForRepurchaseOfEquityAndLegalFee", "crdr": "credit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration paid for purchased shares and expenses", "documentation": "Payments for repurchase of equity and legal fee." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Dividends paid", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r119" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "verboseLabel": "Purchase price", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r25", "r517" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash paid for purchase of Renu", "label": "Cash paid for purchase", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r117" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash paid for fixed assets", "label": "Cash paid for fixed assets", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r118" ] }, "us-gaap_PaymentsToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToSuppliers", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts paid to supplier", "label": "Payments to Suppliers", "documentation": "Payments of cash to suppliers for goods and services during the current period." } } }, "auth_ref": [ "r971", "r972" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r903" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r902" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r905" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r901" ] }, "srt_PlatformOperatorCryptoAssetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "PlatformOperatorCryptoAssetLineItems", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto Asset [Line Items]" } } }, "auth_ref": [ "r359" ] }, "srt_PlatformOperatorCryptoAssetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "PlatformOperatorCryptoAssetTable", "presentation": [ "http://investview.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto Asset [Table]" } } }, "auth_ref": [ "r359" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r902" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r846" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r848" ] }, "INVU_PreferredStockDesignated": { "xbrltype": "sharesItemType", "nsuri": "http://investview.com/20241231", "localname": "PreferredStockDesignated", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock designated", "documentation": "Preferred stock designated." } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockDividendsIncomeStatementImpact", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends on Preferred Stock", "label": "Preferred Stock Dividends, Income Statement Impact", "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders." } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r827", "r828", "r831", "r832", "r833", "r834", "r1106", "r1112" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r100", "r409" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r100", "r693" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r100", "r409" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://investview.com/role/BalanceSheetsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r100", "r693", "r712", "r1112", "r1113" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r100", "r618", "r821" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r209", "r343", "r344", "r774" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Statement Reclassification", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r957" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Proceeds from debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Received proceeds from related party debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ProceedsFromRepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentsOfDebt", "crdr": "debit", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayment of debt", "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash received from the disposal of fixed assets", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r116" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from the exercise of warrants", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r969" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r320", "r604", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r771", "r801", "r822", "r823", "r824", "r825", "r826", "r1021", "r1022", "r1032", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r320", "r604", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r771", "r801", "r822", "r823", "r824", "r825", "r826", "r1021", "r1022", "r1032", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalFees", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Professional fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r787", "r836", "r1110", "r1111" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "http://investview.com/role/StatementsOfCashFlows", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss)", "label": "Net income (loss)", "verboseLabel": "Net income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r190", "r214", "r215", "r223", "r232", "r243", "r251", "r254", "r255", "r332", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r512", "r520", "r522", "r525", "r526", "r542", "r553", "r611", "r628", "r663", "r714", "r735", "r736", "r811", "r812", "r837", "r967", "r1024" ] }, "INVU_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "PromissoryNoteMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]", "documentation": "Promissory Note [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9", "r575" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfFixedAssetsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r128", "r195", "r626" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r575" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://investview.com/role/ScheduleOfFixedAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fixed assets, net", "totalLabel": "Net book value", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r575", "r612", "r626", "r821" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fixed Assets", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r9", "r173", "r179", "r624" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FIXED ASSETS", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r128", "r575" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful life of fixed assets", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r900" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r900" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/ScheduleOfFixedAssetsDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r367", "r368", "r369", "r370", "r439", "r447", "r470", "r471", "r472", "r474", "r548", "r597", "r598", "r599", "r641", "r642", "r651", "r683", "r684", "r745", "r746", "r747", "r748", "r756", "r767", "r768", "r793", "r800", "r807", "r815", "r816", "r817", "r818", "r823", "r829", "r1019", "r1028", "r1050", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/ScheduleOfFixedAssetsDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [ "r367", "r368", "r369", "r370", "r439", "r447", "r470", "r471", "r472", "r474", "r548", "r597", "r598", "r599", "r641", "r642", "r651", "r683", "r684", "r745", "r746", "r747", "r748", "r756", "r767", "r768", "r793", "r800", "r807", "r815", "r816", "r817", "r818", "r823", "r829", "r1019", "r1028", "r1050", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Receivables", "verboseLabel": "Receivable balance arise out of credit card transaction", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r821" ] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Receivables", "label": "Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r327", "r328", "r329", "r331", "r996" ] }, "INVU_RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Recognition of lease liability and ROU asset at lease commencement", "documentation": "Recognition of lease liability and ROU assets at lease commencement." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://investview.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://investview.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues." } } }, "auth_ref": [ "r40", "r42" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r863", "r874", "r888", "r914" ] }, "INVU_RefundsIncentivesCreditsAndChargebacks": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "RefundsIncentivesCreditsAndChargebacks", "crdr": "debit", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails" ], "lang": { "en-us": { "role": { "label": "Refunds, incentives, credits, and chargebacks", "documentation": "Represents the monetary amount of Refunds, Incentives, Credits, and Chargebacks, during the indicated time period." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r325", "r446", "r585", "r586", "r615", "r623", "r686", "r687", "r688", "r689", "r690", "r711", "r713", "r744" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r235", "r236", "r585", "r586", "r587", "r588", "r615", "r623", "r686", "r687", "r688", "r689", "r690", "r711", "r713", "r744" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related party transaction amounts of advance", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r83", "r585" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r585", "r586", "r1062" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r325", "r718", "r719", "r722" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r325", "r446", "r585", "r586", "r615", "r623", "r686", "r687", "r688", "r689", "r690", "r711", "r713", "r744", "r1062" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://investview.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r582", "r583", "r584", "r586", "r589", "r660", "r661", "r662", "r720", "r721", "r722", "r741", "r743" ] }, "INVU_RenuLaboratoriesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "RenuLaboratoriesIncMember", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Renu Laboratories, Inc [Member]", "documentation": "Renu Laboratories, Inc [Member]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfConvertibleDebt", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Repayments on the loan", "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r120" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebt", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical", "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments for debt", "label": "Repayments of debt", "verboseLabel": "Repayment of debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r970" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "presentation": [ "http://investview.com/role/LiquidityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayments for debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r120", "r657" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments for related party debt", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r120" ] }, "us-gaap_ReportableSubsegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReportableSubsegmentsMember", "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Reportable Subsegments [Member]", "documentation": "Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r864", "r875", "r889", "r915" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r865", "r876", "r890", "r916" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r872", "r883", "r897", "r923" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r27", "r149", "r194", "r228", "r617" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "lang": { "en-us": { "role": { "label": "Restricted cash, current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r958", "r975" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r33" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r103", "r139", "r621", "r646", "r650", "r658", "r694", "r821" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r188", "r238", "r239", "r240", "r244", "r251", "r253", "r255", "r333", "r336", "r358", "r500", "r501", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r532", "r533", "r536", "r540", "r564", "r566", "r643", "r645", "r664", "r1112" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total revenue, net", "verboseLabel": "Net revenue", "terseLabel": "Revenues", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r161", "r162", "r288", "r297", "r298", "r312", "r316", "r320", "r322", "r323", "r436", "r437", "r604" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r161", "r162", "r288", "r297", "r298", "r312", "r316", "r320", "r322", "r323", "r436", "r437", "r604" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r186", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r770" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesAbstract", "presentation": [ "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Revenue:" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exchange for new operating lease liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r571", "r820" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r932" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r932" ] }, "INVU_RyanSmithAndChandMillerMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "RyanSmithAndChandMillerMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ryan Smith And Chand Miller [Member]", "documentation": "Ryan Smith And Chand Miller [Member]" } } }, "auth_ref": [] }, "INVU_SSATechnologiesLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "SSATechnologiesLLCMember", "presentation": [ "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "SSA Technologies LLC [Member]", "documentation": "SSA Technologies LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_SalariesAndWages": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalariesAndWages", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Salary and related", "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [ "r968" ] }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockDescriptionOfTransaction", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of offering", "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination." } } }, "auth_ref": [ "r14", "r71", "r146" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued in transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, price per share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://investview.com/role/AcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r62", "r64", "r516" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://investview.com/role/AcquisitionTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r62", "r64" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TAX PROVISION BENEFIT", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1043" ] }, "us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECEIVABLES", "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as current." } } }, "auth_ref": [ "r165", "r998" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://investview.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEBT", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r1041" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r11", "r55", "r56", "r57", "r58" ] }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "presentation": [ "http://investview.com/role/DerivativeLiabilityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DERIVATIVE LIABILITY", "documentation": "Tabular disclosure of derivative liabilities at fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DILUTED EARNINGS PER SHARE", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r988" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r1047", "r1048" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCOME BEFORE INCOME TAXES", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r979" ] }, "INVU_ScheduleOfIncomeFromContinuingOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://investview.com/20241231", "localname": "ScheduleOfIncomeFromContinuingOperationsTableTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCOME FROM CONTINUING OPERATIONS", "documentation": "Schedule Of Income From Continuing Operations [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://investview.com/role/ScheduleOfRevenueGeneratedDetails", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://investview.com/role/ScheduleOfFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9", "r575" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetails", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r82", "r83", "r718", "r719", "r722" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RELATED PARTY PAYABLES", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r20", "r149", "r1074" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r37", "r38", "r39" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS OUTSTANDING", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r60" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Table]", "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability." } } }, "auth_ref": [ "r90" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock, Class of Stock [Table]", "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks." } } }, "auth_ref": [ "r48", "r49", "r50", "r51", "r52", "r53", "r135", "r137", "r138", "r139", "r201", "r202", "r203", "r290", "r409", "r410", "r411", "r413", "r416", "r421", "r423", "r654", "r655", "r656", "r657", "r800", "r950", "r976" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANTS ISSUED", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "presentation": [ "http://investview.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNRECOGNIZED TAX BENEFITS", "documentation": "Tabular disclosure of the change in unrecognized tax benefits." } } }, "auth_ref": [ "r487", "r809" ] }, "INVU_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]", "documentation": "Securities Purchase Agreement [Member]" } } }, "auth_ref": [] }, "INVU_SecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "SecuritiesPurchaseAgreementsMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreements [Member]", "documentation": "Securities Purchase Agreements [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r840" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r844" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r843" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r849" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://investview.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r164", "r288", "r292", "r293", "r294", "r295", "r296", "r302", "r303", "r304", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r323", "r782", "r785", "r786", "r787", "r789", "r791", "r792" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Operating Segments", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r319", "r322", "r783", "r784", "r790" ] }, "INVU_SegmentReportingReconcilingItemAllOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "SegmentReportingReconcilingItemAllOtherNet", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "All other, net", "documentation": "Segment reporting reconciling item all other net.", "label": "SegmentReportingReconcilingItemAllOtherNet" } } }, "auth_ref": [] }, "INVU_SegmentReportingReconcilingItemBankInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "SegmentReportingReconcilingItemBankInterest", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Bank interest", "documentation": "Segment reporting reconciling item bank interest.", "label": "SegmentReportingReconcilingItemBankInterest" } } }, "auth_ref": [] }, "INVU_SegmentReportingReconcilingItemEventTicketSales": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "SegmentReportingReconcilingItemEventTicketSales", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Event ticket sales", "documentation": "Segment reporting reconciling item event ticket sales.", "label": "SegmentReportingReconcilingItemEventTicketSales" } } }, "auth_ref": [] }, "INVU_SegmentReportingReconcilingItemGainOnWinddownOfOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "SegmentReportingReconcilingItemGainOnWinddownOfOperations", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on winddown of operations", "documentation": "Segment reporting reconciling item gain on winddown of operations.", "label": "SegmentReportingReconcilingItemGainOnWinddownOfOperations" } } }, "auth_ref": [] }, "INVU_SegmentReportingReconcilingItemLeasingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "SegmentReportingReconcilingItemLeasingIncome", "crdr": "debit", "calculation": { "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Leasing income", "documentation": "Segment reporting reconciling item leasing income.", "label": "SegmentReportingReconcilingItemLeasingIncome" } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Selling and marketing", "verboseLabel": "Advertising, selling, and marketing expenses", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r961", "r962", "r1030" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation expenses", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vest over period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r808" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Warrants Exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "label": "Number of Warrants Canceled/Expired", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r142" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "label": "Number of Warrants Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Warrants Outstanding, Beginning", "periodEndLabel": "Number of Warrants Outstanding, Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r140", "r141" ] }, "INVU_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://investview.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning", "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending", "documentation": "Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "INVU_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled": { "xbrltype": "perShareItemType", "nsuri": "http://investview.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Canceled", "documentation": "Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price canceled." } } }, "auth_ref": [] }, "INVU_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised": { "xbrltype": "perShareItemType", "nsuri": "http://investview.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Exercised", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price exercised." } } }, "auth_ref": [] }, "INVU_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted": { "xbrltype": "perShareItemType", "nsuri": "http://investview.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsIssuedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Granted", "documentation": "Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price granted." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://investview.com/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Exercisable", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r453" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price of Options Exercisable", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r453" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options, Canceled/Expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r1033" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Canceled/Expired", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r1033" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options to purchase shares of common stock, stock options", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r457" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of Options, Granted", "verboseLabel": "Number of options to purchase shares of common stock", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Options outstanding, beginning", "periodEndLabel": "Number of Options, Options outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r451", "r452" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Options outstanding, beginning", "periodEndLabel": "Weighted Average Exercise Price, Options outstanding, ending", "label": "Exercise price increase", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r451", "r452" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options to purchase shares of common stock", "documentation": "Number of shares purchased for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r456" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r455" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "srt_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share Repurchase Program [Axis]" } } }, "auth_ref": [ "r1031" ] }, "srt_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [ "r1031" ] }, "INVU_ShareRepurchaseProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "ShareRepurchaseProgramMember", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share Repurchase Program [Member]", "documentation": "Share Repurchase Program [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://investview.com/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Contractual Life of Options Exercisable (Years)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options, canceled", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Per Share Fair Value, Canceled/Expired", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning", "periodEndLabel": "Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://investview.com/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Contractual Life of Options Outstanding (Years)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r143" ] }, "INVU_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingVestingPeriodContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://investview.com/20241231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingVestingPeriodContractualTerm", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average vesting period", "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining vesting period contractual term." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options, vested", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Per Share Fair Value, Granted", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtLineItems", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r124", "r229" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r847" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r187", "r201", "r202", "r203", "r232", "r262", "r265", "r281", "r283", "r290", "r291", "r332", "r373", "r375", "r376", "r377", "r380", "r381", "r409", "r410", "r413", "r416", "r423", "r553", "r654", "r655", "r656", "r657", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r693", "r715", "r737", "r757", "r758", "r759", "r760", "r761", "r950", "r976", "r987" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/StatementsOfStockholdersEquityDeficit", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r15", "r101", "r104", "r105", "r188", "r217", "r218", "r219", "r238", "r239", "r240", "r244", "r251", "r253", "r255", "r289", "r333", "r336", "r358", "r425", "r500", "r501", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r531", "r532", "r533", "r534", "r536", "r540", "r554", "r555", "r556", "r557", "r558", "r559", "r564", "r566", "r579", "r631", "r643", "r644", "r645", "r664", "r737" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r238", "r239", "r240", "r289", "r566", "r604", "r652", "r675", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r696", "r697", "r698", "r699", "r700", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r711", "r713", "r716", "r717", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r737", "r830" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedAtDateOfAcquisitionDetailsParenthetical", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r238", "r239", "r240", "r289", "r325", "r566", "r604", "r652", "r675", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r696", "r697", "r698", "r699", "r700", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r711", "r713", "r716", "r717", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r737", "r830" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r867", "r878", "r892", "r918" ] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchased from related parties and canceled, shares", "label": "Stock Issued During Period, Shares, Other", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of common stock shares cancelled", "documentation": "Number of shares (or other type of equity) forfeited during the period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://investview.com/role/ScheduleOfOptionsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r15", "r100", "r101", "r139", "r456" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued for services and other stock-based compensation", "verboseLabel": "Purchase price", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r15", "r100", "r101", "r139", "r664", "r737", "r758", "r837" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchased from related parties and canceled", "label": "Stock Issued During Period, Value, Other", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "crdr": "credit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares purchased value", "label": "Stock Issued During Period, Value, Purchase of Assets", "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock issued for services and other stock-based compensation", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r61", "r100", "r101", "r139" ] }, "us-gaap_StockOptionPlanExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockOptionPlanExpense", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense", "documentation": "Amount of noncash expense for option under share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "INVU_StockPurchaseAndReleaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "StockPurchaseAndReleaseAgreementMember", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Purchase And Release Agreement [Member]", "documentation": "Stock Purchase And Release Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRedeemedOrCalledDuringPeriodShares", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares cancelled", "documentation": "Number of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r15" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRedeemedOrCalledDuringPeriodValue", "crdr": "debit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exchange for cash", "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r15" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares repurchased", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r15", "r100", "r101", "r139", "r657", "r737", "r760" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares purchased value", "verboseLabel": "Number of shares repurchased, value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r15", "r100", "r101", "r139", "r664", "r737", "r760", "r837" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets", "http://investview.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity (deficit)", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r101", "r104", "r105", "r127", "r695", "r712", "r738", "r739", "r821", "r838", "r978", "r997", "r1053", "r1112" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity (deficit):" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r136", "r231", "r408", "r410", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r422", "r425", "r538", "r740", "r742", "r762" ] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsAxis", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsConsolidationItemsAxis", "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Subsegments Consolidation Items [Axis]", "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsConsolidationItemsDomain", "presentation": [ "http://investview.com/role/ScheduleOfReconciliationOfSegmentOperatingIncomeToNetIncomeBeforeTaxesDetails", "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsDomain", "presentation": [ "http://investview.com/role/ScheduleOfSegmentRevenueAndSegmentNetIncomeFromOperationsIncludingSignificantExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r560", "r592" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r560", "r592" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r560", "r592" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r560", "r592" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r560", "r592" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://investview.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r591", "r593" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://investview.com/role/Liquidity" ], "lang": { "en-us": { "role": { "label": "LIQUIDITY", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r89" ] }, "INVU_SummaryOfWarrantsOutstandingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://investview.com/20241231", "localname": "SummaryOfWarrantsOutstandingTableTextBlock", "presentation": [ "http://investview.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANTS OUTSTANDING", "documentation": "Summary Of Warrants Outstanding [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://investview.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r911" ] }, "us-gaap_TangibleAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TangibleAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asset impairment charges", "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value." } } }, "auth_ref": [ "r87", "r129" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://investview.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://investview.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r90", "r91" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r995", "r1061" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://investview.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r910" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r934" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r935" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r935" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r933" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r933" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r934" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://investview.com/role/RelatedPartyTransactionsDetailsNarrative", "http://investview.com/role/ScheduleOfRelatedPartyPayablesDetailsParenthetical", "http://investview.com/role/StockholdersEquityDetailsNarrative", "http://investview.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "INVU_USSmallBusinessAdministrationMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "USSmallBusinessAdministrationMember", "presentation": [ "http://investview.com/role/ScheduleOfDebtDetails", "http://investview.com/role/ScheduleOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "US Small Business Administration [Member]", "documentation": "US Small Business Administration [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r930" ] }, "INVU_UnitOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "UnitOfferingMember", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unit Offering [Member]", "documentation": "Unit Offering [Member]" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning of the year", "periodEndLabel": "Balance at the end of the year", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r476", "r487", "r809" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://investview.com/role/ScheduleOfUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Increases related to positions taken in prior years", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r488", "r809" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://investview.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized tax benefits", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r1040" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://investview.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r34", "r35", "r36", "r170", "r171", "r174", "r175" ] }, "INVU_ValueOfCommonStockSharesDecreased": { "xbrltype": "monetaryItemType", "nsuri": "http://investview.com/20241231", "localname": "ValueOfCommonStockSharesDecreased", "crdr": "credit", "presentation": [ "http://investview.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value of common stock shares decreased", "documentation": "Value of common stock shares decreased." } } }, "auth_ref": [] }, "INVU_WarminsterLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "WarminsterLeaseMember", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warminster Lease [Member]", "documentation": "Warminster Lease [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantMember", "presentation": [ "http://investview.com/role/ScheduleOfAssumptionsUsedInBinominalOptionPricingModelDetails", "http://investview.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r827", "r828", "r831", "r832", "r833", "r834" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Contractual Life (Years)", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1049", "r1050", "r1051" ] }, "INVU_WarrantsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://investview.com/20241231", "localname": "WarrantsExercisable", "presentation": [ "http://investview.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable", "documentation": "Warrants exercisable." } } }, "auth_ref": [] }, "INVU_WealthGeneratorsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "WealthGeneratorsLLCMember", "presentation": [ "http://investview.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Wealth Generators LLC [Member]", "documentation": "Wealth Generators LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Diluted weighted average number of common shares outstanding", "totalLabel": "Diluted weighted average number of common shares outstanding (denominator)", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r261", "r283" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://investview.com/role/ScheduleOfDilutedEarningsPerShareDetails", "http://investview.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Basic weighted average number of common shares outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r259", "r283" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://investview.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r948" ] }, "INVU_WyckoffLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://investview.com/20241231", "localname": "WyckoffLeaseMember", "presentation": [ "http://investview.com/role/OperatingLeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Wyckoff Lease [Member]", "documentation": "Wyckoff Lease [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-40/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "SubTopic": "30", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-14" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "SubTopic": "30", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "44", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-44" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "48", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "48", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-51" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-52" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-53" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "54", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-54" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.FF.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478790/946-405-45-2" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r940": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r941": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r942": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r943": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r950": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org/705/tableOfContent" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-1" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-4" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 102 0001641172-25-001193-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001641172-25-001193-xbrl.zip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end XML 103 form10-k_htm.xml IDEA: XBRL DOCUMENT 0000862651 2024-01-01 2024-12-31 0000862651 2024-06-28 0000862651 2025-03-20 0000862651 2024-10-01 2024-12-31 0000862651 2024-12-31 0000862651 2023-12-31 0000862651 us-gaap:RelatedPartyMember 2024-12-31 0000862651 us-gaap:RelatedPartyMember 2023-12-31 0000862651 us-gaap:NonrelatedPartyMember 2024-12-31 0000862651 us-gaap:NonrelatedPartyMember 2023-12-31 0000862651 2023-01-01 2023-12-31 0000862651 INVU:MembershipRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MembershipRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:MiningMember 2024-01-01 2024-12-31 0000862651 INVU:MiningMember 2023-01-01 2023-12-31 0000862651 INVU:HealthAndWellnessRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:HealthAndWellnessRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:CryptocurrencyRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:CryptocurrencyRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:MiningEquipmentRepairRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MiningEquipmentRepairRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:OtherMember 2024-01-01 2024-12-31 0000862651 INVU:OtherMember 2023-01-01 2023-12-31 0000862651 us-gaap:NonrelatedPartyMember 2024-01-01 2024-12-31 0000862651 us-gaap:NonrelatedPartyMember 2023-01-01 2023-12-31 0000862651 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0000862651 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0000862651 us-gaap:PreferredStockMember 2022-12-31 0000862651 us-gaap:CommonStockMember 2022-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000862651 us-gaap:RetainedEarningsMember 2022-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2022-12-31 0000862651 2022-12-31 0000862651 us-gaap:PreferredStockMember 2023-12-31 0000862651 us-gaap:CommonStockMember 2023-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000862651 us-gaap:RetainedEarningsMember 2023-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2023-12-31 0000862651 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000862651 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000862651 us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-12-31 0000862651 us-gaap:PreferredStockMember 2024-12-31 0000862651 us-gaap:CommonStockMember 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-12-31 0000862651 INVU:WealthGeneratorsLLCMember INVU:ContributionAgreementMember 2017-04-01 0000862651 INVU:WealthGeneratorsLLCMember INVU:ContributionAgreementMember 2017-04-01 2017-04-01 0000862651 INVU:MarketTrendStrategiesLLCMember INVU:AcquisitionAgreementMember 2017-06-06 2017-06-06 0000862651 INVU:BitcoinMember 2023-01-01 2023-12-31 0000862651 INVU:MiningRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:MiningRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:ForeignRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:DomesticRevenueMember 2024-01-01 2024-12-31 0000862651 INVU:ForeignRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:DomesticRevenueMember 2023-01-01 2023-12-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2024-12-31 0000862651 INVU:FurnitureFixturesAndEquipmentMember 2023-12-31 0000862651 us-gaap:ComputerEquipmentMember 2024-12-31 0000862651 us-gaap:ComputerEquipmentMember 2023-12-31 0000862651 INVU:DataProcessingEquipmentMember 2024-12-31 0000862651 INVU:DataProcessingEquipmentMember 2023-12-31 0000862651 srt:MinimumMember INVU:ManufacturingEquipmentMember 2024-12-31 0000862651 srt:MaximumMember INVU:ManufacturingEquipmentMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember 2024-12-31 0000862651 INVU:ManufacturingEquipmentMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000862651 INVU:MinerRepairRevenueMember 2023-01-01 2023-12-31 0000862651 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0000862651 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0000862651 us-gaap:WarrantMember 2024-01-01 2024-12-31 0000862651 us-gaap:WarrantMember 2023-01-01 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-12-31 0000862651 INVU:ChairmanMember INVU:ConvertiblePromissoryNoteMember INVU:DBRCapitalLLCMember 2020-04-27 2020-04-27 0000862651 INVU:ChairmanMember INVU:ConvertiblePromissoryNoteMember INVU:DBRCapitalLLCMember 2020-04-27 0000862651 INVU:ChairmanMember INVU:ConvertiblePromissoryNoteMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ChairmanMember INVU:ConvertiblePromissoryNoteMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-05-27 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-05-27 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteOneMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-11-09 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteTwoMember INVU:DBRCapitalLLCMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2024-01-01 2024-12-31 0000862651 INVU:SSATechnologiesLLCMember INVU:ConvertiblePromissoryNoteThreeMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 srt:MaximumMember INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2023-01-01 2023-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 2021-03-22 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-09-30 0000862651 INVU:DBRCapitalLLCMember INVU:SecuritiesPurchaseAgreementsMember 2020-04-27 2020-04-27 0000862651 INVU:MarioRomanoAndAnnetteRaynorMember INVU:StockPurchaseAndReleaseAgreementMember 2023-09-29 2023-09-29 0000862651 INVU:MarioRomanoAndAnnetteRaynorMember INVU:StockPurchaseAndReleaseAgreementMember 2023-09-29 0000862651 INVU:MarioRomanoAndAnnetteRaynorMember INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember 2024-12-31 0000862651 INVU:RyanSmithAndChandMillerMember us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember 2024-02-07 2024-02-07 0000862651 INVU:RyanSmithAndChandMillerMember us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember 2024-02-07 0000862651 INVU:RyanSmithAndChandMillerMember us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:RyanSmithAndChandMillerMember INVU:StockPurchaseAndReleaseAgreementMember 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2023-12-31 0000862651 INVU:APEXTexLLCMember 2024-12-31 0000862651 INVU:APEXTexLLCMember 2023-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-01 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2024-01-01 2024-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2023-01-01 2023-12-31 0000862651 INVU:APEXTexLLCMember 2020-11-30 0000862651 INVU:APEXTexLLCMember 2021-03-31 0000862651 INVU:APEXTexLLCMember 2020-04-01 2021-03-31 0000862651 INVU:APEXTexLLCMember 2024-01-01 2024-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2023-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2023-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2023-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2023-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2024-12-31 0000862651 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2023-12-31 0000862651 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2023-12-31 0000862651 INVU:WyckoffLeaseMember 2024-12-31 0000862651 INVU:WyckoffLeaseMember 2024-01-01 2024-12-31 0000862651 INVU:HaverfordLeaseMember 2024-12-31 0000862651 INVU:HaverfordLeaseMember 2024-01-01 2024-12-31 0000862651 INVU:WarminsterLeaseMember 2024-12-31 0000862651 INVU:IvylandLeaseMember 2024-12-31 0000862651 INVU:BoardOfDirectorsMember us-gaap:SeriesBPreferredStockMember 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2024-12-31 0000862651 INVU:UnitOfferingMember 2020-04-01 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-03-31 0000862651 INVU:UnitOfferingMember 2021-08-17 2021-08-17 0000862651 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-12-31 0000862651 INVU:CryptocurrencyMember 2024-01-01 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-12-31 0000862651 INVU:CryptocurrencyMember 2023-01-01 2023-12-31 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:StockPurchaseAndReleaseAgreementMember 2024-01-01 2024-12-31 0000862651 INVU:MarioRomanoAndAnnetteRaynorMember INVU:StockPurchaseAndReleaseAgreementMember 2023-01-01 2023-12-31 0000862651 INVU:MarioRomanoAndAnnetteRaynorMember INVU:StockPurchaseAndReleaseAgreementMember 2023-01-01 2023-12-31 0000862651 us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0000862651 srt:OfficerMember 2024-01-01 2024-12-31 0000862651 INVU:DavidBRothrockAndJamesRBellMember INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2024-12-31 0000862651 INVU:DavidBRothrockAndJamesRBellMember INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2023-12-31 0000862651 INVU:DavidBRothrockAndJamesRBellMember INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2024-01-01 2024-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-02 2021-09-03 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember 2021-09-03 0000862651 us-gaap:SubsequentEventMember 2025-01-17 2025-01-17 0000862651 INVU:PromissoryNoteMember 2024-12-01 2024-12-31 0000862651 2023-08-01 2023-08-31 0000862651 INVU:IGeniusLLCMember 2024-12-31 0000862651 INVU:JosephCammarataMember 2021-03-30 0000862651 INVU:JosephCammarataMember 2021-09-21 0000862651 INVU:JosephCammarataMember 2024-01-01 2024-12-31 0000862651 INVU:FinancialEducationAndTechnologyMember us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-12-31 0000862651 INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-12-31 0000862651 INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-12-31 0000862651 us-gaap:ReportableSubsegmentsMember 2024-01-01 2024-12-31 0000862651 INVU:FinancialEducationAndTechnologyMember us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-12-31 0000862651 INVU:BlockchainTechnologyAndCryptoMiningProductsAndServicesMember us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-12-31 0000862651 us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-12-31 0000862651 INVU:GoldmansPharmaceuticalsLLCMember 2024-10-11 0000862651 INVU:ElrtTechnologiesLLCMember 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-01-01 2024-12-31 0000862651 2024-10-11 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 0000862651 srt:MinimumMember us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 0000862651 srt:MaximumMember us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 0000862651 INVU:DBRCapitalMember us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 0000862651 INVU:DBRCapitalMember us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 2025-02-28 0000862651 us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 2025-02-28 0000862651 us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementsMember 2025-02-28 0000862651 us-gaap:SubsequentEventMember INVU:SecuritiesPurchaseAgreementMember 2025-02-28 0000862651 srt:MaximumMember INVU:ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2025-03-06 2025-03-06 0000862651 INVU:ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2025-03-06 0000862651 INVU:ShareRepurchaseProgramMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2025-03-06 2025-03-06 iso4217:USD shares iso4217:USD shares pure utr:sqft INVU:Segments false FY 0000862651 P5Y 10-K true 2024-12-31 --12-31 2024 false 000-27019 INVESTVIEW, INC. NV 87-0369205 521 West Lancaster Avenue Second Floor Haverford PA 19041 732 889-4300 No No Yes Yes Non-accelerated Filer true false false false false 26798138 1859231786 0.001 NONE <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Management and Strategy</b></span><div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zCndavmJdar5">The Company’s cybersecurity risk management practices are intended to assess, identify and manage risks from threats to the security of our information, systems, products and network. Our cybersecurity program is a key component of our broader risk management strategy in which cyber risk has been identified and is actively managed with preventive and mitigating measures. We design and assess our cybersecurity program based on the National Institute of Standards and Technology’s Cybersecurity Framework, ISO 27001, and industry-specific regulations. This does not imply that we meet any particular technical standards, specifications or requirements, but rather that we use them as a guide to help us identify, assess and manage cybersecurity risks relevant to our business.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cybersecurity incidents could result from unintentional events, or from deliberate attacks by unauthorized entities or individuals attempting to gain access to Investview’s System Technology for the purposes of misappropriating assets or information or causing operational disruption and damage. To mitigate the risk of an impact to our business operations and/or damage from cybersecurity incidents or cyberattacks, Investview invests in multiple forms of cybersecurity and operational safeguards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbF_c20240101__20241231_zkwEQ605gS6f">On an ongoing basis, we assess our people, processes, and technology, and when necessary, modify the overall program in order to meet the demands of the ever-changing cyber risk environment. As part of our regular training and readiness program, we conduct phishing and penetration testing campaigns in order to ensure that our employees are familiar with all types of phishing emails and similar threats.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our data is dynamically backed up to mitigate against data loss. To prevent unauthorized access and data breaches, we encrypt sensitive data both in transit and at rest. We have also implemented access controls and multi-factor authentication to ensure that only authorized personnel can access sensitive information. We also utilize third-party information technology systems vendors to conduct regular network and endpoint monitoring.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our risk management program is comprised of, among other things, policies that are designed to identify, assess, manage, and mitigate cybersecurity risk, and is based on applicable laws and regulations, derived from industry standards and best practices. These policies are intended to identify cybersecurity threats that may be associated with both internally managed systems and systems managed by third-party service providers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct risk assessments to evaluate the effectiveness of our systems and processes in addressing threats and to identify opportunities for enhancements. Additionally, we conduct privacy and cybersecurity reviews, as well as annual employee training, and monitor emerging laws and regulations related to information security and data protection. We utilize third party tools and techniques to test and enhance our security controls, perform annual cybersecurity framework assessments, conduct ongoing penetration testing of our systems, and benchmark against best practices. Our internal audit function provides an independent assessment on the overall operations of our cybersecurity program and the supporting framework.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_z054DVkVCKre">Our cybersecurity team engages and utilizes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zFTdNefMRExe">third-party services</span> as it monitors and actively responds to cybersecurity threats. We utilize an Endpoint Detection and Response (EDR) platform, an anti-virus application, through which incoming electronic communications are filtered, and an email security platform which seeks out identifiers in communications that disguise, impersonate, or otherwise misrepresent the source of the communication. If such a communication is detected, it is subject to quarantine or removal depending on the severity of issue. Additionally, we use a Security Information and Event Management (SIEM) system, which allows us to store logs off the system of record to prevent log tampering and provides the cybersecurity team functionality to build alerts on specific use cases that are important and unique to our business. If our applications fail or our software does not successfully block a malicious electronic communication, employees are required to notify an immediate supervisor or the cybersecurity team promptly, but in no circumstances later than twenty-four (24) hours after such occurrence.</span></span></p> </div><div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span>Upon detection of a cybersecurity incident and initial intake and validation by our cybersecurity team, our incident response team triages and evaluates the cybersecurity incident, and, depending on the severity, escalates the incident to management and a cross-functional working group. Any incident assessed as potentially being or potentially becoming material is immediately escalated for further assessment and reported to executive management. Determination of what resources are needed to address the incident, prioritizing of response activities, forming of action plans, and notification of external parties as needed are then undertaken by executive management and the cross-functional working group, led by our Senior Information Officer (SIO). We consult with outside counsel as appropriate, including on materiality analysis and disclosure matters, and our executive management makes the final materiality and disclosure determinations, among other compliance decisions.</span></span></span></p> </div> The Company’s cybersecurity risk management practices are intended to assess, identify and manage risks from threats to the security of our information, systems, products and network. Our cybersecurity program is a key component of our broader risk management strategy in which cyber risk has been identified and is actively managed with preventive and mitigating measures. We design and assess our cybersecurity program based on the National Institute of Standards and Technology’s Cybersecurity Framework, ISO 27001, and industry-specific regulations. This does not imply that we meet any particular technical standards, specifications or requirements, but rather that we use them as a guide to help us identify, assess and manage cybersecurity risks relevant to our business. false true true <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governance</b></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zXrh15SQaL8e">Our board, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zuGSRM57GQFd">Senior Information Officer</span> (“SIO”) and management actively assess the Company’s cybersecurity and data privacy risk management practices with the goal of being proactive rather than reactive. Our SIO and management regularly review the Company’s cybersecurity and data privacy risks, including our policies, controls and procedures for identifying, managing and mitigating such risks. Our SIO provides management with periodic reports regarding cybersecurity and data privacy measures and procedures, the identification of security gaps and compliance with applicable cybersecurity and data privacy regulations. Management then briefs our board at scheduled meetings regarding cybersecurity and data privacy developments</span>.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management and our SIO are responsible for day-to-day monitoring of the prevention, detection, mitigation and remediation of cybersecurity incidents. Our SIO, who reports to our Chief Operating Officer, has primary oversight of the material risks from cybersecurity and data privacy matters. Our SIO has more than 20 years of experience across various information technology, information security and management roles, including leading the development and implementation of cybersecurity and data privacy strategies for the employee and customer-facing aspects of our business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2024, we did not identify any cybersecurity incidents or threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations or financial condition. However, despite our efforts, we may not be successful in eliminating all risks from cybersecurity threats and can provide no assurances that undetected cybersecurity incidents have not occurred. <b>See Part I, Item 1A. “Risk Factors” </b>of this Annual Report for more information regarding the cybersecurity risks we face.</span></p>   Our board, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zuGSRM57GQFd">Senior Information Officer</span> (“SIO”) and management actively assess the Company’s cybersecurity and data privacy risk management practices with the goal of being proactive rather than reactive. Our SIO and management regularly review the Company’s cybersecurity and data privacy risks, including our policies, controls and procedures for identifying, managing and mitigating such risks. Our SIO provides management with periodic reports regarding cybersecurity and data privacy measures and procedures, the identification of security gaps and compliance with applicable cybersecurity and data privacy regulations. Management then briefs our board at scheduled meetings regarding cybersecurity and data privacy developments true The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. false false false false true 2738 M&K CPAS, PLLC The Woodlands, TX 22467710 20912276 230354 497620 492607 936434 2534727 2232725 495865 459872 1127891 585632 28520119 24453594 1868441 6536823 873701 40310 211996 110427 57028 2588127 1183035 2698554 31571595 33688971 7139684 5854093 271606 187419 202573 1004535 3029145 2703398 758 5732 245101 256392 165707 109628 1204567 1203247 29244 715127 12288385 12039571 46433 6048 45532 1189643 1501041 1162349 490619 501062 2083625 2859102 14372010 14898673 0.001 0.001 50000000 50000000 252192 252192 252192 252192 252 252 0.001 0.001 10000000000 10000000000 1859231786 1859231786 2333356496 2333356496 1859231 2333356 102560320 104056807 -23218 -23218 8070 -87205070 -87576899 17199585 18790298 31571595 33688971 47061290 56036052 5186606 11348156 110671 513285 23378 23404 52381971 67920871 6056491 10736709 25913260 31716399 569491 560065 6626588 7112954 1547288 1378367 1771891 2056386 -180223 -223630 8022020 9531431 50687252 63315941 1694719 4604930 375000 4974 18691 452450 255268 18801 18750 1240529 1239603 1240529 1239603 1567543 1389796 390637 405402 2085356 5010332 894940 2178412 1190416 2831920 -753 1191169 2831920 819340 819340 371829 2012580 0.00 0.00 0.00 0.00 1908219120 2559093504 2944647691 3595522075 252192 252 2636275489 2636275 104350746 -23218 -89589479 17374576 2575496 2575496 230 23 23 3 3 302919223 302919 2869461 3172380 819340 819340 2831920 2831920 252192 252 2333356496 2333356 104056807 -23218 -87576899 18790298 252192 252 2333356496 2333356 104056807 -23218 -87576899 18790298 1600534 1600534 472374710 472375 3098771 3571146 -1750000 -1750 1750 8823 8823 819340 819340 1191169 -753 1190416 252192 252 1859231786 1859231 102560320 -23218 -87205070 8070 17199585 252192 252 1859231786 1859231 102560320 -23218 -87205070 8070 17199585 1190416 2831920 3875614 4450466 338691 337767 1600534 2575496 5105 -1283 -180223 -223630 4974 18691 452450 255268 1771891 2056386 302002 977183 326986 -74645 5013 126046 -459872 535932 535461 5396521 2439 2114529 1559877 -350764 -801962 763932 -96609 -239279 628824 18801 18750 901837 901837 8302341 6065257 1495 1144426 23278 461945 2561001 -1604876 -2537723 900516 900516 441086 1948906 3371763 396547 659020 627856 23 -5372385 -3873802 1325080 -346268 21142630 21488898 22467710 21142630 929760 932197 2156774 2178412 3571146 2775833 1597104 819340 819340 223364 23520 274041 5322058 171611 171722 1750 9913 3 <p id="xdx_807_eus-gaap--NatureOfOperations_z3KYB6WWTex5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/> <b><span id="af_006"></span>NOTE 1 – <span id="xdx_82E_zu8txUPHsZOh">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investview, Inc. was incorporated on <span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_dd_c20240101__20241231_z6qhu7cahsre" title="Entity incorporation, date of incorporation">January 30, 1946</span>, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed <span id="xdx_905_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_zcGBfWX9KNNj" title="Percentage of shares contributed">100</span>% of the outstanding securities of Wealth Generators in exchange for an aggregate of <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20170401__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_z5vSFtV7yxV4" title="Number of shares exchanged for common stock">1,358,670,942</span> shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20170606__20170606__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--MarketTrendStrategiesLLCMember_zGVtXsWIPu1g" title="Value pre-merger liabilities">419,139</span> in pre-merger liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate a diversified financial technology services company offering multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion: an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1946-01-30 1 1358670942 419139 <p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_z14IYSfeBftd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_826_zL6ynZWP8zZ9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTOokXVW2DRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of Accounting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our policy is to prepare our financial statements <span style="color: #303030">on the </span>accrual <span style="color: #303030">basis of </span>accounting in accordance with accounting principles generally <span style="color: #303030">accepted </span>in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zrqnCsyERqP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zRImkimWpmdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Segments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zkUlr7xfIF09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statement Reclassification</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zVWP5Kg1VKS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_z035CAJ89kb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zebR3ozZIy11" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2024 and 2023, cash balances that exceeded FDIC limits were $<span id="xdx_904_eus-gaap--CashUninsuredAmount_iI_c20241231_zwc7SIj1kRnl" title="Cash balances exceeded FDIC limits">10,837,830</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_iI_c20231231_z0wIwG71v696" title="Cash balances exceeded FDIC limits">3,778,085</span>, respectively. We have not experienced significant losses relating to these concentrations in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zixu4BfRg8ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash Equivalents and Restricted Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2024 and 2023, we had <span id="xdx_907_eus-gaap--RestrictedCashAndCashEquivalents_iI_do_c20241231_zcpy9svPfhDh" title="Cash equivalents"><span id="xdx_90B_eus-gaap--RestrictedCashAndCashEquivalents_iI_do_c20231231_zwrzfY3KfoBh" title="Cash equivalents">no</span></span> cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_z1yuONEkD6Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zkVCI5QqqJek" style="display: none">SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231_z0uGhW4U4fBi" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20231231_zpNg1wzujtHl" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maCCERCzRmQ_zZ7eYoXBIz8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,912,276</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maCCERCzRmQ_zduLJYcn8Da4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash, current</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,354</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_mtCCERCzRmQ_zGrOjygfv0wd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash, cash equivalents, and restricted cash shown on the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,142,630</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zG0OTplP0Wsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount included in restricted cash represent funds required to be held in an escrow account by a contractual agreement and will be used for paying dividends to our Series B Preferred Stockholders and funds required to be held in an account as collateral for business charges on our Company credit card.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ReceivablesPolicyTextBlock_zrIpy8E5k3ud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivables</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_89C_eus-gaap--ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_ziZyKgOjKMW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables were made up of the following as of each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zLangaCoHFhh">SCHEDULE OF RECEIVABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20241231_z6t7cJRpqXI9" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zcavq84dkSAh" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DueFromMerchantProcessors_iI_maARGzmLm_zWln2dXMUJAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from merchant processors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,921</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,732,456</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks_iI_maARGzmLm_z29VYwmhFaUe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Held in reserve by merchant processors for future returns and chargebacks <span id="xdx_F43_zWXJPwSddrk7">[1]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,872,035</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,219,342</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--DueFromPayoutServiceProviders_iI_maARGzmLm_zQFueOMcdyNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from payout service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,558</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,251</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGzmLm_zMTfHf7eOBE9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts and other receivables</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,213</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0753">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccountsReceivableGross_iTI_mtARGzmLm_maARNz574_zz1L5lQMbet6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Receivable, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,955,049</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_di_msARNz574_zF3ILqLOSFVl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(722,324</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--AccountsReceivableNet_iTI_mtARNz574_z1oAtyT2cZY" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,232,725</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_z7ITZphKHbWb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zOwcYEYIvJE6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_zwu6BFdeD4dk" title="Credit card receivables">1.87</span> million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”</span></td></tr></table> <p id="xdx_8A3_zU2fwSwzKvIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zr2ccO4IXnW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fixed Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zYkuyU2K4cma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets were made up of the following at each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_z2gePXTC3kkj" style="display: none">SCHEDULE OF FIXED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture, fixtures, and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zFh2KwDr4Txb" title="Estimated useful life of fixed assets">10</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zV8E8y3duoSj" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zHqMCknt8Oc2" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4VJPYEtVFY" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zMCqMvJHw5na" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zfprGu0GMk9k" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,308</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data processing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zTVUX9Z1VEG4" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zhwnSoMqtP8" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,824,560</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zYxW9oMnblhg" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,084,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z0hfr65oawqk" title="Estimated useful life of fixed assets">3</span>-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zvWPZNxidO57" title="Estimated useful life of fixed assets">25</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_z0KJvDF461N4" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,161,701</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zrmeaohGpva" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20241231_zAcX63zxC0ug" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,015,549</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20231231_zxSXBkvWKul4" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,096,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20241231_zGnJtiIeiTXk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,147,108</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20231231_z3eRhSrvjrMg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,559,872</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20241231_zPgL8ZvskRI2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,868,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20231231_zaTDlS2QOh0g" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,536,823</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zvMh3XLlRYRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total depreciation expense for the years ended December 31, 2024 and 2023, was $<span id="xdx_90B_eus-gaap--Depreciation_c20240101__20241231_zoNaLp0FKa03" title="Depreciation expense">3,875,614</span> and $<span id="xdx_90B_eus-gaap--Depreciation_c20230101__20231231_zcGsCyDPZ0Db" title="Depreciation expense">4,450,466</span>, respectively, all of which was recorded in our general and administrative expenses on our statement of operations. During the year ended December 31, 2024, we disposed of assets with a net book value of $<span id="xdx_905_eus-gaap--GainLossOnDispositionOfAssets_c20240101__20241231_ziCEfoNq50v8" title="Gain loss on disposal of assets">180,223</span>. During the year ended December 31, 2023, we sold assets with a total net book value of $<span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iI_c20231231_zpKehQwCfS8l" title="Net book value">26,731</span> for cash of $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_c20230101__20231231_zTl09pAq9hyf" title="Cash received from the disposal of fixed assets">23,278</span> and bitcoin worth $<span id="xdx_902_ecustom--CryptocurrencyReceivedFromSaleOfFixedAssets_c20230101__20231231__srt--CryptoAssetAxis__custom--BitcoinMember_zb20c9xf7bc1" title="Bitcoin received from sale of fixed assets">9,913</span>, therefore recognized a gain on disposal of assets of $<span id="xdx_900_eus-gaap--GainLossOnDispositionOfAssets_c20230101__20231231_z0agBtUdgTVf" title="Gain loss on disposal of assets">6,460</span>. This gain was offset by loss on disposal of assets with a net book value of $<span id="xdx_909_eus-gaap--GainLossOnDispositionOfAssets1_c20230101__20231231__srt--CryptoAssetAxis__custom--BitcoinMember_zsyj8uBNugL3" title="Loss on disposal of assets">55,255</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zCtOBHXRvG6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Lived Assets – Cryptocurrencies &amp; Intangible Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $<span id="xdx_904_eus-gaap--OtherAssetsCurrent_iI_c20241231_zUltmPqSCIlk" title="Cryptocurrencies">1,127,891</span> and $<span id="xdx_90A_eus-gaap--OtherAssetsCurrent_iI_c20231231_z3wf055f8bDi" title="Cryptocurrencies">585,632</span>, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20241231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_zxfR0LEztcla" title="Revenue">5,186,606</span> and $<span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_z0cq0c13Vhs3" title="Revenue">11,348,156</span> for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $<span id="xdx_907_eus-gaap--CryptoAssetRealizedGainLossOperating_c20240101__20241231_zeBVPgA43ngb" title="Realized gain (losses) on cryptocurrency">452,450</span> and $<span id="xdx_90C_eus-gaap--CryptoAssetRealizedGainLossOperating_c20230101__20231231_ztaXHgPGC6Kg" title="Realized gains (losses) on cryptocurrency">255,268</span>, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $<span id="xdx_90F_eus-gaap--AssetImpairmentCharges_c20230101__20231231_z1PyLspt6Yfd" title="Asset impairment charges">2,056,386</span>. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $<span id="xdx_90B_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_c20230101__20231231_zjAg466iTel9" title="Crypto Impairment expense">0</span> due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zjCEdLoOlupi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of Long-Lived Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $<span id="xdx_90D_eus-gaap--TangibleAssetImpairmentCharges_c20240101__20241231_zjggRJGkYLsk" title="Asset impairment charges">1,771,891</span>. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, <span id="xdx_90B_eus-gaap--TangibleAssetImpairmentCharges_do_c20230101__20231231_zFcC8VB9p0F" title="Asset impairment charges">no</span> impairment was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPEk7QSFY1q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quoted prices for similar assets or liabilities in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quoted prices for identical or similar assets or liabilities in markets that are not active;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs other than quoted prices that are observable for the asset or liability; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments consist of cash, accounts receivable, and accounts payable. We have determined that the book value of our outstanding financial instruments as of December 31, 2024 and 2023, approximates the fair value due to their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zsd0FYLMeWnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zTxcAMGvNKml" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpUGROwgf30a" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdMX8pvhixS6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYdpxuzxApUd" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ze4sipRcHxlf" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zqXq95TxxC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DerivativeLiabilities_iI_zyb3jthhC9Ui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_zDsltS0mcN6j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zamKgWJNdb23" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znbVULTitou5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGSVFwbhNcld" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z35l7wrD9zl7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_z5C53CAOvtY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_iI_ziHw4eEtOTJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_zkpgqkOE3vNl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_z2RdlkqTcgC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6ees6iucqgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $<span id="xdx_906_eus-gaap--DeferredRevenue_iI_c20241231_zoBoYJVSRmJc" title="Deferred revenues">1,905,734</span> and $<span id="xdx_908_eus-gaap--DeferredRevenue_iI_c20231231_z7QTVnIzMnLf" title="Deferred revenues">2,703,398</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health and Wellness Product Sales and Other Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $<span id="xdx_90C_ecustom--DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate_iI_c20241231_z8OQRoPXWEf9" title="deposits collected from customers for orders to be filled at future date">1,014,164</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cryptocurrency Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, we generated <span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dxL_c20240101__20241231__srt--ProductOrServiceAxis__custom--CryptocurrencyRevenueMember_zPb7zK8o2Kje" title="Revenue::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0891">no</span></span> revenue from the sale of cryptocurrency packages.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Equipment Repair Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue generated for the year ended December 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zm5KsCXvA088" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2024, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z9KBS0FvLMy3" style="display: none">SCHEDULE OF REVENUE GENERATED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_z5rJGPBbLrNj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_znbZLngBabD4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240101__20241231__srt--ProductOrServiceAxis__custom--HealthAndWellnessRevenueMember_z4k984IOw6r1" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health and wellness product sales</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20240101__20241231__srt--ProductOrServiceAxis__custom--OtherMember_zgIIVDDRtEC4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240101__20241231_zjA6yroYJJ05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_z74lzZWK2gke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,086,839</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,856</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,407,705</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_zbqkMSAeGAdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,549</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(185</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0904">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,734</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eus-gaap--PaymentsToSuppliers_iN_di_zZQNzvLpgQOa" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwmwKbGZxnj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,061,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,381,971</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign revenues for the year ended December 31, 2024 were approximately $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--ForeignRevenueMember_zaIwNC99FVKb" title="Revenues">42.9</span> million while domestic revenue for the year ended December 31, 2024 was approximately $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--DomesticRevenueMember_zdERaginF9I2" title="Revenues">9.5</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue generated for the year ended December 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2023, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20230101__20231231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_zPiKrNWYxb3k" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231__srt--ProductOrServiceAxis__custom--CryptocurrencyRevenueMember_zf5deNEl4M04" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cryptocurrency Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_zarUWqiGtJnc" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231__srt--ProductOrServiceAxis__custom--MinerRepairRevenueMember_zYywCotwFSFh" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miner Repair Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231_zlzpqOLuZs05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_zv1I1Aq6YOP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,516,836</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">990,785</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,879,155</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_z2wB8gaVpP8a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eus-gaap--PaymentsToSuppliers_iN_di_z9hZqGKGHbif" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zN5rF2G8qlH" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,036,052</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,285</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,920,871</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zKbR7fTNmPad" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign revenues for the year ended December 31, 2023 were approximately $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__custom--ForeignRevenueMember_zmnVDdBeiNR2" title="Revenues">51.0</span> million while domestic revenue for the year ended December 31, 2023 was approximately $<span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__custom--DomesticRevenueMember_zfdQlywUTPha" title="Revenues">16.9</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVasHQdwgPdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advertising, Selling, and Marketing Costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the year ended December 31, 2024 and 2023, totaled $<span id="xdx_902_eus-gaap--SellingAndMarketingExpense_c20240101__20241231_z87pqyT45Vte" title="Advertising, selling, and marketing expenses">569,491</span> and $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230101__20231231_z83VeGonbPC4" title="Advertising, selling, and marketing expenses">560,065</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zIGGSBB9kUGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of Sales and Service</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the year ended December 31, 2024 and 2023, totaled $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_c20240101__20241231_zydggLDXsmxi" title="Cost of sales and service">6,056,491</span> and $<span id="xdx_902_eus-gaap--OperatingCostsAndExpenses_c20230101__20231231_zgRzpPLJ0eDb" title="Cost of sales and service">10,736,709</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zRfzZvvUEK24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventory</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024, inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the discontinuation of our miner repair business during the quarter ended June 30, 2023, all related inventory was sold. During the year ended December 31, 2023, we recognized a loss on disposal of assets of $<span id="xdx_90E_eus-gaap--GainLossOnSaleOfOtherAssets_c20230101__20231231_zjK4DditzgQ" title="Loss on disposal on assets">174,835</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023 the net realizable value of our inventory was $<span id="xdx_908_eus-gaap--InventoryNet_iI_c20241231_zxV3cthhODXf" title="Inventory, entirely finished goods">495,865</span> and $<span id="xdx_90D_eus-gaap--InventoryNet_iI_dxL_c20231231_zXZqMhhPT8I2" title="Inventory, entirely finished goods::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0969">0</span></span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zvtp2O2LjeBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted ASC Subtopic 740-10, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerShareTextBlock_zCF85BIFmtQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Income (Loss) per Share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGpBJwKfpkI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_z4RofvmEg0wk" style="display: none">SCHEDULE OF DILUTED EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20240101__20241231_zHeGZsGiySri" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_zrA3hxfcbcnj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--ProfitLoss_z5jpvBM7NyHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,190,416</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,831,920</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DividendsPreferredStock_iN_di_zYPEqmGYvYf4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: preferred dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--InterestOnConvertibleDebtNetOfTax_zkIbkVNmKH1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add: interest expense on convertible debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_iT_zigBkUP0mg4j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income available to common shareholders (numerator)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,271,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,913,096</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zs8xeeMTrhD4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic weighted average number of common shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,908,219,120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,559,093,504</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_zHgjIivaEd4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of convertible notes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_zqX2NP0L8zX3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of non-voting membership interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_iT_zefylA882Pwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted weighted average number of common shares outstanding (denominator)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,944,647,691</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,595,522,075</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zA1bfGZFWgr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zD0rzhiVJGc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zSdLkA61Rjc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zbHm3e6rBQqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zrONxYQ1KvDe" style="display: none">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z9jd2yECeIof" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">359,698,857</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zKBIWOemKZHb" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,416,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zGS2Vt0MvYv" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zz9BR9iPJtpj" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zEEYDVDFyiej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_ze3PQc70ZWE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Obligation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We <span style="background-color: white">determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). <span style="background-color: white">Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for </span>each separate lease component and non-lease component associated with the lease components as a single lease component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTOokXVW2DRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of Accounting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our policy is to prepare our financial statements <span style="color: #303030">on the </span>accrual <span style="color: #303030">basis of </span>accounting in accordance with accounting principles generally <span style="color: #303030">accepted </span>in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zrqnCsyERqP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: iGenius, LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, Renu Laboratories LLC, and Goldman’s Pharmaceuticals LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements and the Company has recorded a noncontrolling interest for the 50% interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zRImkimWpmdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Segments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the CEO, President and COO and the CFO. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s three reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zkUlr7xfIF09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statement Reclassification</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zVWP5Kg1VKS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_z035CAJ89kb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20241231_zebR3ozZIy11" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2024 and 2023, cash balances that exceeded FDIC limits were $<span id="xdx_904_eus-gaap--CashUninsuredAmount_iI_c20241231_zwc7SIj1kRnl" title="Cash balances exceeded FDIC limits">10,837,830</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_iI_c20231231_z0wIwG71v696" title="Cash balances exceeded FDIC limits">3,778,085</span>, respectively. We have not experienced significant losses relating to these concentrations in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 10837830 3778085 <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zixu4BfRg8ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash Equivalents and Restricted Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2024 and 2023, we had <span id="xdx_907_eus-gaap--RestrictedCashAndCashEquivalents_iI_do_c20241231_zcpy9svPfhDh" title="Cash equivalents"><span id="xdx_90B_eus-gaap--RestrictedCashAndCashEquivalents_iI_do_c20231231_zwrzfY3KfoBh" title="Cash equivalents">no</span></span> cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_z1yuONEkD6Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zkVCI5QqqJek" style="display: none">SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231_z0uGhW4U4fBi" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20231231_zpNg1wzujtHl" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maCCERCzRmQ_zZ7eYoXBIz8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,912,276</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maCCERCzRmQ_zduLJYcn8Da4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash, current</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,354</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_mtCCERCzRmQ_zGrOjygfv0wd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash, cash equivalents, and restricted cash shown on the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,142,630</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zG0OTplP0Wsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount included in restricted cash represent funds required to be held in an escrow account by a contractual agreement and will be used for paying dividends to our Series B Preferred Stockholders and funds required to be held in an account as collateral for business charges on our Company credit card.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_895_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_z1yuONEkD6Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zkVCI5QqqJek" style="display: none">SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231_z0uGhW4U4fBi" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20231231_zpNg1wzujtHl" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maCCERCzRmQ_zZ7eYoXBIz8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,912,276</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maCCERCzRmQ_zduLJYcn8Da4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash, current</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,354</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_mtCCERCzRmQ_zGrOjygfv0wd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash, cash equivalents, and restricted cash shown on the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,467,710</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,142,630</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 22467710 20912276 230354 22467710 21142630 <p id="xdx_847_eus-gaap--ReceivablesPolicyTextBlock_zrIpy8E5k3ud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivables</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_89C_eus-gaap--ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_ziZyKgOjKMW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables were made up of the following as of each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zLangaCoHFhh">SCHEDULE OF RECEIVABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20241231_z6t7cJRpqXI9" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zcavq84dkSAh" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DueFromMerchantProcessors_iI_maARGzmLm_zWln2dXMUJAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from merchant processors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,921</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,732,456</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks_iI_maARGzmLm_z29VYwmhFaUe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Held in reserve by merchant processors for future returns and chargebacks <span id="xdx_F43_zWXJPwSddrk7">[1]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,872,035</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,219,342</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--DueFromPayoutServiceProviders_iI_maARGzmLm_zQFueOMcdyNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from payout service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,558</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,251</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGzmLm_zMTfHf7eOBE9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts and other receivables</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,213</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0753">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccountsReceivableGross_iTI_mtARGzmLm_maARNz574_zz1L5lQMbet6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Receivable, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,955,049</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_di_msARNz574_zF3ILqLOSFVl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(722,324</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--AccountsReceivableNet_iTI_mtARNz574_z1oAtyT2cZY" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,232,725</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_z7ITZphKHbWb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zOwcYEYIvJE6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_zwu6BFdeD4dk" title="Credit card receivables">1.87</span> million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”</span></td></tr></table> <p id="xdx_8A3_zU2fwSwzKvIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_ziZyKgOjKMW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables were made up of the following as of each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zLangaCoHFhh">SCHEDULE OF RECEIVABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20241231_z6t7cJRpqXI9" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zcavq84dkSAh" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DueFromMerchantProcessors_iI_maARGzmLm_zWln2dXMUJAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from merchant processors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,921</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,732,456</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--HeldInReserveByMerchantProcessorsForFutureReturnsAndChargebacks_iI_maARGzmLm_z29VYwmhFaUe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Held in reserve by merchant processors for future returns and chargebacks <span id="xdx_F43_zWXJPwSddrk7">[1]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,872,035</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,219,342</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--DueFromPayoutServiceProviders_iI_maARGzmLm_zQFueOMcdyNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due from payout service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,558</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,251</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGzmLm_zMTfHf7eOBE9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts and other receivables</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,213</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0753">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccountsReceivableGross_iTI_mtARGzmLm_maARNz574_zz1L5lQMbet6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Receivable, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,955,049</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_di_msARNz574_zF3ILqLOSFVl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(722,324</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--AccountsReceivableNet_iTI_mtARNz574_z1oAtyT2cZY" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,534,727</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,232,725</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_z7ITZphKHbWb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zOwcYEYIvJE6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_zwu6BFdeD4dk" title="Credit card receivables">1.87</span> million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.”</span></td></tr></table> 318921 1732456 1872035 1219342 296558 3251 47213 2534727 2955049 722324 2534727 2232725 1870000 <p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zr2ccO4IXnW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fixed Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zYkuyU2K4cma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets were made up of the following at each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_z2gePXTC3kkj" style="display: none">SCHEDULE OF FIXED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture, fixtures, and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zFh2KwDr4Txb" title="Estimated useful life of fixed assets">10</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zV8E8y3duoSj" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zHqMCknt8Oc2" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4VJPYEtVFY" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zMCqMvJHw5na" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zfprGu0GMk9k" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,308</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data processing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zTVUX9Z1VEG4" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zhwnSoMqtP8" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,824,560</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zYxW9oMnblhg" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,084,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z0hfr65oawqk" title="Estimated useful life of fixed assets">3</span>-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zvWPZNxidO57" title="Estimated useful life of fixed assets">25</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_z0KJvDF461N4" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,161,701</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zrmeaohGpva" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20241231_zAcX63zxC0ug" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,015,549</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20231231_zxSXBkvWKul4" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,096,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20241231_zGnJtiIeiTXk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,147,108</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20231231_z3eRhSrvjrMg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,559,872</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20241231_zPgL8ZvskRI2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,868,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20231231_zaTDlS2QOh0g" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,536,823</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zvMh3XLlRYRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total depreciation expense for the years ended December 31, 2024 and 2023, was $<span id="xdx_90B_eus-gaap--Depreciation_c20240101__20241231_zoNaLp0FKa03" title="Depreciation expense">3,875,614</span> and $<span id="xdx_90B_eus-gaap--Depreciation_c20230101__20231231_zcGsCyDPZ0Db" title="Depreciation expense">4,450,466</span>, respectively, all of which was recorded in our general and administrative expenses on our statement of operations. During the year ended December 31, 2024, we disposed of assets with a net book value of $<span id="xdx_905_eus-gaap--GainLossOnDispositionOfAssets_c20240101__20241231_ziCEfoNq50v8" title="Gain loss on disposal of assets">180,223</span>. During the year ended December 31, 2023, we sold assets with a total net book value of $<span id="xdx_90E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iI_c20231231_zpKehQwCfS8l" title="Net book value">26,731</span> for cash of $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_c20230101__20231231_zTl09pAq9hyf" title="Cash received from the disposal of fixed assets">23,278</span> and bitcoin worth $<span id="xdx_902_ecustom--CryptocurrencyReceivedFromSaleOfFixedAssets_c20230101__20231231__srt--CryptoAssetAxis__custom--BitcoinMember_zb20c9xf7bc1" title="Bitcoin received from sale of fixed assets">9,913</span>, therefore recognized a gain on disposal of assets of $<span id="xdx_900_eus-gaap--GainLossOnDispositionOfAssets_c20230101__20231231_z0agBtUdgTVf" title="Gain loss on disposal of assets">6,460</span>. This gain was offset by loss on disposal of assets with a net book value of $<span id="xdx_909_eus-gaap--GainLossOnDispositionOfAssets1_c20230101__20231231__srt--CryptoAssetAxis__custom--BitcoinMember_zsyj8uBNugL3" title="Loss on disposal of assets">55,255</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zYkuyU2K4cma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets were made up of the following at each balance sheet date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_z2gePXTC3kkj" style="display: none">SCHEDULE OF FIXED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture, fixtures, and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zFh2KwDr4Txb" title="Estimated useful life of fixed assets">10</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zV8E8y3duoSj" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixturesAndEquipmentMember_zHqMCknt8Oc2" style="width: 14%; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4VJPYEtVFY" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zMCqMvJHw5na" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zfprGu0GMk9k" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,308</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data processing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zTVUX9Z1VEG4" title="Estimated useful life of fixed assets">3</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zhwnSoMqtP8" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,824,560</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DataProcessingEquipmentMember_zYxW9oMnblhg" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,084,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z0hfr65oawqk" title="Estimated useful life of fixed assets">3</span>-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zvWPZNxidO57" title="Estimated useful life of fixed assets">25</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_z0KJvDF461N4" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,161,701</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zrmeaohGpva" style="border-bottom: Black 1pt solid; text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20241231_zAcX63zxC0ug" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,015,549</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_ma1_c20231231_zxSXBkvWKul4" style="text-align: right" title="Property, plant and equipment, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,096,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20241231_zGnJtiIeiTXk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,147,108</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_ms1_c20231231_z3eRhSrvjrMg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,559,872</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20241231_zPgL8ZvskRI2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,868,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mt1_c20231231_zaTDlS2QOh0g" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,536,823</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> P10Y 717 717 P3Y 28571 11308 P3Y 11824560 14084670 P3Y P25Y 1161701 13015549 14096695 11147108 7559872 1868441 6536823 3875614 4450466 180223 26731 23278 9913 6460 55255 <p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zCtOBHXRvG6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Lived Assets – Cryptocurrencies &amp; Intangible Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our cryptocurrencies and intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Our cryptocurrencies are deemed to have an indefinite useful life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We hold cryptocurrency-denominated assets and include them in our consolidated balance sheet as other assets. The value of our cryptocurrencies as of December 31, 2024 and December 31, 2023, were $<span id="xdx_904_eus-gaap--OtherAssetsCurrent_iI_c20241231_zUltmPqSCIlk" title="Cryptocurrencies">1,127,891</span> and $<span id="xdx_90A_eus-gaap--OtherAssetsCurrent_iI_c20231231_z3wf055f8bDi" title="Cryptocurrencies">585,632</span>, respectively. Cryptocurrencies purchased or received for payment from customers are recorded in accordance with ASC 350-30 and cryptocurrencies awarded to the Company through its mining activities ($<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20241231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_zxfR0LEztcla" title="Revenue">5,186,606</span> and $<span id="xdx_909_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_z0cq0c13Vhs3" title="Revenue">11,348,156</span> for the year ended December 31, 2024 and 2023, respectively) are accounted for in connection with the Company’s revenue recognition policy. The use of cryptocurrencies is accounted for in accordance with the first in first out method of accounting. For the year ended December 31, 2024 and 2023, we recorded realized gains (losses) on our cryptocurrency transactions of $<span id="xdx_907_eus-gaap--CryptoAssetRealizedGainLossOperating_c20240101__20241231_zeBVPgA43ngb" title="Realized gain (losses) on cryptocurrency">452,450</span> and $<span id="xdx_90C_eus-gaap--CryptoAssetRealizedGainLossOperating_c20230101__20231231_ztaXHgPGC6Kg" title="Realized gains (losses) on cryptocurrency">255,268</span>, respectively. For the year ended December 31, 2023, we recognized impairment expense related to our cryptocurrency holdings of $<span id="xdx_90F_eus-gaap--AssetImpairmentCharges_c20230101__20231231_z1PyLspt6Yfd" title="Asset impairment charges">2,056,386</span>. The impairment was due to carrying value of our ndau coins exceeding its fair value what was deemed $<span id="xdx_90B_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_c20230101__20231231_zjAg466iTel9" title="Crypto Impairment expense">0</span> due to NDAU having no trade volume and not being listed on an exchange as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1127891 585632 5186606 11348156 452450 255268 2056386 0 <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zjCEdLoOlupi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of Long-Lived Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for the impairment of our long-lived assets in accordance with ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, data processing equipment which is our bitcoin miners were impaired $<span id="xdx_90D_eus-gaap--TangibleAssetImpairmentCharges_c20240101__20241231_zjggRJGkYLsk" title="Asset impairment charges">1,771,891</span>. The impairment was due to the carrying value of our data processing equipment exceeding its fair value which was determined using the price that similar equipment would sell for in the open market. During the year ended December 31, 2023, <span id="xdx_90B_eus-gaap--TangibleAssetImpairmentCharges_do_c20230101__20231231_zFcC8VB9p0F" title="Asset impairment charges">no</span> impairment was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1771891 0 <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPEk7QSFY1q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quoted prices for similar assets or liabilities in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quoted prices for identical or similar assets or liabilities in markets that are not active;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs other than quoted prices that are observable for the asset or liability; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments consist of cash, accounts receivable, and accounts payable. We have determined that the book value of our outstanding financial instruments as of December 31, 2024 and 2023, approximates the fair value due to their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zsd0FYLMeWnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zTxcAMGvNKml" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpUGROwgf30a" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdMX8pvhixS6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYdpxuzxApUd" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ze4sipRcHxlf" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zqXq95TxxC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DerivativeLiabilities_iI_zyb3jthhC9Ui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_zDsltS0mcN6j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zamKgWJNdb23" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znbVULTitou5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGSVFwbhNcld" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z35l7wrD9zl7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_z5C53CAOvtY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_iI_ziHw4eEtOTJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_zkpgqkOE3vNl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_z2RdlkqTcgC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zsd0FYLMeWnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zTxcAMGvNKml" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpUGROwgf30a" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdMX8pvhixS6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYdpxuzxApUd" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ze4sipRcHxlf" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zqXq95TxxC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DerivativeLiabilities_iI_zyb3jthhC9Ui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_zDsltS0mcN6j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zamKgWJNdb23" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znbVULTitou5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGSVFwbhNcld" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z35l7wrD9zl7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_z5C53CAOvtY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0871">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_iI_ziHw4eEtOTJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_zkpgqkOE3vNl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 758 758 758 758 5732 5732 5732 5732 <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z6ees6iucqgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most of our revenue is generated by membership sales and payment is received at the time of purchase. We recognize membership revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of December 31, 2024 and 2023, our deferred revenues for membership revenue were $<span id="xdx_906_eus-gaap--DeferredRevenue_iI_c20241231_zoBoYJVSRmJc" title="Deferred revenues">1,905,734</span> and $<span id="xdx_908_eus-gaap--DeferredRevenue_iI_c20231231_z7QTVnIzMnLf" title="Deferred revenues">2,703,398</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We generate revenue from mining bitcoin. The Company has entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract is terminable at any time by either party without penalty. Further, since the contract is continuously renewing, second by second, the mining contract is considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only begins when the Company provides computing power to the mining pool operator. In exchange for providing computing power, we are entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculates our share of block rewards, transaction fees, and mining pool operator fees. We are entitled to consideration even if a block is not successfully placed by the mining pool operator.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) is an output of the Company’s ordinary activities. The provision of providing such computing power is the only performance obligation in the Company’s contracts with the mining pool operator. The transaction consideration the Company receives is net of a contractually agreed upon mining pool operator fee charged and kept by the mining pool operator and is noncash, in the form of Bitcoin. Given that the contract is continuously renewing, and the duration is considered to be less than 24 hours, the Company measures the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur. There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health and Wellness Product Sales and Other Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were $<span id="xdx_90C_ecustom--DepositsCollectedFromCustomersForOrdersToBeFilledAtFutureDate_iI_c20241231_z8OQRoPXWEf9" title="deposits collected from customers for orders to be filled at future date">1,014,164</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cryptocurrency Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier. The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to arrange for the third-parties to provide coin and protection (if applicable) to our customers and payment was received from our customers at the time of order placement. All customers were given two weeks to request a refund, therefore we would record a customer advance on our balance sheet upon receipt of payment. After the two weeks have passed from order placement, we request our third-party supplier to deliver coin and protection (if applicable), at which time we recognize revenue and the amounts due to our supplier on our books.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, we generated <span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_dxL_c20240101__20241231__srt--ProductOrServiceAxis__custom--CryptocurrencyRevenueMember_zPb7zK8o2Kje" title="Revenue::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0891">no</span></span> revenue from the sale of cryptocurrency packages.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Equipment Repair Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through our wholly owned subsidiary, SAFETek, LLC, prior to June 30, 2023, we repaired broken mining equipment for sale to third-party customers. Our mining equipment repair business was discontinued during the quarter ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to June 30, 2023, we recognized miner repair revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation was to deliver the promised goods to our customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue generated for the year ended December 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zm5KsCXvA088" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2024, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z9KBS0FvLMy3" style="display: none">SCHEDULE OF REVENUE GENERATED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_z5rJGPBbLrNj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_znbZLngBabD4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240101__20241231__srt--ProductOrServiceAxis__custom--HealthAndWellnessRevenueMember_z4k984IOw6r1" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health and wellness product sales</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20240101__20241231__srt--ProductOrServiceAxis__custom--OtherMember_zgIIVDDRtEC4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240101__20241231_zjA6yroYJJ05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_z74lzZWK2gke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,086,839</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,856</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,407,705</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_zbqkMSAeGAdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,549</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(185</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0904">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,734</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eus-gaap--PaymentsToSuppliers_iN_di_zZQNzvLpgQOa" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwmwKbGZxnj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,061,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,381,971</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign revenues for the year ended December 31, 2024 were approximately $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--ForeignRevenueMember_zaIwNC99FVKb" title="Revenues">42.9</span> million while domestic revenue for the year ended December 31, 2024 was approximately $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--DomesticRevenueMember_zdERaginF9I2" title="Revenues">9.5</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue generated for the year ended December 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2023, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20230101__20231231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_zPiKrNWYxb3k" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231__srt--ProductOrServiceAxis__custom--CryptocurrencyRevenueMember_zf5deNEl4M04" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cryptocurrency Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_zarUWqiGtJnc" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231__srt--ProductOrServiceAxis__custom--MinerRepairRevenueMember_zYywCotwFSFh" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miner Repair Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231_zlzpqOLuZs05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_zv1I1Aq6YOP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,516,836</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">990,785</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,879,155</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_z2wB8gaVpP8a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eus-gaap--PaymentsToSuppliers_iN_di_z9hZqGKGHbif" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zN5rF2G8qlH" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,036,052</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,285</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,920,871</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zKbR7fTNmPad" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign revenues for the year ended December 31, 2023 were approximately $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__custom--ForeignRevenueMember_zmnVDdBeiNR2" title="Revenues">51.0</span> million while domestic revenue for the year ended December 31, 2023 was approximately $<span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20230101__20231231__srt--ProductOrServiceAxis__custom--DomesticRevenueMember_zfdQlywUTPha" title="Revenues">16.9</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1905734 2703398 1014164 <p id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zm5KsCXvA088" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2024, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z9KBS0FvLMy3" style="display: none">SCHEDULE OF REVENUE GENERATED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_z5rJGPBbLrNj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20240101__20241231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_znbZLngBabD4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240101__20241231__srt--ProductOrServiceAxis__custom--HealthAndWellnessRevenueMember_z4k984IOw6r1" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health and wellness product sales</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20240101__20241231__srt--ProductOrServiceAxis__custom--OtherMember_zgIIVDDRtEC4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240101__20241231_zjA6yroYJJ05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_z74lzZWK2gke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,086,839</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,856</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,407,705</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_zbqkMSAeGAdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,549</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(185</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0904">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,025,734</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eus-gaap--PaymentsToSuppliers_iN_di_zZQNzvLpgQOa" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwmwKbGZxnj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,061,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,186,606</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,404</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,381,971</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign revenues for the year ended December 31, 2024 were approximately $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--ForeignRevenueMember_zaIwNC99FVKb" title="Revenues">42.9</span> million while domestic revenue for the year ended December 31, 2024 was approximately $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20240101__20241231__srt--ProductOrServiceAxis__custom--DomesticRevenueMember_zdERaginF9I2" title="Revenues">9.5</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue generated for the year ended December 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue generated for the year ended December 31, 2023, was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20230101__20231231__srt--ProductOrServiceAxis__custom--MembershipRevenueMember_zPiKrNWYxb3k" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership <br/>Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231__srt--ProductOrServiceAxis__custom--CryptocurrencyRevenueMember_zf5deNEl4M04" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cryptocurrency Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231__srt--ProductOrServiceAxis__custom--MiningRevenueMember_zarUWqiGtJnc" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231__srt--ProductOrServiceAxis__custom--MinerRepairRevenueMember_zYywCotwFSFh" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miner Repair Revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231_zlzpqOLuZs05" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--GrossBillingsreceipts_zv1I1Aq6YOP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross billings/receipts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,516,836</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">990,785</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,879,155</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--RefundsIncentivesCreditsAndChargebacks_z2wB8gaVpP8a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refunds, incentives, credits, and chargebacks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,480,784</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eus-gaap--PaymentsToSuppliers_iN_di_z9hZqGKGHbif" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts paid to supplier</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(477,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zN5rF2G8qlH" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,036,052</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,285</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,348,156</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,378</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,920,871</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 50086839 5186606 110856 23404 55407705 -3025549 -185 -3025734 47061290 5186606 110671 23404 52381971 42900000 9500000 60516836 990785 11348156 23378 72879155 -4480784 -4480784 477500 477500 56036052 513285 11348156 23378 67920871 51000000.0 16900000 <p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVasHQdwgPdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advertising, Selling, and Marketing Costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the year ended December 31, 2024 and 2023, totaled $<span id="xdx_902_eus-gaap--SellingAndMarketingExpense_c20240101__20241231_z87pqyT45Vte" title="Advertising, selling, and marketing expenses">569,491</span> and $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230101__20231231_z83VeGonbPC4" title="Advertising, selling, and marketing expenses">560,065</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> 569491 560065 <p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zIGGSBB9kUGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of Sales and Service</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in our costs of sales and services is amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue, and the raw material and manufacturing costs of our health and wellness product sales. Costs of sales and services for the year ended December 31, 2024 and 2023, totaled $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_c20240101__20241231_zydggLDXsmxi" title="Cost of sales and service">6,056,491</span> and $<span id="xdx_902_eus-gaap--OperatingCostsAndExpenses_c20230101__20231231_zgRzpPLJ0eDb" title="Cost of sales and service">10,736,709</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6056491 10736709 <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zRfzZvvUEK24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventory</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024, inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the discontinuation of our miner repair business during the quarter ended June 30, 2023, all related inventory was sold. During the year ended December 31, 2023, we recognized a loss on disposal of assets of $<span id="xdx_90E_eus-gaap--GainLossOnSaleOfOtherAssets_c20230101__20231231_zjK4DditzgQ" title="Loss on disposal on assets">174,835</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023 the net realizable value of our inventory was $<span id="xdx_908_eus-gaap--InventoryNet_iI_c20241231_zxV3cthhODXf" title="Inventory, entirely finished goods">495,865</span> and $<span id="xdx_90D_eus-gaap--InventoryNet_iI_dxL_c20231231_zXZqMhhPT8I2" title="Inventory, entirely finished goods::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0969">0</span></span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 174835 495865 <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zvtp2O2LjeBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted ASC Subtopic 740-10, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerShareTextBlock_zCF85BIFmtQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Income (Loss) per Share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGpBJwKfpkI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_z4RofvmEg0wk" style="display: none">SCHEDULE OF DILUTED EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20240101__20241231_zHeGZsGiySri" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_zrA3hxfcbcnj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--ProfitLoss_z5jpvBM7NyHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,190,416</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,831,920</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DividendsPreferredStock_iN_di_zYPEqmGYvYf4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: preferred dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--InterestOnConvertibleDebtNetOfTax_zkIbkVNmKH1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add: interest expense on convertible debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_iT_zigBkUP0mg4j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income available to common shareholders (numerator)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,271,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,913,096</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zs8xeeMTrhD4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic weighted average number of common shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,908,219,120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,559,093,504</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_zHgjIivaEd4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of convertible notes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_zqX2NP0L8zX3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of non-voting membership interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_iT_zefylA882Pwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted weighted average number of common shares outstanding (denominator)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,944,647,691</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,595,522,075</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zA1bfGZFWgr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zD0rzhiVJGc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zSdLkA61Rjc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zbHm3e6rBQqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zrONxYQ1KvDe" style="display: none">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z9jd2yECeIof" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">359,698,857</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zKBIWOemKZHb" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,416,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zGS2Vt0MvYv" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zz9BR9iPJtpj" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zEEYDVDFyiej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGpBJwKfpkI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the computation of diluted earnings per share for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_z4RofvmEg0wk" style="display: none">SCHEDULE OF DILUTED EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20240101__20241231_zHeGZsGiySri" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_zrA3hxfcbcnj" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--ProfitLoss_z5jpvBM7NyHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,190,416</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,831,920</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DividendsPreferredStock_iN_di_zYPEqmGYvYf4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: preferred dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(819,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--InterestOnConvertibleDebtNetOfTax_zkIbkVNmKH1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add: interest expense on convertible debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,516</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_iT_zigBkUP0mg4j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income available to common shareholders (numerator)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,271,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,913,096</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zs8xeeMTrhD4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic weighted average number of common shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,908,219,120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,559,093,504</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_zHgjIivaEd4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of convertible notes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,428,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_zqX2NP0L8zX3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive impact of non-voting membership interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_iT_zefylA882Pwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted weighted average number of common shares outstanding (denominator)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,944,647,691</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,595,522,075</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zA1bfGZFWgr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zD0rzhiVJGc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1190416 2831920 819340 819340 900516 900516 1271592 2913096 1908219120 2559093504 471428571 471428571 565000000 565000000 2944647691 3595522075 0.00 0.00 <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zbHm3e6rBQqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zrONxYQ1KvDe" style="display: none">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,<br/> 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z9jd2yECeIof" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">359,698,857</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zKBIWOemKZHb" style="width: 14%; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,416,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zGS2Vt0MvYv" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBPVEVOVElBTExZIERJTFVUSVZFIFNFQ1VSSVRJRVMgKERldGFpbHMpAA__" id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zz9BR9iPJtpj" style="text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 359698857 360416665 1178090 1178129 <p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_ze3PQc70ZWE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Obligation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We <span style="background-color: white">determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have elected to not apply the recognition requirements of ASC 842 to short-term leases (leases with terms of twelve months or less). <span style="background-color: white">Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for </span>each separate lease component and non-lease component associated with the lease components as a single lease component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_806_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zinq4x19TpMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_825_zoMriGfJh2dd">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued (or made available for issuance). If an entity adopts the amendments in an interim period, it must adopt them as of the beginning of the fiscal year that includes that interim period. ASU No. 2023-08 requires a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company has not yet adopted ASU No. 2023-08 and is currently evaluating the impact that the adoption will have on the Company’s financial statement presentation and disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company did not elect early adoption and is currently evaluating the impact the updated guidance will have on its 2025 disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance reportable segment disclosures by requiring disclosures of significant segment expenses regularly provided to the CODM, requiring disclosure of the title and position of the CODM and explanation of how the reported measures of segment profit and loss are used by the CODM in assessing segment performance and allocation of resources. ASU 2023-07 is effective for the Company for annual periods beginning after December 31, 2023. The Company adopted ASU 2023-07 for the year ended December 31, 2024. As a result of the adoption, the Company added this disclosure in Note 11. Segment Information, to present significant expenses that are included within cost of revenue, by reportable segment, which are presented to the CODM.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zEiUstYlsv5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_829_zcSCKRBzIDrg">LIQUIDITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, we met our short-and long-term working capital and capital expenditure requirements. Our net cash provided by operating activities for the year ended December 31, 2024, was $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_c20240101__20241231_ziLithgyR78f" title="Net cash provided by operating activities">8.3</span> million. We used our cash provided by operating activities for the acquisition of substantially all the assets of Renu Labs for $<span id="xdx_90B_eus-gaap--PaymentsToAcquireInvestments_pn5n6_c20240101__20241231_zTtLS9HHUJol" title="Cash paid for purchase">1.1</span> million, the purchase of fixed assets in the amount of $<span id="xdx_904_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_pn5n6_c20240101__20241231_zOabUU2huIRg" title="Cash paid for fixed assets">0.5</span> million, principal and interest payments on debt of $<span id="xdx_903_eus-gaap--RepaymentsOfLongTermDebt_pn5n6_c20240101__20241231_zdfA6azcyHlc" title="Repayments for debt">1.3</span> million, the repurchase of common shares totaling $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfEquity_pn5n6_c20240101__20241231_zmlEsuxNeMH8" title="Payments for shares repurchased from related parties">3.4</span> million, total dividend payments on our preferred stock of $<span id="xdx_900_eus-gaap--PaymentsOfDividends_pn5n6_c20240101__20241231_zAt7r4xSqprd" title="Dividends paid">0.7</span> million and added $<span id="xdx_90E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_pn5n6_c20240101__20241231_zo2NLiIRO5dh" title="Net increase (decrease) in cash, cash equivalents, and restricted cash">1.3</span> million to our cash balance, which totaled $<span id="xdx_903_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iI_pn5n6_c20241231_z8FuFMLoq9o3" title="Cash, cash equivalents, and restricted cash">22.5</span> million at December 31, 2024. We believe we will have sufficient resources, including cash flow from operations and access to capital markets, to meet debt service and other obligations in a timely manner and be able to meet our objectives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8300000 1100000 500000 1300000 3400000 700000 1300000 22500000 <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zYxNufjVukqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82D_zBwX4l2gJNK">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party Debt</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zVkspc8HuMwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our related party debt consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_z0sVVl7v0ssh" style="display: none">SCHEDULE OF RELATED PARTY PAYABLES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20241231_zPH2NVsPI611" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231_zlzfgSUo0Eq6" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember_maDTRPCzjvc_zLgY9KAWlUC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 4/27/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zgmMKn9BiVlg">692,004 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F4F_zf2H8e1EJ209">[1]</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">607,996</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">477,711</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteOneMember_maDTRPCzjvc_zmbAiRQSxdyg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 5/27/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z4u7mgrtVJuc">375,700 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F44_zKH2ypfPcmFg">[2]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">324,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,566</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteTwoMember_maDTRPCzjvc_zTsVgWaL9jX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 11/9/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zxwHFJlkJn38">731,254 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F49_zJdUddmKCrtg">[3]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">568,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteThreeMember_zKDrTGRE42qk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working Capital Promissory Note entered into on 3/22/21 <span id="xdx_F4A_zJ5btSdck6ca">[4]</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,204,567</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,203,247</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqIyombq0tfd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total related-party debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,705,608</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,365,596</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zBpFinYX1nb9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,204,567</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,203,247</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbTwMlsBA7vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related-party debt, long term</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,501,041</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,162,349</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zRm3FYJwu9x6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8qIAm1wNCf4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 27, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ProceedsFromRelatedPartyDebt_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zLqHsavJIrA1" title="Proceeds from related parties">1,300,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zFQKjZ1JlcPk" title="Debt instrument interest percentage">20</span>% per annum, payable monthly, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zGymu318rwu" title="Debt instrument due date">April 27, 2030</span>. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zMn11q64fuDh" title="Debt conversion price per share">0.01257</span> per share, which was amended on November 9, 2020 to reduce the conversion price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z6TL4Hs4hwrf" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zTMAOkZqDqkd" title="Beneficial conversion feature">1,300,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zmw5xwoSZ4x3" title="Amortization of debt discount">130,285</span> of the debt discount into interest expense, as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zXCQpOFQEZ9a" title="Interest expense">260,016</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F01_zpeX2tMF2eDc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zxYwN5lM33Gg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 27, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zsdkvlPm105h" title="Proceeds from related parties">700,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z0UYINPQFxri" title="Debt instrument interest percentage">20</span>% per annum, payable monthly, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zWlmqhvZpI03" title="Debt instrument due date">April 27, 2030</span>. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z7DT2hv18Oih" title="Debt conversion price">0.01257</span> per share, which was amended on November 9, 2020 to reduce the conversion price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_ztpQmr3tvKeb" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zlUMtXM879Al" title="Beneficial conversion feature">700,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zvrwuo6YbpK4" title="Amortization of Debt Discount (Premium)">70,738</span> of the debt discount into interest expense as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zIcRfdOK7hyb" title="Interest expense">140,000</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zlF34PgzbK21" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[3]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zJVwq51M4uG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ProceedsFromRelatedPartyDebt_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zLfN9RVN8jeb" title="Received proceeds from related party debt">1,300,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z71eOZ7PIwsj" title="Debt interest rate">38.5</span>% per annum, made up of a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zpvRcLGiBei2" title="Debt interest rate">25</span>% interest rate per annum and a facility fee of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_dp_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zakAhYDgYRr3" title="Facility fee percentage">13.5</span>% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zAdNab7JAcEa" title="Debt instrument maturity date">April 27, 2030</span>. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z0IWUsa1RpOd" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zuEKEJ34Np5l" title="Beneficial conversion feature and debt discount">1,300,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zRKpLpMGz0C4" title="Debt discount into interest expense">137,670</span> of the debt discount into interest expense as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_z4khmfMWTDV4" title="Interest expenses">500,500</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0C_zoQJIiq7mFpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[4]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z9dWc7UmUbc2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, we entered into Securities Purchase Agreements to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20210322__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--BusinessAcquisitionAxis__custom--SSATechnologiesLLCMember_zyWoymzSCb83" title="Acquired percentage">100</span>% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__srt--RangeAxis__srt--MaximumMember_zAwds6kKwOqc" title="Debt instrument face amount">1,500,000</span> before the end of 2021; however, SSA only provided advances of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zRXuRDZrh0o" title="Debt instrument face amount">1,200,000</span>, to date. The note bears interest at the rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zOA2BGAqpFl7" title="Debt interest rate">0.11</span>% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zZ1dcm4zdnkj" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--InterestExpenseOther_pp0p0_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zU8kSRWVCOvb" title="Interest expense">1,320</span></span> on the note. The note was to have been secured by the pledge of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_pp0p0_c20210322__20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zfyXEPydbP15" title="Debt instrument conversion feature">12,000,000</span> shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.</span></td></tr></table> <p id="xdx_8AD_zQQcgLLTimu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $<span id="xdx_901_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn6n6_c20200427__20200427__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DBRCapitalLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zG553zqcA0Z4" title="Related party transaction amounts of advance">11</span> million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2025, we and DBR Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated or ever.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Related Party Arrangements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zga4bIgbDLAg" title="Number of shares repurchased">302,919,223</span> shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $<span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodValue_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zj06GRxjunej" title="Shares purchased value">2,922,380</span>, representing a price of $<span id="xdx_900_eus-gaap--SharePrice_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_z70whVlkGQDc" title="Share price">0.00964739</span> per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zisV4YYxeN2g" title="Shares purchased value">1,189,643</span> under the Romano/Raynor Agreement of which $<span id="xdx_90C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember_zhsPs05MvQci" title="Accounts payable and accrued liabilities">1,189,643</span> is included in Accounts payable and accrued liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $<span id="xdx_90E_eus-gaap--LegalFees_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zooSO7cMl0ub" title="Legal fees">250,000</span> expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consideration paid for the Purchased Shares of $<span id="xdx_905_eus-gaap--PaymentsForRepurchaseOfEquity_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zCWJsXOriDXi" title="Consideration paid for purchased shares">2,922,380</span> plus the $<span id="xdx_902_eus-gaap--LegalFees_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_zK0cg1dVHjtl" title="Legal fees">250,000</span> expense allowance was allocated to the share purchase for a total of $<span id="xdx_90C_ecustom--PaymentsForRepurchaseOfEquityAndLegalFee_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_z8RTCtKhSR6a" title="Consideration paid for purchased shares and expenses">3,172,380</span> (see NOTE 9).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of <span id="xdx_900_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20240207__20240207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zlX0RSyZvWNb" title="Shares cancelled">472,374,710</span> shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240207__20240207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zIJMCOlSpwjj" title="Purchase price">3,571,146</span>, representing a price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20240207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zXehwKivbgkk" title="Purchase price per share">0.007559985</span> per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of December 31, 2024, we owed $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zdaA9YoyOLqe" title="Shares purchased value">1,785,573</span> under the Smith/Miller Agreement of which $<span id="xdx_90E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zdRg0FgQ4Rme" title="Accounts payable and accrued liabilities">1,785,572</span> is included in Accounts payable and accrued liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consideration paid for the Purchased Shares of $<span id="xdx_90B_ecustom--PaymentsForRepurchaseOfEquityAndLegalFee_c20240207__20240207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RyanSmithAndChandMillerMember_zRmkTsFky63j" title="Consideration paid for purchased shares and expenses">3,571,146</span> was allocated to the share purchase (see NOTE 9).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_891_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zVkspc8HuMwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our related party debt consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_z0sVVl7v0ssh" style="display: none">SCHEDULE OF RELATED PARTY PAYABLES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20241231_zPH2NVsPI611" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231_zlzfgSUo0Eq6" style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember_maDTRPCzjvc_zLgY9KAWlUC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 4/27/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zgmMKn9BiVlg">692,004 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F4F_zf2H8e1EJ209">[1]</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">607,996</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">477,711</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteOneMember_maDTRPCzjvc_zmbAiRQSxdyg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 5/27/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z4u7mgrtVJuc">375,700 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F44_zKH2ypfPcmFg">[2]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">324,304</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,566</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteTwoMember_maDTRPCzjvc_zTsVgWaL9jX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Promissory Note entered into on 11/9/20, net of debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zxwHFJlkJn38">731,254 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2024 <span id="xdx_F49_zJdUddmKCrtg">[3]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">568,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteThreeMember_zKDrTGRE42qk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working Capital Promissory Note entered into on 3/22/21 <span id="xdx_F4A_zJ5btSdck6ca">[4]</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,204,567</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,203,247</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqIyombq0tfd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total related-party debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,705,608</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,365,596</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zBpFinYX1nb9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,204,567</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,203,247</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbTwMlsBA7vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related-party debt, long term</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,501,041</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,162,349</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_zRm3FYJwu9x6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8qIAm1wNCf4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 27, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ProceedsFromRelatedPartyDebt_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zLqHsavJIrA1" title="Proceeds from related parties">1,300,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zFQKjZ1JlcPk" title="Debt instrument interest percentage">20</span>% per annum, payable monthly, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zGymu318rwu" title="Debt instrument due date">April 27, 2030</span>. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zMn11q64fuDh" title="Debt conversion price per share">0.01257</span> per share, which was amended on November 9, 2020 to reduce the conversion price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z6TL4Hs4hwrf" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20200427__20200427__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zTMAOkZqDqkd" title="Beneficial conversion feature">1,300,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zmw5xwoSZ4x3" title="Amortization of debt discount">130,285</span> of the debt discount into interest expense, as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--ChairmanMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zXCQpOFQEZ9a" title="Interest expense">260,016</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F01_zpeX2tMF2eDc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zxYwN5lM33Gg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 27, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zsdkvlPm105h" title="Proceeds from related parties">700,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z0UYINPQFxri" title="Debt instrument interest percentage">20</span>% per annum, payable monthly, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zWlmqhvZpI03" title="Debt instrument due date">April 27, 2030</span>. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z7DT2hv18Oih" title="Debt conversion price">0.01257</span> per share, which was amended on November 9, 2020 to reduce the conversion price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_ztpQmr3tvKeb" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20200527__20200527__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zlUMtXM879Al" title="Beneficial conversion feature">700,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zvrwuo6YbpK4" title="Amortization of Debt Discount (Premium)">70,738</span> of the debt discount into interest expense as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--InterestExpense_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zIcRfdOK7hyb" title="Interest expense">140,000</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zlF34PgzbK21" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[3]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zJVwq51M4uG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2020, we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ProceedsFromRelatedPartyDebt_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zLfN9RVN8jeb" title="Received proceeds from related party debt">1,300,000</span> from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z71eOZ7PIwsj" title="Debt interest rate">38.5</span>% per annum, made up of a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zpvRcLGiBei2" title="Debt interest rate">25</span>% interest rate per annum and a facility fee of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_dp_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zakAhYDgYRr3" title="Facility fee percentage">13.5</span>% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zAdNab7JAcEa" title="Debt instrument maturity date">April 27, 2030</span>. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_z0IWUsa1RpOd" title="Debt conversion price per share">0.007</span> per share. At inception we recorded a beneficial conversion feature and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20201109__20201109__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zuEKEJ34Np5l" title="Beneficial conversion feature and debt discount">1,300,000</span>. During the year ended December 31, 2024, we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--RelatedPartyTransactionAxis__custom--DBRCapitalLLCMember_zRKpLpMGz0C4" title="Debt discount into interest expense">137,670</span> of the debt discount into interest expense as well as expensed an additional $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_z4khmfMWTDV4" title="Interest expenses">500,500</span> of interest expense on the note, all of which was repaid during the period.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0C_zoQJIiq7mFpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[4]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z9dWc7UmUbc2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, we entered into Securities Purchase Agreements to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20210322__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--BusinessAcquisitionAxis__custom--SSATechnologiesLLCMember_zyWoymzSCb83" title="Acquired percentage">100</span>% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__srt--RangeAxis__srt--MaximumMember_zAwds6kKwOqc" title="Debt instrument face amount">1,500,000</span> before the end of 2021; however, SSA only provided advances of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zRXuRDZrh0o" title="Debt instrument face amount">1,200,000</span>, to date. The note bears interest at the rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zOA2BGAqpFl7" title="Debt interest rate">0.11</span>% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zZ1dcm4zdnkj" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--InterestExpenseOther_pp0p0_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zU8kSRWVCOvb" title="Interest expense">1,320</span></span> on the note. The note was to have been secured by the pledge of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_pp0p0_c20210322__20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zfyXEPydbP15" title="Debt instrument conversion feature">12,000,000</span> shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.</span></td></tr></table> 692004 607996 477711 375700 324304 253566 731254 568742 431072 1204567 1203247 2705608 2365596 1204567 1203247 1501041 1162349 1300000 0.20 2030-04-27 0.01257 0.007 1300000 130285 260016 700000 0.20 2030-04-27 0.01257 0.007 700000 70738 140000 1300000 0.385 0.25 0.135 2030-04-27 0.007 1300000 137670 500500 1 1500000 1200000 0.0011 1320 1320 12000000 11000000 302919223 2922380 0.00964739 1189643 1189643 250000 2922380 250000 3172380 472374710 3571146 0.007559985 1785573 1785572 3571146 <p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_zox2r5uIK31" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_823_za10RCMd7rr2">DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfDebtTableTextBlock_zURElWEkVvdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our debt consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zuAwU44cAhOf" style="display: none">SCHEDULE OF DEBT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/>2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/>2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan with the U.S. Small Business Administration dated 4/19/20 [1]</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_fWzFd_zbc8NA1gN5Ta" style="width: 14%; text-align: right" title="Loan with the U.S. Small Business Administration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,863</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_fWzFd_zx3KXwYDsuc3" style="width: 14%; text-align: right" title="Loan with the U.S. Small Business Administration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">530,306</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term notes for APEX lease buyback [2]</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--APEXTexLLCMember_fWzJd_z795yv35Bekk" style="border-bottom: Black 1pt solid; text-align: right" title="Long term notes for APEX lease buyback"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--APEXTexLLCMember_fWzJd_zIXe6LfkIMb8" style="border-bottom: Black 1pt solid; text-align: right" title="Long term notes for APEX lease buyback"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">685,883</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zLgVTn0xhcRh" style="text-align: right" title="Total debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,863</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z7Vjif8LWgX4" style="text-align: right" title="Total debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,216,189</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DebtDiscountCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zupFuwNGIS5b" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,244</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--DebtDiscountCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z8erMaE4XKwk" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">715,127</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt, long term portion</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z3bTyV6HV8u9" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt, long term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">490,619</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zkwLBi2WLLKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt, long term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">501,062</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_z6xCdlw0jQ31" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zn29gC3Guqta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2020 we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zplSr6KNPqwh" title="Proceeds from debt">500,000</span> from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zY3GNA9OoNK6" title="Debt instrument interest rate">3.75</span>% per annum and installment payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zZuShPF71tr" title="Monthly installment payments">2,437</span> monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_z6PqIfTJBPL7" title="Debt Instrument, interest">18,801</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zh5eShn7BtW1" title="Debt Instrument, interest">18,750</span> worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--RepaymentsOfConvertibleDebt_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_z8qGKHNWZvF4" title="Repayments on the loan">29,244</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--RepaymentsOfConvertibleDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zVfAP4ubbURb" title="Repayments on the loan">31,681</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfP9t2N9K8nc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zX07OTcY0X3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November of 2020, we entered into notes with third parties for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherLiabilities_iI_c20201130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_z3QWt3zc7kK2" title="Other liabilities">19,089,500</span> in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zYQNFmWHx78k" title="Common stock shares issued">48,000,000</span> shares of our common stock, issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zBf7AbnnkJ1g" title="Preferred stock shares issued">49,418</span> shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_z08UVNKPtrjh" title="Debt instrument interest percentage">75</span>% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200401__20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zrfAWgUIPwD8" title="Debt instrument, maturity date">December 31, 2024</span>, when the last monthly payment will be made, along with a balloon payment equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_ecustom--DebtInstrumentPeriodicPaymentTermsBalloonPaymentPercentage_iI_dp_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zl4ZEK0RgK25" title="Payment percentage">25</span>% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--RepaymentsOfDebt_c20240101__20241231__dei--LegalEntityAxis__custom--APEXTexLLCMember_zJGYBqmnXzG7" title="Repayments of debt">411,842</span> and issuances of cryptocurrency then valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--IssuancesOfCryptocurrencyValue_c20240101__20241231__dei--LegalEntityAxis__custom--APEXTexLLCMember_zujC0WRo7wxl" title="Issuances of cryptocurrency value">274,041</span>. As of December 31, 2024, the debt was paid in full.</span></td></tr></table> <p id="xdx_8A3_zS0RdtwhBOS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfDebtTableTextBlock_zURElWEkVvdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our debt consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zuAwU44cAhOf" style="display: none">SCHEDULE OF DEBT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/>2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/>2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan with the U.S. Small Business Administration dated 4/19/20 [1]</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_fWzFd_zbc8NA1gN5Ta" style="width: 14%; text-align: right" title="Loan with the U.S. Small Business Administration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,863</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_fWzFd_zx3KXwYDsuc3" style="width: 14%; text-align: right" title="Loan with the U.S. Small Business Administration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">530,306</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term notes for APEX lease buyback [2]</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--DebtInstrumentAxis__custom--APEXTexLLCMember_fWzJd_z795yv35Bekk" style="border-bottom: Black 1pt solid; text-align: right" title="Long term notes for APEX lease buyback"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--APEXTexLLCMember_fWzJd_zIXe6LfkIMb8" style="border-bottom: Black 1pt solid; text-align: right" title="Long term notes for APEX lease buyback"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">685,883</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zLgVTn0xhcRh" style="text-align: right" title="Total debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,863</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z7Vjif8LWgX4" style="text-align: right" title="Total debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,216,189</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DebtDiscountCurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zupFuwNGIS5b" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,244</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--DebtDiscountCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z8erMaE4XKwk" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">715,127</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt, long term portion</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z3bTyV6HV8u9" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt, long term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">490,619</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zkwLBi2WLLKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt, long term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">501,062</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_z6xCdlw0jQ31" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zn29gC3Guqta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2020 we received proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zplSr6KNPqwh" title="Proceeds from debt">500,000</span> from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zY3GNA9OoNK6" title="Debt instrument interest rate">3.75</span>% per annum and installment payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zZuShPF71tr" title="Monthly installment payments">2,437</span> monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_z6PqIfTJBPL7" title="Debt Instrument, interest">18,801</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zh5eShn7BtW1" title="Debt Instrument, interest">18,750</span> worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--RepaymentsOfConvertibleDebt_c20240101__20241231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_z8qGKHNWZvF4" title="Repayments on the loan">29,244</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--RepaymentsOfConvertibleDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--USSmallBusinessAdministrationMember_zVfAP4ubbURb" title="Repayments on the loan">31,681</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfP9t2N9K8nc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zX07OTcY0X3f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November of 2020, we entered into notes with third parties for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherLiabilities_iI_c20201130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_z3QWt3zc7kK2" title="Other liabilities">19,089,500</span> in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zYQNFmWHx78k" title="Common stock shares issued">48,000,000</span> shares of our common stock, issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zBf7AbnnkJ1g" title="Preferred stock shares issued">49,418</span> shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_z08UVNKPtrjh" title="Debt instrument interest percentage">75</span>% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200401__20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zrfAWgUIPwD8" title="Debt instrument, maturity date">December 31, 2024</span>, when the last monthly payment will be made, along with a balloon payment equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_ecustom--DebtInstrumentPeriodicPaymentTermsBalloonPaymentPercentage_iI_dp_c20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--APEXTexLLCMember_zl4ZEK0RgK25" title="Payment percentage">25</span>% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--RepaymentsOfDebt_c20240101__20241231__dei--LegalEntityAxis__custom--APEXTexLLCMember_zJGYBqmnXzG7" title="Repayments of debt">411,842</span> and issuances of cryptocurrency then valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--IssuancesOfCryptocurrencyValue_c20240101__20241231__dei--LegalEntityAxis__custom--APEXTexLLCMember_zujC0WRo7wxl" title="Issuances of cryptocurrency value">274,041</span>. As of December 31, 2024, the debt was paid in full.</span></td></tr></table> 519863 530306 685883 519863 1216189 29244 715127 490619 501062 500000 0.0375 2437 18801 18750 29244 31681 19089500 48000000 49418 0.75 2024-12-31 0.25 411842 274041 <p id="xdx_807_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zH5iTss6qqdg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_827_zHDCnfp23FA8">DERIVATIVE LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zzN0uaWtVu4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024 and 2023, we had the following activity in our derivative liability account:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zwmY1hTtZEU8" style="display: none">SCHEDULE OF DERIVATIVE LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20230101__20231231_zS0pecXvILa4" style="width: 14%; text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative extinguished with warrant exercise (see NOTE 9)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--DerivativeExtinguishedWithWarrantExercise_c20230101__20231231_zkek4V3cO5Ub" style="text-align: right" title="Derivative extinguished with warrant exercise"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230101__20231231_zRDyfIlICUXc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,691</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20240101__20241231_z6U8MEFjZwwb" style="text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20240101__20241231_zL5Y0q2UXzvk" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,974</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20240101__20241231_zc5GCXzlGrP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zA2V0YTJjpQk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zu7eFAPtgCAg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the binomial option pricing model to estimate fair value for those instruments, at inception, at warrant exercise, and at each reporting date. During the years ended December 31, 2024 and 2023, the assumptions used in our binomial option pricing model were in the following range:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_z3nP9DxsBvuh" style="display: none">SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3MPe7ZU0802" title="Fair value measurements valuation techniques, percent">4.16</span> - <span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfDvcntvu4b9" title="Fair value measurements valuation techniques, percent">4.25</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrdXNy7zzZvc" title="Fair value measurements valuation techniques, percent">4.01</span> - <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI6lgWzJ7pe9" title="Fair value measurements valuation techniques, percent">4.23</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life in years</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6sh56R8C5Nl" title="Expected life in years">0.58</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z58NOfIYQDfa" title="Expected life in years">1.50</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztDJ4203shdb" title="Expected life in years">1.58</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkGwhZuJPrxl" title="Expected life in years">2.50</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmS4duMWJnH9" title="Derivative liability measurement input">122</span>% - <span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw7PdDqwnkel" title="Derivative liability measurement input">142</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfIfkM1EkeFa" title="Derivative liability measurement input">116</span>% - <span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEO0bCknHRui" title="Derivative liability measurement input">122</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A8_zAYHlUg1gUa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zzN0uaWtVu4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024 and 2023, we had the following activity in our derivative liability account:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zwmY1hTtZEU8" style="display: none">SCHEDULE OF DERIVATIVE LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20230101__20231231_zS0pecXvILa4" style="width: 14%; text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative extinguished with warrant exercise (see NOTE 9)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--DerivativeExtinguishedWithWarrantExercise_c20230101__20231231_zkek4V3cO5Ub" style="text-align: right" title="Derivative extinguished with warrant exercise"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230101__20231231_zRDyfIlICUXc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,691</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20240101__20241231_z6U8MEFjZwwb" style="text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20240101__20241231_zL5Y0q2UXzvk" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,974</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20240101__20241231_zc5GCXzlGrP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 24426 -3 18691 5732 4974 758 <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zu7eFAPtgCAg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the binomial option pricing model to estimate fair value for those instruments, at inception, at warrant exercise, and at each reporting date. During the years ended December 31, 2024 and 2023, the assumptions used in our binomial option pricing model were in the following range:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_z3nP9DxsBvuh" style="display: none">SCHEDULE OF ASSUMPTIONS USED IN BINOMINAL OPTION PRICING MODEL</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3MPe7ZU0802" title="Fair value measurements valuation techniques, percent">4.16</span> - <span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfDvcntvu4b9" title="Fair value measurements valuation techniques, percent">4.25</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrdXNy7zzZvc" title="Fair value measurements valuation techniques, percent">4.01</span> - <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI6lgWzJ7pe9" title="Fair value measurements valuation techniques, percent">4.23</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life in years</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6sh56R8C5Nl" title="Expected life in years">0.58</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z58NOfIYQDfa" title="Expected life in years">1.50</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztDJ4203shdb" title="Expected life in years">1.58</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkGwhZuJPrxl" title="Expected life in years">2.50</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmS4duMWJnH9" title="Derivative liability measurement input">122</span>% - <span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw7PdDqwnkel" title="Derivative liability measurement input">142</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfIfkM1EkeFa" title="Derivative liability measurement input">116</span>% - <span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEO0bCknHRui" title="Derivative liability measurement input">122</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> 4.16 4.25 4.01 4.23 0.58 1.50 1.58 2.50 122 142 116 122 <p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zAmcHxHbwGla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82D_zyGM22aA8bL">OPERATING LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the MPower acquisition. This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (“the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered for use by our newly formed subsidiary Renu Laboratories LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $<span id="xdx_900_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20241231__us-gaap--LeaseContractualTermAxis__custom--WyckoffLeaseMember_zIB7i7MwgJA" title="Operating lease liability">22,034</span>. The original <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20241231__us-gaap--LeaseContractualTermAxis__custom--WyckoffLeaseMember_z0hMUlGYclud" title="Operating lease, term of contract">24.5</span>-month term of the Wyckoff Lease was extended through July 2025 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2024. The earliest termination date is July 31, 2024. At the extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $<span id="xdx_90B_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c20240101__20241231__us-gaap--LeaseContractualTermAxis__custom--WyckoffLeaseMember_zCt9NedR87e2" title="Operating lease liability">23,520</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20241231__us-gaap--LeaseContractualTermAxis__custom--HaverfordLeaseMember_z3NJ6lQGzDml" title="Operating lease right of use asset">125,522</span> and $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20241231__us-gaap--LeaseContractualTermAxis__custom--HaverfordLeaseMember_zXEKx4bJzR2a" title="Operating lease liability">152,961</span>, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $<span id="xdx_90D_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c20240101__20241231__us-gaap--LeaseContractualTermAxis__custom--HaverfordLeaseMember_zn7wOtWkaRVf" title="Exchange for new operating lease liability">172,042</span>. On August 7, 2024, the term of the Haverford Lease was extended through December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20241231__us-gaap--LeaseContractualTermAxis__custom--WarminsterLeaseMember_zbhX0ZSNCSki" title="Operating lease right of use asset">108,327</span>. The Warminster Lease will automatically terminate after the <span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20241231__us-gaap--LeaseContractualTermAxis__custom--WarminsterLeaseMember_zBUroz5jVvYj" title="Operating lease, term of contract">14</span>-month term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20241231__us-gaap--LeaseContractualTermAxis__custom--IvylandLeaseMember_z9OZdWEdC26b" title="Operating lease right of use asset">115,037</span>. The Ivyland Lease will automatically terminate after the <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20241231__us-gaap--LeaseContractualTermAxis__custom--IvylandLeaseMember_zmcaewlNSQZ5" title="Operating lease, term of contract">24</span>-month term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease expense was $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20240101__20241231_zqu4HF9F9ASa" title="Operating lease expense">130,710</span> for the year ended December 31, 2024. Operating cash flows used for the operating leases during the year ended December 31, 2024, was $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_c20240101__20241231_zXuoIYhpXpQl" title="Operating lease cost">135,809</span>. As of December 31, 2024, the weighted average remaining lease term was <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zOiJkmwmMlMe" title="Lease term">1.48</span> years, and the weighted average discount rate was <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20241231_zdnGe25ZiIR7" title="Weighted average discount rate">12</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zWDg0r6TC0a7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zzSqW7UvAFE4" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20241231_z9tuLxkTT7n9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzXm8_zp0o7bJArEQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,148</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzXm8_zK30HyxWPiVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,057</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzXm8_zu9mTIFFJVFd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232,205</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcJivAFOO4Uh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,065</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_zyyx2SMoVsKd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zaORpTrfMeHj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, current <span id="xdx_F4D_z8sF4zYQAbc7">[1]</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(165,707</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zFiOT7iX4z6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, long term</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,433</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F00_zbnaqP3VcLMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zMHawYTmwk6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents lease payments to be made in the next 12 months.</span></td></tr> </table> <p id="xdx_8AB_zorLzYguuwD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 22034 P24M15D 23520 125522 152961 172042 108327 P14M 115037 P24M 130710 135809 P1Y5M23D 0.12 <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zWDg0r6TC0a7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zzSqW7UvAFE4" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20241231_z9tuLxkTT7n9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzXm8_zp0o7bJArEQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,148</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzXm8_zK30HyxWPiVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,057</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzXm8_zu9mTIFFJVFd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232,205</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcJivAFOO4Uh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,065</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_zyyx2SMoVsKd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zaORpTrfMeHj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, current <span id="xdx_F4D_z8sF4zYQAbc7">[1]</span></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(165,707</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zFiOT7iX4z6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, long term</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,433</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F00_zbnaqP3VcLMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zMHawYTmwk6f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents lease payments to be made in the next 12 months.</span></td></tr> </table> 171148 61057 232205 20065 212140 165707 46433 <p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zdPDMiRamdq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82B_zpQAZQMiQuz1">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue up to <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20241231_zrkjPspr1aAh" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zBx5DTkR4DB8" title="Preferred stock, shares authorized">50,000,000</span></span> shares of preferred stock with a par value of $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20241231_zA4O6AugPPuc" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_z5ullqgev7Te" title="Preferred stock, par value">0.001</span></span> and our board of directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors approved the designation of <span id="xdx_902_ecustom--PreferredStockDesignated_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zofPk0hLfrc6" title="Preferred stock designated">2,000,000</span> of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zBLTiJvM9Zt1" title="Preferred stock par value">25</span> per share. Our Series B Preferred Stockholders are entitled to receive cumulative dividends at the annual rate of <span id="xdx_90D_ecustom--CumulativeDividendsAnnualRatePercentage_iI_dp_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQafqquZZtgl" title="Cumulative dividends annual rate percentage">13</span>% per annum of the stated value, equal to $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zExjiiEvNHtg" title="Preferred stock, par value">3.25</span> per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended March 31, 2021, we commenced an offering to sell a total of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200401__20210331__us-gaap--SubsidiarySaleOfStockAxis__custom--UnitOfferingMember_z9jlMt58so1e" title="Number of shares issued in transaction">2,000,000</span> units at $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20210331__us-gaap--SubsidiarySaleOfStockAxis__custom--UnitOfferingMember_z1nBULNlo7wd" title="Sale of stock, price per share">25</span> per unit (“Unit Offering”), with each unit consisting of: <span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20200401__20210331__us-gaap--SubsidiarySaleOfStockAxis__custom--UnitOfferingMember_zgntEXmEVs49" title="Description of offering">(i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 7).</span> The Unit Offering was completed on or about August 17, 2021, having resulted in the public offer and sale of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210817__20210817__us-gaap--SubsidiarySaleOfStockAxis__custom--UnitOfferingMember_z2KQIemuOq2g" title="Number of shares issued in transaction">252,192</span> Units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023, we had <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20241231_zDl8HXFSwF2f" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20241231_zpxR6zKmhu4l" title="Preferred stock, shares outstanding"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20231231_zih3xWCxo9jg" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20231231_zsz73Upa6W35" title="Preferred stock, shares outstanding">252,192</span></span></span></span> shares of preferred stock issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock Dividends</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, we recorded $<span id="xdx_90C_eus-gaap--DividendsCash_pp0p0_c20240101__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoj2yDmnvBS1" title="Dividends, cash">819,340</span> for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $<span id="xdx_907_eus-gaap--DividendsPreferredStockCash_pp0p0_c20240101__20241231_zoCFI0CfMQrl" title="Payments to preferred stock dividend">659,020</span> in cash and issued $<span id="xdx_906_eus-gaap--DividendsPreferredStockPaidinkind_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--CryptocurrencyMember_zvdN2g5o3Amh" title="Payments to preferred stock dividend crypto">171,611</span> worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $<span id="xdx_900_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20241231_zPuaAP3jExO9" title="Dividend liability">245,101</span> as a dividend liability on our balance sheet as of December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, we recorded $<span id="xdx_904_eus-gaap--DividendsCash_pp0p0_c20230101__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zRR88WnsISZk" title="Dividends, cash">819,340</span> for the cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $<span id="xdx_90C_eus-gaap--DividendsPreferredStockCash_pp0p0_c20230101__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zwqjsvwGCC0l" title="Payments to preferred stock dividend cash">627,856</span> in cash and issued $<span id="xdx_907_eus-gaap--DividendsPreferredStockPaidinkind_pp0p0_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--CryptocurrencyMember_zrHVUb1qfth9" title="Payments to preferred stock dividend crypto">171,722</span> worth of cryptocurrency to reduce the amounts owing. As a result, we recorded $<span id="xdx_906_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20231231_zGGYvadUoU88" title="Dividend liability">256,392</span> as a dividend liability on our balance sheet as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock Transactions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, we repurchased <span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember_z9fl4Gyi3rI1" title="Number of shares repurchased">472,374,710</span> shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $<span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember_zqLS4378CQK9" title="Exchange for cash">446,391</span> and payables of $<span id="xdx_909_ecustom--CommonStockRepurchasedForPayables_c20240101__20241231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember_zCcudUk9vc65" title="Consideration payable for purchased shares and expenses">3,124,755</span> (see NOTE 5). Also, during the year ended December 31, 2024, we cancelled <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb9g7B4XFtxb" title="Number of common stock shares cancelled">1,750,000</span> shares that had been issued but were forfeited by choice. As a result, we decreased common stock by $<span id="xdx_908_ecustom--ValueOfCommonStockSharesDecreased_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8noylEtvP7a" title="Value of common stock shares decreased">1,750</span> and increased additional paid in capital by the same. The forfeiture also resulted in the reversal of previously recorded expense resulting in a net $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20240101__20241231_z4FAN0qiyktk" title="Share based compensation expenses">10,002</span> reduction in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, we issued <span id="xdx_904_ecustom--AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2WZLegJGPH6" title="Warrant Exercise, shares">230</span> shares of common stock as a result of warrants exercised, resulting in proceeds of $<span id="xdx_906_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zZQCvPdxJz6c" title="Proceeds from warrant exercised">23</span> and an increase in additional paid in capital of $<span id="xdx_90E_ecustom--AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zAsTlvrV8YBf" title="Derivative liability extinguished with warrant exercise">3</span> for the derivative liability extinguished with the exercise (see NOTE 7). Also, during the year ended December 31, 2023, we repurchased <span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodShares_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarioRomanoAndAnnetteRaynorMember_z1SwWfxGrbIi" title="Number of shares repurchased">302,919,223</span> shares from two of the original founders of the Company and a series of their family members and related entities in exchange for cash of $<span id="xdx_90E_ecustom--PaymentsForRepurchaseOfEquityAndLegalFee_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__srt--TitleOfIndividualAxis__custom--MarioRomanoAndAnnetteRaynorMember_znDVJlUXtGZj" title="Consideration paid for purchased shares and expenses">396,547</span> and payables of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20230101__20231231_z5ZcdMaJSFC" title="Share based compensation expenses">2,775,833</span> (see NOTE 5). We also recognized $<span id="xdx_909_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAndReleaseAgreementMember__srt--TitleOfIndividualAxis__custom--MarioRomanoAndAnnetteRaynorMember_zVLpznq8AdH7" title="Stock-based compensation based on grant">20,341</span> in stock-based compensation based on grant date fair values and vesting terms of awards granted in prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024 and 2023, we had <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20241231_zki2ZBmQUe53" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20241231_zqDkpPBQUmzi" title="Common stock, shares outstanding">1,859,231,786</span></span> and <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20231231_zwwPRe4VmL31" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20231231_zEjwWz6IpCo2" title="Common stock, shares outstanding">2,333,356,496</span></span> shares of common stock issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhsc0wxmlcA1" title="Number of options to purchase shares of common stock">600,000,000</span> shares of the Company’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, we issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20240101__20241231_z916SVjPurMi" title="Number of options to purchase shares of common stock">1,000,000</span> stock options as part of the acquisition of Opencash Finance, Inc., <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20240101__20241231_zmOJHuvNUMUb" title="Number of options to purchase shares of common stock, stock options">10,000,000</span> stock options as part of a compensation package offered to a new officer of the Company, and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231__srt--TitleOfIndividualAxis__srt--OfficerMember_zXSnk5KcY0h3" title="Number of options to purchase shares of common stock">5,000,000</span> stock options as part of the purchase of the business and assets of Renu Laboratories, Inc. The options vest in equal amounts over a <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20240101__20241231_zrM9QP6ALvO3" title="Vest over period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1402">five</span></span>-year period, at an exercise price of $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231_zC8khvoJR35c" title="Exercise price increase">0.05</span> per share, with a seven-year life. We utilized the Black Scholes Model to value these options, and the expense related to these options is being recognized over the vesting term. Also, during the year ended December 31, 2024, we cancelled <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20240101__20241231_zJ3LXn7xCum1" title="Number of options, canceled">15,000,000</span> unvested options and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20240101__20241231_zo1hsakH3mTa" title="Number of options, vested">10,000,000</span> vested options expired upon the resignation of an officer of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zpARSDrNhYdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our options are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zSJxcWfUgXL3" style="display: none">SCHEDULE OF OPTIONS ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per Share</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding at December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231_z5qahgR91quh" style="width: 14%; text-align: right" title="Number of Options, Options outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,416,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zncfP9ZeAef6" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, Options outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zD3wcwck0J49" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20241231_zCeKZh2us0ek" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zFPZpP6xg2sk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20240101__20241231_zKVdVgUfoPhe" style="text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231_zJIY2jZc3dJ7" style="text-align: right" title="Number of Options, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zyKwCXWPTGU6" style="text-align: right" title="Weighted Average Exercise Price, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20240101__20241231_zZb8CgBa8wAj" style="text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20241231_zUvbgkUN91qe" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20241231_zJ3B65tmyQfa" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231_zMXJ2h9YFCM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Options outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,416,665</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zwkB314B0fGh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_z1emBAoMBCGl" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zcT59kNLEEFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zQHkE5f0kEPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of our options outstanding as of December 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_zXsd40C3d2H2" style="display: none">SCHEDULE OF OPTIONS OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Exercise Price of Options <br/>Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Contractual Life of Options <br/>Exercisable (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Contractual Life of Options <br/>Outstanding (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zmDpgA2xgBaj" style="width: 22%; text-align: right" title="Options Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,291,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231_zmpL4fnKlas4" style="width: 22%; text-align: right" title="Weighted Average Exercise Price of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231_zSpyL2gM0B24" title="Weighted Average Contractual Life of Options Exercisable (Years)">4.48</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zvcvSVjrg4Ga" title="Weighted Average Contractual Life of Options Outstanding (Years)">4.62</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_z27iPHHC3uW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total stock compensation expense related to the options for the year ended December 31, 2024 and 2023, was $<span id="xdx_903_eus-gaap--StockOptionPlanExpense_c20240101__20241231_z06lzaTZOK18" title="Stock compensation expense">1,610,536</span> and $<span id="xdx_900_eus-gaap--StockOptionPlanExpense_c20230101__20231231_zkoC1sxs1U4b" title="Stock compensation expense">2,555,155</span>, respectively. As of December 31, 2024 there was approximately $<span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn5n6_c20241231_zz5oh0XgOQNl" title="Unrecognized compensation cost">3.3</span> million of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingVestingPeriodContractualTerm_dtY_c20240101__20241231_z2zseDUGQ7xd" title="Weighted average vesting period">1.2</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_znL45aJHeol8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our warrants are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zyGnW6ddAXeh" style="display: none">SCHEDULE OF WARRANTS ISSUED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_zOEZ5LCLQTy" style="width: 14%; text-align: right" title="Number of Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,320</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zWDLMpAmou1i" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231_zgzt9CWAoRw1" style="text-align: right" title="Number of Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230101__20231231_zAHIVkP4rLd4" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20230101__20231231_z4wcoNTdWRw9" style="text-align: right" title="Number of Warrants Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1468">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled_c20230101__20231231_zUR6VG3i39ec" style="text-align: right" title="Weighted Average Exercise Price Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231_zEwscBN7RvSl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(230</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230101__20231231_zCaXC4IJOqoj" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_z3LaXBGmEQ7c" style="text-align: right" title="Number of Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zFYwfIgfKQMe" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zGAxpQRpEAKh" style="text-align: right" title="Number of Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20240101__20241231_zCUzRxc3xlGl" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20240101__20241231_zY0b8ipmr6Z5" style="text-align: right" title="Number of Warrants Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled_c20240101__20241231_zRxcxAuJBtof" style="text-align: right" title="Weighted Average Exercise Price Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20240101__20241231_zDee7EQorlIf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20240101__20241231_ztlyBvfw7Pd4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_zzW5hnb9V2A8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zImxwFWRNizd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zJ7MhKLkATL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--SummaryOfWarrantsOutstandingTableTextBlock_zAgkYvr3UpS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of our warrants outstanding as of December 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zLt37mVflOJk" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Contractual Life (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--WarrantsExercisable_iI_c20241231_zmxc44MdklGc" style="width: 45%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 49%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20241231_z3XPWHY18icf" title="Weighted Average Contractual Life (Years)">1.14</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zL5I9e8P36u3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B Units of Investview Financial Group Holdings, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2024, and December 31, 2023, there were <span id="xdx_903_eus-gaap--CommonUnitOutstanding_iI_c20241231__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember__srt--TitleOfIndividualAxis__custom--DavidBRothrockAndJamesRBellMember__us-gaap--StatementClassOfStockAxis__custom--ClassBUnitsMember_ztonHZJMf7l4" title="Common unit, outstanding"><span id="xdx_906_eus-gaap--CommonUnitOutstanding_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember__srt--TitleOfIndividualAxis__custom--DavidBRothrockAndJamesRBellMember__us-gaap--StatementClassOfStockAxis__custom--ClassBUnitsMember_z9RSBVBqy8Na" title="Common unit, outstanding">565,000,000</span></span> Units of Class B Investview Financial Group Holdings, LLC issued and outstanding. These units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. <span id="xdx_90C_eus-gaap--CommonStockVotingRights_c20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember__srt--TitleOfIndividualAxis__custom--DavidBRothrockAndJamesRBellMember__us-gaap--StatementClassOfStockAxis__custom--ClassBUnitsMember_zNTUgNUiAojd" title="Common stock, voting rights">The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement.</span> In order to properly account for the purchase transaction on the Company’s financial statements, we were required by applicable financial reporting standards to value the Class B Units issued to MPower in the transaction as of the closing date of the MPower sale transaction (September 3, 2021). For these accounting purposes, we concluded that the “fair value” of the consideration for financial accounting purposes, at the if-converted market value of the underlying common shares was $<span id="xdx_900_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_pn5n6_c20210902__20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_ztMkhzNk3KG1" title="Converted market value">58.9</span> million, based on the closing market price of $<span id="xdx_908_eus-gaap--BusinessAcquisitionSharePrice_iI_c20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_ztMxOB3hYmy6" title="Closing market price per share">0.1532</span> on the closing date of September 3, 2021, as discounted from $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_zIsDpAPrERP6" title="Transaction cost">86.6</span> million by <span id="xdx_903_ecustom--FairValueDiscountedPercentage_iI_pid_dp_c20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_zSnBJEPoMya2" title="Fair value discounted percentage">32</span>% (or $<span id="xdx_90C_ecustom--BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount_iI_pn5n6_c20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_zKL7tv06q9o2" title="Business acquisition, transaction costs discount value">27.7</span> million) to reflect the significant lock up period. The “fair value” valuation of the Class B Units, however, was completed relying on a certain set of methodologies that are accepted for accounting purposes and is not necessarily indicative of the “fair market value” that may be implied relative to such Units in a commercial transaction not governed by financial reporting standards. In particular, the methodology used to value the Class B Units at their “fair value” did not take into account any blockage discounts that may otherwise apply after the expiration of the lock-up period in 2025; while other valuation methodologies, not bound by financial reporting codifications, would possibly determine that the blockage discount associated with the resale of <span id="xdx_902_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pn6n6_c20210902__20210903__us-gaap--BusinessAcquisitionAxis__custom--InvestviewFinancialGroupHoldingLLCMember_zn76qCDMrGde" title="Number of exchange shares issuable">565</span> million shares after the expiration of the lock-up period, into a marketplace that has limited market liquidity, could possibly have a material downward influence on the valuation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 50000000 50000000 0.001 0.001 2000000 25 0.13 3.25 2000000 25 (i) one share of our newly authorized Series B Preferred Stock and (ii) five warrants each exercisable to purchase one share of common stock at an exercise price of $0.10 per warrant share. Each Warrant offered is immediately exercisable on the date of issuance, will expire 5 years from the date of issuance, and its value has been classified as a fair value liability due to the terms of the instrument (see NOTE 7). 252192 252192 252192 252192 252192 819340 659020 171611 245101 819340 627856 171722 256392 472374710 446391 3124755 1750000 1750 10002 230 23 3 302919223 396547 2775833 20341 1859231786 1859231786 2333356496 2333356496 600000000 1000000 10000000 5000000 0.05 15000000 10000000 <p id="xdx_892_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zpARSDrNhYdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our options are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zSJxcWfUgXL3" style="display: none">SCHEDULE OF OPTIONS ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per Share</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding at December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231_z5qahgR91quh" style="width: 14%; text-align: right" title="Number of Options, Options outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,416,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zncfP9ZeAef6" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, Options outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20241231_zD3wcwck0J49" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Options outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20241231_zCeKZh2us0ek" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zFPZpP6xg2sk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20240101__20241231_zKVdVgUfoPhe" style="text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20240101__20241231_zJIY2jZc3dJ7" style="text-align: right" title="Number of Options, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20241231_zyKwCXWPTGU6" style="text-align: right" title="Weighted Average Exercise Price, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20240101__20241231_zZb8CgBa8wAj" style="text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20241231_zUvbgkUN91qe" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20241231_zJ3B65tmyQfa" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20241231_zMXJ2h9YFCM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Options outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,416,665</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zwkB314B0fGh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Options outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20241231_z1emBAoMBCGl" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Per Share Fair Value, Options outstanding ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 360416665 0.05 0.03 16000000 0.05 0.01 25000000 0.05 0.03 351416665 0.05 0.03 <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zQHkE5f0kEPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of our options outstanding as of December 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_zXsd40C3d2H2" style="display: none">SCHEDULE OF OPTIONS OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Exercise Price of Options <br/>Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Contractual Life of Options <br/>Exercisable (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average <br/>Contractual Life of Options <br/>Outstanding (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zmDpgA2xgBaj" style="width: 22%; text-align: right" title="Options Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,291,665</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20241231_zmpL4fnKlas4" style="width: 22%; text-align: right" title="Weighted Average Exercise Price of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231_zSpyL2gM0B24" title="Weighted Average Contractual Life of Options Exercisable (Years)">4.48</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zvcvSVjrg4Ga" title="Weighted Average Contractual Life of Options Outstanding (Years)">4.62</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 183291665 0.05 P4Y5M23D P4Y7M13D 1610536 2555155 3300000 P1Y2M12D <p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_znL45aJHeol8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our warrants are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zyGnW6ddAXeh" style="display: none">SCHEDULE OF WARRANTS ISSUED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_zOEZ5LCLQTy" style="width: 14%; text-align: right" title="Number of Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,320</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zWDLMpAmou1i" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231_zgzt9CWAoRw1" style="text-align: right" title="Number of Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230101__20231231_zAHIVkP4rLd4" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20230101__20231231_z4wcoNTdWRw9" style="text-align: right" title="Number of Warrants Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1468">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled_c20230101__20231231_zUR6VG3i39ec" style="text-align: right" title="Weighted Average Exercise Price Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231_zEwscBN7RvSl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(230</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230101__20231231_zCaXC4IJOqoj" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20241231_z3LaXBGmEQ7c" style="text-align: right" title="Number of Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zFYwfIgfKQMe" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20241231_zGAxpQRpEAKh" style="text-align: right" title="Number of Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20240101__20241231_zCUzRxc3xlGl" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled/Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20240101__20241231_zY0b8ipmr6Z5" style="text-align: right" title="Number of Warrants Canceled/Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled_c20240101__20241231_zRxcxAuJBtof" style="text-align: right" title="Weighted Average Exercise Price Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20240101__20241231_zDee7EQorlIf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20240101__20241231_ztlyBvfw7Pd4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding at December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20241231_zzW5hnb9V2A8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20240101__20241231_zImxwFWRNizd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1178320 0.10 230 0.10 1178090 0.10 1178090 0.10 <p id="xdx_893_ecustom--SummaryOfWarrantsOutstandingTableTextBlock_zAgkYvr3UpS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of our warrants outstanding as of December 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zLt37mVflOJk" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Contractual Life (Years)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--WarrantsExercisable_iI_c20241231_zmxc44MdklGc" style="width: 45%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,178,090</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 49%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20241231_z3XPWHY18icf" title="Weighted Average Contractual Life (Years)">1.14</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1178090 P1Y1M20D 565000000 565000000 The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement. 58900000 0.1532 86600000 0.32 27700000 565000000 <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZ6zShYWUm0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_823_zz9bqgKZo9X1">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Litigation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, we may be, or have been, involved in legal proceedings. On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted, however, agreed to pay a civil monetary penalty of $<span id="xdx_909_eus-gaap--LitigationSettlementExpense_pp2d_c20250117__20250117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhalVInaedc3">375,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to conclude the inquiry. The Company considers this matter to be closed. As of December 31, 2024, the penalty of $<span id="xdx_90F_eus-gaap--EscrowDeposit_iI_c20241231_zQo0a4ZUpyg7" title="Escrow deposit">375,000</span> was in escrow with our SEC attorney.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $<span id="xdx_90C_eus-gaap--ProceedsFromRepaymentsOfDebt_pn6n6_c20241201__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDemcnrCSuI5" title="Repayment of debt">19</span> million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a <span id="xdx_900_ecustom--DebtPremiumPercentage_pid_dp_c20241201__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zBwcLhW3hWRa" title="Debt premium percentage">25</span>% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled the approximately $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_pn6n6_c20241201__20241231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zRDifNbP5O56" title="Repayment of debt">19</span> million of promissory notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered and managed by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separately, iGenius members who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm that had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau in August 2023, we distributed over $<span id="xdx_906_ecustom--DistributionOfDigitalCurrenciesPriorToTermination_pn5n6_c20230801__20230831_zlmWdwpxYj6c">16.6</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in ndau to our members purportedly supported by the TPP Program. As in the same case as had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, and those premiums were included in the purchase price for the ndau program, at no additional cost to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our members; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program has recently increased materially as we have come to learn that: (i) certain of our customers have been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) certain customers have informed us that the TPP website has been inoperative and customers have been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, has been received by certain of customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now has no ability to satisfy the commitments originally made by TPP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To respond to these concerns, and in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP, despite the substantial payments made to TPP to secure the benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed and administered by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims could have an adverse effect on our business, financial condition, and operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statements as of December 31, 2024, reflect a receivables balance of $<span id="xdx_90B_eus-gaap--OtherReceivablesNetCurrent_iI_pn4n6_c20241231_z5x0JG9ErFxg" title="Receivable balances">2.53</span> million. Of that balance, $<span id="xdx_903_eus-gaap--ReceivablesNetCurrent_iI_pn4n6_c20241231__srt--ConsolidatedEntitiesAxis__custom--IGeniusLLCMember_z2Zx3i6GHpW" title="Receivable balance arise out of credit card transaction">2.19</span> million represents receivables that arise out of credit card transactions generated by the Company’s iGenius subsidiary. The credit card transactions that arise out of the ordinary course operations of the Company’s iGenius subsidiary are processed by the Company’s credit card processors, in conjunction with their clearing banks. Over time, the balance of credit card collections being held by one of our credit card processors and its clearing bank, which are legally supposed to be held for the benefit of the Company, subject to coverage for chargebacks and other normal course collection issues, has increased to approximately $<span id="xdx_90B_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_z0ZWORI9RAb7" title="Credit card receivables">1.87</span> million, an amount that has been generally confirmed by the credit card processor. As they had been unresponsive to our repeated demands for payment, claiming that they were in the process of concluding their internal accounting of the amounts due and status of our accounts, in March 2024, the Company instituted a lawsuit against this credit card processor and its clearing bank seeking, among other things, an accounting for and repayment of the withheld funds. Notwithstanding, to date, we have been unable, through negotiations and through our lawsuit, to recover any amount of the receivable balances owed to us as the credit card processor asserts, among others, that it continues to evaluate possible exposure to chargebacks and other normal course collection issues. Recently, however, the Company’s application for a pre-judgment writ of attachment against both the credit card processor and the clearing bank, has been granted. Although the Company’s collection efforts will likely be enhanced by application of the pre-judgment writ of attachment, there can still be no assurances that the Company will be able to collect some or all of the funds owed to it. Should the Company be unable to collect some or all of the funds owed, it will be caused to incur a corollary bad debt expense of up to the uncollected amount which is currently approximately $<span id="xdx_904_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_zVHWH0LK54Tj">1.87</span> million. Furthermore, the Company may be caused under generally accepted accounting principles, to incur a bad debt expense if it is determined that the amounts owed to the Company are unlikely to be collected, although the Company has not yet reached that conclusion. A charge of up to $<span id="xdx_906_eus-gaap--CreditCardReceivables_iI_pn4n6_c20241231_zGXkVkDGpiJ7">1.87</span> million, which represents less than 10% of the Company’s current assets, would not have a material adverse effect upon the Company’s long-term liquidity, however, could have a material adverse effect upon the Company’s net earnings in the period incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to his termination, Mr. Cammarata and the Company engaged in certain transactions as described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210330__srt--TitleOfIndividualAxis__custom--JosephCammarataMember_zS56lbcwz4rg" title="Debt instrument, principal amount">1,550,000</span> (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210330__srt--TitleOfIndividualAxis__custom--JosephCammarataMember_zAGEYQjGqwvd" title="Debt conversion price per share">0.02</span> per share, Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210921__srt--TitleOfIndividualAxis__custom--JosephCammarataMember_zeT4GsLZ7lGl" title="Debt conversion price per share">0.008</span> per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the proscribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. <span id="xdx_90F_eus-gaap--CommonStockConversionFeatures_c20240101__20241231__srt--TitleOfIndividualAxis__custom--JosephCammarataMember_ziq1jOM1p0K6" title="Common stock, terms of conversion">As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, we entered into Securities Purchase Agreements to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20210322__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--BusinessAcquisitionAxis__custom--SSATechnologiesLLCMember_zpTgvXKoYVdd" title="Acquired percentage">100</span>% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__srt--RangeAxis__srt--MaximumMember_zRnS22Lu3V41" title="Debt instrument face amount">1,500,000</span> before the end of 2021; however, SSA has only provided advances of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_ziH7N7qKgCsg" title="Debt instrument face amount">1,200,000</span> to date. The note bears interest at the rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zRFRBvFG5PZk" title="Debt interest rate">0.11</span>% per annum therefore we recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--InterestExpenseOther_pp0p0_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zQ3AoP82dDZi" title="Interest expense">990</span> worth of interest expense on the loan during the nine months ended September 30, 2024. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgUEFZQUJMRVMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pp0p0_c20210322__20210322__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__us-gaap--RelatedPartyTransactionAxis__custom--SSATechnologiesLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember_zOYV7f7ABqMk" title="Debt instrument conversion feature">12,000,000</span> shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 375000 375000 19000000 0.25 19000000 16600000 2530000 2190000 1870000 1870000 1870000 1550000 0.02 0.008 As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages by Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his recent incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata. 1 1500000 1200000 0.0011 990 12000000 <p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zVT4MNvwJDt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_822_zWx9pD6v2mu7">SEGMENT REPORTING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company has <span id="xdx_904_eus-gaap--NumberOfReportableSegments_dc_c20240101__20241231_zBrqz9FBkPma" title="Number of reportable segments">three</span> reportable segments, <span id="xdx_90E_eus-gaap--DescriptionOfTypesOfProductsAndServicesFromWhichEachReportableSegmentDerivesItsRevenues_c20240101__20241231_zw5IgkvXBj9l" title="Description of Products and Services">Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products</span>. <span id="xdx_900_eus-gaap--FactorsUsedToIdentifyEntitysReportableSegments_c20240101__20241231_zXwkBXyEGGM5" title="Factors used to identify entity's reportable segments">The reportable segments are identified based on the types of products that generate revenue.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 2024 and 2023, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Financial Education and Technology segment generates revenue through membership fees. The Blockchain Technology and Crypto Mining segment generates revenue primarily through its Bitcoin mining operation. The Manufacturing and Development of Health, Beauty and Wellness Products generates revenue primarily through the sale of health and wellness products manufactured to wholesale and retail customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_za79FtOp7Stk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zkXHU7s49kAc">SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--FinancialEducationAndTechnologyMember_zvdiZUHGMlZh" style="border-bottom: Black 1pt solid; text-align: center">Financial Education and Technology</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--BlockchainTechnologyAndCryptoMiningProductsAndServicesMember_zvdjYTmwS4xe" style="border-bottom: Black 1pt solid; text-align: center">Blockchain Technology and Crypto Mining Products and Services</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember_zBSnBvZnvRC7" style="border-bottom: Black 1pt solid; text-align: center">Manufacturing and Development of Health, Beauty and Wellness Products <span id="xdx_F5D_zY3cD2kTromh">[1]</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_zJLkPxmrg3q3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zQq9JrW45kth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">47,061,290</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,186,606</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">134,075</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">52,381,971</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--Commissions_z2Wlg5fx49kk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,913,260</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,913,260</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--MarketExperts_zVXQVxeCFKv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Market experts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,065,350</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1581">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,065,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--CreditCardProcessing_zI8HzFkt2PDi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Credit card processing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,949,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1586">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1587">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,949,087</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SalariesAndWages_zC7CGQb8NOSd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Salary and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,051,064</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">980,302</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">251,632</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,282,998</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--SellingAndMarketingExpense_zdI4rSf6xxr1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">565,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,803</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">568,240</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--EnergyAndHosting_z4wtsrLCqAOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Energy and hosting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,924,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,924,717</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Depreciation_zxxVrazrvDed" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,565</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,871,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1607">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,873,305</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AssetImpairmentCharges_zlbTI5hEo56h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Impairment expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1610">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,771,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1612">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,771,891</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_zevvSGsHg5K" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Cost of sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--GainLossOnDispositionOfAssets1_z0eUahyiVhS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss (gain) on disposal of assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1620">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,223</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1622">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,223</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_zK9fx6VE1CC7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative <span id="xdx_F42_zT6oVh1Imzg3">[2]</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,491,652</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">391,040</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">116,221</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,998,913</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_iT_zGDORS0Zhypk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment net income (loss) from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,023,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,935,110</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(291,299</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,797,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_zjavtKsDb3H9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zyXlFdbquTkf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Development of Health, Beauty and Wellness Products business was acquired in October 2024.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0E_zhsIQ2qz64If" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z1Quvg8Jr6Ab" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--FinancialEducationAndTechnologyMember_zowTb3RK9vKi" style="border-bottom: Black 1pt solid; text-align: center">Financial Education and Technology</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--BlockchainTechnologyAndCryptoMiningProductsAndServicesMember_z5RRPTor4uWb" style="border-bottom: Black 1pt solid; text-align: center">Blockchain Technology and Crypto Mining Products and Services</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_z012aBJmBhnf" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zPtnzf76SN4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">56,549,336</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">11,371,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">67,920,871</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Commissions_zEfu9tTdEQve" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,498,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,498,098</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--MarketExperts_z7Xes4eRDAI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Market experts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,239,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1646">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,239,347</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--CreditCardProcessing_zlYI7Tc9bkvl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Credit card processing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,922</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--SalariesAndWages_zgNMgojWm7g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Salary and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,132,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,178,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,311,248</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--SellingAndMarketingExpense_z8fT9uh3iFD7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">549,776</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,174</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">550,950</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--EnergyAndHosting_zw97lyg8RMvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Energy and hosting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,475,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,475,908</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Depreciation_zSYGhMRog0ma" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,446,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,449,546</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--GainLossOnDispositionOfAssets1_zCib983AeTF4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss (gain) on disposal of assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">201,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_z1MKd0GViy96" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative <span id="xdx_F46_z1RjZhOcOA08">[1]</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">845,457</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">844,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,690,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingIncomeLoss_iT_zWThilVELqA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment income (loss) from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,889,694</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,777,571</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,112,123</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0D_zBVxzbvPe6kh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zc2Tqqh736Cd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.</span></td></tr> </table> <p id="xdx_8A9_zSqQEBFMsnY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_zxQY1fZFdXSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the reconciliation of segment operating income to net income before taxes for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zq4lthF7VtN3">SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_zGhRrmS9j0O7" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_z7XVKWR4yxp2" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--GrossProfit_maILFCOzxbi_zVFJjlJJSaJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Segment income from operations</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,797,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">13,112,123</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Reconciling items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SegmentReportingReconcilingItemBankInterest_iN_di_msILFCOzxbi_zCR5V90S02Qf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Bank interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--SegmentReportingReconcilingItemEventTicketSales_iN_di_msILFCOzxbi_zZ0VoCs8ZLLe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Event ticket sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">350,635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288,454</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--SegmentReportingReconcilingItemLeasingIncome_iN_di_msILFCOzxbi_z2VRIpvg81ug" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Leasing income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">391,985</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">446,667</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentReportingReconcilingItemGainOnWinddownOfOperations_iN_di_msILFCOzxbi_zNZ9jgKUcSBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Gain on winddown of operations <span id="xdx_F44_zt7slO3oAnr6" style="font-family: Times New Roman, Times, Serif">[1]</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1696">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,422</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentReportingReconcilingItemAllOtherNet_iN_di_msILFCOzxbi_z5aW0JpWLFlh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">All other, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,684</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzxbi_zZRRFR9sN1K5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net income before taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,608,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,948,314</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z5Lf5WM9MAre" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zMmU6xexhKXk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents a gain on the winddown of SAFETek’s North American operations.</span></td></tr> </table> <p id="xdx_8AB_zMH1OrHayVIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3 Financial Education and Technology, Blockchain Technology and Crypto Mining Products and Services, and Manufacturing and Development of Health, Beauty and Wellness Products The reportable segments are identified based on the types of products that generate revenue. <p id="xdx_896_eus-gaap--ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_za79FtOp7Stk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zkXHU7s49kAc">SCHEDULE OF SEGMENT REVENUE AND SEGMENT NET INCOME FROM OPERATIONS, INCLUDING SIGNIFICANT EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--FinancialEducationAndTechnologyMember_zvdiZUHGMlZh" style="border-bottom: Black 1pt solid; text-align: center">Financial Education and Technology</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--BlockchainTechnologyAndCryptoMiningProductsAndServicesMember_zvdjYTmwS4xe" style="border-bottom: Black 1pt solid; text-align: center">Blockchain Technology and Crypto Mining Products and Services</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember_zBSnBvZnvRC7" style="border-bottom: Black 1pt solid; text-align: center">Manufacturing and Development of Health, Beauty and Wellness Products <span id="xdx_F5D_zY3cD2kTromh">[1]</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_zJLkPxmrg3q3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zQq9JrW45kth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">47,061,290</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,186,606</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">134,075</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">52,381,971</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--Commissions_z2Wlg5fx49kk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,913,260</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,913,260</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--MarketExperts_zVXQVxeCFKv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Market experts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,065,350</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1581">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,065,350</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--CreditCardProcessing_zI8HzFkt2PDi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Credit card processing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,949,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1586">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1587">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,949,087</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SalariesAndWages_zC7CGQb8NOSd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Salary and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,051,064</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">980,302</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">251,632</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,282,998</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--SellingAndMarketingExpense_zdI4rSf6xxr1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">565,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,803</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">568,240</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--EnergyAndHosting_z4wtsrLCqAOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Energy and hosting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,924,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,924,717</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Depreciation_zxxVrazrvDed" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,565</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,871,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1607">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,873,305</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AssetImpairmentCharges_zlbTI5hEo56h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Impairment expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1610">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,771,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1612">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,771,891</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_zevvSGsHg5K" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Cost of sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--GainLossOnDispositionOfAssets1_z0eUahyiVhS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss (gain) on disposal of assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1620">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,223</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1622">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,223</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_zK9fx6VE1CC7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative <span id="xdx_F42_zT6oVh1Imzg3">[2]</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,491,652</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">391,040</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">116,221</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,998,913</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_iT_zGDORS0Zhypk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment net income (loss) from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,023,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,935,110</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(291,299</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,797,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_zjavtKsDb3H9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zyXlFdbquTkf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Development of Health, Beauty and Wellness Products business was acquired in October 2024.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0E_zhsIQ2qz64If" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z1Quvg8Jr6Ab" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--FinancialEducationAndTechnologyMember_zowTb3RK9vKi" style="border-bottom: Black 1pt solid; text-align: center">Financial Education and Technology</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember__us-gaap--SubsegmentsAxis__custom--BlockchainTechnologyAndCryptoMiningProductsAndServicesMember_z5RRPTor4uWb" style="border-bottom: Black 1pt solid; text-align: center">Blockchain Technology and Crypto Mining Products and Services</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_z012aBJmBhnf" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zPtnzf76SN4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">56,549,336</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">11,371,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">67,920,871</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Commissions_zEfu9tTdEQve" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,498,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,498,098</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--MarketExperts_z7Xes4eRDAI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Market experts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,239,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1646">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,239,347</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--CreditCardProcessing_zlYI7Tc9bkvl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Credit card processing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,922</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--SalariesAndWages_zgNMgojWm7g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Salary and related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,132,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,178,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,311,248</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--SellingAndMarketingExpense_z8fT9uh3iFD7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">549,776</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,174</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">550,950</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--EnergyAndHosting_zw97lyg8RMvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Energy and hosting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,475,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,475,908</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Depreciation_zSYGhMRog0ma" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,446,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,449,546</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--GainLossOnDispositionOfAssets1_zCib983AeTF4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Loss (gain) on disposal of assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">201,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_z1MKd0GViy96" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative <span id="xdx_F46_z1RjZhOcOA08">[1]</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">845,457</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">844,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,690,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingIncomeLoss_iT_zWThilVELqA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment income (loss) from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,889,694</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,777,571</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,112,123</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0D_zBVxzbvPe6kh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zc2Tqqh736Cd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.</span></td></tr> </table> 47061290 5186606 134075 52381971 25913260 25913260 1065350 1065350 1949087 1949087 2051064 980302 251632 3282998 565437 1803 1000 568240 4924717 4924717 1565 3871740 3873305 1771891 1771891 56521 56521 180223 180223 1491652 391040 116221 1998913 14023875 -6935110 -291299 6797466 56549336 11371535 67920871 31498098 31498098 1239347 1239347 2390922 2390922 2132340 1178908 3311248 549776 1174 550950 9475908 9475908 2606 4446940 4449546 1096 201512 202608 845457 844664 1690121 17889694 -4777571 13112123 <p id="xdx_895_eus-gaap--ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_zxQY1fZFdXSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the reconciliation of segment operating income to net income before taxes for the years ended December 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zq4lthF7VtN3">SCHEDULE OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20240101__20241231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_zGhRrmS9j0O7" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231__us-gaap--SubsegmentsConsolidationItemsAxis__us-gaap--ReportableSubsegmentsMember_z7XVKWR4yxp2" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--GrossProfit_maILFCOzxbi_zVFJjlJJSaJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Segment income from operations</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,797,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">13,112,123</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Reconciling items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SegmentReportingReconcilingItemBankInterest_iN_di_msILFCOzxbi_zCR5V90S02Qf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Bank interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--SegmentReportingReconcilingItemEventTicketSales_iN_di_msILFCOzxbi_zZ0VoCs8ZLLe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Event ticket sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">350,635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288,454</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--SegmentReportingReconcilingItemLeasingIncome_iN_di_msILFCOzxbi_z2VRIpvg81ug" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Leasing income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">391,985</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">446,667</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentReportingReconcilingItemGainOnWinddownOfOperations_iN_di_msILFCOzxbi_zNZ9jgKUcSBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Gain on winddown of operations <span id="xdx_F44_zt7slO3oAnr6" style="font-family: Times New Roman, Times, Serif">[1]</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1696">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,422</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentReportingReconcilingItemAllOtherNet_iN_di_msILFCOzxbi_z5aW0JpWLFlh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">All other, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,684</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzxbi_zZRRFR9sN1K5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net income before taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,608,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,948,314</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z5Lf5WM9MAre" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[1]</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zMmU6xexhKXk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents a gain on the winddown of SAFETek’s North American operations.</span></td></tr> </table> 6797466 13112123 -64376 -56258 -350635 -288454 -391985 -446667 -56422 -3684 11500 7608146 13948314 <p id="xdx_806_eus-gaap--BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_zzx8W9W4k3l3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_82A_z1KCV1H4qCrd">ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20241011__srt--OwnershipAxis__custom--GoldmansPharmaceuticalsLLCMember_zy0wRurcc6qh" title="Ownership interest, percentage">100</span>% ownership interest in Goldman’s Pharmaceuticals LLC and a <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20241011__srt--OwnershipAxis__custom--ElrtTechnologiesLLCMember_zf5B0pojNref" title="Ownership interest, percentage">50</span>% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $<span id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_c20241011__20241011__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zEzHkLkDLXtd" title="Purchase price">1,780,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:</span></p> <p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zSO85s833vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zjmXwNmAfwQ3" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20241011_zVY8CSne5UT5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzCpV_zrRpJPX8CAIh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,495</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany_iI_maBCRIAzCpV_zZZtX0uWeupe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,360</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDomainNames_iI_maBCRIAzCpV_zLeaBR7835ig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain names <span id="xdx_F4D_zanavehuSBda">[1]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRawMaterials_iI_maBCRIAzCpV_ziMxlDbcxXg3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,260</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedManufacturingEquipment_iI_maBCRIAzCpV_zvXalu91osQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717,020</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzCpV_maBCRIAzLpw_zx9KR2amlQEj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets acquired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">915,445</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_maBCRIAzGSt_zJb6qk43VFff" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits_iNI_di_msBCRIAzGSt_zPvHWuViqQlb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572,386</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iTI_mtBCRIAzGSt_msBCRIAzLpw_zQP0XwSZfGwj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total liabilities assumed</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572,709</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_mtBCRIAzLpw_z91PJhvXHScd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets acquired</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,736</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_maBCRIAzxCN_zas6ZxWZQ9Ml" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration <span id="xdx_F4F_zLrBTvGkOEde">[2]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,207,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iI_msBCRIAzxCN_zs8Q9OL6aCJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of noncontrolling interest in ELRT Technologies, LLC</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,823</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iTI_mtBCRIAzxCN_z8P6YyYPMdE3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,216,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--Goodwill_iI_z6I4K7CJoPF8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">873,701</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F0F_zFVEl1hs3oel" style="text-align: justify">[1]</td><td style="text-align: justify"> </td><td id="xdx_F18_zAZIpho3c815" style="text-align: justify">Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.</td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: justify"> </td><td style="text-align: justify"> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: justify"><span id="xdx_F04_zMywuZnmwd16" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="text-align: justify; width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_znaQu9WMHpm2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This amount is equal to the $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZBSVIgVkFMVUUgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIEFUIERBVEUgT0YgQUNRVUlTSVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20241011__20241011__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zi9jtghSx4W1">1,780,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase price less $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZBSVIgVkFMVUUgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIEFUIERBVEUgT0YgQUNRVUlTSVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits_iI_c20241011__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zypBPcSMluQl" title="Customer deposits">572,386 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of customer deposits collected by Renu Labs, Inc. prior to acquisition.</span></td> </tr></table> <p id="xdx_8AE_zpA4ucxFOgRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renu Laboratories LLC recorded revenue of $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20240101__20241231__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zKUNDRaRKh35" title="Revenue">110,671</span> and net loss of $<span id="xdx_900_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zXnY81Q26rL8" title="Net loss">291,227</span> since the October 11, 2024 acquisition date, which were included in our consolidated statement of operations for the year ended December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the pro forma revenue and net income (loss) for the years ended December 31, 2023 and 2024, assuming the acquisition had occurred on January 1, 2023, pursuant to ASC Subtopic 805-10-50. This pro forma information does not purport to represent what the actual results of our operations would have been had the acquisition occurred on this date nor does it purport to predict the results of operations for future periods.</span></p> <p id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_ze7m14tKoW4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zCn0xso4uNY9" style="display: none">SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20240101__20241231_zjp2UZ8LREA4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231_zLNWE8PHZqJi" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zHXAjVle7Lke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,327,940</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,534,369</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zP326kk20h4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(325,257</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,736</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20240101__20241231_ztnBBEO5yZA7" title="Loss per common share - Basic"><span id="xdx_906_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_c20240101__20241231_zQ54zTiJtb3k" title="Loss per common share - Diluted">(0.00</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20230101__20231231_zvVjXSEIZwK1" title="Loss per common share - Basic"><span id="xdx_90B_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_c20230101__20231231_zdOGMZUr5Xb9" title="Loss per common share - Diluted">(0.00</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8A5_znZRmulmq9ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> 1 0.50 1780000 <p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zSO85s833vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zjmXwNmAfwQ3" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20241011_zVY8CSne5UT5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzCpV_zrRpJPX8CAIh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,495</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerDepositsIntercompany_iI_maBCRIAzCpV_zZZtX0uWeupe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,360</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDomainNames_iI_maBCRIAzCpV_zLeaBR7835ig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain names <span id="xdx_F4D_zanavehuSBda">[1]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRawMaterials_iI_maBCRIAzCpV_ziMxlDbcxXg3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,260</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedManufacturingEquipment_iI_maBCRIAzCpV_zvXalu91osQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">717,020</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzCpV_maBCRIAzLpw_zx9KR2amlQEj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets acquired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">915,445</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_maBCRIAzGSt_zJb6qk43VFff" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits_iNI_di_msBCRIAzGSt_zPvHWuViqQlb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572,386</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iTI_mtBCRIAzGSt_msBCRIAzLpw_zQP0XwSZfGwj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total liabilities assumed</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572,709</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_mtBCRIAzLpw_z91PJhvXHScd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets acquired</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,736</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_maBCRIAzxCN_zas6ZxWZQ9Ml" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration <span id="xdx_F4F_zLrBTvGkOEde">[2]</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,207,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iI_msBCRIAzxCN_zs8Q9OL6aCJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of noncontrolling interest in ELRT Technologies, LLC</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,823</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iTI_mtBCRIAzxCN_z8P6YyYPMdE3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,216,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--Goodwill_iI_z6I4K7CJoPF8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">873,701</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F0F_zFVEl1hs3oel" style="text-align: justify">[1]</td><td style="text-align: justify"> </td><td id="xdx_F18_zAZIpho3c815" style="text-align: justify">Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.</td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: justify"> </td><td style="text-align: justify"> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: justify"><span id="xdx_F04_zMywuZnmwd16" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[2]</span></td><td style="text-align: justify; width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_znaQu9WMHpm2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This amount is equal to the $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZBSVIgVkFMVUUgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIEFUIERBVEUgT0YgQUNRVUlTSVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20241011__20241011__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zi9jtghSx4W1">1,780,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase price less $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZBSVIgVkFMVUUgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIEFUIERBVEUgT0YgQUNRVUlTSVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCustomerDeposits_iI_c20241011__dei--LegalEntityAxis__custom--RenuLaboratoriesIncMember_zypBPcSMluQl" title="Customer deposits">572,386 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of customer deposits collected by Renu Labs, Inc. prior to acquisition.</span></td> </tr></table> 1495 7360 40310 149260 717020 915445 323 -572386 572709 342736 1207614 8823 1216437 873701 1780000 572386 110671 291227 <p id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_ze7m14tKoW4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zCn0xso4uNY9" style="display: none">SCHEDULE OF PROFORMA REVENUE AND NET INCOME LOSS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20240101__20241231_zjp2UZ8LREA4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231_zLNWE8PHZqJi" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zHXAjVle7Lke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,327,940</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,534,369</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zP326kk20h4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(325,257</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,736</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20240101__20241231_ztnBBEO5yZA7" title="Loss per common share - Basic"><span id="xdx_906_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_c20240101__20241231_zQ54zTiJtb3k" title="Loss per common share - Diluted">(0.00</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20230101__20231231_zvVjXSEIZwK1" title="Loss per common share - Basic"><span id="xdx_90B_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_c20230101__20231231_zdOGMZUr5Xb9" title="Loss per common share - Diluted">(0.00</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 1327940 1534369 -325257 -43736 -0.00 -0.00 -0.00 -0.00 <p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zPRubTMltphj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_820_zSi42kgfx1l3">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company used an effective tax rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_c20240101__20241231_z4qDrVhn3IT1" title="Effective tax rate">21</span>% when calculating the deferred tax assets and liabilities and income tax provision below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zcVP3tieCmcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s income (loss) before income taxes were broken down as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_ztRD9Md7jGs1" style="display: none">SCHEDULE OF INCOME BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20240101__20241231_zRWdELqbL1Kl" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_z8D1KX9uXjaf" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzkaU_zv5wpZQS9Qjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,085,356</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzkaU_zEcmENQvs1la" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzkaU_zVom4Vzx3bNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Income (loss) before income taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,085,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,332</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zlOxCZKT2Gpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zm9SmTphsb3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s tax provision (benefit) as of December 31, 2024 and 2023 is summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zSOabbLh65r5" style="display: none">SCHEDULE OF TAX PROVISION BENEFIT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20240101__20241231_z8Z824zM0uB2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_zTepxjiheRy6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalTaxExpenseBenefit_maCITEBzjfw_zpLkyppy6Yoh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">903,347</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,138,412</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzjfw_zVM6rNqPg577" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,407</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CurrentForeignTaxExpenseBenefit_maCITEBzjfw_zajvXU0qav37" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1793">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_mtCITEBzjfw_zqRc2rhjFQW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_zwy29mlZ0Ll8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zAuO2vH8T2V7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zxTo6AZ7rSCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets consist of the following components as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zoxo9Z3dC3Tb" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20241231_zJGH8sXN6vq" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231_zvZVlNSlyIQl" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOL carryover</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,417,161</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,982,071</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsAmortization_iI_pp0p0_zvg0zt2Qzc4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,850,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,771,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_zOra3KeDfNwc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,988,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,800,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">862,384</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">562,982</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership_iI_pp0p0_zxBADV0DEavc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in partnership</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,985,183</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,964,704</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxLiabilities_iI_pp0p0_zS4IKMzEG0Nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zFM8iJazCNBe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,104,216</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,082,064</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pp0p0_di_zXxm0FhPCLe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_z6c8X8RHRSI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the year ended December 31, 2024 and 2023, due to the following:</span></p> <p id="xdx_897_ecustom--ScheduleOfIncomeFromContinuingOperationsTableTextBlock_zcqwrOU2uJbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zHquXVdJkVS7" style="display: none">SCHEDULE OF INCOME FROM CONTINUING OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240101__20241231_zo69F9bgJPd1" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zbeVWYufDa61" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBz9Ly_z5GtYvuvLgm4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes at statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,052,169</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBz9Ly_zYNHipJj3rP" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State taxes – net of federal benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,641</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBz9Ly_zGeYpmyduDHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">581,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,809,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiAmount_iN_di_msITEBz9Ly_ztRHyPcMZqw7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign derived intangible income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(420,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(781,561</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_ecustom--IncomeTaxReconciliationInterest_maITEBz9Ly_zdvC04yw4I8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,511</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBz9Ly_zqv0wUqNQ6n9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,378</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(193,878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz9Ly_zNctISlG1yEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax provision (benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zIna7ik27SQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2024 AND 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231_zIHEbIGE4P02" title="Net operating loss carryforwards">2.4</span> million (tax effected) and $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231_zxWnmfJAKoF2" title="Net operating loss carryforwards">3.0</span> million (tax effected), portions of which will begin to expire in 2025. Utilization of some of the federal and state net operating losses carryforwards are subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will recognize penalties and interest accrued related to unrecognized tax benefits as a component of income taxes. As of December 31, 2024, the Company had $<span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_c20241231_zgJxugrSjNuf" title="Income tax accrued interest and penalties">18,764</span> of accrued interest and penalties related to state income tax uncertain tax positions, in which $<span id="xdx_90F_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c20240101__20241231_zozNL9yUlNf1" title="Unrecognized tax benefits">4,144</span> has been recognized in the Company’s statements of operations in the current year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is required to file income tax returns in various States. The Company is subject to income tax examinations by federal and state taxing authorities. The taxable years that are open under federal and state statute of limitations are 2020 through 2024. Due to net operating loss carryforwards that remain unutilized, such loss carryforwards remain subject to review until utilized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zA4YlawNbrMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zhqcFCAPds05" style="display: none">SCHEDULE OF UNRECOGNIZED TAX BENEFITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20240101__20241231_zDG3z8M9x2sa" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>December 31, 2024</p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zDoQ3aGHZyhd" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>December 31, 2023</p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--UnrecognizedTaxBenefits_iS_zfRCaXBJCle1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at the beginning of the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_zwsKOlLuUUX4" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increases related to positions taken in prior years</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,768</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <span style="-sec-ix-hidden: xdx2ixbrl1864">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--UnrecognizedTaxBenefits_iE_zh1xefURjQPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at the end of the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,768</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1867">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zoMpZxxfu7Tj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.21 <p id="xdx_895_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zcVP3tieCmcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s income (loss) before income taxes were broken down as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_ztRD9Md7jGs1" style="display: none">SCHEDULE OF INCOME BEFORE INCOME TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20240101__20241231_zRWdELqbL1Kl" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_z8D1KX9uXjaf" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzkaU_zv5wpZQS9Qjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,085,356</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzkaU_zEcmENQvs1la" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzkaU_zVom4Vzx3bNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Income (loss) before income taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,085,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,332</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2085356 5010332 2085356 5010332 <p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zm9SmTphsb3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s tax provision (benefit) as of December 31, 2024 and 2023 is summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zSOabbLh65r5" style="display: none">SCHEDULE OF TAX PROVISION BENEFIT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20240101__20241231_z8Z824zM0uB2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_zTepxjiheRy6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalTaxExpenseBenefit_maCITEBzjfw_zpLkyppy6Yoh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">903,347</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,138,412</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzjfw_zVM6rNqPg577" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,407</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CurrentForeignTaxExpenseBenefit_maCITEBzjfw_zajvXU0qav37" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1793">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_mtCITEBzjfw_zqRc2rhjFQW8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_zwy29mlZ0Ll8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 903347 2138412 -8407 40000 894940 2178412 894940 2178412 <p id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zxTo6AZ7rSCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets consist of the following components as of December 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zoxo9Z3dC3Tb" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20241231_zJGH8sXN6vq" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231_zvZVlNSlyIQl" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOL carryover</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,417,161</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,982,071</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsAmortization_iI_pp0p0_zvg0zt2Qzc4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,850,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,771,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_zOra3KeDfNwc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,988,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,800,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">862,384</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">562,982</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership_iI_pp0p0_zxBADV0DEavc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in partnership</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,985,183</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,964,704</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxLiabilities_iI_pp0p0_zS4IKMzEG0Nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zFM8iJazCNBe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,104,216</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,082,064</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pp0p0_di_zXxm0FhPCLe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2417161 2982071 1850667 1771645 1988821 1800662 862384 562982 10985183 10964704 18104216 18082064 <p id="xdx_897_ecustom--ScheduleOfIncomeFromContinuingOperationsTableTextBlock_zcqwrOU2uJbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zHquXVdJkVS7" style="display: none">SCHEDULE OF INCOME FROM CONTINUING OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240101__20241231_zo69F9bgJPd1" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zbeVWYufDa61" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBz9Ly_z5GtYvuvLgm4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes at statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,052,169</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBz9Ly_zYNHipJj3rP" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State taxes – net of federal benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,641</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBz9Ly_zGeYpmyduDHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">581,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,809,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiAmount_iN_di_msITEBz9Ly_ztRHyPcMZqw7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign derived intangible income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(420,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(781,561</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_ecustom--IncomeTaxReconciliationInterest_maITEBz9Ly_zdvC04yw4I8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,511</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBz9Ly_zqv0wUqNQ6n9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,378</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(193,878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz9Ly_zNctISlG1yEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax provision (benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">894,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,412</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 437925 1052169 -6641 31600 581800 1809765 420033 781561 260511 260317 41378 -193878 894940 2178412 2400000 3000000.0 18764 4144 <p id="xdx_894_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zA4YlawNbrMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zhqcFCAPds05" style="display: none">SCHEDULE OF UNRECOGNIZED TAX BENEFITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20240101__20241231_zDG3z8M9x2sa" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>December 31, 2024</p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zDoQ3aGHZyhd" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>December 31, 2023</p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--UnrecognizedTaxBenefits_iS_zfRCaXBJCle1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at the beginning of the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_zwsKOlLuUUX4" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increases related to positions taken in prior years</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,768</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <span style="-sec-ix-hidden: xdx2ixbrl1864">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--UnrecognizedTaxBenefits_iE_zh1xefURjQPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at the end of the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,768</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1867">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 26768 26768 <p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zyqEC4dYnyA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_823_zQQSqq3asKr1">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”), approved by the disinterested members of the Company’s Board of Directors. Pursuant to the Amendment, DBR has been given until August 31,2025 to lend to the Company a minimum of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zOCKOrJHF2li" title="Debt amount">2.0</span> million, and until December 31, 2026 to lend to the Company the balance of up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_zXjqOjKzlqy1" title="Debt amount">5.7</span> million. The Amendment also substantially reduces the interest rate for the first $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ConsolidatedEntitiesAxis__custom--DBRCapitalMember_zmS7LtqRNmT8" title="Debt amount">2</span> million that may be advanced by DBR Capital from <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ConsolidatedEntitiesAxis__custom--DBRCapitalMember_z2wJiGxdEfFg" title="Debt instrument interest rate">38.5</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ConsolidatedEntitiesAxis__custom--DBRCapitalMember_ztSHM7y3B9Nk" title="Debt instrument, reduced interest rate">18.75</span>% per annum, and further substantially reduces the interest rate to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9cs2z8Zt467" title="Debt instrument, reduced interest rate">10</span>% per annum (also from <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVQlNFUVVFTlQgRVZFTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbrBkbrtR1j1" title="Debt instrument interest rate">38.5</span>%) for any amounts loaned in excess of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20250228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzppFbwVg776" title="Debt amount">2</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $<span id="xdx_903_eus-gaap--PaymentsForRepurchaseOfCommonStock_c20250306__20250306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_z7U6wjD9MaRe" title="Repurchase of common stock, value">1,000,000</span> in aggregate value of shares of the Company’s common stock, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_zgox0em6KPL6" title="Common stock, par value">0.001</span> per share, through March 6, 2026. As of the date of this filing, <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20250306__20250306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_zACD8LJLcue9" title="Number of shares repurchased">705,890</span> shares have been repurchased for $<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_c20250306__20250306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_z3NS160tMeG3" title="Number of shares repurchased, value">16,618</span>. These shares are being held by the Company in Treasury.</span></p> 2000000.0 5700000 2000000 0.385 0.1875 0.10 0.385 2000000 1000000 0.001 705890 16618 We have recently had to pursue collection efforts through litigation against one of our credit card processors and its clearing bank, as efforts to collect approximately $1.87 million of our credit card receivables has not proven timely. See “NOTE 10-Commitments and Contingencies.” On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $130,285 of the debt discount into interest expense, as well as expensed an additional $260,016 of interest expense on the note, all of which was repaid during the period. On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the year ended December 31, 2024, we recognized $70,738 of the debt discount into interest expense as well as expensed an additional $140,000 of interest expense on the note, all of which was repaid during the period. On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the year ended December 31, 2024, we recognized $137,670 of the debt discount into interest expense as well as expensed an additional $500,500 of interest expense on the note, all of which was repaid during the period. On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the year ended December 31, 2024 and 2023, we recorded interest expense of $1,320 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the years ended December 31, 2024 and 2023, we recorded $18,801 and $18,750 worth of interest on the loan, respectively. During the years ended December 31, 2024 and 2023, we made repayments on the loan of $29,244 and $31,681. In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000 shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing cryptocurrency. The remaining notes are all due December 31, 2024, and have a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments began the last day of January 2021 and continue until December 31, 2024, when the last monthly payment will be made, along with a balloon payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered all note holders an early payoff option. During the year ended December 31, 2024, we repaid a portion of the debt with cash payments of $411,842 and issuances of cryptocurrency then valued at $274,041. As of December 31, 2024, the debt was paid in full. Represents lease payments to be made in the next 12 months. The Development of Health, Beauty and Wellness Products business was acquired in October 2024. General and administrative costs consist mainly of professional fees, insurance, information technology and software and other payment processing fees. General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software. Represents a gain on the winddown of SAFETek’s North American operations. Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy. This amount is equal to the $1,780,000

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